8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  May 23, 2012

COMMUNITY HEALTH SYSTEMS, INC.

(Exact name of registrant as specified in its charter)

Delaware	001-15925	13-3893191
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

4000 Meridian Boulevard

Franklin, Tennessee 37067

(Address of principal executive offices)

Registrant’s telephone number, including area code:  (615) 465-7000

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01. Other Events.

This Current Report on Form 8-K is being filed to revise the presentation of certain items included in the audited consolidated financial statements of Community Health Systems, Inc. (“the Company”), which were included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2011, as originally filed with the Securities and Exchange Commission (“SEC”) on February 23, 2012 (the “Form 10-K”). This revised presentation is specifically related to the presentation of the provision for bad debts in the consolidated statements of income, the addition of the consolidated statements of comprehensive income, and the related notes thereto, in each case for periods prior to January 1, 2012, to reflect the adoption on January 1, 2012 of the following Accounting Standards Updates (“ASU”) of the Financial Accounting Standards Board:

(i)    ASU 2011-07, which requires healthcare organizations that perform services for patients for which the ultimate collection of all or a portion of the amounts billed or billable cannot be determined at the time services are rendered to present all bad debt expense associated with such patient service revenue as an offset to the patient service revenue line item in the statement of operations, and

(ii)    ASU 2011-05, as amended by ASU 2011-12, which requires the presentation of the components of other comprehensive income be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements.

The information in this Current Report on Form 8-K is not an amendment to or restatement of the Form 10-K. The following Items of the Form 10-K have been presented to retrospectively reflect the adoption of the ASUs as discussed above, and are attached as Exhibit 99.1 to this Form 8-K:

• Part I, Item 1. Business

• Part I, Item 1A. Risk Factors

• Part II, Item 6. Selected Financial Data

• Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

• Part II, Item 8. Financial Statements and Supplementary Data

• Part IV, Item 15. Exhibits and Financial Statement Schedules.

Other than as specified above in the adoption of these new accounting standards, this Form 8-K does not modify, update or affect any other disclosures or financial statements set forth in the Form 10-K. Furthermore, this Current Report on Form 8-K does not purport to provide a general update or discussion of any developments of the Company subsequent to the filing of the Form 10-K. Accordingly, the Form 10-K with the revised presentation reflected in the consolidated financial statements and related notes included in this Current Report on Form 8-K, should be read in conjunction with the Company’s filings made with the SEC subsequent to the date of the Form 10-K.

Item 9.01. Financial Statements and Exhibits.

The following items are included as Exhibits to this report and incorporated herein by reference:

EXHIBIT NO.	DESCRIPTION OF EXHIBIT
23.1	Consent of Deloitte & Touche LLP*
99.1	Certain adjusted Items from Form 10-K for the fiscal year ended December 31, 2011, previously filed with the SEC on February 23, 2012*
101.INS	XBRL Instance Document**
101.SCH	XBRL Taxonomy Extension Schema**
101.CAL	XBRL Taxonomy Extension Calculation Linkbase**
101.DEF	XBRL Taxonomy Extension Definition Linkbase**
101.LAB	XBRL Taxonomy Extension Label Linkbase**
101.PRE	XBRL Taxonomy Extension Presentation Linkbase**

* Filed herewith.

** Pursuant to applicable securities laws and regulations, we are deemed to have complied with the reporting obligation relating to the submission of interactive data files in such exhibits and are not subject to liability under any anti-fraud provisions of the federal securities laws as long as we have made a good faith attempt to comply with the submission requirements and promptly amend the interactive data files after becoming aware that the interactive data files fail to comply with the submission requirements. Users of this data are advised pursuant to Rule 406T of Regulation S-T that this interactive data file is deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

	COMMUNITY HEALTH SYSTEMS, INC.
Date: May 23, 2012	By:	/s/ Wayne T. Smith
		Wayne T. Smith
		Chairman of the Board, President and Chief Executive Officer (principal executive officer)
	By:	/s/ W. Larry Cash
		W. Larry Cash
		Executive Vice President, Chief Financial Officer and Director (principal financial officer)
	By:	/s/ Kevin J. Hammons
		Kevin J. Hammons
		Vice President and Chief Accounting Officer (principal financial officer)

EXHIBIT INDEX

EXHIBIT NO.	DESCRIPTION OF EXHIBIT
23.1	Consent of Deloitte & Touche LLP*
99.1	Certain adjusted Items from Form 10-K for the fiscal year ended December 31, 2011, previously filed with the SEC on February 23, 2012*
101.INS	XBRL Instance Document**
101.SCH	XBRL Taxonomy Extension Schema**
101.CAL	XBRL Taxonomy Extension Calculation Linkbase**
101.DEF	XBRL Taxonomy Extension Definition Linkbase**
101.LAB	XBRL Taxonomy Extension Label Linkbase**
101.PRE	XBRL Taxonomy Extension Presentation Linkbase**

* Filed herewith.

** Pursuant to applicable securities laws and regulations, we are deemed to have complied with the reporting obligation relating to the submission of interactive data files in such exhibits and are not subject to liability under any anti-fraud provisions of the federal securities laws as long as we have made a good faith attempt to comply with the submission requirements and promptly amend the interactive data files after becoming aware that the interactive data files fail to comply with the submission requirements. Users of this data are advised pursuant to Rule 406T of Regulation S-T that this interactive data file is deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.

EX-23.1

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement No. 333-156405 on Form S-3 and Registration Nos. 333-44870, 333-61614, 333-100349, 333-107810, 333-121282, 333-121283, 333-144525, 333-163688, 333-163689, 333-163690, 333-163691 and 333-176893 on Form S-8 of our report dated February 22, 2012 (May 23, 2012, as to the adoption of Accounting Standards Updates (“ASU”) No. 2011-07, Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Healthcare Entities and ASU No. 2011-05, Presentation of Comprehensive Income as described in Note 1), relating to the consolidated financial statements of Community Health Systems, Inc. and subsidiaries (the “Company”) (which report expresses an unqualified opinion and includes an explanatory paragraph referring to the Company adopting ASU 2011-07 and ASU 2011-05), appearing in the current report on Form 8-K.

/s/ Deloitte & Touche LLP

Nashville, Tennessee

May 23, 2012

EX-99.1

Exhibit 99.1

TABLE OF CONTENTS

FORM 10-K ANNUAL REPORT

COMMUNITY HEALTH SYSTEMS, INC.

Year ended December 31, 2011

		Page
	PART I
Item 1.	Business		1
Item 1A.	Risk Factors		24
	PART II
Item 6.	Selected Financial Data		33
Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		34
Item 8.	Financial Statements and Supplementary Data		60
	PART IV
Item 15.	Exhibits and Financial Statement Schedules		124

PART I

Item 1. Business of Community Health Systems, Inc.

Overview of Our Company

We are one of the largest publicly-traded operators of hospitals in the United States in terms of number of facilities and net operating revenues. We were originally founded in 1986 and were reincorporated in 1996 as a Delaware corporation. We provide healthcare services through the hospitals that we own and operate in non-urban and selected urban markets throughout the United States. As of December 31, 2011, we owned or leased 131 hospitals, including four stand-alone rehabilitation or psychiatric hospitals. These hospitals are geographically diversified across 29 states, with an aggregate of 19,695 licensed beds. We generate revenues by providing a broad range of general and specialized hospital healthcare services to patients in the communities in which we are located. Services provided by our hospitals include general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric and rehabilitation services. As an integral part of providing these services, we also employ approximately 2,000 physicians and an additional 500 licensed healthcare practitioners, and provide additional outpatient services at urgent care centers, occupational medicine clinics, imaging centers, cancer centers, ambulatory surgery centers and home health and hospice agencies. Through our management and operation of these businesses, we provide standardization and centralization of operations across key business areas; strategic assistance to expand and improve services and facilities; implementation of patient safety and quality of care improvement programs; and assistance in the recruitment of additional physicians and licensed healthcare practitioners to the markets in which our hospitals are located. In a number of our markets, we have partnered with local physicians or not-for-profit providers, or both, in the ownership of our facilities. In addition to our hospitals and related businesses, we also own and operate 63 licensed home care agencies and 30 licensed hospice agencies, located primarily in markets where we also operate a hospital. Also, through our wholly-owned subsidiary, Quorum Health Resources, LLC, or QHR, we provide management and consulting services to non-affiliated general acute care hospitals located throughout the United States. The home care agencies and the hospital management services businesses constitute operating segments, but are not considered reportable segments since they do not meet the quantitative thresholds for a separate identifiable reportable segment. The financial information for our reportable operating segments is presented in Note 14 of the Notes to our Consolidated Financial Statements included under Item 8 of this Report.

Our strategy has also included growth by acquisition. We generally target hospitals in growing, non-urban and selected urban healthcare markets for acquisition because of their favorable demographic and economic trends and competitive conditions. Because non-urban service areas have smaller populations, there are generally fewer hospitals and other healthcare service providers in these communities and generally a lower level of managed care presence in these markets. We believe that smaller populations support less direct competition for hospital-based services and these communities generally view the local hospital as an integral part of the community. We believe opportunities exist for skilled, disciplined operators in selected urban markets to create networks between urban hospitals and non-urban hospitals while improving physician alignment in those markets and making it more attractive to managed care.

Throughout this Form 10-K, we refer to Community Health Systems, Inc., or the Parent Company, and its consolidated subsidiaries in a simplified manner and on a collective basis, using words like “we” and “our.” This drafting style is suggested by the Securities and Exchange Commission, or SEC, and is not meant to indicate that the publicly-traded Parent Company or any other subsidiary of the Parent Company owns or operates any asset, business or property. The hospitals, operations and businesses described in this filing are owned and operated, and management services provided, by distinct and indirect subsidiaries of Community Health Systems, Inc.

Available Information

Our website address is www.chs.net and the investor relations section of our website is located at www.chs.net/investor/index.html. We make available free of charge, through the investor relations section of our website, annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K as well as amendments to those reports, as soon as reasonably practical after they are filed with the SEC. Our filings are also available to the public at the website maintained by the SEC, www.sec.gov.

1

We also make available free of charge, through the investor relations section of our website, our Governance Principles, our Code of Conduct and the charters of our Audit and Compliance Committee, Compensation Committee and Governance and Nominating Committee.

We have included the Chief Executive Officer and the Chief Financial Officer certifications regarding the public disclosure required by Sections 302 and 906 of the Sarbanes-Oxley Act of 2002 as Exhibits 31.1, 31.2, 32.1 and 32.2 of this report.

Our Business Strategy

With the objective of increasing shareholder value and improving care, the key elements of our business strategy are to:

• increase revenue at our facilities,

• improve profitability,

• improve patient safety and quality of care and

• grow through selective acquisitions.

Increase Revenue at Our Facilities

Overview. We seek to increase revenue at our facilities by providing a broader range of services in a more attractive care setting, as well as by supporting and recruiting physicians. We identify the healthcare needs of the community by analyzing demographic data and patient referral trends. We also work with local hospital boards, management teams and medical staffs to determine the number and type of additional physician specialties needed. Our initiatives to increase revenue include:

• recruiting and/or employing additional primary care physicians and specialists,

• expanding the breadth of services offered at our hospitals and in the communities in which we operate through targeted capital expenditures and physician alignment to support the addition of more complex services, including orthopedics, cardiovascular services and urology and

• providing the capital to invest in technology and the physical plant at our facilities, particularly in our emergency rooms, surgery departments, critical care departments and diagnostic services.

We believe that appropriate capital investments in our facilities, combined with the development of our service capabilities, will reduce the migration of patients to competing providers while providing an attractive return on investment.

Our industry is highly regulated by the government and other third parties who provide payment for the services we provide to patients. Accordingly, we seek to review all initiatives to increase revenue through our corporate-wide voluntary compliance program in an effort to ensure compliance with laws and regulation.

Physician Recruiting. The primary method of adding or expanding medical services is the recruitment of new physicians into the community. A core group of primary care physicians is necessary as an initial contact point for all local healthcare. The addition of specialists who offer services, including general surgery, obstetrics and gynecology, cardiovascular services, orthopedics and urology, completes the full range of medical and surgical services required to meet a community’s core healthcare needs. At the time we acquire a hospital and from time to time thereafter, we identify the healthcare needs of the community by analyzing demographic data and patient referral trends. As a result of this analysis, we are able to determine what we believe to be the optimum mix of primary care physicians and specialists. We employ recruiters at the corporate level to support the local hospital managers in their recruitment efforts. We have increased the number of physicians affiliated with us through our

2

recruiting efforts, net of turnover, by approximately 869 in 2011, 935 in 2010 and 772 in 2009. The percentage of recruited or other physicians commencing practice with us that were specialists was over 50% in 2011. Additionally, in response to the recent trend in physicians seeking employment, we have begun employing more physicians, including, in some instances, acquiring physician practices. However, most of the physicians in our communities remain in private practice and are not our employees. We believe we have been successful in recruiting physicians because of the practice opportunities afforded physicians in our markets, as well as lower managed care penetration as compared to larger urban areas.

Emergency Room Initiatives. Approximately 60% of our patients initiate their encounter with our hospitals through the emergency room. Accordingly, we believe that making sure that this experience is as satisfying and efficient for the patient as it reasonably can be, but at the same time seeking to ensure that a safe and high quality service is provided to each patient, will in turn result in an optimized revenue stream and provide growth in services performed by our hospitals. We take numerous steps to seek to achieve these intertwined objectives, including:

• Improving safety, service, satisfaction and waiting times – initiatives include rounding on patients while in the emergency room, applying quality monitoring tools in evaluating the care provided, implementing a five-level triage system and fast-tracking patients with non-emergency conditions, post-discharge calls to patients and monitoring practitioner utilization rates and practices,

• Raise community awareness of the services offered and the efforts to improve service and quality through marketing campaigns and

• Improving patient flow by renovating and expanding our emergency room facilities – 13 such projects have been undertaken in the past three years, including four in 2011.

One of our emergency room initiatives that spans our efforts across all three of these areas is the use of specialized emergency room information management software. Such software is designed to collect information to monitor the patients’ experience and care provided; assist nurses, physicians and other clinicians in communicating with each other about the clinical condition of the patients and provide consistent discharge instructions to patients. We believe that these information management systems enable our hospitals and their medical staffs to also monitor and seek to improve aggregate performance and patient outcomes. In addition, these information management systems are integral to our efforts to achieve “meaningful use” of electronic health records and qualify for and retain payments under the Health Information Technology for Economic and Clinical Health Act, or HITECH Act.

Expansion of Services. In an effort to better meet the healthcare needs of the communities we serve and to capture a greater portion of the healthcare spending in our markets, we have added a broad range of services to our facilities and, in certain markets, acquired physician practices to broaden our service offerings. These services range from various types of diagnostic equipment capabilities to additional and renovated emergency rooms, surgical and critical care suites and specialty services. For example, we spent approximately $203.7 million on 48 major construction projects that were completed in 2011. The 2011 projects included new emergency rooms, cardiac cathertization laboratories, intensive care units, hospital additions and surgical suites. These projects improved various diagnostic and other inpatient and outpatient service capabilities. We continue to believe that appropriate capital investments in our facilities, combined with the development of our service capabilities, will reduce the migration of patients to competing providers while providing an attractive return on investment. We also employ a small group of clinical consultants at our corporate headquarters to assist the hospitals in their development of surgery, emergency, critical care, cardiovascular and hospitalist services. In addition to spending capital on expanding services at our existing hospitals, we also build replacement facilities in certain markets to better meet the healthcare needs in those communities. In 2011, we spent $162.9 million on construction projects related to three replacement hospitals that we are required to build pursuant to either a hospital purchase agreement or an amendment to a lease agreement. In addition, in September 2010, we received approval of our request for a certificate of need, or CON, from the Alabama Certificate of Need Review Board for the construction of a replacement hospital in Birmingham, Alabama. This CON remains subject to an appeal process. The total cost of these four replacement hospitals is estimated to be $597.2 million.

3

Managed Care Strategy. Managed care has seen growth across the U.S. as health plans expand service areas and membership in an attempt to control rising medical costs. As we service primarily non-urban markets, we do not have significant relationships with individual managed care organizations, including Medicare Advantage. We have responded with a proactive and carefully considered strategy developed specifically for each of our facilities. Our experienced corporate managed care department reviews and approves all managed care contracts, which are organized and monitored using a central database. The primary mission of this department is to select and evaluate appropriate managed care opportunities, manage existing reimbursement arrangements and negotiate increases. Generally, we do not intend to enter into capitated or risk sharing contracts. However, some purchased hospitals have risk sharing contracts at the time we acquire them. We seek to discontinue these contracts to eliminate risk retention related to payment for patient care. We do not believe that we have, at the present time, any risk sharing contracts that would have a material impact on our results of operations.

Improve Profitability

Overview. To improve efficiencies and increase operating margins, we implement cost containment programs and adhere to operating philosophies that include:

• standardizing and centralizing our methods of operation and management,

• improving patient safety and optimizing resource allocation through our case and resource management program, which assists in improving clinical care and containing costs,

• monitoring and enhancing productivity of our human resources,

• capitalizing on purchasing efficiencies through the use of company-wide standardized purchasing contracts and terminating or renegotiating specified vendor contracts and

• installing a standardized management information system, resulting in more streamlined clinical operations and more efficient billing and collection procedures.

In addition, each of our hospital management teams is supported by our centralized operational, reimbursement, regulatory and compliance expertise, as well as by our senior management team, a seasoned group of executives with an average of over 25 years of experience in the healthcare industry.

Standardization and Centralization. Our standardization and centralization initiatives encompass nearly every aspect of our business, from developing standard policies and procedures with respect to patient accounting and physician practice management to implementing standard processes to initiate, evaluate and complete construction projects. Our standardization and centralization initiatives are a key element in improving our operating results.

• Billing and Collections. We have adopted standard policies and procedures with respect to billing and collections. We have also automated and standardized various components of the collection cycle, including statement and collection letters and the movement of accounts through the collection cycle. Upon completion of an acquisition, our management information systems team converts the hospital’s existing information system to our standardized system. This enables us to quickly implement our business controls and cost containment initiatives.

• Physician Support. We support our newly recruited physicians to enhance their transition into our communities. All newly recruited physicians who enter into contracts with us are required to attend a three-day introductory seminar that covers issues involved in starting up a practice. We have also implemented physician practice management seminars, webinars and other training. We host these seminars monthly.

• Procurement and Materials Management. We have standardized and centralized our operations with respect to medical supplies, equipment and pharmaceuticals used in our hospitals. We have a participation agreement with HealthTrust Purchasing Group, L.P., or HealthTrust, a group purchasing organization, or GPO. HealthTrust contracts with certain vendors who supply a substantial portion of our medical supplies, equipment and pharmaceuticals. Our agreement with HealthTrust extends to January 2013, with automatic renewal terms of one year unless either party terminates by giving notice of non-renewal.

4

• Facilities Management. We have standardized interiors, lighting and furniture programs. We have also implemented a standard process to initiate, evaluate and complete construction projects. Our corporate staff monitors all construction projects, and reviews and pays all construction project invoices. Our initiatives in this area have reduced our construction costs while maintaining the same level of quality and have shortened the time it takes us to complete these projects.

• Other Initiatives. We have also improved margins by implementing standard programs with respect to ancillary services in areas, including emergency rooms, pharmacy, laboratory, imaging, home care, skilled nursing, centralized outpatient scheduling and health information management. We have improved quality and reduced costs associated with these services by improving contract terms and standardizing information systems. We work to identify and communicate best practices and monitor these improvements throughout the Company.

• Internal Controls Over Financial Reporting. We have centralized many of our significant internal controls over financial reporting and standardized those other controls that are performed at our hospital locations. We continuously monitor compliance with and evaluate the effectiveness of our internal controls over financial reporting.

Case and Resource Management. The primary goal of our case management program is to ensure the delivery of safe, high quality care in an efficient and cost effective manner. The program focuses on:

• appropriate management of length of stay consistent with national standards and benchmarks;

• reducing unnecessary utilization;

• discharge planning;

• developing and implementing operational best practices; and

• compliance with all regulatory standards.

Our case management program integrates the functions of utilization review, discharge planning, assessment of medical necessity and resource management. Patients are assessed upon presentation to the hospital with ongoing reviews throughout their course of care. Industry standard criteria are utilized in patient assessments, and discharge plans are adjusted according to patient needs. Cases are monitored to prevent delays in service or unnecessary utilization of resources. When a patient is ready for discharge, a case manager works with the patient’s attending physician to evaluate and coordinate the patient’s needs for continued care in the post-acute setting. Each hospital has the support of a physician advisor to act as a liaison to the medical staff and assist with all the activities of the program.

Improve Patient Safety and Quality of Care

Each of our hospitals has a board of trustees, which includes members of the hospital’s medical staff. The board of trustees establishes policies concerning the hospital’s medical, professional, and ethical practices, monitors these practices, and is responsible for ensuring that these practices conform to legally required standards. We maintain quality assurance programs to support and monitor quality of care standards and to meet Medicare and Medicaid accreditation and regulatory requirements. Patient care evaluations and other quality of care assessment activities are reviewed and monitored continuously.

We have implemented various programs to support our hospitals in an effort to ensure continuous improvement in patient safety and the quality of care provided. We have developed training programs for all senior hospital management, chief nursing officers, quality directors, physicians and other clinical staff. We share information among our hospital management to implement best practices and assist in complying with regulatory requirements.

5

We have standardized our process for documenting compliance with accreditation requirements. All hospitals conduct patient, physician and staff satisfaction surveys to help identify methods of improving patient safety and the quality of care.

To ensure the experience of our emergency room patients meets our service and quality expectations, we have implemented a program to contact selected patients as a follow-up to the services they received. We verify that patients were able to obtain any prescriptions and outpatient appointments recommended at discharge. We also ensure that their symptoms have abated and that they understood the discharge instructions given at the hospital. Through this program, we placed in excess of one million follow-up calls in 2011.

In 2011, we established a component patient safety organization, or PSO, which was listed by the U.S. Department of Health and Human Services Agency for Healthcare Research and Quality on January 11, 2012. We believe we are the first for-profit hospital company to form a component PSO and that it will assist us in improving patient safety at our hospitals.

Grow Through Selective Acquisitions

Acquisition Criteria. Each year we intend to acquire, on a selective basis, approximately two to four hospitals that fit our acquisition criteria. Generally, we pursue acquisition candidates that:

• have a service area population between 20,000 and 400,000 with a stable or growing population base,

• are the sole or primary provider of acute care services in the community,

• are located in an area with the potential for service expansion,

• are not located in an area that is dependent upon a single employer or industry and

• have financial performance that we believe will benefit from our management’s operating skills.

Occasionally, we have pursued acquisition opportunities outside of our specified criteria when such opportunities have had uniquely favorable characteristics. In addition, in recent years, we have been successful in acquiring a few multi-hospital systems. In 2009, we acquired a total of three hospitals-two hospitals located in Wilkes-Barre, Pennsylvania and one hospital in Siloam Springs, Arkansas-and purchased the remaining equity in a hospital located in El Dorado, Arkansas in which we previously had a noncontrolling interest. In 2010, we acquired five hospitals located in Marion, South Carolina; Youngstown, Ohio; Warren, Ohio and Bluefield, West Virginia and in 2011, we acquired four hospitals located in Scranton, Pennsylvania; Tunkhannock, Pennsylvania; Nanticoke, Pennsylvania and Tomball, Texas. We believe that our access to capital, reputation for providing quality care and ability to recruit physicians makes us an attractive partner for these communities.

Disciplined Acquisition Approach. We believe that we have been disciplined in our approach to acquisitions. We have a dedicated team of internal and external professionals who complete a thorough review of the hospital’s financial and operating performance, the demographics and service needs of the market and the physical condition of the facilities. Based on our historical experience, we then build a pro forma financial model that reflects what we believe can be accomplished under our ownership. Whether we buy or lease the existing facility or agree to construct a replacement hospital, we believe we have been disciplined in our approach to pricing. We typically begin the acquisition process by entering into a non-binding letter of intent with an acquisition candidate. After we complete business and financial due diligence and financial modeling, we decide whether or not to enter into a definitive agreement. Once an acquisition is completed, we have an organized and systematic approach to transitioning and integrating the new hospital into our system of hospitals.

Acquisition Efforts. Most of our acquisition targets are municipal or other not-for-profit hospitals. We believe that our access to capital, ability to recruit physicians and reputation for providing quality care make us an attractive partner for these communities. In addition, we have found that communities located in states where we already operate a hospital are more receptive to our acquiring their hospitals, because they are aware of our operating track record with respect to our other hospitals within the state.

6

At the time we acquire a hospital, we may commit to an amount of capital expenditures, such as a replacement facility, renovations, or equipment over a specified period of time. As obligations under two hospital purchase agreements in effect as of December 31, 2011, we are required to build a replacement facility in Valparaiso, Indiana by April 2011 and in Siloam Springs, Arkansas by February 2013. Due to delays in receiving government approved building and zoning permits, the replacement facility in Valparaiso, Indiana is not expected to be completed until the fourth quarter of 2012. These delays did not result in any penalties under the terms of the purchase agreement and we do not expect such delays to result in any significant increase in the costs to construct the replacement facility. Also, as required by an amendment to a lease agreement entered into in 2005, we agreed to build a replacement hospital at our Barstow, California location by November 2012. Estimated construction costs, including equipment costs, are approximately $317.2 million for these three replacement facilities, of which approximately $210.3 million has been incurred to date. In addition, in October 2008, after the purchase of the noncontrolling owner’s interest in our Birmingham, Alabama facility, we initiated the purchase of a site, which includes a partially constructed hospital structure, for a potential replacement for our existing Birmingham facility. In September 2010, we received approval of our request for a CON from the Alabama Certificate of Need Review Board; however, this CON remains subject to an appeal process. Our estimated construction costs, including the acquisition of the site and equipment costs, are approximately $280.0 million for the Birmingham replacement facility, of which approximately $3.5 million has been incurred to date. Under other purchase agreements in effect as of December 31, 2011, we have committed to spend $652.5 million, generally over a five to seven year period after acquisition, for costs such as capital improvements, equipment, selected leases and physician recruiting. Through December 31, 2011, we have incurred approximately $247.8 million related to these commitments.

Industry Overview

The Centers for Medicare and Medicaid Services, or CMS, reported that in 2010 total U.S. healthcare expenditures grew by 3.9% to approximately $2.6 trillion. CMS also projected total U.S. healthcare spending to grow by 4.8% in 2011 and by an average of 5.8% annually from 2010 through 2020. By these estimates, healthcare expenditures will account for approximately $4.6 trillion, or 19.8% of the total U.S. gross domestic product, by 2020.

Hospital services, the market in which we operate, is the largest single category of healthcare at 31.4% of total healthcare spending in 2010, or approximately $814.0 billion, as reported by CMS. CMS projects the hospital services category to grow by at least 4.7% per year through 2020. It expects growth in hospital healthcare spending to continue due to the aging of the U.S. population and consumer demand for expanded medical services. As hospitals remain the primary setting for healthcare delivery, CMS expects hospital services to remain the largest category of healthcare spending.

U.S. Hospital Industry. The U.S. hospital industry is broadly defined to include acute care, rehabilitation and psychiatric facilities that are either public (government owned and operated), not-for-profit private (religious or secular), or for-profit institutions (investor owned). According to the American Hospital Association, there are approximately 5,000 inpatient hospitals in the U.S. which are not-for-profit owned, investor owned, or state or local government owned. Of these hospitals, approximately 40% are located in non-urban communities. We believe that a majority of these hospitals are owned by not-for-profit or governmental entities. These facilities offer a broad range of healthcare services, including internal medicine, general surgery, cardiology, oncology, orthopedics, OB/GYN and emergency services. In addition, hospitals also offer other ancillary services, including psychiatric, diagnostic, rehabilitation, home care and outpatient surgery services.

Urban vs. Non-Urban Hospitals

According to the U.S. Census Bureau, 21% of the U.S. population lives in communities designated as non-urban. In these non-urban communities, hospitals are typically the primary source of healthcare. In many cases a single hospital is the only provider of general healthcare services in these communities.

7

Factors Affecting Performance. Among the many factors that can influence a hospital’s financial and operating performance are:

• facility size and location,

• facility ownership structure (i.e., tax-exempt or investor owned) ,

• a facility’s ability to participate in group purchasing organizations and

• facility payor mix.

Patients needing the most complex care are more often served by the larger and/or more specialized urban hospitals. We believe opportunities exist in selected urban markets to create networks between urban hospitals and non-urban hospitals in order to expand the breadth of services offered in the non-urban hospitals while improving physician alignment in those markets and making it more attractive to managed care.

Hospital Industry Trends

Demographic Trends. According to the U.S. Census Bureau, there are presently approximately 40.3 million Americans aged 65 or older in the U.S. who comprise approximately 13.0% of the total U.S. population. By the year 2030, the number of Americans aged 65 or older is expected to climb to 72.1 million, or 19.3% of the total population. Due to the increasing life expectancy of Americans, the number of people aged 85 years and older is also expected to increase from 5.8 million to 8.7 million by the year 2030. This increase in life expectancy will increase demand for healthcare services and, as importantly, the demand for innovative, more sophisticated means of delivering those services. Hospitals, as the largest category of care in the healthcare market, will be among the main beneficiaries of this increase in demand. Based on data compiled for us, the populations of the service areas where our hospitals are located grew by 24.0% from 1990 to 2010 and are expected to grow by 3.9% from 2010 to 2015. The number of people aged 65 or older in these service areas grew by 27.4% from 1990 to 2010 and is expected to grow by 14.9% from 2010 to 2015.

Consolidation. In addition to our own acquisitions in recent years, consolidation activity in the hospital industry, primarily through mergers and acquisitions involving both for-profit and not-for-profit hospital systems, is continuing. Reasons for this activity include:

• excess capacity of available capital,

• valuation levels,

• financial performance issues, including challenges associated with changes in reimbursement and collectability of self-pay revenue,

• the desire to enhance the local availability of healthcare in the community,

• the need and ability to recruit primary care physicians and specialists,

• the need to achieve general economies of scale and to gain access to standardized and centralized functions, including favorable supply agreements and access to malpractice coverage and

• regulatory changes.

The healthcare industry is also undergoing consolidation, first, in anticipation of, and second, in reaction to, efforts to reform the payment system. Hospital systems are acquiring physician practices and other outpatient and sub-acute providers to position themselves for readmission, bundling and other payment restructuring. Similarly, payors are consolidating and acquiring disease management service providers in an effort to offer more competitive programs.

8

Selected Operating Data

The following table sets forth operating statistics for our hospitals for each of the years presented, which are included in our continuing operations. Statistics for 2011 include a full year of operations for 127 hospitals and partial periods for four hospitals acquired during the year. Statistics for 2010 include a full year of operations for 122 hospitals and partial periods for five hospitals acquired during the year. Statistics for 2009 include a full year of operations for 118 hospitals and partial periods for three hospitals acquired during the year and one hospital in which we previously had a noncontrolling interest and purchased the remaining interest during the year. Statistics for hospitals which have been sold are excluded from all periods presented.

	Year Ended December 31,
	2011			2010			2009
	(Dollars in thousands)
Consolidated Data
Number of hospitals (at end of period)		131			127			122
Licensed beds (at end of period)(1)		19,695			19,004			17,557
Beds in service (at end of period)(2)		16,832			16,264			15,539
Admissions(3)		675,050			678,284			675,902
Adjusted admissions(4)		1,330,988			1,277,235			1,242,647
Patient days(5)		2,970,044			2,891,699			2,874,125
Average length of stay (days)(6)		4.4			4.3			4.3
Occupancy rate (beds in service)(7)		49.1	%		50.2	%		51.3	%
Net operating revenues	$	11,906,212		$	11,092,422		$	10,333,501
Net inpatient revenues as a % of total net operating revenues before provision for bad debts		46.1	%		49.3	%		50.4	%
Net outpatient revenues as a % of total net operating revenues before provision for bad debts		51.9	%		48.5	%		47.3	%
Net income attributable to Community Health Systems, Inc.	$	201,948		$	279,983		$	243,150
Net income attributable to Community Health Systems, Inc. as a % of total net operating revenues		1.7	%		2.5	%		2.4	%
Liquidity Data
Adjusted EBITDA(8)	$	1,836,650		$	1,761,484		$	1,652,405
Adjusted EBITDA as a % of total net operatingrevenues(8)		15.4	%		15.9	%		16.0	%
Net cash flows provided by operating activities	$	1,261,908		$	1,188,730		$	1,076,429
Net cash flows provided by operating activities as a % of total net operating revenues		10.6	%		10.7	%		10.4	%
Net cash flows used in investing activities	$	(1,195,775	)	$	(1,044,310	)	$	(867,182	)
Net cash flows used in financing activities	$	(235,437	)	$	(189,792	)	$	(85,361	)

See pages 10 and 11 for footnotes.

9

	Year Ended December 31,						(Decrease) Increase
	2011			2010
	(Dollars in thousands)
Same-Store Data(9)
Admissions(3)		640,302			678,284			(5.6	)%
Adjusted admissions(4)		1,267,860			1,277,235			(0.7	)%
Patient days(5)		2,806,139			2,891,699
Average length of stay (days)(6)		4.4			4.3
Occupancy rate (beds in service)(7)		48.9	%		50.2	%
Net operating revenues	$	11,410,431		$	11,086,993			2.9	%
Income from operations	$	1,188,176		$	1,131,850			5.0	%
Income from operations as a % of net operating revenues		10.4	%		10.2	%
Depreciation and amortization	$	633,417		$	594,997
Equity in earnings of unconsolidated affiliates	$	49,507		$	45,380

(1) Licensed beds are the number of beds for which the appropriate state agency licenses a facility regardless of whether the beds are actually available for patient use.

(2) Beds in service are the number of beds that are readily available for patient use.

(3) Admissions represent the number of patients admitted for inpatient treatment.

(4) Adjusted admissions is a general measure of combined inpatient and outpatient volume. We computed adjusted admissions by multiplying admissions by gross patient revenues and then dividing that number by gross inpatient revenues.

(5) Patient days represent the total number of days of care provided to inpatients.

(6) Average length of stay (days) represents the average number of days inpatients stay in our hospitals.

(7) We calculated occupancy rate percentages by dividing the average daily number of inpatients by the weighted-average number of beds in service.

(8) EBITDA consists of net income attributable to Community Health Systems, Inc. before interest, income taxes, depreciation and amortization. Adjusted EBITDA is EBITDA adjusted to exclude discontinued operations, gain/loss from early extinguishment of debt and net income attributable to noncontrolling interests. We have from time to time sold noncontrolling interests in certain of our subsidiaries or acquired subsidiaries with existing noncontrolling interest ownership positions. We believe that it is useful to present adjusted EBITDA because it excludes the portion of EBITDA attributable to these third-party interests and clarifies for investors our portion of EBITDA generated by continuing operations. We use adjusted EBITDA as a measure of liquidity. We have included this measure because we believe it provides investors with additional information about our ability to incur and service debt and make capital expenditures. Adjusted EBITDA is the basis for a key component in the determination of our compliance with some of the covenants under our senior secured credit facility, as well as to determine the interest rate and commitment fee payable under the senior secured credit facility (although adjusted EBITDA does not include all of the adjustments described in the senior secured credit facility).

Adjusted EBITDA is not a measurement of financial performance or liquidity under generally accepted accounting principles. It should not be considered in isolation or as a substitute for net income, operating income, cash flows from operating, investing or financing activities, or any other measure calculated in accordance with generally accepted accounting principles. The items excluded from adjusted EBITDA are significant components in understanding and evaluating financial performance and liquidity. Our calculation of adjusted EBITDA may not be comparable to similarly titled measures reported by other companies.

10

The following table reconciles adjusted EBITDA, as defined, to our net cash provided by operating activities as derived directly from our Consolidated Financial Statements for the years ended December 31, 2011, 2010 and 2009 (in thousands):

	Year Ended December 31,
	2011			2010			2009
Adjusted EBITDA	$	1,836,650		$	1,761,484		$	1,652,405
Interest expense, net		(644,410	)		(647,593	)		(643,608	)
Provision for income taxes		(137,653	)		(163,681	)		(141,851	)
Deferred income taxes		107,032			97,370			34,268
(Loss) income from operations of hospitals sold		(7,769	)		(6,772	)		971
Depreciation and amortization of discontinued operations		4,991			14,842			15,500
Stock compensation expense		42,542			38,779			44,501
(Excess tax benefit) income tax payable increase relating to stock-based compensation		(5,290	)		(10,219	)		3,472
Other non-cash expenses, net		28,716			12,503			22,870
Changes in operating assets and liabilities, net of effects of acquisitions and divestitures:
Patient accounts receivable		(138,332	)		(27,049	)		58,390
Supplies, prepaid expenses and other current assets		(42,858	)		(39,904	)		(34,535	)
Accounts payable, accrued liabilities and income taxes		246,110			161,952			86,098
Other		(27,821	)		(2,982	)		(22,052	)
Net cash provided by operating activities	$	1,261,908		$	1,188,730		$	1,076,429

(9) Includes acquired hospitals to the extent we operated them during comparable periods in both years.

Sources of Revenue

We receive payment for healthcare services provided by our hospitals from:

• the federal Medicare program,

• state Medicaid or similar programs,

• healthcare insurance carriers, health maintenance organizations or “HMOs,” preferred provider organizations or “PPOs,” and other managed care programs and

• patients directly.

11

The following table presents the approximate percentages of operating revenues, net of contractual allowances and discounts (but before the provision for bad debts) by payor source for the periods indicated. The data for the years presented are not strictly comparable due to the effect that hospital acquisitions have had on these statistics.

	Year Ended December 31,
	2011			2010			2009
Medicare		26.8	%		27.4	%		27.4	%
Medicaid		9.7	%		10.7	%		9.8	%
Managed Care and other third-party payors		51.5	%		50.4	%		51.6	%
Self-pay		12.0	%		11.5	%		11.2	%
Total		100.0	%		100.0	%		100.0	%

As shown above, we receive a substantial portion of our revenues from the Medicare and Medicaid programs. Included in Managed Care and other third-party payors is net operating revenues from insurance companies with which we have insurance provider contracts, Medicare managed care, insurance companies for which we do not have insurance provider contracts, workers’ compensation carriers and non-patient service revenue, such as rental income and cafeteria sales. In the future, we generally expect revenues received from the Medicare and Medicaid programs to increase due to the general aging of the population. In addition, we expect the Reform Legislation (as defined below) to increase the number of insured patients, which should reduce revenues from self-pay patients and reduce our provision for bad debts. The Reform Legislation, however, imposes significant reductions in amounts the government pays Medicare managed care plans. Other provisions in the Reform Legislation impose minimum medical-loss ratios and require insurers to meet specific benefit requirements. In addition, specified managed care programs, insurance companies and employers are actively negotiating the amounts paid to hospitals. The trend toward increased enrollment in managed care may adversely affect our net operating revenue growth. There can be no assurance that we will retain our existing reimbursement arrangements or that these third-party payors will not attempt to further reduce the rates they pay for our services.

Medicare is a federal program that provides medical insurance benefits to persons age 65 and over, some disabled persons, and persons with end-stage renal disease. Medicaid is a federal-state funded program, administered by the states, which provides medical benefits to individuals who are unable to afford healthcare. All of our hospitals are certified as providers of Medicare and Medicaid services. Amounts received under the Medicare and Medicaid programs are generally significantly less than a hospital’s customary charges for the services provided. Since a substantial portion of our revenue comes from patients under Medicare and Medicaid programs, our ability to operate our business successfully in the future will depend in large measure on our ability to adapt to changes in these programs.

In addition to government programs, we are paid by private payors, which include insurance companies, HMOs, PPOs, other managed care companies, employers and by patients directly. Blue Cross payors are included in the “Managed Care and other third-party payors” line in the above table. Patients are generally not responsible for any difference between customary hospital charges and amounts paid for hospital services by Medicare and Medicaid programs, insurance companies, HMOs, PPOs and other managed care companies, but are responsible for services not covered by these programs or plans, as well as for deductibles and co-insurance obligations of their coverage. The amount of these deductibles and co-insurance obligations has increased in recent years. Collection of amounts due from individuals is typically more difficult than collection of amounts due from government or business payors. To further reduce their healthcare costs, an increasing number of insurance companies, HMOs, PPOs and other managed care companies are negotiating discounted fee structures or fixed amounts for hospital services performed, rather than paying healthcare providers the amounts billed. We negotiate discounts with managed care companies, which are typically smaller than discounts under governmental programs. If an increased number of insurance companies, HMOs, PPOs and other managed care companies succeed in negotiating discounted fee structures or fixed amounts, our results of operations may be negatively affected. For more information on the payment programs on which our revenues depend, see “Payment” on page 19.

12

As of December 31, 2011, Indiana, Texas and Pennsylvania represented our only areas of geographic concentration. Operating revenues, net of contractual allowances and discounts (but before the provision for bad debts) generated in Indiana as a percentage of consolidated operating revenues were 10.3% in 2011, 10.6% in 2010 and 11.2% in 2009. Operating revenues, net of contractual allowances and discounts (but before the provision for bad debts) generated in Texas as a percentage of consolidated operating revenues were 13.1% in 2011, 13.0% in 2010 and 13.2% in 2009. Operating revenues, net of contractual allowances and discounts (but before the provision for bad debts) generated in Pennsylvania as a percentage of consolidated operating revenues were 11.5% in 2011, 10.3% in 2010 and 10.2% in 2009.

Hospital revenues depend upon inpatient occupancy levels, the volume of outpatient procedures and the charges or negotiated payment rates for hospital services provided. Charges and payment rates for routine inpatient services vary significantly depending on the type of service performed and the geographic location of the hospital. In recent years, we have experienced a significant increase in revenue received from outpatient services. We attribute this increase to:

• advances in technology, which have permitted us to provide more services on an outpatient basis and

• pressure from Medicare or Medicaid programs, insurance companies and managed care plans to reduce hospital stays and to reduce costs by having services provided on an outpatient rather than on an inpatient basis.

Government Regulation

Overview. The healthcare industry is required to comply with extensive government regulation at the federal, state and local levels. Under these regulations, hospitals must meet requirements to be certified as hospitals and qualified to participate in government programs, including the Medicare and Medicaid programs. These requirements relate to the adequacy of medical care, equipment, personnel, operating policies and procedures, maintenance of adequate records, hospital use, rate-setting, compliance with building codes and environmental protection laws. There are also extensive regulations governing a hospital’s participation in these government programs. If we fail to comply with applicable laws and regulations, we can be subject to criminal penalties and civil sanctions, our hospitals can lose their licenses and we could lose our ability to participate in these government programs. In addition, government regulations may change. If that happens, we may have to make changes in our facilities, equipment, personnel and services so that our hospitals remain certified as hospitals and qualified to participate in these programs. We believe that our hospitals are in substantial compliance with current federal, state and local regulations and standards.

Hospitals are subject to periodic inspection by federal, state and local authorities to determine their compliance with applicable regulations and requirements necessary for licensing and certification. All of our hospitals are licensed under appropriate state laws and are qualified to participate in Medicare and Medicaid programs. In addition, most of our hospitals are accredited by the Joint Commission on Accreditation of Healthcare Organizations. This accreditation indicates that a hospital satisfies the applicable health and administrative standards to participate in Medicare and Medicaid programs.

Healthcare Reform. The American Recovery and Reinvestment Act of 2009, or ARRA, was signed into law on February 17, 2009, providing for a temporary increase in the federal matching assistance percentage (FMAP), a temporary increase in federal Medicaid Disproportionate Share Hospital, or DSH, allotments, subsidization of health insurance premiums (COBRA) for up to nine months, and grants and loans for infrastructure and incentive payments for providers who adopt and use health information technology. This act also provides penalties by reducing reimbursement from Medicare in the form of reductions to scheduled market basket increases beginning in federal fiscal year 2015 if eligible hospitals and professionals fail to demonstrate meaningful use of electronic health record technology.

The Patient Protection and Affordable Care Act, or PPACA, was signed into law on March 23, 2010. In addition, the Health Care and Education Affordability Reconciliation Act of 2010, or Reconciliation Act, which contains a number of amendments to PPACA, was signed into law on March 30, 2010. These two healthcare acts, referred to collectively as the Reform Legislation, include a mandate that requires substantially all U.S. citizens to maintain

13

medical insurance coverage which will ultimately increase the number of persons with access to health insurance in the United States. The Reform Legislation should result in a reduction in uninsured patients, which should reduce our expense from uncollectible accounts receivable; however, this legislation makes a number of other changes to Medicare and Medicaid, such as reductions to the Medicare annual market basket update for federal fiscal years 2010 through 2019, a productivity offset to the Medicare market basket update which began October 1, 2011, and a reduction to the Medicare and Medicaid disproportionate share payments, that could adversely impact the reimbursement received under these programs. The various provisions in the Reform Legislation that directly or indirectly affect reimbursement are scheduled to take effect over a number of years, and we cannot predict their impact at this time. Other provisions of the Reform Legislation, such as requirements related to employee health insurance coverage, should increase our operating costs.

Also included in the Reform Legislation are provisions aimed at reducing fraud, waste and abuse in the healthcare industry. These provisions allocate significant additional resources to federal enforcement agencies and expand the use of private contractors to recover potentially inappropriate Medicare and Medicaid payments. The Reform Legislation amends several existing federal laws, including the Medicare Anti-Kickback Statute and the False Claims Act, making it easier for government agencies and private plaintiffs to prevail in lawsuits brought against healthcare providers. These amendments also make it easier for potentially severe fines and penalties to be imposed on healthcare providers accused of violating applicable laws and regulations.

In a number of markets, we have partnered with local physicians in the ownership of our facilities. Such investments have been permitted under an exception to the physician self-referral law, or Stark Law, that allows physicians to invest in an entire hospital (as opposed to individual hospital departments). The Reform Legislation changes the “whole hospital” exception to the Stark Law. The Reform Legislation permits existing physician investments in a whole hospital to continue under a “grandfather” clause if the arrangement satisfies certain requirements and restrictions, but physicians became prohibited, from the time the Reform Legislation became effective, from increasing the aggregate percentage of their ownership in the hospital. The Reform Legislation also restricts the ability of existing physician-owned hospitals to expand the capacity of their facilities.

The impact of the Reform Legislation on each of our hospitals will vary depending on payor mix and a variety of other factors. We anticipate that many of the provisions in the Reform Legislation will be subject to further clarification and modification through the rule-making process, the development of agency guidance and judicial interpretations. Moreover, twenty-six state attorneys general have jointly filed a challenge to certain aspects of the Reform Legislation. Currently, rulings in four separate federal Courts of Appeals have led to a split among the federal Circuit Courts regarding the constitutionality of the Reform Legislation. The Fourth Circuit, Sixth Circuit and the Court of Appeals for the D.C. Circuit have ruled in favor of the Reform Legislation while the Eleventh Circuit ruled the individual mandate within the Reform Legislation unconstitutional. The United States Supreme Court granted certiorari on or about November 14, 2011 to hear the appeal of the Eleventh Circuit’s ruling, with oral argument set for March 26 through 28, 2012. The Supreme Court will hear oral argument on four issues: (1) does the Anti-Injunction Act bar a legal challenge to the individual mandate aspect of the Reform Legislation until that mandate takes effect in 2014; (2) is the individual mandate aspect of the Reform Legislation constitutional; (3) if not, is the individual mandate aspect of the Reform Legislation severable from the Reform Legislation as a whole such that it may be stricken without nullifying the Reform Legislation in its entirety and (4) can the states be compelled by the federal government to expand their Medicaid expenditures or risk losing federal funding if they refuse. We cannot predict the impact the Reform Legislation may have on our business, results of operations, cash flow, capital resources and liquidity or the ultimate outcome of the Supreme Court case. Furthermore, we cannot predict whether we will be able to modify certain aspects of our operations to offset any potential adverse consequences from the Reform Legislation.

Fraud and Abuse Laws. Participation in the Medicare program is heavily regulated by federal statute and regulation. If a hospital fails substantially to comply with the requirements for participating in the Medicare program, the hospital’s participation in the Medicare program may be terminated and/or civil or criminal penalties may be imposed. For example, a hospital may lose its ability to participate in the Medicare program if it performs any of the following acts:

• making claims to Medicare for services not provided or misrepresenting actual services provided in order to obtain higher payments,

14

• paying money to induce the referral of patients where services are reimbursable under a federal health program or

• paying money to limit or reduce the services provided to Medicare beneficiaries.

The Health Insurance Portability and Accountability Act of 1996, or HIPAA, broadened the scope of the fraud and abuse laws. Under HIPAA, any person or entity that knowingly and willfully defrauds or attempts to defraud a healthcare benefit program, including private healthcare plans, may be subject to fines, imprisonment or both. Additionally, any person or entity that knowingly and willfully falsifies or conceals a material fact or makes any material false or fraudulent statements in connection with the delivery or payment of healthcare services by a healthcare benefit plan is subject to a fine, imprisonment or both.

Another law regulating the healthcare industry is a section of the Social Security Act, known as the “anti-kickback” statute. This law prohibits some business practices and relationships under Medicare, Medicaid and other federal healthcare programs. These practices include the payment, receipt, offer, or solicitation of remuneration of any kind in exchange for items or services that are reimbursed under most federal or state healthcare programs. Violations of the anti-kickback statute may be punished by criminal and civil fines, exclusion from federal healthcare programs and damages up to three times the total dollar amount involved.

The Office of Inspector General of the Department of Health and Human Services, or OIG, is responsible for identifying and investigating fraud and abuse activities in federal healthcare programs. As part of its duties, the OIG provides guidance to healthcare providers by identifying types of activities that could violate the anti-kickback statute. The OIG also publishes regulations outlining activities and business relationships that would be deemed not to violate the anti-kickback statute. These regulations are known as “safe harbor” regulations. However, the failure of a particular activity to comply with the safe harbor regulations does not necessarily mean that the activity violates the anti-kickback statute.

The OIG has identified the following incentive arrangements as potential violations of the anti-kickback statute:

• payment of any incentive by the hospital when a physician refers a patient to the hospital,

• use of free or significantly discounted office space or equipment for physicians in facilities usually located close to the hospital,

• provision of free or significantly discounted billing, nursing, or other staff services,

• free training for a physician’s office staff, including management and laboratory techniques (but excluding compliance training),

• guarantees which provide that if the physician’s income fails to reach a predetermined level, the hospital will pay any portion of the remainder,

• low-interest or interest-free loans, or loans which may be forgiven if a physician refers patients to the hospital,

• payment of the costs of a physician’s travel and expenses for conferences,

• payment of services which require few, if any, substantive duties by the physician, or payment for services in excess of the fair market value of the services rendered or

• purchasing goods or services from physicians at prices in excess of their fair market value.

We have a variety of financial relationships with physicians who refer patients to our hospitals. Physicians own interests in a number of our facilities. Physicians may also own our stock. We also have contracts with physicians providing for a variety of financial arrangements, including employment contracts, leases, management agreements and professional service agreements. We provide financial incentives to recruit physicians to relocate to communities served by our hospitals. These incentives include relocation, reimbursement for certain direct

15

expenses, income guarantees and, in some cases, loans. Although we believe that we have structured our arrangements with physicians in light of the “safe harbor” rules, we cannot assure you that regulatory authorities will not determine otherwise. If that happens, we could be subject to criminal and civil penalties and/or exclusion from participating in Medicare, Medicaid, or other government healthcare programs.

The Social Security Act also includes a provision commonly known as the “Stark Law.” This law prohibits physicians from referring Medicare patients to healthcare entities in which they or any of their immediate family members have ownership interests or other financial arrangements. These types of referrals are commonly known as “self referrals.” Sanctions for violating the Stark Law include denial of payment, civil money penalties, assessments equal to twice the dollar value of each service and exclusion from government payor programs. There are ownership and compensation arrangement exceptions to the self-referral prohibition. One exception allows a physician to make a referral to a hospital if the physician owns an interest in the entire hospital, as opposed to an ownership interest in a department of the hospital. Another exception allows a physician to refer patients to a healthcare entity in which the physician has an ownership interest if the entity is located in a rural area, as defined in the statute. There are also exceptions for many of the customary financial arrangements between physicians and providers, including employment contracts, leases and recruitment agreements. From time to time, the federal government has issued regulations which interpret the provisions included in the Stark Law. The Reform Legislation changed the “whole hospital” exception to the Stark Law. The Reform Legislation permitted existing physician investments in a whole hospital to continue under a “grandfather” clause if the arrangement satisfies certain requirements and restrictions, but physicians became prohibited, from the time the Reform Legislation became effective, from increasing the aggregate percentage of their ownership in the hospital. The Reform Legislation also restricted the ability of existing physician-owned hospitals to expand the capacity of their aggregate licensed beds, operating rooms and procedure rooms. The whole hospital exception, as amended, also contains additional disclosure requirements. For example, a grandfathered physician-owned hospital is required to submit an annual report to the Department of Health and Human Services, or the DHHS, listing each investor in the hospital, including all physician owners. In addition, grandfathered physician-owned hospitals must have procedures in place that require each referring physician owner to disclose to patients, with enough notice for the patient to make a meaningful decision regarding receipt of care, the physician’s ownership interest and, if applicable, any ownership interest held by the treating physician. A grandfathered physician-owned hospital also must disclose on its web site and in any public advertising the fact that it has physician ownership. The Reform Legislation required grandfathered physician-owned hospitals to comply with these new requirements by September 23, 2011, and requires audits of the hospitals’ compliance beginning no later than May 1, 2012.

Sanctions for violating the Stark Law include denial of payment, civil monetary penalties of up to $15,000 per claim submitted and exclusion from federal healthcare programs. The statute also provides for a penalty of up to $100,000 for a scheme intended to circumvent the Stark Law prohibitions.

In addition to the restrictions and disclosure requirements applicable to physician-owned hospitals under the Stark Law, CMS regulations require physician-owned hospitals and their physician owners to disclose certain ownership information to patients. Physician-owned hospitals that receive referrals from physician owners must disclose in writing to patients that such hospitals are owned by physicians and that patients may receive a list of the hospitals’ physician investors upon request. Additionally, a physician-owned hospital must require all physician owners who are members of the hospital’s medical staff to agree, as a condition of continued medical staff membership or admitting privileges, to disclose in writing to all patients whom they refer to the hospital their (or an immediate family member’s) ownership interest in the hospital. A hospital is considered to be physician-owned if any physician, or an immediate family member of a physician, holds debt, stock or other types of investment in the hospital or in any owner of the hospital, excluding physician ownership through publicly-traded securities that meet certain conditions. If a hospital fails to comply with these regulations, the hospital could lose its Medicare provider agreement and be unable to participate in Medicare.

16

Evolving interpretations of current, or the adoption of new, federal or state laws or regulations could affect many of the arrangements entered into by each of our hospitals. In addition, law enforcement authorities, including the OIG, the courts and Congress are increasing scrutiny of arrangements between healthcare providers and potential referral sources to ensure that the arrangements are not designed as a mechanism to improperly pay for patient referrals and/or other business. Investigators also have demonstrated a willingness to look behind the formalities of a business transaction to determine the underlying purpose of payments between healthcare providers and potential referral sources.

Many states in which we operate have also adopted laws that prohibit payments to physicians in exchange for referrals similar to the federal anti-kickback statute or that otherwise prohibit fraud and abuse activities. Many states have also passed self-referral legislation similar to the Stark Law, prohibiting the referral of patients to entities with which the physician has a financial relationship. Often these state laws are broad in scope and may apply regardless of the source of payment for care. These statutes typically provide criminal and civil penalties, as well as loss of licensure. Little precedent exists for the interpretation or enforcement of these state laws.

Our operations could be adversely affected by the failure of our arrangements to comply with the anti-kickback statute, the Stark Law, billing laws and regulations, current state laws or other legislation or regulations in these areas adopted in the future. We are unable to predict whether other legislation or regulations at the federal or state level in any of these areas will be adopted, what form such legislation or regulations may take or how they may affect our operations. We are continuing to enter into new financial arrangements with physicians and other providers in a manner structured to comply in all material respects with these laws. We cannot assure you, however, that governmental officials responsible for enforcing these laws or whistleblowers will not assert that we are in violation of them or that such statutes or regulations ultimately will be interpreted by the courts in a manner consistent with our interpretation.

We strive to comply with the Stark Law and regulations; however, the government may interpret the law and regulations differently. If we are found to have violated the Stark Law or regulations, we could be subject to significant sanctions, including damages, penalties and exclusion from federal healthcare programs.

Federal False Claims Act and Similar State Laws. Another trend affecting the healthcare industry today is the increased use of the federal False Claims Act, or FCA, and, in particular, actions being brought by individuals on the government’s behalf under the FCA’s “qui tam” or whistleblower provisions. Whistleblower provisions allow private individuals to bring actions on behalf of the government alleging that the defendant has defrauded the federal government. If the government intervenes in the action and prevails, the party filing the initial complaint may share in any settlement or judgment. If the government does not intervene in the action, the whistleblower plaintiff may pursue the action independently and may receive a larger share of any settlement or judgment. When a private party brings a qui tam action under the FCA, the defendant generally will not be made aware of the lawsuit until the government commences its own investigation or makes a determination whether it will intervene. Further, every entity that receives at least $5 million annually in Medicaid payments must have written policies for all employees, contractors or agents providing detailed information about false claims, false statements and whistleblower protections under certain federal laws, including the FCA, and similar state laws.

When a defendant is determined by a court of law to be liable under the FCA, the defendant must pay three times the actual damages sustained by the government, plus mandatory civil penalties of between $5,500 and $11,000 for each separate false claim. Settlements entered into prior to litigation usually involve a less severe calculation of damages. There are many potential bases for liability under the FCA. Liability often arises when an entity knowingly submits a false claim for reimbursement to the federal government. The FCA broadly defines the term “knowingly.” Although simple negligence will not give rise to liability under the FCA, submitting a claim with reckless disregard to its truth or falsity can constitute “knowingly” submitting a false claim and result in liability. In some cases, whistleblowers, the federal government and courts have taken the position that providers who allegedly have violated other statutes, such as the anti-kickback statute or the Stark Law, have thereby submitted false claims under the FCA. The Reform Legislation clarifies this issue with respect to the anti-kickback statute by providing that submission of a claim for an item or service generated in violation of the anti-kickback statute constitutes a false or fraudulent claim under the FCA. The Fraud Enforcement and Recovery Act of 2009 expanded the scope of the FCA by, among other things, creating liability for knowingly and improperly avoiding repayment of an overpayment received from the government and broadening protections for whistleblowers. Under the Reform Legislation, the

17

FCA is implicated by the knowing failure to report and return an overpayment within 60 days of identifying the overpayment or by the date a corresponding cost report is due, whichever is later. Further, the FCA will cover payments involving federal funds in connection with the new health insurance exchanges to be created pursuant to the Reform Legislation. Even if the FCA is not implicated and a mistake is made in the submission of claims, substantial financial liability can arise with respect to any overpayments. There is a notable gap in the time periods for which overpayments may be recouped by the government but for which corrected claims can be submitted.

A number of states, including states in which we operate, have adopted their own false claims provisions as well as their own whistleblower provisions whereby a private party may file a civil lawsuit in state court. The Deficit Reduction Act of 2005 created an incentive for states to enact false claims laws that are comparable to the FCA. From time to time, companies in the healthcare industry, including ours, may be subject to actions under the FCA or similar state laws.

Corporate Practice of Medicine; Fee-Splitting. Some states have laws that prohibit unlicensed persons or business entities, including corporations, from employing physicians. Some states also have adopted laws that prohibit direct or indirect payments or fee-splitting arrangements between physicians and unlicensed persons or business entities. Possible sanctions for violations of these restrictions include loss of a physician’s license, civil and criminal penalties and rescission of business arrangements. These laws vary from state to state, are often vague and have seldom been interpreted by the courts or regulatory agencies. We structure our arrangements with healthcare providers to comply with the relevant state law. However, we cannot be assured that governmental officials responsible for enforcing these laws will not assert that we, or transactions in which we are involved, are in violation of these laws. These laws may also be interpreted by the courts in a manner inconsistent with our interpretations.

Emergency Medical Treatment and Active Labor Act. The Emergency Medical Treatment and Active Labor Act imposes requirements as to the care that must be provided to anyone who comes to facilities providing emergency medical services seeking care before they may be transferred to another facility or otherwise denied care. Sanctions for failing to fulfill these requirements include exclusion from participation in Medicare and Medicaid programs and civil money penalties. In addition, the law creates private civil remedies which enable an individual who suffers personal harm as a direct result of a violation of the law to sue the offending hospital for damages and equitable relief. A medical facility that suffers a financial loss as a direct result of another participating hospital’s violation of the law also has a similar right. Although we believe that our practices are in compliance with the law, we can give no assurance that governmental officials responsible for enforcing the law or others will not assert we are in violation of these laws.

Conversion Legislation. Many states, including some where we have hospitals and others where we may in the future acquire hospitals, have adopted legislation regarding the sale or other disposition of hospitals operated by not-for-profit entities. In other states that do not have specific legislation, the attorneys general have demonstrated an interest in these transactions under their general obligations to protect charitable assets from waste. These legislative and administrative efforts primarily focus on the appropriate valuation of the assets divested and the use of the proceeds of the sale by the not-for-profit seller. While these reviews and, in some instances, approval processes can add additional time to the closing of a hospital acquisition, we have not had any significant difficulties or delays in completing the process. There can be no assurance, however, that future actions on the state level will not seriously delay or even prevent our ability to acquire hospitals. If these activities are widespread, they could limit our ability to acquire hospitals.

Certificates of Need. The construction of new facilities, the acquisition of existing facilities and the addition of new services at our facilities may be subject to state laws that require prior approval by state regulatory agencies. These CON laws generally require that a state agency determine the public need and give approval prior to the construction or acquisition of facilities or the addition of new services. As of December 31, 2011, we operated 57 hospitals in 16 states that have adopted CON laws for acute care facilities. If we fail to obtain necessary state approval, we will not be able to expand our facilities, complete acquisitions or add new services in these states. Violation of these state laws may result in the imposition of civil sanctions or the revocation of a hospital’s licenses.

HIPAA Administrative Simplification and Privacy and Security Requirements. HIPAA requires the use of uniform electronic data transmission standards for healthcare claims and payment transactions submitted or received electronically. These provisions are intended to encourage electronic commerce in the healthcare industry. The

18

DHHS has established electronic data transmission standards that all healthcare providers must use when submitting or receiving certain healthcare transactions electronically. In addition, HIPAA requires that each provider use a National Provider Identifier. In January 2009, CMS published a final rule making changes to the formats used for certain electronic transactions and requiring the use of updated standard code sets for certain diagnoses and procedures known as ICD-10 code sets. Although use of the ICD-10 code sets is not mandatory until October 1, 2013, we will be modifying our payment systems and processes to prepare for their implementation. Use of the ICD-10 code sets will require significant changes; however, we believe that the cost of compliance with these regulations has not had and is not expected to have a material adverse effect on our business, financial position or results of operations. The Reform Legislation requires the DHHS to adopt standards for additional electronic transactions and to establish operating rules to promote uniformity in the implementation of each standardized electronic transaction.

As required by HIPAA, the DHHS has issued privacy and security regulations that extensively regulate the use and disclosure of individually identifiable health-related information and require healthcare providers to implement administrative, physical and technical practices to protect the security of individually identifiable health information that is electronically maintained or transmitted. ARRA broadens the scope of the HIPAA privacy and security regulations. In addition, ARRA extends the application of certain provisions of the security and privacy regulations to business associates (entities that handle identifiable health-related information on behalf of covered entities) and subjects business associates to civil and criminal penalties for violation of the regulations. On July 14, 2010, the DHHS issued a proposed rule that would implement these ARRA provisions. If finalized, these changes would likely require amendments to existing agreements with business associates and would subject business associates and their subcontractors to direct liability under the HIPAA privacy and security regulations. We have developed and utilize a HIPAA compliance plan as part of our effort to comply with HIPAA privacy and security requirements. The privacy regulations and security regulations have and will continue to impose significant costs on our facilities in order to comply with these standards.

As required by ARRA, the DHHS published an interim final rule on August 24, 2009, that requires covered entities to report breaches of unsecured protected health information to affected individuals without unreasonable delay, but not to exceed 60 days of discovery of the breach by the covered entity or its agents. Notification must also be made to the DHHS and, in certain situations involving large breaches, to the media. Various state laws and regulations may also require us to notify affected individuals in the event of a data breach involving individually identifiable information.

Violations of the HIPAA privacy and security regulations may result in civil and criminal penalties, and ARRA has strengthened the enforcement provisions of HIPAA, which may result in increased enforcement activity. Under ARRA, the DHHS is required to conduct periodic compliance audits of covered entities and their business associates. ARRA broadens the applicability of the criminal penalty provisions to employees of covered entities and requires the DHHS to impose penalties for violations resulting from willful neglect. ARRA significantly increases the amount of the civil penalties, with penalties of up to $50,000 per violation for a maximum civil penalty of $1,500,000 in a calendar year for violations of the same requirement. Further, ARRA authorizes state attorneys general to bring civil actions seeking either injunction or damages in response to violations of HIPAA privacy and security regulations that threaten the privacy of state residents. Our facilities also are subject to any federal or state privacy-related laws that are more restrictive than the privacy regulations issued under HIPAA. These laws vary and could impose additional penalties.

Payment

Medicare. Under the Medicare program, we are paid for inpatient and outpatient services performed by our hospitals.

Payments for inpatient acute services are generally made pursuant to a prospective payment system, commonly known as “PPS.” Under PPS, our hospitals are paid a predetermined amount for each hospital discharge based on the patient’s diagnosis. Specifically, each discharge is assigned to a diagnosis-related group, commonly known as a “DRG,” based upon the patient’s condition and treatment during the relevant inpatient stay. Commencing with the federal fiscal year 2009 (i.e., the federal fiscal year beginning October 1, 2008), each DRG is assigned a payment rate using 100% of the national average cost per case and 100% of the severity adjusted DRG weights. DRG payments are based on national averages and not on charges or costs specific to a hospital. Severity adjusted DRGs

19

more accurately reflect the costs a hospital incurs for caring for a patient and account more fully for the severity of each patient’s condition. However, DRG payments are adjusted by a predetermined geographic adjustment factor assigned to the geographic area in which the hospital is located. While a hospital generally does not receive payment in addition to a DRG payment, hospitals may qualify for an “outlier” payment when the relevant patient’s treatment costs are extraordinarily high and exceed a specified regulatory threshold.

The DRG payment rates are adjusted by an update factor on October 1 of each year, the beginning of the federal fiscal year. The index used to adjust the DRG payment rates, known as the “market basket index,” gives consideration to the inflation experienced by hospitals in purchasing goods and services. DRG payment rates were increased by the full “market basket index,” for the federal fiscal years 2012, 2011, 2010 and 2009, by 3.0%, 2.6%, 2.1% and 3.6%, respectively. In addition, the DRG payment rates were reduced by 0.25% on April 1, 2010 and by 0.25% on October 1, 2010, as mandated by the Reform Legislation. The DRG payment rates were also reduced by 2.9% for federal fiscal year 2011 for behavioral changes in coding practices related to MS-DRG. In addition, for federal fiscal year 2012, the DRG payment rates were reduced by 1% for the multi-factor productivity adjustment; reduced by 0.1% in accordance with the Reform Legislation; reduced by 2% for documentation and coding; and increased by 1.1% as a result of the decision in Cape Cod Hospital v. Sebelius. The Deficit Reduction Act of 2005 imposed a two percentage point reduction to the market basket index beginning October 1, 2007, and each year thereafter, if patient quality data is not submitted. We are complying with this data submission requirement. Future legislation may decrease the rate of increase for DRG payments or even decrease such payment rates, but we are not able to predict the amount of any reduction or the effect that any reduction will have on us.

In addition, hospitals may qualify for Medicare disproportionate share payments when their percentage of low income patients exceeds specified regulatory thresholds. A majority of our hospitals qualify to receive Medicare disproportionate share payments. For the majority of our hospitals that qualify to receive Medicare disproportionate share payments, these payments were increased by the Medicare Prescription Drug, Improvement and Modernization Act of 2003 effective April 1, 2004. These Medicare disproportionate share payments as a percentage of net operating revenues were 1.8%, 1.9% and 1.9% for the years ended December 31, 2011, 2010 and 2009, respectively.

Beginning August 1, 2000, we began receiving Medicare reimbursement for outpatient services through a PPS. Under the Balanced Budget Refinement Act of 1999, non-urban hospitals with 100 beds or less were held harmless. The Medicare Improvements for Patients and Providers Act extended the hold harmless provision for non-urban hospitals with 100 beds or less, including non-urban sole community hospitals, through December 31, 2009, at 85% of the hold harmless amount. Of our 125 hospitals at December 31, 2009, 44 qualified for this relief. The Reform Legislation extended the hold harmless provision for non-urban hospitals with 100 beds or less, including non-urban sole community hospitals, through December 31, 2010. Of our 130 hospitals at December 31, 2010, 46 qualified for this relief. The Medicare and Medicaid Extenders Act of 2010 extended the hold harmless provision for non-urban hospitals with 100 beds or less, including non-urban sole community hospitals, through December 31, 2011. Of our 131 hospitals at December 31, 2011, 45 qualified for this relief. The outpatient conversion factor was increased 3.6% effective January 1, 2009; however, coupled with adjustments to other variables with outpatient PPS, an approximate 3.5% to 3.9% net increase in outpatient payments occurred. The outpatient conversion factor was increased 2.1% effective January 1, 2010; however, coupled with adjustments to other variables with outpatient PPS, an approximate 1.8% to 2.2% net increase in outpatient payments occurred. The outpatient conversion factor was increased 2.35% effective January 1, 2011; however, coupled with adjustments to other variables with outpatient PPS, an approximate 2.1% to 2.5% net increase in outpatient payments occurred. The outpatient conversion factor was increased 3.0 % effective January 1, 2012; however, coupled with adjustments to other variables with outpatient PPS, an approximate 2.1% to 2.5% net increase in outpatient payments is expected to occur. The Medicare Improvements and Extension Act of the Tax Relief and Health Care Act of 2006 imposed a two percentage point reduction to the market basket index beginning January 1, 2009, and each year thereafter, if patient quality data is not submitted. We are complying with this data submission requirement.

The DHHS established a PPS for home health services (i.e., home care) effective October 1, 2000. The home health agency PPS per episodic payment rate increased by 2.9% on January 1, 2009; however, coupled with adjustments to other variables with home health agency PPS, an approximate 0.2% net increase in home health agency payments occurred. The home health agency PPS per episodic payment rate increased 2.0% on January 1, 2010; however, coupled with adjustments to other variables with home health agency PPS, an approximate 2.3% net

20

increase in home health agency payments occurred. The home health agency PPS per episodic payment rate increased 1.1% on January 1, 2011; however, coupled with adjustments to other variables with home health agency PPS, an approximate 4.9% net decrease in home health agency payments occurred. The home health agency PPS per episodic payment rate increased 2.4% on January 1, 2012; however, coupled with adjustments to other variables with home health agency PPS, an approximate 2.31% net decrease in home health agency payments is expected to occur. The Reform Legislation increases the home health agency PPS per episodic payment rate by 3.0% for home health services provided to patients in rural areas on or after April 1, 2010 through December 31, 2016. The Deficit Reduction Act of 2005 imposed a two percentage point reduction to the market basket index beginning January 1, 2007, and each year thereafter, if patient quality data is not submitted. We are complying with this data submission requirement.

Medicaid. Most state Medicaid payments are made under a PPS or under programs which negotiate payment levels with individual hospitals. Medicaid is currently funded jointly by state and federal government. The federal government and many states are currently considering significantly reducing Medicaid funding, while at the same time expanding Medicaid benefits. Currently, several states utilize supplemental reimbursement programs for the purpose of providing reimbursement to providers to offset a portion of the cost of providing care to Medicaid and indigent patients. These programs are designed with input from CMS and are funded with a combination of state and federal resources, including, in certain instances, fees or taxes levied on the providers. Similar programs are also being considered by other states. We can provide no assurance that reductions to Medicaid fundings will not have a material adverse effect on our consolidated results of operations.

Annual Cost Reports. Hospitals participating in the Medicare and some Medicaid programs, whether paid on a reasonable cost basis or under a PPS, are required to meet specified financial reporting requirements. Federal and, where applicable, state regulations require submission of annual cost reports identifying medical costs and expenses associated with the services provided by each hospital to Medicare beneficiaries and Medicaid recipients.

Annual cost reports required under the Medicare and some Medicaid programs are subject to routine governmental audits. These audits may result in adjustments to the amounts ultimately determined to be due to us under these reimbursement programs. Finalization of these audits often takes several years. Providers can appeal any final determination made in connection with an audit. DRG outlier payments have been and continue to be the subject of CMS audit and adjustment. The DHHS OIG is also actively engaged in audits and investigations into alleged abuses of the DRG outlier payment system.

Commercial Insurance and Managed Care Companies. Our hospitals provide services to individuals covered by private healthcare insurance or by health plans administered by managed care companies. These payors pay our hospitals or in some cases reimburse their policyholders based upon the hospital’s established charges and the coverage provided in the insurance policy. They try to limit the costs of hospital services by negotiating discounts, including PPS, which would reduce payments by commercial insurers or health plans to our hospitals. Commercial insurers and Managed Care companies also seek to reduce payments to hospitals by establishing payment rules that in effect recharacterize the services ordered by physicians. For example, some payors vigorously review each patient’s length of stay in the hospital and recharacterize as outpatient all in-patient stays of less than a particular duration (e.g. 24 hours). Reductions in payments for services provided by our hospitals to individuals covered by these payors could adversely affect us.

Supply Contracts

In March 2005, we began purchasing items, primarily medical supplies, medical equipment and pharmaceuticals, under an agreement with HealthTrust, a GPO in which we are a noncontrolling partner. Triad Hospitals, Inc., or Triad, was also a noncontrolling partner in HealthTrust and we acquired Triad’s ownership interest and contractual rights when we acquired Triad. As of December 31, 2011, we have a 17.6% ownership interest in HealthTrust. By participating in this organization, we are able to procure items at competitively priced rates for our hospitals. There can be no assurance that our arrangement with HealthTrust will continue to provide the discounts that we have historically received.

21

Competition

The hospital industry is highly competitive. An important part of our business strategy is to continue to acquire hospitals in non-urban markets and selected urban markets. However, other for-profit hospital companies and not-for-profit hospital systems generally attempt to acquire the same type of hospitals as we do. In addition, some hospitals are sold through an auction process, which may result in higher purchase prices than we believe are reasonable.

In addition to the competition we face for acquisitions, we must also compete with other hospitals and healthcare providers for patients. The competition among hospitals and other healthcare providers for patients has intensified in recent years. Our hospitals are located in non-urban and selected urban service areas. Those hospitals in non-urban service areas face no direct competition because there are no other hospitals in their primary service areas. However, these hospitals do face competition from hospitals outside of their primary service area, including hospitals in urban areas that provide more complex services. Patients in those service areas may travel to these other hospitals for a variety of reasons, including the need for services we do not offer or physician referrals. Patients who are required to seek services from these other hospitals may subsequently shift their preferences to those hospitals for services we do provide. Those hospitals in selected urban service areas may face competition from hospitals that are more established than our hospitals. Certain of these competing facilities offer services, including extensive medical research and medical education programs, which are not offered by our facilities. In addition, in certain markets where we operate, there are large teaching hospitals that provide highly specialized facilities, equipment and services that may not be available at our hospitals.

Some of our hospitals operate in primary service areas where they compete with another hospital. Some of these competing hospitals use equipment and services more specialized than those available at our hospitals and/or are owned by tax-supported governmental agencies or not-for-profit entities supported by endowments and charitable contributions. These hospitals do not pay income or property taxes, and can make capital expenditures without paying sales tax. We also face competition from other specialized care providers, including outpatient surgery, orthopedic, oncology and diagnostic centers.

The number and quality of the physicians on a hospital’s staff is an important factor in a hospital’s competitive position. Physicians decide whether a patient is admitted to the hospital and the procedures to be performed. Admitting physicians may be on the medical staffs of other hospitals in addition to those of our hospitals. We attempt to attract our physicians’ patients to our hospitals by offering quality services and facilities, convenient locations and state-of-the-art equipment.

Compliance Program

We take an operations team approach to compliance and utilize corporate experts for program design efforts and facility leaders for employee-level implementation. We believe compliance is another area that demonstrates our utilization of standardization and centralization techniques and initiatives which yield efficiencies and consistency throughout our facilities. We recognize that our compliance with applicable laws and regulations depends on individual employee actions as well as company operations. Our approach focuses on integrating compliance responsibilities with operational functions. This approach is intended to reinforce our company-wide commitment to operate strictly in accordance with the laws and regulations that govern our business.

Our company-wide compliance program has been in place since 1997. Currently, the program’s elements include leadership, management and oversight at the highest levels, a Code of Conduct, risk area specific policies and procedures, employee education and training, an internal system for reporting concerns, auditing and monitoring programs and a means for enforcing the program’s policies.

Since its initial adoption, the compliance program continues to be expanded and developed to meet the industry’s expectations and our needs. Specific written policies, procedures, training and educational materials and programs, as well as auditing and monitoring activities, have been prepared and implemented to address the functional and operational aspects of our business. Included within these functional areas are materials and activities for business sub-units, including laboratory, radiology, pharmacy, emergency, surgery, observation, home care, skilled nursing and clinics. Specific areas identified through regulatory interpretation and enforcement activities have also been

22

addressed in our program. Claims preparation and submission, including coding, billing and cost reports, comprise the bulk of these areas. Financial arrangements with physicians and other referral sources, including compliance with the federal anti-kickback statute and the Stark Law, emergency department treatment and transfer requirements and other patient disposition issues, are also the focus of policy and training, standardized documentation requirements and review and audit. Another focus of the program is the interpretation and implementation of the HIPAA standards for privacy and security.

We have a Code of Conduct which applies to all directors, officers, employees and consultants, and a confidential disclosure program to enhance the statement of ethical responsibility expected of our employees and business associates who work in the accounting, financial reporting and asset management areas of our Company. Our Code of Conduct is posted on our website at www.chs.net/company_overview/code_conduct.html.

Employees

At December 31, 2011, we employed approximately 66,000 full-time employees and 22,000 part-time employees. We have approximately 8,000 employees who are union members. We currently believe that our labor relations are good.

Professional Liability Claims

As part of our business of owning and operating hospitals, we are subject to legal actions alleging liability on our part. To cover claims arising out of the operations of hospitals, we maintain professional malpractice liability insurance and general liability insurance on a claims made basis in excess of those amounts for which we are self-insured, in amounts we believe to be sufficient for our operations. We also maintain umbrella liability coverage for claims which, due to their nature or amount, are not covered by our other insurance policies. However, our insurance coverage does not cover all claims against us or may not continue to be available at a reasonable cost for us to maintain adequate levels of insurance. For a further discussion of our insurance coverage, see our discussion of professional liability claims in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 7 of this Report.

Environmental Matters

We are subject to various federal, state and local laws and regulations governing the use, discharge and disposal of hazardous materials, including medical waste products. Compliance with these laws and regulations is not expected to have a material adverse effect on us. It is possible, however, that environmental issues may arise in the future which we cannot now predict.

We are insured for damages of personal property or environmental injury arising out of environmental impairment for both above ground and underground storage tank issues under one insurance policy for all of our hospitals. Our policy coverage is $5 million per occurrence with a $50,000 deductible and a $20 million annual aggregate. This policy also provides pollution legal liability coverage.

23

Item 1A. Risk Factors

The following risk factors could materially and adversely affect our future operating results and could cause actual results to differ materially from those predicted in the forward-looking statements we make about our business.

Our level of indebtedness could adversely affect our ability to raise additional capital to fund our operations, limit our ability to react to changes in the economy or our industry and prevent us from meeting our obligations under the agreements relating to our indebtedness.

We are significantly leveraged. The table below shows our level of indebtedness and other information as of December 31, 2011. In connection with the consummation of our acquisition of Triad in July 2007, approximately $7.2 billion of senior secured financing under a new credit facility, or the Credit Facility, was obtained by our wholly-owned subsidiary, CHS/Community Health Systems, Inc., or CHS. CHS also issued 8.875% senior notes, or the 8 ⁷/8% Senior Notes, having an aggregate principal amount of approximately $3.0 billion. Both the indebtedness under the Credit Facility and the 8 ⁷/8% Senior Notes are senior obligations of CHS and are guaranteed on a senior basis by us and by certain of our domestic subsidiaries. We used the net proceeds from the 8 ⁷/8% Senior Notes offering and the net proceeds of the approximately $6.1 billion term loans under the Credit Facility to pay the consideration under the merger agreement with Triad, to refinance certain of our existing indebtedness and the indebtedness of Triad, to complete certain related transactions, to pay certain costs and expenses of the transactions and for general corporate uses. As of December 31, 2011, a $750 million revolving credit facility was available to us for working capital and general corporate purposes under the Credit Facility, with $37.7 million of the revolving credit facility being set aside for outstanding letters of credit and $30.0 million outstanding at December 31, 2011. On November 5, 2010, we entered into an amendment and restatement of our existing Credit Facility, which extended by two and a half years, until January 25, 2017, the maturity date of $1.5 billion of our existing term loans under the Credit Facility. In addition, effective February 2, 2012, we completed an additional amendment and restatement of the Credit Facility, which extended by two and a half years the maturity date of an additional $1.6 billion of our existing non-extended term loans under the Credit Facility, until January 25, 2017 (subject to customary acceleration events) or, if more than $50 million of our 8 ⁷/8% Senior Notes are outstanding on April 15, 2015, to April 15, 2015. The remaining approximately $2.9 billion in term loans mature in 2014. On November 22, 2011, CHS completed its offering of $1.0 billion aggregate principal amount of 8% Senior Notes, or the 8% Senior Notes, which were issued in a private placement. The net proceeds from this issuance, together with available cash on hand, were used to finance the purchase of up to $1.0 billion aggregate principal amount of outstanding 8 ⁷/8% Senior Notes and related fees and expenses. The 8% Senior Notes are unsecured senior obligations of CHS and are guaranteed on a senior basis by us and by certain of our domestic subsidiaries. With the exception of some small principal payments of our term loans under our Credit Facility, representing less than 1% of the outstanding balance each year through 2013, approximately $2.9 billion of term loans under our Credit Facility mature in 2014, our 8 ⁷/8% Senior Notes are due in 2015, the remaining $3.1 billion in term loans mature in 2017 and our 8% Senior Notes are due in 2019.

	December 31, 2011
	($ in millions)
Senior secured credit facility term loans	$	5,949.4
Revolving credit facility		30.0
8 7/8% Senior Notes		1,777.6
8% Senior Notes		1,000.0
Other		89.5
Total debt	$	8,846.5
Community Health Systems, Inc. stockholders’ equity	$	2,397.1

24

As of December 31, 2011, our approximately $4.9 billion notional amount of interest rate swap agreements represented approximately 82% of our variable rate debt. On a prospective basis, a 1% change in interest rates on the remaining unhedged variable rate debt existing as of December 31, 2011, would result in interest expense fluctuating approximately $11.0 million per year.

The Credit Facility and/or both of the 8 ⁷/8% Senior Notes and the 8% Senior Notes, or collectively known as the Senior Notes, contain various covenants that limit our ability to take certain actions, including our ability to:

• incur, assume or guarantee additional indebtedness,

• issue redeemable stock and preferred stock,

• repurchase capital stock,

• make restricted payments, including paying dividends and making investments,

• redeem debt that is junior in right of payment to the Senior Notes,

• create liens,

• sell or otherwise dispose of assets, including capital stock of subsidiaries,

• enter into agreements that restrict dividends from subsidiaries,

• merge, consolidate, sell or otherwise dispose of substantial portions of our assets,

• enter into transactions with affiliates and

• guarantee certain obligations.

In addition, our Credit Facility contains restrictive covenants and requires us to maintain specified financial ratios and satisfy other financial condition tests. Our ability to meet these restrictive covenants and financial ratios and tests can be affected by events beyond our control, and we cannot assure you that we will meet those tests.

The counterparty to the interest rate swap agreements exposes us to credit risk in the event of non-performance. However, at December 31, 2011, we do not anticipate non-performance by the counterparty due to the net settlement feature of the agreements and our liability position with respect to each of our counterparties.

A breach of any of these covenants could result in a default under our Credit Facility and/or the Senior Notes. Upon the occurrence of an event of default under our Credit Facility or the Senior Notes, all amounts outstanding under our Credit Facility and the Senior Notes may become immediately due and payable and all commitments under the Credit Facility to extend further credit may be terminated.

Our leverage could have important consequences for you, including the following:

• it may limit our ability to obtain additional debt or equity financing for working capital, capital expenditures, debt service requirements, acquisitions and general corporate or other purposes,

• a substantial portion of our cash flows from operations will be dedicated to the payment of principal and interest on our indebtedness and will not be available for other purposes, including our operations, capital expenditures and future business opportunities,

• the debt service requirements of our indebtedness could make it more difficult for us to satisfy our financial obligations,

25

• some of our borrowings, including borrowings under our Credit Facility, are at variable rates of interest, exposing us to the risk of increased interest rates,

• it may limit our ability to adjust to changing market conditions and place us at a competitive disadvantage compared to our competitors that have less debt and

• we may be vulnerable in a downturn in general economic conditions or in our business, or we may be unable to carry out capital spending that is important to our growth.

The ratio of earnings to fixed charges is a measure of our ability to meet our fixed obligations related to our indebtedness. The following table shows the ratio of earnings to fixed charges for the periods indicated:

	Year Ended December 31,
	2007		2008		2009		2010		2011
Ratio of earnings to fixed charges(1)		1.21x		1.47x		1.60x		1.69x		1.61x

(1) Fixed charges include interest expensed and capitalized during the year plus an estimate of the interest component of rent expense. There are no shares of preferred stock outstanding. See exhibit 12 filed as part of this Report for the calculation of this ratio.

Despite current indebtedness levels, we may be able to incur substantially more debt. This could further exacerbate the risks described above.

We may be able to incur substantial additional indebtedness in the future. The terms of the indentures governing the Senior Notes do not fully prohibit us from doing so. For example, under the indentures for the 8 ⁷/8% Senior Notes and the 8% Senior Notes, we may incur up to approximately $7.8 billion pursuant to a credit facility or a qualified receivables transaction, less certain amounts repaid with the proceeds of asset dispositions. As of December 31, 2011, our Credit Facility provided for commitments of up to approximately $6.7 billion in the aggregate. Additionally, our Credit Facility also gives us the ability to provide for one or more additional tranches of term loans in the aggregate principal amount of up to $1.0 billion without the consent of the existing lenders if specified criteria are satisfied and for up to $300 million of borrowing capacity from receivable transactions (including securitizations). If new debt is added to our current debt levels, the related risks that we now face could be further exacerbated.

If competition decreases our ability to acquire additional hospitals on favorable terms, we may be unable to execute our acquisition strategy.

An important part of our business strategy is to acquire two to four hospitals each year. However, not-for-profit hospital systems and other for-profit hospital companies generally attempt to acquire the same type of hospital as we do. Some of these other purchasers have greater financial resources than us. Our principal competitors for acquisitions have included Health Management Associates, Inc. and LifePoint Hospitals, Inc. On some occasions, we also compete with HCA Holdings Inc., Universal Health Services, Inc., other non-public, for-profit hospitals and local market hospitals. In addition, some hospitals are sold through an auction process, which may result in higher purchase prices than we believe are reasonable. Therefore, we may not be able to acquire additional hospitals on terms favorable to us.

If we fail to improve the operations of acquired hospitals, we may be unable to achieve our growth strategy.

Many of the hospitals we have acquired had, or future acquisitions may have, significantly lower operating margins than we do and/or operating losses prior to the time we acquired or will acquire them. In the past, we have occasionally experienced temporary delays in improving the operating margins or effectively integrating the operations of these acquired hospitals. In the future, if we are unable to improve the operating margins of acquired hospitals, operate them profitably, or effectively integrate their operations, we may be unable to achieve our growth strategy.

26

If we acquire hospitals with unknown or contingent liabilities, we could become liable for material obligations.

Hospitals that we acquire may have unknown or contingent liabilities, including liabilities for failure to comply with healthcare laws and regulations. Although we generally seek indemnification from prospective sellers covering these matters, we may nevertheless have material liabilities for past activities of acquired hospitals.

State efforts to regulate the construction, acquisition or expansion of hospitals could prevent us from acquiring additional hospitals, renovating our facilities or expanding the breadth of services we offer.

Some states require prior approval for the construction or acquisition of healthcare facilities and for the expansion of healthcare facilities and services. In giving approval, these states consider the need for additional or expanded healthcare facilities or services. In some states in which we operate, we are required to obtain CONs for capital expenditures exceeding a prescribed amount, changes in bed capacity or services and some other matters. Other states may adopt similar legislation. We may not be able to obtain the required CONs or other prior approvals for additional or expanded facilities in the future. In addition, at the time we acquire a hospital, we may agree to replace or expand the facility we are acquiring. If we are not able to obtain required prior approvals, we would not be able to replace or expand the facility and expand the breadth of services we offer. Furthermore, if a CON or other prior approval, upon which we relied to invest in construction of a replacement or expanded facility, were to be revoked or lost through an appeal process, then we may not be able to recover the value of our investment.

State efforts to regulate the sale of hospitals operated by not-for-profit entities could prevent us from acquiring additional hospitals and executing our business strategy.

Many states, including some where we have hospitals and others where we may in the future acquire hospitals, have adopted legislation regarding the sale or other disposition of hospitals operated by not-for-profit entities. In other states that do not have specific legislation, the attorneys general have demonstrated an interest in these transactions under their general obligations to protect the use of charitable assets. These legislative and administrative efforts focus primarily on the appropriate valuation of the assets divested and the use of the proceeds of the sale by the non-profit seller. While these review and, in some instances, approval processes can add additional time to the closing of a hospital acquisition, we have not had any significant difficulties or delays in completing acquisitions. However, future actions on the state level could seriously delay or even prevent our ability to acquire hospitals.

If we are unable to effectively compete for patients, local residents could use other hospitals.

The hospital industry is highly competitive. In addition to the competition we face for acquisitions and physicians, we must also compete with other hospitals and healthcare providers for patients. The competition among hospitals and other healthcare providers for patients has intensified in recent years. The majority of our hospitals are located in non-urban service areas. In over 60% of our markets, we are the sole provider of general acute care health services. In most of our other markets, the primary competitor is a not-for-profit hospital. These not-for-profit hospitals generally differ in each jurisdiction. However, our hospitals face competition from hospitals outside of their primary service area, including hospitals in urban areas that provide more complex services. Patients in our primary service areas may travel to these other hospitals for a variety of reasons. These reasons include physician referrals or the need for services we do not offer. Patients who seek services from these other hospitals may subsequently shift their preferences to those hospitals for the services we provide.

Some of our hospitals operate in primary service areas where they compete with one other hospital; 25 of our hospitals compete with more than one other hospital in their respective primary service areas. Some of these competing hospitals use equipment and services more specialized than those available at our hospitals. In addition, some competing hospitals are owned by tax-supported governmental agencies or not-for-profit entities supported by endowments and charitable contributions. These hospitals do not pay income or property taxes, and can make capital expenditures without paying sales tax. We also face competition from other specialized care providers, including outpatient surgery, orthopedic, oncology and diagnostic centers.

We expect that these competitive trends will continue. Our inability to compete effectively with other hospitals and other healthcare providers could cause local residents to use other hospitals.

27

The failure to obtain our medical supplies at favorable prices could cause our operating results to decline.

We have a participation agreement with HealthTrust, a GPO. This agreement extends to January 2013, with automatic renewal terms of one year, unless either party terminates by giving notice of non-renewal. GPOs attempt to obtain favorable pricing on medical supplies with manufacturers and vendors who sometimes negotiate exclusive supply arrangements in exchange for the discounts they give. To the extent these exclusive supply arrangements are challenged or deemed unenforceable, we could incur higher costs for our medical supplies obtained through HealthTrust. These higher costs could cause our operating results to decline.

There can be no assurance that our arrangement with HealthTrust will provide the discounts we expect to achieve.

If the fair value of our reporting units declines, a material non-cash charge to earnings from impairment of our goodwill could result.

At December 31, 2011, we had approximately $4.3 billion of goodwill recorded on our books. We expect to recover the carrying value of this goodwill through our future cash flows. On an ongoing basis, we evaluate, based on the fair value of our reporting units, whether the carrying value of our goodwill is impaired. If the carrying value of our goodwill is impaired, we may incur a material non-cash charge to earnings.

A significant decline in operating results or other indicators of impairment at one or more of our facilities could result in a material, non-cash charge to earnings to impair the value of long-lived assets.

Our operations are capital intensive and require significant investment in long-lived assets, such as property, equipment and other long-lived intangible assets, including capitalized internal-use software. If one of our facilities experiences declining operating results or is adversely impacted by one or more of these risk factors, we may not be able to recover the carrying value of those assets through our future operating cash flows. On an ongoing basis, we evaluate whether changes in future undiscounted cash flows reflect an impairment in the fair value of our long-lived assets. If the carrying value of those assets is impaired, we may incur a material non-cash charge to earnings.

Risks related to our industry

We are subject to uncertainties regarding healthcare reform.

In recent years, Congress and some state legislatures have introduced an increasing number of proposals to make major changes in the healthcare system, including an increased emphasis on the linkage between quality of care criteria and payment levels such as the submission of patient quality data to the Secretary of Health and Human Services. In addition, CMS conducts ongoing reviews of certain state reimbursement programs.

ARRA was signed into law on February 17, 2009, providing for a temporary increase in the federal matching assistance percentage (FMAP), a temporary increase in federal Medicaid DSH allotments, subsidization of health insurance premiums (COBRA) for up to nine months and grants and loans for infrastructure and incentive payments for providers who adopt and use health information technology. This act also provides penalties by reducing reimbursement from Medicare in the form of reductions to scheduled market basket increases beginning in federal fiscal year 2015 if eligible hospitals and professionals fail to demonstrate meaningful use of electronic health record technology.

PPACA was signed into law on March 23, 2010. In addition, the Reconciliation Act, which contains a number of amendments to PPACA, was signed into law on March 30, 2010. These two healthcare acts, referred to collectively as the Reform Legislation, include a mandate that requires substantially all U.S. citizens to maintain medical insurance coverage which will ultimately increase the number of persons with access to health insurance in the United States. The Reform Legislation should result in a reduction in uninsured patients, which should reduce our expense from uncollectible accounts receivable; however, this legislation makes a number of other changes to Medicare and Medicaid, such as reductions to the Medicare annual market basket update for federal fiscal years 2010 through 2019, a productivity offset to the Medicare market basket update which began October 1, 2011, and a reduction to the Medicare and Medicaid disproportionate share payments, that could adversely impact the reimbursement received under these programs. The various provisions in the Reform Legislation that directly or indirectly affect reimbursement are scheduled to take effect over a number of years, and we cannot predict their impact at this time. Other provisions of the Reform Legislation, such as requirements related to employee health insurance coverage, should increase our operating costs.

28

Also included in the Reform Legislation are provisions aimed at reducing fraud, waste and abuse in the healthcare industry. These provisions allocate significant additional resources to federal enforcement agencies and expand the use of private contractors to recover potentially inappropriate Medicare and Medicaid payments. The Reform Legislation amends several existing federal laws, including the Medicare Anti-Kickback Statute and the False Claims Act, making it easier for government agencies and private plaintiffs to prevail in lawsuits brought against healthcare providers. These amendments also make it easier for potentially severe fines and penalties to be imposed on healthcare providers accused of violating applicable laws and regulations.

In a number of markets, we have partnered with local physicians in the ownership of our facilities. Such investments have been permitted under an exception to the physician self-referral law, or the Stark Law, that allows physicians to invest in an entire hospital (as opposed to individual hospital departments). The Reform Legislation changes the “whole hospital” exception to the Stark Law. The Reform Legislation permits existing physician investments in a whole hospital to continue under a “grandfather” clause if the arrangement satisfies certain requirements and restrictions, but physicians became prohibited, from the time the Reform Legislation became effective, from increasing the aggregate percentage of their ownership in the hospital. The Reform Legislation also restricts the ability of existing physician-owned hospitals to expand the capacity of their facilities. Physician investments in hospitals that are under development are protected by the grandfather clause only if the physician investments have been made and the hospital has a Medicare provider agreement as of a specific date.

The impact of the Reform Legislation on each of our hospitals will vary depending on payor mix and a variety of other factors. We anticipate that many of the provisions in the Reform Legislation will be subject to further clarification and modification through the rule-making process, the development of agency guidance and judicial interpretations. In particular, the Supreme Court of the United States has accepted an appeal of one of the many cases challenging various aspects, including constitutionality of the Reform Legislation. We cannot predict the impact the Reform Legislation may have on our business, results of operations, cash flow, capital resources and liquidity or the ultimate outcome of the judicial rulings. Furthermore, we cannot predict whether we will be able to modify certain aspects of our operations to offset any potential adverse consequences from the Reform Legislation.

If federal or state healthcare programs or managed care companies reduce the payments we receive as reimbursement for services we provide, our net operating revenues may decline.

In 2011, 36.5% of our operating revenues, net of contractual allowances and discounts (but before the provision for bad debts) came from the Medicare and Medicaid programs. Federal healthcare expenditures continue to increase and state governments continue to face budgetary shortfalls as a result of the current economic downturn and accelerating Medicaid enrollment. As a result, federal and state governments have made, and continue to make, significant changes in the Medicare and Medicaid programs. Some of these changes have decreased, or could decrease, the amount of money we receive for our services relating to these programs.

In addition, insurance and managed care companies and other third parties from whom we receive payment for our services increasingly are attempting to control healthcare costs by requiring that hospitals discount payments for their services in exchange for exclusive or preferred participation in their benefit plans. We believe that this trend may continue and our inability to negotiate increased reimbursement rates or maintain existing rates may reduce the payments we receive for our services.

If we fail to comply with extensive laws and government regulations, including fraud and abuse laws, we could suffer penalties or be required to make significant changes to our operations.

The healthcare industry is required to comply with many laws and regulations at the federal, state and local government levels. These laws and regulations require that hospitals meet various requirements, including those relating to the adequacy of medical care, equipment, personnel, operating policies and procedures, maintenance of adequate records, compliance with building codes, environmental protection and privacy. These laws include, in part, the Health Insurance Portability and Accountability Act of 1996 and a section of the Social Security Act, known as the “anti-kickback” statute. If we fail to comply with applicable laws and regulations, including fraud and abuse laws, we could suffer civil or criminal penalties, including the loss of our licenses to operate and our ability to participate in the Medicare, Medicaid and other federal and state healthcare programs.

29

In addition, there are heightened coordinated civil and criminal enforcement efforts by both federal and state government agencies relating to the healthcare industry, including the hospital segment. Recent enforcement actions have focused on financial arrangements between hospitals and physicians, billing for services without adequately documenting the medical necessity for such services and billing for services outside the coverage guidelines for such services. Specific to our hospitals, we have received inquiries and subpoenas from various governmental agencies regarding these and other matters, and we are also subject to various claims and lawsuits relating to such matters. For a further discussion of these matters, see “Legal Proceedings” in Item 3 of this Report.

In the future, different interpretations or enforcement of these laws and regulations could subject our current practices to allegations of impropriety or illegality or could require us to make changes in our facilities, equipment, personnel, services, capital expenditure programs and operating expenses.

A shortage of qualified nurses could limit our ability to grow and deliver hospital healthcare services in a cost-effective manner.

Hospitals are currently experiencing a shortage of nursing professionals, a trend which we expect to continue for some time. If the supply of qualified nurses declines in the markets in which our hospitals operate, it may result in increased labor expenses and lower operating margins at those hospitals. In addition, in some markets like California, there are requirements to maintain specified nurse-staffing levels. To the extent we cannot meet those levels, the healthcare services that we provide in these markets may be reduced.

If we become subject to significant legal actions, we could be subject to substantial uninsured liabilities or increased insurance costs.

In recent years, physicians, hospitals and other healthcare providers have become subject to an increasing number of legal actions alleging malpractice, product liability, or related legal theories. Even in states that have imposed caps on damages, litigants are seeking recoveries under new theories of liability that might not be subject to the caps on damages. Many of these actions involve large claims and significant defense costs. To protect us from the cost of these claims, we maintain claims made professional malpractice liability insurance and general liability insurance coverage in excess of those amounts for which we are self-insured. This insurance coverage is in amounts that we believe to be sufficient for our operations. However, our insurance coverage does not cover all claims against us or may not continue to be available at a reasonable cost for us to maintain adequate levels of insurance. As a percentage of net operating revenues, our expense related to malpractice and other professional liability claims, including the cost of excess insurance, increased in 2009 by 0.3%, decreased in 2010 by 0.3% and decreased in 2011 by 0.2%. If these costs rise rapidly, our profitability could decline. For a further discussion of our insurance coverage, see our discussion of professional liability claims in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 7 of this Report.

If we experience growth in self-pay volume and revenues, our financial condition or results of operations could be adversely affected.

Like others in the hospital industry, we have experienced an increase in our provision for bad debts as a percentage of net operating revenues due to a growth in self-pay volume and revenues. Although we continue to seek ways of improving point of service collection efforts and implementing appropriate payment plans with our patients, if we experience growth in self-pay volume and revenues, our results of operations could be adversely affected. Further, our ability to improve collections for self-pay patients may be limited by statutory, regulatory and investigatory initiatives, including private lawsuits directed at hospital charges and collection practices for uninsured and underinsured patients.

Currently, the global economies, and in particular the United States, are experiencing a period of economic uncertainty and the related financial markets are experiencing a high degree of volatility. This current financial turmoil is adversely affecting the banking system and financial markets and resulting in a tightening in the credit markets, a low level of liquidity in many financial markets and extreme volatility in fixed income, credit, currency

30

and equity markets. This uncertainty poses a risk as it could potentially lead to higher levels of uninsured patients, result in higher levels of patients covered by lower paying government programs and/or result in fiscal uncertainties at both government payors and private insurers.

If our implementation of electronic health record systems is not effective or exceeds our budget and timeline, our consolidated results of operations could be adversely affected.

ARRA created an incentive payment program for eligible hospitals and healthcare professionals to adopt and meaningfully use certified electronic health records, or EHR, technology. The implementation of EHR that meets the meaningful use criteria requires a significant capital investment, and our current plan to implement EHR anticipates maximizing the incentive payment program created by ARRA. If our hospitals and employed professionals are unable to meet the requirements for participation in the incentive payment program, we will not be eligible to receive incentive payments that could offset some of the costs of implementing EHR systems. As additional incentive, beginning in federal fiscal year 2015, if eligible hospitals and professionals fail to demonstrate meaningful use of certified EHR technology, they will be penalized with reduced reimbursement from Medicare in the form of reductions to scheduled market basket increases. If we fail to implement EHR systems effectively and in a timely manner, there could be a material adverse effect on our consolidated financial position and consolidated results of operations.

This Report includes forward-looking statements which could differ from actual future results.

Some of the matters discussed in this Report include forward-looking statements. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” “thinks,” and similar expressions are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results and performance to be materially different from any future results or performance expressed or implied by these forward-looking statements. These factors include the following:

• general economic and business conditions, both nationally and in the regions in which we operate,

• implementation and effect of adopted and potential federal and state healthcare legislation,

• risks associated with our substantial indebtedness, leverage and debt service obligations,

• demographic changes,

• changes in, or the failure to comply with, governmental regulations,

• potential adverse impact of known and unknown government investigations, audits, and Federal and State False Claims Act litigation and other legal proceedings,

• our ability, where appropriate, to enter into and maintain managed care provider arrangements and the terms of these arrangements,

• changes in, or the failure to comply with, managed care provider contracts could result in disputes and changes in reimbursement that could be applied retroactively,

• changes in inpatient or outpatient Medicare and Medicaid payment levels,

• increases in the amount and risk of collectability of patient accounts receivable,

• increases in wages as a result of inflation or competition for highly technical positions and rising supply costs due to market pressure from pharmaceutical companies and new product releases,

• liabilities and other claims asserted against us, including self-insured malpractice claims,

31

• competition,

• our ability to attract and retain, without significant employment costs, qualified personnel, key management, physicians, nurses and other healthcare workers,

• trends toward treatment of patients in less acute or specialty healthcare settings, including ambulatory surgery centers or specialty hospitals,

• changes in medical or other technology,

• changes in U.S. GAAP,

• the availability and terms of capital to fund additional acquisitions or replacement facilities,

• our ability to successfully acquire additional hospitals or complete divestitures,

• our ability to successfully integrate any acquired hospitals or to recognize expected synergies from such acquisitions,

• our ability to obtain adequate levels of general and professional liability insurance and

• timeliness of reimbursement payments received under government programs.

Although we believe that these statements are based upon reasonable assumptions, we can give no assurance that our goals will be achieved. Given these uncertainties, prospective investors are cautioned not to place undue reliance on these forward-looking statements. These forward-looking statements are made as of the date of this filing. We assume no obligation to update or revise them or provide reasons why actual results may differ.

32

PART II

Item 6. Selected Financial Data

The following table summarizes specified selected financial data and should be read in conjunction with our related Consolidated Financial Statements and accompanying Notes to Consolidated Financial Statements. The amounts shown below have been adjusted for discontinued operations.

Community Health Systems, Inc.

Five Year Summary of Selected Financial Data

	Year Ended December 31,
	2011			2010			2009		2008		2007(1)
	(in thousands, except share and per share data)
Consolidated Statement of Income Data
Net operating revenues	$	11,906,212		$	11,092,422		$	10,333,501	$	9,398,781	$	6,059,374
Income from operations		1,134,485			1,121,044			1,064,831		970,086		470,598
Income from continuing operations		335,894			355,213			305,811		238,386		70,351
Net income		277,623			348,441			306,377		252,734		44,691
Net income attributable to noncontrolling interests		75,675			68,458			63,227		34,430		14,402
Net income attributable to Community Health Systems, Inc		201,948			279,983			243,150		218,304		30,289
Basic earnings per share attributable to Community Health Systems, Inc. common stockholders (2):
Continuing operations	$	2.89		$	3.13		$	2.68	$	2.18	$	0.61
Discontinued operations		(0.65	)		(0.07	)		—		0.16		(0.29	)
Net income	$	2.24		$	3.05		$	2.68	$	2.34	$	0.32
Diluted earnings per share attributable to Community Health Systems, Inc. common stockholders (2):
Continuing operations	$	2.87		$	3.08		$	2.65	$	2.16	$	0.60
Discontinued operations		(0.64	)		(0.07	)		—		0.16		(0.28	)
Net income	$	2.23		$	3.01		$	2.66	$	2.32	$	0.32
Weighted-average number of shares outstanding
Basic		89,966,933			91,718,791			90,614,886		93,371,782		93,517,337
Diluted (3)		90,666,348			92,946,048			91,517,274		94,288,829		94,642,294
Consolidated Balance Sheet Data
Cash and cash equivalents	$	129,865		$	299,169		$	344,541	$	220,655	$	133,574
Total assets		15,208,840			14,698,123			14,021,472		13,818,254		13,493,644
Long-term obligations		10,437,513			10,418,234			10,179,402		10,287,535		9,974,516
Redeemable noncontrolling interests in equity of consolidated subsidiaries		395,743			387,472			368,857		348,816		346,999
Community Health Systems, Inc. stockholders’ equity		2,397,096			2,189,464			1,950,635		1,611,029		1,687,293
Noncontrolling interests in equity of consolidated subsidiaries		67,349			60,913			64,782		61,457		51,419

(1) Includes the results of operations of the former Triad hospitals from July 25, 2007, the date of acquisition.

(2) Total per share amounts may not add due to rounding.

(3) See Note 12 to the Consolidated Financial Statements, included in Item 8 of this Form 10-K.

33

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

You should read this discussion together with our Consolidated Financial Statements and the accompanying Notes to Consolidated Financial Statements and “Selected Financial Data” included elsewhere in this Form 10-K.

Executive Overview

We are one of the largest publicly-traded operators of hospitals in the United States in terms of number of facilities and net operating revenues. We provide healthcare services through the hospitals that we own and operate in non-urban and selected urban markets. We generate revenue primarily by providing a broad range of general hospital healthcare services to patients in the communities in which we are located. We currently own and operate 133 hospitals comprised of 129 general acute care hospitals and four stand-alone rehabilitation or psychiatric hospitals. In addition, we own and operate home care agencies, located primarily in markets where we also operate a hospital, and through our wholly-owned subsidiary, Quorum Health Resources, LLC, or QHR, we provide management and consulting services to non-affiliated general acute care hospitals located throughout the United States. For the hospitals and home care agencies that we own and operate, we are paid for our services by governmental agencies, private insurers and directly by the patients we serve. For our management and consulting services, we are paid by the non-affiliated hospitals utilizing our services.

In 2011, we continued the execution of our acquisition strategy by acquiring a total of four hospitals located in Scranton, Pennsylvania; Tunkhannock, Pennsylvania; Nanticoke, Pennsylvania and Tomball, Texas. In 2010, we acquired a total of five hospitals located in Marion, South Carolina; Youngstown and Warren, Ohio and Bluefield, West Virginia.

Additionally, during 2011, we sold three hospitals and a multi-specialty physician clinic. Accordingly, the related results of operations, impairment of long-lived assets held for sale and the loss on sale of these entities have been classified as discontinued operations in the consolidated statements of income for all years presented.

During 2011, we experienced same-store decreases of 5.6% in inpatient admissions and 0.7% in adjusted admissions, when compared to the year ended December 31, 2010. Same-store outpatient surgeries increased 4.0% in 2011, when compared to the year ended December 31, 2010. Contributing to the decrease in inpatient admissions were decreases in admissions from women’s services including obstetrics and gynecology, reductions in one day stay inpatient admissions from the emergency room, reductions in surgical inpatient admissions, reductions due to certain service closures in a few of our hospitals and reductions due to competition and weather. Offsetting these decreases, we experienced increases in outpatient surgical visits and outpatient registrations and had an increase in the average acuity of inpatient admissions. Our net operating revenues for the year ended December 31, 2011 increased to approximately $11.9 billion, as compared to approximately $11.1 billion for the year ended December 31, 2010. The loss on early extinguishment of debt decreased income from continuing operations, before noncontrolling interests for the year ended December 31, 2011, resulting in a decrease of 5.4% over the year ended December 31, 2010. The loss on early extinguishment of debt related to the purchase of $1.0 billion aggregate principal amount of the 8 ⁷/8% Senior Notes with proceeds from the sale of $1.0 billion aggregate principal amount of the 8% Senior Notes. Excluding the loss on early extinguishment of debt, our income from continuing operations, before noncontrolling interests, for the year ended December 31, 2011 increased 6.4% compared to the year ended December 31, 2010. This increase is due primarily to higher revenues from an increase in outpatient services, which offset the decrease in inpatient admissions, an increase in average acuity of inpatient admissions and the elimination of certain unprofitable services in a few of our hospitals. It also reflects our ability to reduce supply expense as a percentage of net operating revenues, although our expense savings were partially offset by expenses related to the Tenet lawsuit, shareholder lawsuits and government investigations.

Self-pay revenues represented approximately 12.0% of our operating revenues, net of contractual allowances and discounts (but before the provision for bad debts) in 2011 compared to 11.5% in 2010. The amount of foregone revenue related to providing charity care services as a percentage of net operating revenues was approximately 5.5% and 4.6% in 2011 and 2010, respectively. Direct and indirect costs incurred by us in providing charity care services were approximately 1.1% and 1.0% of net operating revenues in 2011 and 2010, respectively.

34

The Patient Protection and Affordable Care Act, or PPACA, was signed into law on March 23, 2010. In addition, the Health Care and Education Affordability Reconciliation Act of 2010, or Reconciliation Act, which contains a number of amendments to PPACA, was signed into law on March 30, 2010. These two healthcare acts, referred to collectively as the Reform Legislation, include a mandate that requires substantially all United States citizens to maintain medical insurance coverage which will ultimately increase the number of persons with access to health insurance in the United States. The Reform Legislation should result in a reduction in uninsured patients, which should reduce our expense from uncollectible accounts receivable; however, this legislation makes a number of other changes to Medicare and Medicaid, such as reductions to the Medicare annual market basket update for federal fiscal years 2010 through 2019, a productivity offset to the Medicare market basket update, and a reduction to the Medicare and Medicaid disproportionate share payments, that could adversely impact the reimbursement received under these programs. The various provisions in the Reform Legislation that directly or indirectly affect reimbursement are scheduled to take effect over a number of years, and we cannot predict their impact at this time. Other provisions of the Reform Legislation, such as requirements related to employee health insurance coverage, should increase our operating costs.

Also included in the Reform Legislation are provisions aimed at reducing fraud, waste and abuse in the healthcare industry. These provisions allocate significant additional resources to federal enforcement agencies and expand the use of private contractors to recover potentially inappropriate Medicare and Medicaid payments. The Reform Legislation amends several existing federal laws, including the federal anti-kickback statute and the False Claims Act, making it easier for government agencies and private plaintiffs to prevail in lawsuits brought against healthcare providers. These amendments also make it easier for potentially severe fines and penalties to be imposed on healthcare providers accused of violating applicable laws and regulations.

In a number of markets, we have partnered with local physicians in the ownership of our facilities. Such investments have been permitted under an exception to the physician self-referral law, or the Stark Law, that allows physicians to invest in an entire hospital (as opposed to individual hospital departments). The Reform Legislation changes the “whole hospital” exception to the Stark Law. The Reform Legislation permits existing physician investments in a whole hospital to continue under a “grandfather” clause if the arrangement satisfies certain requirements and restrictions, but physicians became prohibited, from the time the Reform Legislation became effective, from increasing the aggregate percentage of their ownership in the hospital. The Reform Legislation also restricts the ability of existing physician-owned hospitals to expand the capacity of their facilities.

The impact of the Reform Legislation on each of our hospitals will vary depending on payor mix and a variety of other factors. We anticipate that many of the provisions in the Reform Legislation will be subject to further clarification and modification through the rule-making process, the development of agency guidance and judicial interpretations. Moreover, twenty-six state attorneys general have jointly filed a challenge to certain aspects of the Reform Legislation. Currently, rulings in four separate federal Courts of Appeals have led to a split among the federal Circuit Courts regarding the constitutionality of the Reform Legislation. The Fourth Circuit, Sixth Circuit and the Court of Appeals for the D.C. Circuit have ruled in favor of the Reform Legislation while the Eleventh Circuit ruled the individual mandate within the Reform Legislation unconstitutional. The United States Supreme Court granted certiorari on or about November 14, 2011 to hear the appeal of the Eleventh Circuit’s ruling, with oral argument set for March 26 through 28, 2012. The Supreme Court will hear oral argument on four issues: (1) does the Anti-Injunction Act bar a legal challenge to the individual mandate aspect of the Reform Legislation until that mandate takes effect in 2014; (2) is the individual mandate aspect of the Reform Legislation constitutional; (3) if not, is the individual mandate aspect of the Reform Legislation severable from the Reform Legislation as a whole such that it may be stricken without nullifying the Reform Legislation in its entirety and (4) can the states be compelled by the federal government to expand their Medicaid expenditures or risk losing federal funding if they refuse. We cannot predict the impact the Reform Legislation may have on our business, results of operations, cash flow, capital resources and liquidity or the ultimate outcome of the Supreme Court case. Furthermore, we cannot predict whether we will be able to modify certain aspects of our operations to offset any potential adverse consequences from the Reform Legislation.

In addition to the Reform Legislation, the American Recovery and Reinvestment Act of 2009 included provisions for implementing health information technology under the Health Information Technology for Economic and Clinical Health Act, or HITECH. These provisions were designed to increase the use of electronic health records, or EHR, technology and establish the requirements for a Medicare and Medicaid incentive payments program

35

beginning in 2011 for eligible hospitals and providers that adopt and meaningfully use certified EHR technology. These incentive payments are intended to offset a portion of the costs incurred to implement and qualify as a meaningful user of EHR. Rules adopted in July 2010 by the Department of Health and Human Services established an initial set of standards and certification criteria. Our hospital facilities have begun to implement EHR technology on a facility-by-facility basis beginning in 2011. We anticipate recognizing incentive reimbursement related to the Medicare or Medicaid incentives as we are able to implement the certified EHR technology, meet the defined “meaningful use criteria,” and information from completed cost report periods is available from which to calculate the incentive reimbursement. The timing of recognizing incentive reimbursement will not correlate with the timing of recognizing operating expenses and incurring capital costs in connection with the implementation of EHR technology which may result in material period-to-period changes in our future results of operations. Hospitals that do not qualify as a meaningful user of EHR technology by 2015 are subject to a reduced market basket update to the inpatient prospective payment system standardized amount in 2015 and each subsequent fiscal year. Although we believe that our hospital facilities will be in compliance with the EHR standards by 2015, there can be no assurance that all of our facilities will be in compliance and therefore not subject to the penalty provisions of HITECH. During the year ended December 31, 2011, we recognized approximately $63.4 million of HITECH incentive reimbursements from Medicaid, which are presented as a reduction of operating expenses.

Effective January 1, 2012, we completed the acquisition of Moses Taylor Healthcare System, located in northeast Pennsylvania. This healthcare system includes Moses Taylor Hospital in Scranton, Pennsylvania (217 licensed beds) and Mid-Valley Hospital in Peckville, Pennsylvania (25 licensed beds). The total cash consideration paid at closing for long-lived assets was approximately $152.0 million and for preliminary net working capital was approximately $10.0 million. We have signed definitive agreements for the acquisition of two hospitals, located in York, Pennsylvania and Blue Island, Illinois, which are scheduled to close in 2012.

In addition, effective February 2, 2012, we completed an amendment and restatement of our existing Credit Facility. The amendment extended by two and a half years the maturity date of $1.6 billion of our existing non-extended term loans under the Credit Facility to January 25, 2017 (subject to customary acceleration events) or, if more than $50 million of our 8 ⁷/8% Senior Notes are outstanding on April 15, 2015, to April 15, 2015. The amendment also increased the pricing on the newly extended term loans by 125 basis points and amended certain covenants and certain other terms and conditions of the Credit Facility.

As a result of our current levels of cash, available borrowing capacity, long-term outlook on our debt repayments, the refinancing of our term loans and our continued projection of our ability to generate cash flows, we do not anticipate a significant impact on our ability to invest the necessary capital in our business over the next twelve months and into the foreseeable future. We believe there continues to be ample opportunity for growth in substantially all of our markets by decreasing the need for patients to travel outside their communities for healthcare services. Furthermore, we continue to benefit from synergies from our acquisitions and will continue to strive to improve operating efficiencies and procedures in order to improve our profitability at all of our hospitals.

Acquisitions and Divestitures

Effective October 22, 2011, we sold Cleveland Regional Medical Center, located in Cleveland, Texas, and other related healthcare assets affiliated with the hospital to New Directions Health Systems, LLC for approximately $0.9 million in cash. The carrying amount of the net assets sold in this transaction, including an allocation of reporting unit goodwill, was approximately $14.2 million.

Effective October 1, 2011, we completed the acquisition of Tomball Regional Hospital (358 licensed beds) located in Tomball, Texas. The total cash consideration paid for fixed assets and working capital was approximately $192.0 million and $17.5 million, respectively, with additional consideration of $15.8 million assumed in liabilities, for a total consideration of $225.3 million. Based upon our preliminary purchase price allocation relating to this acquisition as of December 31, 2011, approximately $30.8 million of goodwill has been recorded. The preliminary allocation of the purchase price has been determined by us based on available information and is subject to settling amounts related to purchased working capital and final appraisals of tangible and intangible assets. Adjustments to the purchase price allocation are not expected to be material.

36

Effective September 1, 2011, we sold Southcrest Hospital, located in Tulsa, Oklahoma, Claremore Regional Hospital, located in Claremore, Oklahoma, and other related healthcare assets affiliated with those hospitals to Hillcrest Healthcare System, part of Ardent Health Services, for approximately $154.2 million in cash. The carrying amount of the net assets sold in this transaction, including an allocation of reporting unit goodwill, was approximately $193.0 million.

Effective May 1, 2011, we completed the acquisition of Mercy Health Partners based in Scranton, Pennsylvania, which is a healthcare system comprised of two acute care hospitals, a long-term acute care facility and other healthcare providers. This healthcare system includes Regional Hospital of Scranton (198 licensed beds) located in Scranton, Pennsylvania, and Tyler Memorial Hospital (48 licensed beds) located in Tunkhannock, Pennsylvania. This healthcare system also includes a long-term acute care facility, Special Care Hospital (67 licensed beds) located in Nanticoke, Pennsylvania, as well as several outpatient clinics and other ancillary facilities. The total cash consideration paid for fixed assets was approximately $150.8 million, with additional consideration of $12.3 million assumed in liabilities as well as a credit applied at closing of $2.1 million for negative acquired working capital, for a total consideration of $161.0 million. Based upon our final purchase price allocation relating to this acquisition as of December 31, 2011, approximately $43.1 million of goodwill has been recorded.

Effective February 1, 2011, we sold Willamette Community Medical Group, which is a physician clinic operating as Oregon Medical Group, or OMG, located in Springfield, Oregon, to Oregon Healthcare Resources, LLC, for $14.6 million in cash; this business had a carrying amount of net assets, including an allocation of reporting unit goodwill, of $19.7 million.

Additionally, during 2011, we paid approximately $57.9 million to acquire the operating assets and related businesses of certain physician practices, clinics and other ancillary businesses that operate within the communities served by our hospitals. In connection with these acquisitions, we allocated approximately $13.1 million of the consideration paid to property and equipment, $2.9 million to net working capital, $1.6 million to other intangible assets and the remainder, approximately $40.3 million consisting of intangible assets that do not qualify for separate recognition, was allocated to goodwill. These acquisition transactions were accounted for as purchase business combinations.

Sources of Revenue

The following table presents the approximate percentages of operating revenues, net of contractual allowances and discounts (but before provision for bad debts) by payor source for the periods indicated. The data for the years presented are not strictly comparable due to the effect that hospital acquisitions have had on these statistics.

	Year Ended December 31,
	2011			2010			2009
Medicare		26.8	%		27.4	%		27.4	%
Medicaid		9.7	%		10.7	%		9.8	%
Managed Care and other third-party payors		51.5	%		50.4	%		51.6	%
Self-pay		12.0	%		11.5	%		11.2	%
Total		100.0	%		100.0	%		100.0	%

Net operating revenues include amounts estimated by management to be reimbursable by Medicare and Medicaid under prospective payment systems and provisions of cost-based reimbursement and other payment methods. In addition, we are reimbursed by non-governmental payors using a variety of payment methodologies. Amounts we receive for treatment of patients covered by these programs are generally less than the standard billing rates. We account for the differences between the estimated program reimbursement rates and the standard billing rates as contractual allowance adjustments, which we deduct from gross revenues to arrive at net operating revenues. Final settlements under some of these programs are subject to adjustment based on administrative review and audit by third parties. We account for adjustments to previous program reimbursement estimates as contractual allowance adjustments and report them in the periods that such adjustments become known. Contractual allowance adjustments related to final settlements and previous program reimbursement estimates impacted net operating revenues and net

37

income by an insignificant amount in each of the years ended December 31, 2011, 2010 and 2009. In the future, we expect the percentage of revenues received from the Medicare program to increase due to the general aging of the population.

Currently, several states utilize supplemental reimbursement programs for the purpose of providing reimbursement to providers to offset a portion of the cost of providing care to Medicaid and indigent patients. These programs are designed with input from Centers for Medicare and Medicaid Services, or CMS, and are funded with a combination of state and federal resources, including, in certain instances, fees or taxes levied on the providers. Similar programs are also being considered by other states. After these supplemental programs are signed into law, we recognize revenue and related expenses in the period in which amounts are estimable and collection is reasonably assured. Reimbursement under these programs is reflected in net operating revenues and included as Medicaid revenue in the table above, and fees, taxes or other program related costs are reflected in other operating costs and expenses.

The payment rates under the Medicare program for hospital inpatient and outpatient acute care services are based on a prospective payment system, depending upon the diagnosis of a patient’s condition. These rates are indexed for inflation annually, although increases have historically been less than actual inflation. On August 18, 2011, CMS issued the final rule to adjust this index by 3.0% for hospital inpatient acute care services that are reimbursed under the prospective payment system. The final rule also made other payment adjustments that, coupled with the 0.1% reduction to hospital inpatient rates implemented pursuant to the Reform Legislation, yielded a net 1.1% increase in reimbursement for hospital inpatient acute care services beginning October 1, 2011. Reductions in the rate of increase or overall reductions in Medicare reimbursement may cause a decline in the growth of our net operating revenues. In addition, specified managed care programs, insurance companies and employers are actively negotiating the amounts paid to hospitals. The trend toward increased enrollment in managed care may adversely affect our net operating revenue growth.

In addition, specified managed care programs, insurance companies and employers are actively negotiating the amounts paid to hospitals. The trend toward increased enrollment in managed care may adversely affect our net operating revenue growth.

Results of Operations

Our hospitals offer a variety of services involving a broad range of inpatient and outpatient medical and surgical services. These include general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic services, psychiatric and rehabilitation services. The strongest demand for hospital services generally occurs during January through April and the weakest demand for these services occurs during the summer months. Accordingly, eliminating the effect of new acquisitions, our net operating revenues and earnings are historically highest during the first quarter and lowest during the third quarter.

38

The following tables summarize, for the periods indicated, selected operating data.

	Year Ended December 31,
	2011			2010			2009
	(Expressed as a percentage of net operating revenues)
Consolidated
Net operating revenues		100.0	%		100.0	%		100.0	%
Operating expenses (a)		(85.0	)		(84.5	)		(84.4	)
Depreciation and amortization		(5.5	)		(5.4	)		(5.3	)
Income from operations		9.5			10.1			10.3
Interest expense, net		(5.4	)		(5.8	)		(6.3	)
Loss (gain) from early extinguishment of debt (b)		(0.5	)		—			—
Equity in earnings of unconsolidated affiliates		0.4			0.4			0.4
Impairment of long-lived and other assets		—			—			(0.1	)
Income from continuing operations before income taxes		4.0			4.7			4.3
Provision for income taxes		(1.2	)		(1.5	)		(1.3	)
Income from continuing operations		2.8			3.2			3.0
(Loss) income from discontinued operations, net of taxes		(0.5	)		(0.1	)		—
Net income		2.3			3.1			3.0
Less: Net income attributable to noncontrolling interests		(0.6	)		(0.6	)		(0.6	)
Net income attributable to Community Health Systems, Inc.		1.7	%		2.5	%		2.4	%

	Year Ended December 31,
	2011			2010
	(Expressed in percentages)
Percentage increase (decrease) from same period prior year:
Net operating revenues		7.3	%		7.3	%
Admissions		(0.5	)		0.4
Adjusted admissions(c)		4.2			2.8
Average length of stay		2.3			0.0
Net income attributable to Community Health Systems, Inc. (d)		(27.9	)		15.1
Same-store percentage increase (decrease) from same period prior year(e):
Net operating revenues		2.9	%		3.7	%
Admissions		(5.6	)		(2.4	)
Adjusted admissions(c)		(0.7	)		(0.3	)

(a) Operating expenses include salaries and benefits, supplies, other operating expenses, electronic health records incentive reimbursement and rent.

39

(b) Both the gain from early extinguishment of debt and income from discontinued operations were less than 0.1% for the year ended December 31, 2009.

(c) Adjusted admissions is a general measure of combined inpatient and outpatient volume. We computed adjusted admissions by multiplying admissions by gross patient revenues and then dividing that number by gross inpatient revenues.

(d) Includes income from discontinued operations, if any.

(e) Includes acquired hospitals to the extent we operated them in both years.

Year Ended December 31, 2011 Compared to Year Ended December 31, 2010

Net operating revenues increased by 7.3% to approximately $11.9 billion in 2011, from approximately $11.1 billion in 2010. Growth from hospitals owned throughout both periods contributed $323 million of that increase and $490 million was contributed by hospitals acquired in 2011 and 2010. On a same-store basis, net operating revenues increased 2.9%. The increased net operating revenues contributed by hospitals that we owned throughout both periods were primarily attributable to general rate and reimbursement increases including revenues from states with provider assessment programs.

On a consolidated basis, inpatient admissions decreased by 0.5% and adjusted admissions increased by 4.2%. On a same-store basis, inpatient admissions decreased by 5.6% and adjusted admissions decreased by 0.7% during the year ended December 31, 2011. This decrease in same-store inpatient admissions was due primarily to a decrease in admissions from women’s services including obstetrics and gynecology, reductions in one day stays from the emergency room, reductions in surgical inpatient admissions and reductions due to competition, weather and certain service closures in a few of our hospitals during the year ended December 31, 2011, as compared to the year ended December 31, 2010. The reductions in surgical inpatient admissions were offset with a corresponding increase in outpatient surgical visits.

Operating expenses, excluding depreciation and amortization, as a percentage of net operating revenues, increased from 84.5% in 2010 to 85.0% in 2011. Salaries and benefits, as a percentage of net operating revenues, increased from 45.9% in 2010 to 46.9% in 2011 as a result of recent acquisitions and an increase in the number of employed physicians. Supplies, as a percentage of net operating revenues, decreased from 15.7% in 2010 to 15.4% in 2011. This decrease in supplies expenses is due primarily to greater utilization of and improved pricing under our purchasing program. Other operating expenses, as a percentage of net operating revenues, increased from 20.7% in 2010 to 21.1% in 2011. Rent, as a percentage of net operating revenues, decreased from 2.2% in 2010 to 2.1% in 2011.

Electronic health records incentive reimbursements represent those incentives under the HITECH Act for which the recognition criterion has been met. For the year ended December 31, 2011, we have recognized approximately $63.4 million of incentive reimbursements, or 0.5% of net operating revenues. Of these incentives, we had received payments of $28.9 million through December 31, 2011. Operating expenses incurred related to the installation and adoption of electronic health records, including depreciation and amortization, totaled approximately 0.2% of net operating revenues in 2011, of which depreciation and amortization represented less than 0.1% of net operating revenues.

Depreciation and amortization, as a percentage of net operating revenues, increased from 5.4% in 2010 to 5.5% in 2011.

Interest expense, net, decreased by $3.2 million from $647.6 million in 2010, to $644.4 million in 2011. A decrease in our average outstanding debt during 2011, compared to 2010, resulted in a decrease in interest expense of $1.3 million. Additionally, interest expense decreased by $9.7 million as a result of more interest being capitalized during 2011, as compared to 2010, as the current year period had more major construction projects. These increases were offset by an increase in interest rates during 2011, including the pricing increase on $1.5 billion of our existing term loans under the amended Credit Facility beginning November 5, 2010, compared to 2010, resulting in an increase in interest expense of $7.8 million. Interest savings in 2012 from replacing $1.0 billion aggregate principal amount of our 8 ⁷/8% Senior Notes with our 8% Senior Notes will be more than offset by the higher interest rate on the $1.6 billion of extended term loans under the second amendment and restatement of the Credit Facility that was effective on February 2, 2012.

40

Loss from early extinguishment of debt was recognized after the purchase of up to $1.0 billion aggregate principal amount of CHS’ outstanding 8 ⁷/8% Senior Notes due 2015.

Equity in earnings of unconsolidated affiliates, as a percentage of net operating revenues, remained consistent at 0.4% for 2010 and 2011.

The net results of the above mentioned changes resulted in income from continuing operations before income taxes decreasing $45.4 million from $518.9 million in 2010 to $473.5 million for 2011.

Provision for income taxes from continuing operations decreased from $163.7 million in 2010 to $137.7 million in 2011 due to the decrease in income from continuing operations before income taxes. Our effective tax rates were 29.1% and 31.6% for the years ended December 31, 2011 and 2010, respectively. The decrease in our effective tax rate is primarily related to the release of uncertain tax positions and an increase in federal tax credits.

Income from continuing operations, as a percentage of net operating revenues, decreased from 3.2% in 2010 to 2.8% in 2011. The decrease is primarily due to the loss from early extinguishment of debt discussed above.

Net income, as a percentage of net operating revenues, decreased from 3.1% in 2010 to 2.3% in 2011. The decrease is primarily due to the loss from early extinguishment of debt and loss from discontinued operations.

Net income attributable to noncontrolling interests as a percentage of net operating revenues remained consistent at 0.6% for the years ended December 31, 2011 and 2010.

Net income attributable to Community Health Systems, Inc. was $201.9 million in 2011 compared to $280.0 million in 2010, a decrease of 27.9%. The decrease in net income attributable to Community Health Systems, Inc. is reflective of the loss from early extinguishment of debt and loss from discontinued operations.

Year Ended December 31, 2010 Compared to Year Ended December 31, 2009

Net operating revenues increased by 7.3% to approximately $11.1 billion in 2010, from approximately $10.3 billion in 2009. Growth from hospitals owned throughout both periods contributed $378 million of that increase and $381 million was contributed by hospitals acquired in 2010 and 2009. On a same-store basis, net operating revenues increased 3.7%. The increased net operating revenues contributed by hospitals that we owned throughout both periods were primarily attributable to general rate and reimbursement increases.

On a consolidated basis, inpatient admissions increased by 0.4% and adjusted admissions increased by 2.8%. On a same-store basis, inpatient admissions decreased by 2.4% during the year ended December 31, 2010. This decrease in inpatient admissions was due primarily to a decrease in admissions from a less severe flu season as compared to the prior year period, lower birth rates coinciding with the downturn in the economy, reductions in one day stays and certain service closures during the year ended December 31, 2010, as compared to the year ended December 31, 2009.

Operating expenses, excluding depreciation and amortization, as a percentage of net operating revenues, increased from 84.4% in 2009 to 84.5% in 2010. Salaries and benefits, as a percentage of net operating revenues, increased from 45.5% in 2009 to 45.9% in 2010 as a result of recent acquisitions and an increase in the number of employed physicians, which offset efficiencies gained at hospitals owned throughout both periods. Supplies, as a percentage of net operating revenues, decreased from 16.0% in 2009 to 15.7% in 2010. This decrease in supplies expenses is due primarily to greater utilization of and improved pricing under our purchasing program. Other operating expenses, as a percentage of net operating revenues, increased from 20.6% in 2009 to 20.7% in 2010. Rent, as a percentage of net operating revenues, decreased from 2.3% in 2009 to 2.2% in 2010.

Depreciation and amortization increased from 5.3% of net operating revenues in 2009 to 5.4% of net operating revenues in 2010.

41

Interest expense, net, increased by $4.0 million from $643.6 million in 2009, to $647.6 million in 2010. An increase in interest rates during 2010, including the pricing increase on $1.5 billion of our existing term loans under the amended Credit Facility beginning November 5, 2010, compared to 2009, resulted in an increase in interest expense of $5.9 million. Additionally, interest expense increased by $5.3 million as a result of less interest being capitalized during 2010, as compared to 2009, as the current year period had fewer major construction projects. These increases were offset by a decrease in interest expense of $7.2 million due to a decrease in our average outstanding debt during 2010, compared to 2009.

Equity in earnings of unconsolidated affiliates, as a percentage of net operating revenues, remained consistent at 0.4% in 2009 and 2010.

Impairment of long-lived and other assets of $12.5 million in 2009 resulted from our assessment of the recoverability of these assets. No impairment of long-lived and other assets was recognized in 2010.

The net results of the above mentioned changes resulted in income from continuing operations before income taxes increasing $71.2 million from $447.7 million in 2009 to $518.9 million for 2010.

Provision for income taxes from continuing operations increased from $141.9 million in 2009 to $163.7 million in 2010 due to the increase in income from continuing operations before income taxes. Our effective tax rates were 31.6% and 31.7% for the years ended December 31, 2010 and 2009, respectively. The decrease in our effective tax rate is primarily a result of a decrease in our effective state tax rate.

Income from continuing operations, as a percentage of net operating revenues, increased from 3.0% in 2009 to 3.2% in 2010. The increase is primarily due to the decrease in interest expense as a percentage of net operating revenues, discussed above.

Net income, as a percentage of net operating revenues, increased from 3.0% in 2009 to 3.1% in 2010. The increase is primarily due to the decrease in interest expense as a percentage of net operating revenues, discussed above.

Net income attributable to noncontrolling interests as a percentage of net operating revenues remained consistent at 0.6% for the years ended December 31, 2010 and 2009.

Net income attributable to Community Health Systems, Inc. was $280.0 million in 2010 compared to $243.2 million in 2009, an increase of 15.1%. The increase in net income attributable to Community Health Systems, Inc. is reflective of the increase in net operating revenues while maintaining substantially the same profit margin levels as discussed above.

Liquidity and Capital Resources

2011 Compared to 2010

Net cash provided by operating activities increased $73.2 million, from approximately $1.2 billion for the year ended December 31, 2010 to approximately $1.3 billion for the year ended December 31, 2011. Net income, adjusted for non-cash expenses of depreciation and amortization expense of $47.8 million, impairment of hospitals sold of $47.9 million, loss on early extinguishment of debt of $66.0 million and all other non-cash charges of $37.2 million, resulted in an increase in cash flows from operating activities of $128.1 million. In addition, an increase in cash flows from accounts payable, accrued liabilities and income taxes, primarily as a result of the timing of payments, increased cash flows from operating activities by $84.2 million. These increases in cash flows were offset by a decrease in cash flows from supplies, prepaid expenses and other current assets of $3.0 million, a decrease in cash flows generated from the change in all other assets and liabilities of $24.8 million, and decreases in cash generated from accounts receivable of $111.3 million, primarily a result of delays in payment from the Illinois Medicaid program, which contributed to our three-day decline in account receivable days outstanding in 2011 compared to a two-day improvement in 2010.

42

The cash used in investing activities increased $151.5 million, from approximately $1.0 billion for the year ended December 31, 2010 to approximately $1.2 billion for the year ended December 31, 2011. The increase in cash used in investing activities, in comparison to the prior year, is primarily attributable to an increase in cash paid for acquisitions of facilities and other related equipment of $167.1 million, an increase in the cash used for the purchase of property and equipment of $109.3 million and an increase in cash used for the acquisition of software, primarily related to electronic health records, resulting in an increase in other investments of $51.3 million. These increases in cash used in investing activities were offset by an increase in the amount of the proceeds from the sale of property and equipment of $2.8 million and the proceeds of $173.4 million from the sale of three hospitals in 2011. There were no hospital divestitures in 2010. We anticipate being able to fund future routine capital expenditures with cash flows generated from operations.

In 2011, our net cash used in financing activities increased $45.6 million from $189.8 million in 2010 to $235.4 million in 2011. The increase in cash used in financing activities, in comparison to the prior year, is primarily due to an increase in deferred financing costs of $6.0 million associated with the issuance of our 8% Senior Notes, a reduction in the proceeds from the exercise of stock options of $38.0 million, an increase in the repurchase of restricted stock shares for payroll tax withholding requirements of $13.3 million and a reduction in the proceeds from noncontrolling investors in joint ventures of $6.0 million as the Reform Legislation significantly limits the selling of noncontrolling interests to physician investors. The net increase in all other financing activities was $22.5 million. This included an increase in borrowings under our Credit Facility and the issuance of our 8% Senior Notes, but was mostly offset by repayments of our long-term debt. These increases were offset by a decrease in the repurchases of our common stock of $28.2 million and a reduction in the distributions to noncontrolling investors in joint ventures of $12.0 million.

In 2011, we used $85.7 million for the repurchase and retirement of 3,469,866 shares of our outstanding common stock on the open market. We believed this to be a prudent use of cash as a result of our low market valuation when compared with historical valuations of both our stock and other healthcare providers’ stock. Our Credit Facility limits our ability to pay dividends and/or repurchase stock to an amount not to exceed $50 million in the aggregate after November 5, 2010, the date of the initial amendment and restatement of our Credit Facility. In addition, our Credit Facility allows us to repurchase stock in an amount not to exceed the aggregate amount of proceeds from the exercise of stock options. The indentures governing our Senior Notes also limit our ability to pay dividends and/or repurchase stock. As of December 31, 2011, under the most restrictive test under these agreements, we have approximately $30.1 million remaining available with which to pay permitted dividends and/or make stock and Senior Notes repurchases.

In 2011, we successfully continued efforts commenced in 2010 to access the capital markets and extend the maturities of our long-term indebtedness. Our current debt structure was put into place in connection with our acquisition of Triad in 2007 and the then balance of our $6.1 billion Credit Facility term loans was to mature on July 25, 2014; the approximately $3.0 billion aggregate principal amount of 8 ⁷/8% Senior Notes were due July 25, 2015. In November 2011, we completed an offering of $1.0 billion aggregate principal amount of 8% Senior Notes (due 2019), the proceeds of which were used, together with available cash on hand, to finance the repurchase of up to $1.0 billion aggregate principal amount of our 8 ⁷/8% Senior Notes. Subsequent to year end, on February 2, 2012, we completed an amendment and extension of our Credit Facility to extend the maturity date of $1.6 billion of our existing term loans under the Credit Facility by two and a half years, to January 25, 2017, the same maturity date as the November 2010 amendment and extension of $1.5 billion in principal amount of our existing term loans (and at the same increased pricing by 125 basis points). We believe that we will continue to be able to extend the maturities on the unextended portions of our existing Credit Facility (now, approximately $2.9 billion), albeit at higher interest rates, and that we should be able to replace our remaining 8 ⁷/8% Senior Notes (approximately $1.8 billion in principal amount) at lower interest rates. The table below sets forth addition detail about our upcoming cash obligations and a further discussion of our existing Credit Facility is set out under the section “Capital Resources” in Item 7 of this Report. We do not anticipate the need to use funds currently available under our Credit Facility for purposes of funding our operations, although these funds could be used for the purpose of making further acquisitions or for restructuring our existing debt. Furthermore, we anticipate we will remain in compliance with our debt covenants through the next 12 months and beyond into the foreseeable future.

43

As described in Notes 6, 9 and 15 of the Notes to Consolidated Financial Statements, at December 31, 2011, we had certain cash obligations, which are due as follows (in thousands):

	Total		2012		2013 - 2015		2016 - 2017		2018 and thereafter
Long-term debt(1)	$	6,020,525	$	59,698	$	4,515,632	$	1,441,327	$	3,868
8 7/8% Senior Notes		1,777,617		—		1,777,617		—		—
8% Senior Notes		1,000,000		—		—		—		1,000,000
Interest on Credit Facility and Senior Notes(2)		1,778,254		427,151		1,019,699		221,404		110,000
Capital lease obligations, including interest		91,419		8,386		19,931		11,127		51,975
Total long-term debt		10,667,815		495,235		7,332,879		1,673,858		1,165,843
Operating leases		793,855		176,403		370,766		122,479		124,207
Replacement facilities and other capital commitments(3)		511,692		226,683		254,194		4,509		26,306
Open purchase orders(4)		354,745		354,745		—		—		—
Liability for uncertain tax positions, including interest and penalties		1,028		—		—		—		1,028
Total	$	12,329,135	$	1,253,066	$	7,957,839	$	1,800,846	$	1,317,384

(1) Subsequent to December 31, 2011, we completed an amendment and restatement of our existing Credit Facility. The amendment, effective February 2, 2012, extended by two and a half years the maturity date of $1.6 billion of the existing non-extended term loans under the Credit Facility to January 25, 2017 (subject to customary acceleration events) or, if more than $50 million of our 8 ⁷/8% Senior Notes are outstanding on April 15, 2015, to April 15, 2015.

(2) Estimate of interest payments assumes the interest rates at December 31, 2011 remain constant during the period presented for the Credit Facility, which is variable rate debt. The interest rate used to calculate interest payments for the Credit Facility was the London Interbank Offered Rate, or LIBOR, as of December 31, 2011 plus the applicable spread. The 8 ⁷/8% Senior Notes are fixed at an interest rate of 8.875% per annum. The 8% Senior Notes are fixed at an interest rate of 8% per annum.

(3) Pursuant to hospital purchase agreements in effect as of December 31, 2011, and where final CON approval has been obtained, we have commitments to build the following replacement facilities and the following capital commitments. As required by an amendment to our lease agreement entered into in 2005, we agreed to build a replacement hospital at our Barstow, California location by November 2012. As part of an acquisition in 2007, we agreed to build a replacement hospital in Valparaiso, Indiana by April 2011; however, due to delays in receiving government approved building and zoning permits, completion is not expected until the fourth quarter of 2012. These delays did not result in any penalties under the terms of the purchase agreement and we do not expect such delays to result in any significant increase in the costs to construct the replacement facility. As part of an acquisition in 2009, we agreed to build a replacement hospital in Siloam Springs, Arkansas by February 2013. Construction costs, including equipment costs, for these three replacement facilities are currently estimated to be approximately $317.2 million of which approximately $210.3 million has been incurred to date. In addition, under other purchase agreements, we have committed to spend approximately $652.5 million for costs such as capital improvements, equipment, selected leases and physician recruiting. These commitments are required to be fulfilled generally over a five to seven year period after acquisition. Through December 31, 2011, we have incurred approximately $247.8 million related to these commitments.

(4) Open purchase orders represent our commitment for items ordered but not yet received.

At December 31, 2011, we had issued letters of credit primarily in support of potential insurance related claims and specified outstanding bonds of approximately $37.7 million.

Our debt as a percentage of total capitalization decreased from 80% at December 31, 2010 to 79% at December 31, 2011.

44

2010 Compared to 2009

Net cash provided by operating activities increased $112.3 million, from approximately $1.1 billion for the year ended December 31, 2009 to approximately $1.2 billion for the year ended December 31, 2010. The increase is primarily due to an increase in cash flows from net income of $42.1 million, an increase in non-cash depreciation and amortization expense of $43.3 million, an increase in other non-cash expenses of $22.8 million, an increase in cash flows from accounts payable, accrued liabilities and income taxes of $75.9 million, primarily as a result of the timing of payments, and an increase in cash flows generated from the change in all other assets and liabilities of $19.0 million. These increases in cash flows were offset by decreases in cash flows from supplies, prepaid expenses and other current assets of $5.4 million and decreases in cash generated from accounts receivable of $85.4 million, primarily a result of our two-day improvement in account receivable days outstanding in 2010 compared to a five-day improvement in 2009.

The cash used in investing activities increased $177.1 million, from $867.2 million for the year ended December 31, 2009 to approximately $1.0 billion for the year ended December 31, 2010. The increase in cash used in investing activities, in comparison to the prior year, is primarily attributable to an increase in the cash used for the purchase of property and equipment of $90.5 million, a reduction in the amount of proceeds from the disposition of hospitals and other ancillary operations of $89.5 million due to the sale of one hospital in 2009 and no hospital divestitures in 2010, and a net increase in other non-operating assets of $17.0 million. These increases in cash used in investing activities were offset by a reduction in acquisitions of facilities and other related equipment of $15.5 million and an increase in the amount of the proceeds from the sale of property and equipment of $4.4 million. We anticipate being able to fund future routine capital expenditures with cash flows generated from operations.

In 2010, our net cash used in financing activities increased $104.4 million from $85.4 million in 2009 to $189.8 million in 2010. The increase in cash used in financing activities, in comparison to the prior year, is primarily due to repurchases of our common stock of $114.0 million, an increase in deferred financing costs of $13.2 million associated with the amendment and extension of a portion of the Credit Facility, and a reduction in the proceeds from noncontrolling investors in joint ventures of $22.6 million, as the Reform Legislation significantly limits the selling of noncontrolling interests to physician investors. These increases were offset by an increase in the proceeds from the exercise of stock options of $44.2 million and an increase in the excess tax benefit relating to stock-based compensation of $13.7 million. The net increase in all other financing activities was $12.5 million. This included an increase in borrowings under our Credit Facility, but was mostly offset by repayments of our long-term debt.

Capital Expenditures

Cash expenditures for purchases of facilities were $415.4 million in 2011, $248.3 million in 2010 and $263.8 million in 2009. Our expenditures in 2011 included $357.3 million for the purchase of four hospitals, $56.7 million for the purchase of clinics, surgery centers and physician practices and $1.4 million for the settlement of acquired working capital. Our expenditures in 2010 included $181.1 million for the purchase of five hospitals and $67.2 million for the purchase of clinics, surgery centers and physician practices. Our expenditures in 2009 included $182.2 million for the purchase of three hospitals and the remaining equity in a hospital in which we previously had a noncontrolling interest, $72.3 million for the purchase of clinics, surgery centers and physician practices, and $9.3 million for the settlement of acquired working capital.

Excluding the cost to construct replacement hospitals, our cash expenditures for routine capital for 2011 totaled $611.7 million compared to $631.7 million in 2010, and $572.1 million in 2009. These capital expenditures related primarily to the purchase of additional equipment, minor renovations and information systems infrastructure. Costs to construct replacement hospitals totaled $165.0 million in 2011, $35.7 million in 2010 and $4.8 million in 2009. The costs to construct replacement hospitals for the year ended December 31, 2011 represent both planning and construction costs for the four replacement hospitals discussed below. The costs to construct replacement hospitals for the year ended December 31, 2010 represent both planning and construction costs for the four replacement hospitals. The costs to construct replacement hospitals for the year ended December 31, 2009 represent planning costs for future construction projects since there were no replacement hospitals under construction at year ended December 31, 2009.

45

Pursuant to hospital purchase agreements in effect as of December 31, 2011, and where final CON approval has been obtained, we have commitments to build the following three replacement facilities: As required by an amendment to our lease agreement entered into in 2005, we agreed to build a replacement hospital at our Barstow, California location by November 2012. As part of an acquisition in 2007, we agreed to build a replacement hospital in Valparaiso, Indiana by April 2011; however, due to delays in receiving government approved building and zoning permits, completion is not expected until the fourth quarter of 2012. These delays did not result in any penalties under the terms of the applicable purchase agreement and we do not expect such delays to result in any significant increase in the costs to construct the replacement facility. As part of an acquisition in 2009, we agreed to build a replacement hospital in Siloam Springs, Arkansas by February 2013. Construction costs, including equipment costs, for these three replacement facilities are currently estimated to be approximately $317.2 million, of which approximately$210.3 million has been incurred to date. In addition, in October 2008, after the purchase of the noncontrolling owner’s interest in our Birmingham, Alabama facility, we initiated the purchase of a site, which includes a partially constructed hospital structure, for a potential replacement to our existing Birmingham facility. In September 2010, we received approval of our request for a CON from the Alabama Certificate of Need Review Board; however, this CON remains subject to an appeal process. Our estimated construction costs, including the acquisition of the site and equipment costs, are approximately $280.0 million for the Birmingham replacement facility. We expect total capital expenditures of approximately $800 million to $900 million in 2012 (which includes amounts which are required to be expended pursuant to the terms of hospital purchase agreements), including approximately $640 million to $720 million for renovation and equipment cost and approximately $160 million to $180 million for construction and equipment cost of the replacement hospitals.

Capital Resources

Net working capital was approximately $935.0 million at December 31, 2011, compared to $1.229 billion at December 31, 2010, a decrease of $294.2 million. Contributing to the decrease in net working capital were decreases in cash of approximately $170.3 million, prepaid taxes of approximately $17.1 million, deferred tax assets of approximately $26.0 million and increases in accounts payable of approximately $211.1 million and employee compensation liabilities of approximately $15.6 million. These decreases in working capital were offset by increases in patient accounts receivable of approximately $103.2 million, supplies of approximately $8.3 million, net working capital acquired as part of our business acquisitions of approximately $7.3 million and decreases in deferred tax liabilities of approximately $8.9 million and accrued interest of $36.3 million. All other changes in working capital items decreased net working capital by approximately $18.1 million.

In connection with the consummation of the Triad acquisition in July 2007, we obtained approximately $7.2 billion of senior secured financing under the Credit Facility with a syndicate of financial institutions led by Credit Suisse, as administrative agent and collateral agent. The Credit Facility consisted of an approximately $6.1 billion funded term loan facility with a maturity of seven years, a $300 million delayed draw term loan facility (reduced by us from $400 million) with a maturity of seven years and a $750 million revolving credit facility with a maturity of six years. During the fourth quarter of 2008, $100 million of the delayed draw term loan had been drawn down by us, reducing the delayed draw term loan availability to $200 million at December 31, 2008. In January 2009, we drew down the remaining $200 million of the delayed draw term loan. The revolving credit facility also includes a subfacility for letters of credit and a swingline subfacility. The Credit Facility requires quarterly amortization payments of each term loan facility equal to 0.25% of the outstanding amount of the term loans. On November 5, 2010, we entered into an amendment and restatement of our existing Credit Facility. The amendment extended by two and a half years, until January 25, 2017, the maturity date of $1.5 billion of our existing term loans under the Credit Facility and increased the pricing on these term loans to LIBOR plus 350 basis points. If more than $50 million of our 8 ⁷/8% Senior Notes remain outstanding on April 15, 2015, without having been refinanced, then the maturity date for the extended term loans will be accelerated to April 15, 2015. The amendment also increased our ability to issue additional indebtedness under the uncommitted incremental facility to $1.0 billion from $600 million, permitted us to issue Term A term loans under the incremental facility and provided up to $2.0 billion of borrowing capacity from receivable transactions, an increase of $0.5 billion, of which approximately $1.7 billion would be required to be used for repayment of our existing term loans. In addition, effective February 2, 2012, we completed an additional amendment and restatement of the Credit Facility, which extended by two and a half years, until January 25, 2017, the maturity date of an additional $1.6 billion of our existing non-extended term loans under the Credit Facility and increased the pricing on the newly extended term loans by 125 basis points. The maturity date of the balance of the term loans of approximately $2.9 billion remained unchanged at July 25, 2014.

46

The term loan facility must be prepaid in an amount equal to (1) 100% of the net cash proceeds of certain asset sales and dispositions by us and our subsidiaries, subject to certain exceptions and reinvestment rights, (2) 100% of the net cash proceeds of issuances of certain debt obligations or receivables based financing by us and our subsidiaries, subject to certain exceptions, and (3) 50%, subject to reduction to a lower percentage based on our leverage ratio (as defined in the Credit Facility generally as the ratio of total debt on the date of determination to our EBITDA, as defined, for the four quarters most recently ended prior to such date), of excess cash flow (as defined) for any year, commencing in 2008, subject to certain exceptions. Voluntary prepayments and commitment reductions are permitted in whole or in part, without any premium or penalty, subject to minimum prepayment or reduction requirements.

The obligor under the Credit Facility is CHS. All of our obligations under the Credit Facility are unconditionally guaranteed by Community Health Systems, Inc. and certain existing and subsequently acquired or organized domestic subsidiaries. All obligations under the Credit Facility and the related guarantees are secured by a perfected first priority lien or security interest in substantially all of the assets of Community Health Systems, Inc., CHS and each subsidiary guarantor, including equity interests held by us or any subsidiary guarantor, but excluding, among others, the equity interests of non-significant subsidiaries, syndication subsidiaries, securitization subsidiaries and joint venture subsidiaries.

The loans under the Credit Facility bear interest on the outstanding unpaid principal amount at a rate equal to an applicable percentage plus, at our option, either (a) an Alternate Base Rate (as defined) determined by reference to the greater of (1) the Prime Rate (as defined) announced by Credit Suisse or (2) the Federal Funds Effective Rate (as defined) plus one-half of 1.0% or (3) the adjusted LIBOR rate on such day for a three-month interest period commencing on the second business day after such day plus 1%, or (b) a reserve adjusted LIBOR for dollars (Eurodollar rate) (as defined). The applicable percentage for Alternate Base Rate loans is 1.25% for term loans due 2014 and 2.25% for term loans due 2017. The applicable percentage for Eurodollar rate loans is 2.25% for term loans due 2014 and 3.5% for term loans due 2017. The applicable percentage for revolving loans was initially 1.25% for Alternate Base Rate revolving loans and 2.25% for Eurodollar revolving loans, in each case subject to reduction based on our leverage ratio. Loans under the swingline subfacility bear interest at the rate applicable to Alternate Base Rate loans under the revolving credit facility.

We have agreed to pay letter of credit fees equal to the applicable percentage then in effect with respect to Eurodollar rate loans under the revolving credit facility times the maximum aggregate amount available to be drawn under all letters of credit outstanding under the subfacility for letters of credit. The issuer of any letter of credit issued under the subfacility for letters of credit will also receive a customary fronting fee and other customary processing charges. We were initially obligated to pay commitment fees of 0.50% per annum (subject to reduction based upon our leverage ratio), on the unused portion of the revolving credit facility. For purposes of this calculation, swingline loans are not treated as usage of the revolving credit facility. With respect to the delayed draw term loan facility, we were also obligated to pay commitment fees of 0.50% per annum for the first nine months after the close of the Credit Facility and 0.75% per annum for the next three months after such nine-month period and thereafter 1.0% per annum. In each case, the commitment fee was based on the unused amount of the delayed draw term loan facility. After the draw down of the remaining $200 million of the delayed draw term loan in January 2009, we no longer pay any commitment fees for the delayed draw term loan facility. We also paid arrangement fees on the closing of the Credit Facility and pay an annual administrative agent fee.

The Credit Facility contains customary representations and warranties, subject to limitations and exceptions, and customary covenants restricting our and our subsidiaries’ ability, subject to certain exception, to, among other things, (1) declare dividends, make distributions or redeem or repurchase capital stock, (2) prepay, redeem or repurchase other debt, (3) incur liens or grant negative pledges, (4) make loans and investments and enter into acquisitions and joint ventures, (5) incur additional indebtedness or provide certain guarantees, (6) make capital expenditures, (7) engage in mergers, acquisitions and asset sales, (8) conduct transactions with affiliates, (9) alter the nature of our businesses, (10) grant certain guarantees with respect to physician practices, (11) engage in sale and leaseback transactions or (12) change our fiscal year. We and our subsidiaries are also required to comply with specified financial covenants (consisting of a leverage ratio and an interest coverage ratio) and various affirmative covenants.

47

Events of default under the Credit Facility include, but are not limited to, (1) our failure to pay principal, interest, fees or other amounts under the credit agreement when due (taking into account any applicable grace period), (2) any representation or warranty proving to have been materially incorrect when made, (3) covenant defaults subject, with respect to certain covenants, to a grace period, (4) bankruptcy events, (5) a cross default to certain other debt, (6) certain undischarged judgments (not paid within an applicable grace period), (7) a change of control, (8) certain ERISA-related defaults and (9) the invalidity or impairment of specified security interests, guarantees or subordination provisions in favor of the administrative agent or lenders under the Credit Facility.

As of December 31, 2011, the availability for additional borrowings under our Credit Facility was approximately $750 million pursuant to the revolving credit facility, of which $37.7 million was set aside for outstanding letters of credit and $30.0 million was outstanding at December 31, 2011. We believe that these funds, along with internally generated cash and continued access to the bank credit and capital markets, will be sufficient to finance future acquisitions, capital expenditures and working capital requirements through the next 12 months and into the foreseeable future.

On November 22, 2011, CHS completed its offering of $1.0 billion aggregate principal amount of 8% Senior Notes, which were issued in a private placement. The net proceeds from this issuance, together with available cash on hand, were used to finance the purchase of up to $1.0 billion aggregate principal amount of CHS’ outstanding 8 ⁷/8% Senior Notes and related fees and expenses. This resulted in a loss from early extinguishment of debt of $66.0 million with an after-tax impact of $42.0 million recorded in continuing operations for the year ended December 31, 2011.

As of December 31, 2011, we are currently a party to the following interest rate swap agreements to limit the effect of changes in interest rates on approximately 82% of our variable rate debt. On each of these swaps, we receive a variable rate of interest based on the three-month LIBOR, in exchange for the payment by us of a fixed rate of interest. We currently pay, on a quarterly basis, a margin above LIBOR of 225 basis points for revolving credit and term loans due 2014 and 350 basis points for term loans due 2017 under the Credit Facility.

48

Swap #	Notional Amount (in 000’s)		Fixed Interest Rate			Termination Date		Fair Value of Liability (in 000’s)
1		100,000		3.8470	%		January 4, 2012		30
2		100,000		3.8510	%		January 4, 2012		30
3		100,000		3.8560	%		January 4, 2012		30
4		200,000		3.7260	%		January 8, 2012		152
5		200,000		3.5065	%		January 16, 2012		281
6		250,000		5.0185	%		May 30, 2012		4,509
7		150,000		5.0250	%		May 30, 2012		2,709
8		200,000		4.6845	%		September 11, 2012		5,574
9		100,000		3.3520	%		October 23, 2012		2,161
10		125,000		4.3745	%		November 23, 2012		4,104
11		75,000		4.3800	%		November 23, 2012		2,466
12		150,000		5.0200	%		November 30, 2012		5,900
13		200,000		2.2420	%		February 28, 2013		3,550
14		100,000		5.0230	%		May 30, 2013		5,952
15		300,000		5.2420	%		August 6, 2013		21,085
16		100,000		5.0380	%		August 30, 2013		6,967
17		50,000		3.5860	%		October 23, 2013		2,505
18		50,000		3.5240	%		October 23, 2013		2,451
19		100,000		5.0500	%		November 30, 2013		7,948
20		200,000		2.0700	%		December 19, 2013		5,080
21		100,000		5.2310	%		July 25, 2014		10,706
22		100,000		5.2310	%		July 25, 2014		10,707
23		200,000		5.1600	%		July 25, 2014		21,073
24		75,000		5.0405	%		July 25, 2014		7,685
25		125,000		5.0215	%		July 25, 2014		12,752
26		100,000		2.6210	%		July 25, 2014		4,436
27		100,000		3.1100	%		July 25, 2014		5,612
28		100,000		3.2580	%		July 25, 2014		5,968
29		200,000		2.6930	%		October 26, 2014		9,916
30		300,000		3.4470	%		August 8, 2016		27,728
31		200,000		3.4285	%		August 19, 2016		18,401
32		100,000		3.4010	%		August 19, 2016		9,099
33		200,000		3.5000	%		August 30, 2016		19,048
34		100,000		3.0050	%		November 30, 2016		7,613

The Credit Facility and/or the Senior Notes contain various covenants that limit our ability to take certain actions including; among other things, our ability to:

• incur, assume or guarantee additional indebtedness;

• issue redeemable stock and preferred stock;

• repurchase capital stock;

49

• make restricted payments, including paying dividends and making investments;

• redeem debt that is junior in right of payment to the Senior Notes;

• create liens without securing the Senior Notes;

• sell or otherwise dispose of assets, including capital stock of subsidiaries;

• enter into agreements that restrict dividends from subsidiaries;

• merge, consolidate, sell or otherwise dispose of substantial portions of our assets;

• enter into transactions with affiliates; and

• guarantee certain obligations.

In addition, our Credit Facility contains restrictive covenants and requires us to maintain specified financial ratios and satisfy other financial condition tests. Our ability to meet these restricted covenants and financial ratios and tests can be affected by events beyond our control, and we cannot assure you that we will meet those tests. A breach of any of these covenants could result in a default under our Credit Facility and/or the Senior Notes. Upon the occurrence of an event of default under our Credit Facility or the Senior Notes, all amounts outstanding under our Credit Facility and the Senior Notes may become immediately due and payable and all commitments under the Credit Facility to extend further credit may be terminated.

We believe that internally generated cash flows, availability for additional borrowings under our Credit Facility of $750 million (consisting of a $750 million revolving credit facility, of which $37.7 million is set aside for outstanding letters of credit and $30 million outstanding at December 31, 2011) and our ability to amend the Credit Facility to provide for one or more tranches of term loans in an aggregate principal amount of $1.0 billion, our ability to add up to $300 million of borrowing capacity from receivable transactions (including securitizations) and our continued access to the bank credit and capital markets will be sufficient to finance acquisitions, capital expenditures and working capital requirements through the next 12 months. We believe these same sources of cash, borrowings under our Credit Facility as well as access to bank credit and capital markets will be available to us beyond the next 12 months and into the foreseeable future.

On December 22, 2008, we filed a universal automatic shelf registration statement on Form S-3ASR that will permit us, from time to time, in one or more public offerings, to offer debt securities, common stock, preferred stock, warrants, depositary shares, or any combination of such securities. The shelf registration statement will also permit our subsidiary, CHS, to offer debt securities that would be guaranteed by us, from time to time in one or more public offerings. The terms of any such future offerings would be established at the time of the offering.

Off-balance sheet arrangements

Our consolidated operating results for the years ended December 31, 2011 and 2010, included $202.7 million and $205.6 million, respectively, of net operating revenues and $16.4 million and $26.6 million, respectively, of income from continuing operations, generated from five hospitals operated by us under operating lease arrangements. In accordance with accounting principles generally accepted in the United States of America, or U.S. GAAP, the respective assets and the future lease obligations under these arrangements are not recorded in our consolidated balance sheet. Lease costs under these arrangements are included in rent expense and totaled approximately $11.9 million and $12.4 million for the years ended December 31, 2011 and 2010, respectively. The current terms of these operating leases expire between January 2013 and June 2022, not including lease extension options. If we allow these leases to expire, we would no longer generate revenues nor incur expenses from these hospitals.

In the past, we have utilized operating leases as a financing tool for obtaining the operations of specified hospitals without acquiring, through ownership, the related assets of the hospital and without a significant outlay of cash at the front end of the lease. We utilize the same operating strategies to improve operations at those hospitals held under operating leases as we do at those hospitals that we own. We have not entered into any operating leases for hospital operations since December 2000.

50

During the year ended December 31, 2010, we entered into an agreement with the lessor of Cleveland Regional Medical Center, or Cleveland Regional, our leased facility in Cleveland, TX, to exchange our ownership interest in certain real estate at Hill Regional Medical Center, or Hill Regional, in Hillsboro, TX for the lessor’s ownership interest in the real estate at Cleveland Regional. The related lease agreement was amended to incorporate Hill Regional as a leased asset with no change to the remaining lease term or payment schedule. No monetary consideration was exchanged in this transaction, and the transaction qualifies as a non-taxable, like-kind exchange under the regulations in Section 1031 of the Internal Revenue Code. The assets of Cleveland Regional were recorded in the consolidated balance sheet at fair value on the date of this transaction; however, as a result of our continuing involvement in the Hill Regional assets, the exchange with the lessor does not qualify for sale treatment under U.S. GAAP. Accordingly, the transaction has been accounted for as a financing obligation and the assets of Hill Regional will remain on the consolidated balance sheet as assets recorded under a financing obligation. Starting in the fourth quarter of 2010, future payments under the lease are amortized against the financing obligation rather than recorded as rent expense.

As described more fully in Note 15 of the Notes to Consolidated Financial Statements, at December 31, 2011, we have certain cash obligations for replacement facilities and other construction commitments of $511.7 million and open purchase orders for $354.7 million.

Noncontrolling Interests

We have sold noncontrolling interests in certain of our subsidiaries or acquired subsidiaries with existing noncontrolling interest ownership positions. As of December 31, 2011, we have hospitals in 24 of the markets we serve, with noncontrolling physician ownership interests ranging from less than 1% to 40%, including one hospital that also had a non-profit entity as a partner. In addition, we have three other hospitals with noncontrolling interests owned by non-profit entities. During 2010 (prior to the enactment of the Reform Legislation), we sold noncontrolling interests in two of our hospitals and additional noncontrolling interests in hospitals with existing physician ownership, for total consideration of $7.2 million. During 2009, we sold noncontrolling interests in six of our hospitals, including additional noncontrolling interests in hospitals with existing physician ownership, for total consideration of $19.0 million. Effective June 1, 2009, we acquired from Akron General Medical Center the remaining 20% noncontrolling interest in Massillon Community Health System, LLC not then owned by us. This entity indirectly owns and operates Affinity Medical Center of Massillon, Ohio. The purchase price for this noncontrolling interest was $1.1 million in cash. Affinity Medical Center is now wholly-owned by us. Redeemable noncontrolling interests in equity of consolidated subsidiaries was $395.7 million and $387.5 million as of December 31, 2011 and 2010, respectively, and noncontrolling interests in equity of consolidated subsidiaries was $67.3 million and $60.9 million as of December 31, 2011 and 2010, respectively, and the amount of net income attributable to noncontrolling interests was $75.7 million, $68.5 million and $63.2 million for the years ended December 31, 2011, 2010 and 2009, respectively. As a result of the change in the Stark Law “whole hospital” exception included in the Reform Legislation, we will not introduce physician ownership at any of our wholly-owned facilities or increase the aggregate percentage of physician ownership in any of our existing joint ventures.

Reimbursement, Legislative and Regulatory Changes

The Reform Legislation was enacted in the context of other ongoing legislative and regulatory efforts, which would reduce or otherwise adversely affect the payments we receive from Medicare and Medicaid. Within the statutory framework of the Medicare and Medicaid programs, including programs currently unaffected by the Reform Legislation, there are substantial areas subject to administrative rulings, interpretations and discretion which may further affect payments made under those programs, and the federal and state governments might, in the future, reduce the funds available under those programs or require more stringent utilization and quality reviews of hospital facilities. Additionally, there may be a continued rise in managed care programs and additional restructuring of the financing and delivery of healthcare in the United States. These events could cause our future financial results to decline. We cannot estimate the impact of Medicare and Medicaid reimbursement changes that have been enacted or are under consideration. We cannot predict whether additional reimbursement reductions will be made or whether any such changes would have a material adverse effect on our business, financial conditions, results of operations, cash flow, capital resources and liquidity.

51

Inflation

The healthcare industry is labor intensive. Wages and other expenses increase during periods of inflation and when labor shortages occur in the marketplace. In addition, our suppliers pass along rising costs to us in the form of higher prices. We have implemented cost control measures, including our case and resource management program, to curb increases in operating costs and expenses. We have generally offset increases in operating costs by increasing reimbursement for services, expanding services and reducing costs in other areas. However, we cannot predict our ability to cover or offset future cost increases, particularly any increases in our cost of providing health insurance benefits to our employees as a result of the Reform Legislation.

Critical Accounting Policies

The discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amount of assets and liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities at the date of our consolidated financial statements. Actual results may differ from these estimates under different assumptions or conditions.

Critical accounting policies are defined as those that are reflective of significant judgments and uncertainties, and potentially result in materially different results under different assumptions and conditions. We believe that our critical accounting policies are limited to those described below. For a detailed discussion on the application of these and other accounting policies, see Note 1 in the Notes to the Consolidated Financial Statements included under Item 8 of this Report.

Third-party Reimbursement

Net operating revenues include amounts estimated by management to be reimbursable by Medicare and Medicaid under prospective payment systems and provisions of cost-reimbursement and other payment methods. In addition, we are reimbursed by non-governmental payors using a variety of payment methodologies. Amounts we receive for treatment of patients covered by these programs are generally less than the standard billing rates. Contractual allowances are automatically calculated and recorded through our internally developed “automated contractual allowance system.” Within the automated system, actual Medicare DRG data and payors’ historical paid claims data are utilized to calculate the contractual allowances. This data is automatically updated on a monthly basis. All hospital contractual allowance calculations are subjected to monthly review by management to ensure reasonableness and accuracy. We account for the differences between the estimated program reimbursement rates and the standard billing rates as contractual allowance adjustments, which we deduct from gross revenues to arrive at net operating revenues. The process of estimating contractual allowances requires us to estimate the amount expected to be received based on payor contract provisions. The key assumption in this process is the estimated contractual reimbursement percentage, which is based on payor classification and historical paid claims data. Due to the complexities involved in these estimates, actual payments we receive could be different from the amounts we estimate and record. If the actual contractual reimbursement percentage under government programs and managed care contracts differed by 1% at December 31, 2011 from our estimated reimbursement percentage, net income for the year ended December 31, 2011 would have changed by approximately $35.0 million, and net accounts receivable at December 31, 2011 would have changed by $55.6 million. Final settlements under some of these programs are subject to adjustment based on administrative review and audit by third parties. We account for adjustments to previous program reimbursement estimates as contractual allowance adjustments and report them in the periods that such adjustments become known. Contractual allowance adjustments related to final settlements and previous program reimbursement estimates impacted net operating revenues and net income by an insignificant amount in each of the years ended December 31, 2011, 2010 and 2009.

Allowance for Doubtful Accounts

Substantially all of our accounts receivable are related to providing healthcare services to our hospitals’ patients. Collection of these accounts receivable is our primary source of cash and is critical to our operating performance. Our primary collection risks relate to uninsured patients and outstanding patient balances for which the primary

52

insurance payor has paid some but not all of the outstanding balance, with the remaining outstanding balance (generally deductibles and co-payments) owed by the patient. At the point of service, for patients required to make a co-payment, we generally collect less than 15% of the related revenue. For all procedures scheduled in advance, our policy is to verify insurance coverage prior to the date of the procedure. Insurance coverage is not verified in advance of procedures for walk-in and emergency room patients.

We estimate the allowance for doubtful accounts by reserving a percentage of all self-pay accounts receivable without regard to aging category, based on collection history, adjusted for expected recoveries and, if present, anticipated changes in trends. For all other non-self-pay payor categories, we reserve 100% of all accounts aging over 365 days from the date of discharge. The percentage used to reserve for all self-pay accounts is based on our collection history. We believe that we collect substantially all of our third-party insured receivables, which include receivables from governmental agencies.

Collections are impacted by the economic ability of patients to pay and the effectiveness of our collection efforts. Significant changes in payor mix, business office operations, economic conditions or trends in federal and state governmental healthcare coverage could affect our collection of accounts receivable. The process of estimating the allowance for doubtful accounts requires us to estimate the collectability of self-pay accounts receivable, which is primarily based on our collection history, adjusted for expected recoveries and, if available, anticipated changes in collection trends. Significant change in payor mix, business office operations, economic conditions, trends in federal and state governmental healthcare coverage or other third-party payors could affect our estimates of accounts receivable collectability. If the actual collection percentage at December 31, 2011 differed by 1% from our estimated collection percentage as a result of a change in expected recoveries, net income for the year ended December 31, 2011 would have changed by $19.5 million, and net accounts receivable at December 31, 2011 would have changed by $31.0 million. We also continually review our overall reserve adequacy by monitoring historical cash collections as a percentage of trailing net revenue less provision for bad debts, as well as by analyzing current period net revenue and admissions by payor classification, aged accounts receivable by payor, days revenue outstanding and the impact of recent acquisitions and dispositions.

Our policy is to write-off gross accounts receivable if the balance is under $10.00 or when such amounts are placed with outside collection agencies. We believe this policy accurately reflects our ongoing collection efforts and is consistent with industry practices. We had approximately $2.2 billion and $2.1 billion at December 31, 2011 and 2010, respectively, being pursued by various outside collection agencies. We expect to collect less than 3%, net of estimated collection fees, of the amounts being pursued by outside collection agencies. As these amounts have been written-off, they are not included in our gross accounts receivable or our allowance for doubtful accounts. Collections on amounts previously written-off are recognized as a reduction to bad debt expense when received. However, we take into consideration estimated collections of these future amounts written-off in evaluating the reasonableness of our allowance for doubtful accounts.

All of the following information is derived from our hospitals, excluding clinics, unless otherwise noted.

Patient accounts receivable from our hospitals represent approximately 95% of our total consolidated accounts receivable.

Days revenue outstanding was 56 days at December 31, 2011 and 54 days at December 31, 2010. Our target range for days revenue outstanding is from 53 to 63 days.

Total gross accounts receivable (prior to allowance for contractual adjustments and doubtful accounts) was approximately $8.3 billion as of December 31, 2011 and approximately $7.2 billion as of December 31, 2010.

53

The approximate percentage of total gross accounts receivable (prior to allowances for contractual adjustments and doubtful accounts) summarized by payor is as follows:

	December 31,
	2011			2010
Insured receivables		63.7	%		63.9	%
Self-pay receivables		36.3	%		36.1	%
Total		100.0	%		100.0	%

For the hospital segment, the combined total of the allowance for doubtful accounts for self-pay accounts receivable and related allowances for other self-pay discounts and contractuals, as a percentage of gross self-pay receivables, was approximately 84% at both December 31, 2011 and 2010. If the receivables that have been written-off, but where collections are still being pursued by outside collection agencies, were included in both the allowances and gross self-pay receivables specified above, the percentage of combined allowances to total self-pay receivables would have been approximately 91% at both December 31, 2011 and 2010.

Goodwill and Other Intangibles

Goodwill represents the excess of the fair value of the consideration conveyed in the acquisition over the fair value of net assets acquired. Goodwill is evaluated for impairment at the same time every year and when an event occurs or circumstances change that, more likely than not, reduce the fair value of the reporting unit below its carrying value. There is a two-step method for determining goodwill impairment. Step one is to compare the fair value of the reporting unit with the unit’s carrying amount, including goodwill. If this test indicates the fair value is less than the carrying value, then step two is required to compare the implied fair value of the reporting unit’s goodwill with the carrying value of the reporting unit’s goodwill. We have selected September 30 as our annual testing date. Based on the results of our most recent annual impairment test, we have concluded that we do not have any reporting units that are at risk of failing step one of the goodwill impairment test.

Impairment or Disposal of Long-Lived Assets

Whenever events or changes in circumstances indicate that the carrying values of certain long-lived assets may be impaired, we project the undiscounted cash flows expected to be generated by these assets. If the projections indicate that the reported amounts are not expected to be recovered, such amounts are reduced to their estimated fair value based on a quoted market price, if available, or an estimate based on valuation techniques available in the circumstances.

54

Professional Liability Claims

As part of our business of owning and operating hospitals, we are subject to legal actions alleging liability on our part. We accrue for losses resulting from such liability claims, as well as loss adjustment expenses that are out-of-pocket and directly related to such liability claims. These direct out-of-pocket expenses include fees of outside counsel and experts. We do not accrue for costs that are part of our corporate overhead, such as the costs of our in-house legal and risk management departments. The losses resulting from professional liability claims primarily consist of estimates for known claims, as well as estimates for incurred but not reported claims. The estimates are based on specific claim facts, our historical claim reporting and payment patterns, the nature and level of our hospital operations and actuarially determined projections. The actuarially determined projections are based on our actual claim data, including historic reporting and payment patterns which have been gathered over approximately a 20-year period. As discussed below, since we purchase excess insurance on a claims-made basis that transfers risk to third party insurers, the liability we accrue does include an amount for the losses covered by our excess insurance. We also record a receivable for the expected reimbursement of losses covered by excess insurance. Since we believe that the amount and timing of our future claims payments are reliably determinable, we discount the amount we accrue for losses resulting from professional liability claims using the risk-free interest rate corresponding to the timing of our expected payments.

The net present value of the projected payments was discounted using a weighted-average risk-free rate of 1.2%, 1.3% and 1.4% in 2011, 2010 and 2009, respectively. This liability is adjusted for new claims information in the period such information becomes known to us. Professional malpractice expense includes the losses resulting from professional liability claims and loss adjustment expense, as well as paid excess insurance premiums, and is presented within other operating expenses in the accompanying consolidated statements of income.

Our processes for obtaining and analyzing claims and incident data are standardized across all of our hospitals and have been consistent for many years. We monitor the outcomes of the medical care services that we provide and for each reported claim, we obtain various information concerning the facts and circumstances related to that claim. In addition, we routinely monitor current key statistics and volume indicators in our assessment of utilizing historical trends. The average lag period between claim occurrence and payment of a final settlement is between four and five years, although the facts and circumstances of individual claims could result in the timing of such payments being different from this average. Since claims are paid promptly after settlement with the claimant is reached, settled claims represent less than 1.0% of the total liability at the end of any period.

For purposes of estimating our individual claim accruals, we utilize specific claim information, including the nature of the claim, the expected claim amount, the year in which the claim occurred and the laws of the jurisdiction in which the claim occurred. Once the case accruals for known claims are determined, information is stratified by loss layers and retentions, accident years, reported years, geography and claims relating to the acquired Triad hospitals versus claims relating to our other hospitals. Several actuarial methods are used against this data to produce estimates of ultimate paid losses and reserves for incurred but not reported claims. Each of these methods uses our company-specific historical claims data and other information. This company-specific data includes information regarding our business, including historical paid losses and loss adjustment expenses, historical and current case loss reserves, actual and projected hospital statistical data, a variety of hospital census information, employed physician information, professional liability retentions for each policy year, geographic information and other data.

Based on these analyses we determine our estimate of the professional liability claims. The determination of management’s estimate, including the preparation of the reserve analysis that supports such estimate, involves subjective judgment of management. Changes in reserving data or the trends and factors that influence reserving data may signal fundamental shifts in our future claim development patterns or may simply reflect single-period anomalies. Even if a change reflects a fundamental shift, the full extent of the change may not become evident until years later. Moreover, since our methods and models use different types of data and we select our liability from the results of all of these methods, we typically cannot quantify the precise impact of such factors on our estimates of the liability. Due to our standardized and consistent processes for handling claims and the long history and depth of our company-specific data, our methodologies have produced reliably determinable estimates of ultimate paid losses.

55

The following table presents the amounts of our accrual for professional liability claims and approximate amounts of our activity for each of the respective years (excludes premiums for excess insurance coverage) (in thousands):

	Year Ended December 31,
	2011			2010			2009
Accrual for professional liability claims, beginning of year	$	489,207		$	431,225		$	350,579
Impact from adopting ASU 2010-24		42,171			—			—
Expense (income) related to:
Current accident year		145,396			141,923			136,424
Prior accident years		(30,698	)		(10,583	)		(6,702	)
(Income) expense from discounting		(2,393	)		(2,678	)		11,515
Total incurred loss and loss expense (1)		112,305			128,662			141,237
Paid claims and expenses related to:
Current accident year		(468	)		(1,980	)		(1,387	)
Prior accident years		(75,430	)		(68,700	)		(59,204	)
Total paid claims and expenses		(75,898	)		(70,680	)		(60,591	)
Accrual for professional liability claims, end of year	$	567,785		$	489,207		$	431,225

(1) Total expense, including premiums for insured coverage, was $150.2 million in 2011, $164.2 million in 2010 and $176.4 million in 2009.

The increase in current accident year claims expense in each year from 2009 to 2011 is consistent with the increase in net operating revenues during these periods. Income/expense related to prior accident years reflects changes in estimates resulting from the filing of claims for prior year incidents, claim settlements, updates from litigation and our ongoing investigation of open claims. Expense/income from discounting reflects the changes in the weighted-average risk-free interest rate used and timing of estimated payments for discounting in each year.

We are primarily self-insured for these claims; however, we obtain excess insurance that transfers the risk of loss to a third-party insurer for claims in excess of our self-insured retentions. Our excess insurance is underwritten on a claims-made basis. For claims reported prior to June 1, 2002, substantially all of our professional and general liability risks were subject to a $0.5 million per occurrence self-insured retention and for claims reported from June 1, 2002 through June 1, 2003, these self-insured retentions were $2.0 million per occurrence. Substantially all claims reported after June 1, 2003 and before June 1, 2005 are self-insured up to $4 million per claim. Substantially all claims reported on or after June 1, 2005 are self-insured up to $5 million per claim. Management, on occasion, has selectively increased the insured risk at certain hospitals based upon insurance pricing and other factors and may continue that practice in the future. Excess insurance for all hospitals has been purchased through commercial insurance companies and generally covers us for liabilities in excess of the self-insured retentions. The excess coverage consists of multiple layers of insurance, the sum of which totals up to $95 million per occurrence and in the aggregate for claims reported on or after June 1, 2003 and up to $145 million per occurrence and in the aggregate for claims incurred and reported after January 1, 2008. For certain policy years, if the first aggregate layer of excess coverage becomes fully utilized, then the self-insured retention could increase to $10 million per claim for any subsequent claims in that policy year until our total aggregate coverage is met.

56

Effective January 1, 2008, the former Triad hospitals are insured on a claims-made basis as described above and through commercial insurance companies as described above for substantially all claims occurring on or after January 1, 2002 and reported on or after January 1, 2008. Substantially all losses for the former Triad hospitals in periods prior to May 1, 1999 were insured through a wholly-owned insurance subsidiary of HCA Holdings Inc., or HCA, Triad’s owner prior to that time, and excess loss policies maintained by HCA. HCA has agreed to indemnify the former Triad hospitals in respect of claims covered by such insurance policies arising prior to May 1, 1999. From May 1, 1999 through December 31, 2006, the former Triad hospitals obtained insurance coverage on a claims incurred basis from HCA’s wholly-owned insurance subsidiary, with excess coverage obtained from other carriers that is subject to certain deductibles. Effective for claims incurred after December 31, 2006, Triad began insuring its claims from $1 million to $5 million through its wholly-owned captive insurance company, replacing the coverage provided by HCA. Substantially all claims occurring during 2007 were self-insured up to $10 million per claim.

Income Taxes

We must make estimates in recording provision for income taxes, including determination of deferred tax assets and deferred tax liabilities and any valuation allowances that might be required against the deferred tax assets. We believe that future income will enable us to realize certain deferred tax assets, subject to the valuation allowance we have established.

The total amount of unrecognized benefit that would impact the effective tax rate, if recognized, was approximately $0.8 million as of December 31, 2011. During the year ended December 31, 2011, we decreased liabilities for uncertain tax positions by $5.4 million, including the favorable resolution of an issue on appeal with the IRS related to its tax examination of Triad tax returns, and decreased interest and penalties by approximately $1.1 million. A total of approximately $0.3 million of interest and penalties is included in the amount of liability for uncertain tax positions at December 31, 2011. It is our policy to recognize interest and penalties related to unrecognized benefits in our consolidated statements of income as income tax expense. During the year ended December 31, 2011, we released $2.3 million for income taxes and $0.7 million for accrued interest of our liability for uncertain tax positions, as a result of the expiration of the statute of limitations pertaining to tax positions taken in prior years.

It is possible the amount of unrecognized tax benefit could change in the next twelve months as a result of a lapse of the statute of limitations and settlements with taxing authorities; however, we do not anticipate the change will have a material impact on our consolidated results of operations or consolidated financial position.

We, or one or more of our subsidiaries, file income tax returns in the United States federal jurisdiction and various state jurisdictions. We have extended the federal statute of limitations for Triad for the tax periods ended December 31, 1999, December 31, 2000, April 30, 2001, June 30, 2001, December 31, 2001, December 31, 2002 and December 31, 2003. The IRS has concluded its examination of the federal tax return of Triad for the tax periods ended December 31, 2004, December 31, 2005, December 31, 2006 and July 25, 2007. In September 2011, we reached a favorable resolution of an issue on appeal with the IRS related to its examination of Triad’s tax returns. As a result, we recognized a tax benefit of $4.0 million, which is reflected in the accompanying consolidated statement of income for the year ended December 31, 2011. With few exceptions, we are no longer subject to state income tax examinations for years prior to 2008 and federal income tax examinations with respect to Community Health Systems, Inc. federal returns for years prior to 2007. Our federal income tax returns for the 2007 and 2008 tax years are currently under examination by the IRS. We believe the results of this examination will not be material to our consolidated results of operations or consolidated financial position. In connection with our 2007 and 2008 IRS examinations, the IRS has taken exception to the timing of our malpractice expense deductions. Management believes that our deduction timing is appropriate, and will work to resolve this item over the next 24 months. If management is unable to sustain the current timing of our deduction, then it would be subject to interest and penalty costs. Management does not consider this matter to have met the recognition criteria to be considered an uncertain tax position for which a reserve is necessary.

57

Recent Accounting Pronouncements

In August 2010, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, 2010-24, which provides clarification to companies in the healthcare industry on the accounting for professional liability insurance. This ASU states that receivables related to insurance recoveries should not be netted against the related claim liability and such claim liabilities should be determined without considering insurance recoveries. This ASU is effective for fiscal years beginning after December 15, 2010 and was adopted prospectively by us on January 1, 2011. The adoption of this ASU increased other current assets by $5.3 million, other assets, net by $36.9 million and long-term liabilities by $42.2 million in the consolidated balance sheet at December 31, 2011 and had no impact to the consolidated statement of income for the year ended December 31, 2011.

In August 2010, the FASB issued ASU 2010-23, which requires a company in the healthcare industry to use its direct and indirect costs of providing charity care as the measurement basis for charity care disclosures. This ASU also requires additional disclosures of the method used to determine such costs. We adopted this ASU on January 1, 2011. In the ordinary course of business, we render services to patients who are financially unable to pay for hospital care. Included in the provision for contractual allowances is the value (at our standard charges) of these services to patients who are unable to pay that is eliminated from net operating revenues when it is determined they qualify under our charity care policy. The estimated cost incurred by us to provide these services to patients who are unable to pay was approximately $125.7 million, $105.5 million and $104.0 million for the years ended December 31, 2011, 2010 and 2009, respectively. The estimated cost of these charity care services was determined using a ratio of cost to gross charges and applying that ratio to the gross charges associated with providing care to charity patients for the period. Gross charges associated with providing care to charity patients includes only the related charges for those patients who are financially unable to pay and qualify under our charity care policy and that do not otherwise qualify for reimbursement from a governmental program.

In June 2011, the FASB issued ASU 2011-05, which eliminates the option to present components of other comprehensive income as part of the statement of changes in stockholders’ equity. Instead, ASU 2011-05 requires that all nonowner changes in stockholders’ equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. In December 2011, the FASB issued ASU 2011-12, which amends ASU 2011-05 to defer the requirement to measure and present reclassification adjustments from accumulated other comprehensive income to net income by income statement line item in net income and also in other comprehensive income. ASU 2011-05, as amended by ASU 2011-12, is required to be applied retrospectively and is effective for fiscal years beginning after December 15, 2011, and has been reflected in the accompanying consolidated financial statements for all periods presented. The adoption of ASU 2011-05, as amended by ASU 2011-12, has not impacted our consolidated financial position, results of operations or cash flows, although it will change the presentation of our other comprehensive income for all periods presented.

In July 2011, the FASB issued ASU 2011-07, which requires healthcare organizations that perform services for patients for which the ultimate collection of all or a portion of the amounts billed or billable cannot be determined at the time services are rendered to present all bad debt expense associated with such patient service revenue as an offset to the patient service revenue line item in the statement of operations. The ASU also requires qualitative disclosures about our policy for recognizing revenue and bad debt expense for patient service transactions and quantitative information about the effects of changes in the assessment of collectability of patient service revenue. This ASU is effective for fiscal years beginning after December 15, 2011, and has been reflected in the accompanying consolidated financial statements for all periods presented.

58

In September 2011, the FASB issued ASU 2011-08, which simplifies how entities test goodwill for impairment. Previous guidance required an entity to perform a two-step goodwill impairment test at least annually by comparing the fair value of a reporting unit with its carrying amount, including goodwill, and recording an impairment loss if the fair value is less than the carrying amount. This ASU allows an entity to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If an entity determines after that assessment that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the two-step impairment test is not required. ASU 2011-08 is required to be applied to interim and annual goodwill impairment tests performed for fiscal years beginning after December 15, 2011, and will be adopted by us in 2012. The adoption of ASU 2011-08 is not expected to impact our consolidated financial position, results of operations or cash flows.

59

Item 8. Financial Statements and Supplementary Data

Index to Financial Statements

	Page
Community Health Systems, Inc. Consolidated Financial Statements:
Report of Independent Registered Public Accounting Firm		61
Consolidated Statements of Income for the Years Ended December 31, 2011, 2010 and 2009		62
Consolidated Statements of Comprehensive Income for the Years Ended December 31, 2011, 2010 and 2009		63
Consolidated Balance Sheets as of December 31, 2011 and 2010		64
Consolidated Statements of Stockholders’ Equity for the Years Ended December 31, 2011, 2010 and 2009		65
Consolidated Statements of Cash Flows for the Years Ended December 31, 2011, 2010 and 2009		66
Notes to Consolidated Financial Statements		67

60

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Stockholders of

Community Health Systems, Inc.

Franklin, Tennessee

We have audited the accompanying consolidated balance sheets of Community Health Systems, Inc.

and subsidiaries (the “Company”) as of December 31, 2011 and 2010, and the related consolidated statements of income, other comprehensive income, stockholders’ equity, and cash flows for each of the three years in the period ended December 31, 2011. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, such consolidated financial statements present fairly, in all material respects, the financial position of Community Health Systems, Inc. and subsidiaries as of December 31, 2011 and 2010, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2011, in conformity with accounting principles generally accepted in the United States of America.

As discussed in Note 1 to the consolidated financial statements, the Company changed its presentation of net operating revenues and provision for bad debts as a result of the adoption of Accounting Standards Update (“ASU”) No. 2011-07, Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Healthcare Entities. Additionally, as discussed in Note 1 to the consolidated financial statements, the Company changed its presentation of other comprehensive income as a result of the adoption of ASU No. 2011-05, Presentation of Comprehensive Income.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the Company’s internal control over financial reporting as of December 31, 2011, based on the criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 22, 2012 expressed an unqualified opinion on the Company’s internal control over financial reporting.

/s/ Deloitte & Touche LLP

Nashville, Tennessee

February 22, 2012

(May 23, 2012 as to Note 1)

61

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

	Year Ended December 31,
	2011			2010			2009
	(In thousands, except share and per share data)
Operating revenues (net of contractual allowances and discounts)	$	13,626,168		$	12,623,274		$	11,742,454
Provision for bad debts		1,719,956			1,530,852			1,408,953
Net operating revenues		11,906,212			11,092,422			10,333,501
Operating costs and expenses:
Salaries and benefits		5,577,925			5,093,767			4,701,231
Supplies		1,834,106			1,738,088			1,649,779
Other operating expenses		2,515,638			2,296,063			2,129,081
Electronic health records incentive reimbursement		(63,397	)		—			—
Rent		254,781			248,463			237,536
Depreciation and amortization		652,674			594,997			551,043
Total operating costs and expenses		10,771,727			9,971,378			9,268,670
Income from operations		1,134,485			1,121,044			1,064,831
Interest expense, net of interest income of $4,650, $1,757 and $3,561 in 2011, 2010, and 2009, respectively		644,410			647,593			643,608
Loss (gain) from early extinguishment of debt		66,019			—			(2,385	)
Equity in earnings of unconsolidated affiliates		(49,491	)		(45,443	)		(36,531	)
Impairment of long-lived and other assets		—			—			12,477
Income from continuing operations before income taxes		473,547			518,894			447,662
Provision for income taxes		137,653			163,681			141,851
Income from continuing operations		335,894			355,213			305,811
Discontinued operations, net of taxes:
(Loss) income from operations of entities sold		(7,769	)		(6,772	)		971
Impairment of hospitals sold		(47,930	)		—			—
Loss on sale, net		(2,572	)		—			(405	)
(Loss) income from discontinued operations		(58,271	)		(6,772	)		566
Net income		277,623			348,441			306,377
Less: Net income attributable to noncontrolling interests		75,675			68,458			63,227
Net income attributable to Community Health Systems, Inc.	$	201,948		$	279,983		$	243,150
Basic earnings per share attributable to Community Health Systems, Inc. common stockholders(1):
Continuing operations	$	2.89		$	3.13		$	2.68
Discontinued operations		(0.65	)		(0.07	)		—
Net income	$	2.24		$	3.05		$	2.68
Diluted earnings per share attributable to Community Health Systems, Inc. common stockholders(1):
Continuing operations	$	2.87		$	3.08		$	2.65
Discontinued operations		(0.64	)		(0.07	)		—
Net income	$	2.23		$	3.01		$	2.66
Weighted-average number of shares outstanding:
Basic		89,966,933			91,718,791			90,614,886
Diluted		90,666,348			92,946,048			91,517,274

(1) Total per share amounts may not add due to rounding.

See notes to consolidated financial statements.

62

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

	Year Ended December 31,
	2011			2010			2009
	(In thousands)
Net income	$	277,623		$	348,441		$	306,377
Other comprehensive income, net of income taxes:
Net change in fair value of interest rate swaps		55,145			(15,676	)		76,225
Net change in fair value of available-for-sale securities		(960	)		3,716			412
Amortization and recognition of unrecognized pension cost components		(7,737	)		2,418			(2,447	)
Other comprehensive income		46,448			(9,542	)		74,190
Comprehensive income		324,071			338,899			380,567
Less: Comprehensive income attributable to noncontrolling interests		75,675			68,458			63,227
Comprehensive income attributable to Community Health Systems, Inc.	$	248,396		$	270,441		$	317,340

See notes to consolidated financial statements.

63

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

	December 31,
	2011			2010
	(In thousands, except share data)
ASSETS
Current assets:
Cash and cash equivalents	$	129,865		$	299,169
Patient accounts receivable, net of allowance for doubtful accounts of $1,891,334 and $1,639,198 at December 31, 2011 and December 31, 2010, respectively		1,834,167			1,714,542
Supplies		346,611			329,114
Prepaid income taxes		101,389			118,464
Deferred income taxes		89,797			115,819
Prepaid expenses and taxes		112,613			100,754
Other current assets		231,647			193,331
Total current assets		2,846,089			2,871,193
Property and equipment:
Land and improvements		591,457			538,496
Buildings and improvements		5,715,066			5,108,711
Equipment and fixtures		3,063,005			2,735,915
		9,369,528			8,383,122
Less accumulated depreciation and amortization		(2,513,552	)		(2,058,685	)
Property and equipment, net		6,855,976			6,324,437
Goodwill		4,264,845			4,150,247
Other assets, net of accumulated amortization of $313,028 and $258,547 at December 31, 2011 and December 31, 2010, respectively (including long-lived assets of hospitals held for sale of $0 and $182,688 at December 31, 2011 and 2010, respectively)		1,241,930			1,352,246
Total assets	$	15,208,840		$	14,698,123
LIABILITIES AND EQUITY
Current liabilities:
Current maturities of long-term debt	$	63,706		$	63,139
Accounts payable		748,997			526,338
Deferred income taxes		—			8,882
Accrued liabilities:
Employee compensation		620,508			596,026
Interest		110,121			146,415
Other		367,807			301,240
Total current liabilities		1,911,139			1,642,040
Long-term debt		8,782,798			8,808,382
Deferred income taxes		704,725			608,177
Other long-term liabilities		949,990			1,001,675
Total liabilities		12,348,652			12,060,274
Redeemable noncontrolling interests in equity of consolidated subsidiaries		395,743			387,472
Commitments and contingencies (Note 15)
EQUITY
Community Health Systems, Inc. stockholders’ equity
Preferred stock, $.01 par value per share, 100,000,000 shares authorized; none issued		—			—
Common stock, $.01 par value per share, 300,000,000 shares authorized; 91,547,079 shares issued and 90,571,530 shares outstanding at December 31, 2011 and 93,644,862 shares issued and 92,669,313 shares outstanding at December 31, 2010		915			936
Additional paid-in capital		1,086,008			1,126,751
Treasury stock, at cost, 975,549 shares at December 31, 2011 and December 31, 2010		(6,678	)		(6,678	)
Accumulated other comprehensive loss		(184,479	)		(230,927	)
Retained earnings		1,501,330			1,299,382
Total Community Health Systems, Inc. stockholders’ equity		2,397,096			2,189,464
Noncontrolling interests in equity of consolidated subsidiaries		67,349			60,913
Total equity		2,464,445			2,250,377
Total liabilities and equity	$	15,208,840		$	14,698,123

See notes to consolidated financial statements.

64

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

				Community Health Systems, Inc. Stockholders
	Redeemable Noncontrolling Interests									Additional Paid-in Capital									Accumulated Other Comprehensive Income (Loss)
				Common Stock									Treasury Stock									Retained Earnings		Noncontrolling Interests
				Shares			Amount						Shares			Amount											Total
				(In thousands, except share data)
BALANCE, December 31, 2008	$	348,816			92,483,166		$	925		$	1,136,108			(975,549	)	$	(6,678	)	$	(295,575	)	$	776,249	$	61,457		$	1,672,486
Comprehensive income (loss):
Net income		46,716			—			—			—			—			—			—			243,150		16,511			259,661
Net change in fair value of interest rate swaps, net of tax of $42,876		—			—			—			—			—			—			76,225			—		—			76,225
Net change in fair value of available-for-sale securities		—			—			—			—			—			—			412			—		—			412
Amortization and recognition of unrecognized pension cost components, net of tax benefit of $3,262		—			—			—			—			—			—			(2,447	)		—		—			(2,447	)
Total comprehensive income		46,716			—			—			—			—			—			74,190			243,150		16,511			333,851
Distributions to noncontrolling interests, net of contributions		(27,072	)		—			—			—			—			—			—			—		(13,582	)		(13,582	)
Purchase of subsidiary shares from noncontrolling interests		(5,439	)		—			—			3,106			—			—			—			—		396			3,502
Sale of less-than-wholly-owned subsidiaries		(21,691	)		—			—			—			—			—			—			—		—			—
Adjustment to redemption value of redeemable noncontrolling interests		27,527			—			—			(27,527	)		—			—			—			—		—			(27,527	)
Issuance of common stock in connection with the exercise of stock options		—			680,898			7			12,760			—			—			—			—		—			12,767
Cancellation of restricted stock for tax withholdings on vested shares		—			(328,470	)		(3	)		(7,117	)		—			—			—			—		—			(7,120	)
Income tax payable increase from exercise of stock options		—			—			—			(3,472	)		—			—			—			—		—			(3,472	)
Share-based compensation		—			1,177,943			11			44,501			—			—			—			—		—			44,512
BALANCE, December 31, 2009		368,857			94,013,537			940			1,158,359			(975,549	)		(6,678	)		(221,385	)		1,019,399		64,782			2,015,417
Comprehensive income (loss):
Net income		50,292			—			—			—			—			—			—			279,983		18,166			298,149
Net change in fair value of interest rate swaps, net of tax benefit of $8,818		—			—			—			—			—			—			(15,676	)		—		—			(15,676	)
Net change in fair value of available-for-sale securities		—			—			—			—			—			—			3,716			—		—			3,716
Amortization and recognition of unrecognized pension cost components, net of tax of $1,142		—			—			—			—			—			—			2,418			—		—			2,418
Total comprehensive income (loss)		50,292			—			—			—			—			—			(9,542	)		279,983		18,166			288,607
Distributions to noncontrolling interests, net of contributions		(40,068	)		—			—			—			—			—			—			—		(20,046	)		(20,046	)
Purchase of subsidiary shares from noncontrolling interests		(3,754	)		—			—			(3,529	)		—			—			—			—		—			(3,529	)
Other reclassifications of noncontrolling interests		1,989			—			—			—			—			—			—			—		(1,989	)		(1,989	)
Adjustment to redemption value of redeemable noncontrolling interests		10,156			—			—			(10,156	)		—			—			—			—		—			(10,156	)
Issuance of common stock in connection with the exercise of stock options		—			2,194,862			22			56,916			—			—			—			—		—			56,938
Cancellation of restricted stock for tax withholdings on vested shares		—			(295,171	)		(3	)		(9,876	)		—			—			—			—		—			(9,879	)
Repurchases of common stock		—			(3,415,800	)		(34	)		(113,961	)		—			—			—			—		—			(113,995	)
Excess tax benefit from exercise of stock options		—			—			—			10,219			—			—			—			—		—			10,219
Share-based compensation		—			1,147,434			11			38,779			—			—			—			—		—			38,790
BALANCE, December 31, 2010		387,472			93,644,862			936			1,126,751			(975,549	)		(6,678	)		(230,927	)		1,299,382		60,913			2,250,377
Comprehensive income (loss):
Net income		54,251			—			—			—			—			—			—			201,948		21,424			223,372
Net change in fair value of interest rate swaps, net of tax of $31,154		—			—			—			—			—			—			55,145			—		—			55,145
Net change in fair value of available-for-sale securities		—			—			—			—			—			—			(960	)		—		—			(960	)
Amortization and recognition of unrecognized pension cost components, net of tax benefit of $4,754		—			—			—			—			—			—			(7,737	)		—		—			(7,737	)
Total comprehensive income		54,251			—			—			—			—			—			46,448			201,948		21,424			269,820
Distributions to noncontrolling interests, net of contributions		(39,816	)		—			—			—			—			—			—			—		(15,049	)		(15,049	)
Purchase of subsidiary shares from noncontrolling interests		(7,426	)		—			—			(4,556	)		—			—			—			—		(1,040	)		(5,596	)
Other reclassifications of noncontrolling interests		(2,099	)		—			—			—			—			—			—			—		1,101			1,101
Adjustment to redemption value of redeemable noncontrolling interests		3,361			—			—			(3,361	)		—			—			—			—		—			(3,361	)
Issuance of common stock in connection with the exercise of stock options		—			623,341			6			18,910			—			—			—			—		—			18,916
Cancellation of restricted stock for tax withholdings on vested shares		—			(346,419	)		(3	)		(13,311	)		—			—			—			—		—			(13,314	)
Repurchases of common stock		—			(3,469,099	)		(35	)		(85,790	)		—			—			—			—		—			(85,825	)
Excess tax benefit from exercise of stock options		—			—			—			4,823			—			—			—			—		—			4,823
Share-based compensation		—			1,094,394			11			42,542			—			—			—			—		—			42,553
BALANCE, December 31, 2011	$	395,743			91,547,079		$	915		$	1,086,008			(975,549	)	$	(6,678	)	$	(184,479	)	$	1,501,330	$	67,349		$	2,464,445

See notes to consolidated financial statements.

65

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

	Year Ended December 31,
	2011			2010			2009
	(In thousands)
Cash flows from operating activities:
Net income	$	277,623		$	348,441		$	306,377
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		657,665			609,839			566,543
Deferred income taxes		107,032			97,370			34,268
Stock-based compensation expense		42,542			38,779			44,501
Loss on sale, net		2,572			—			405
Impairment of hospitals sold and other long-lived assets		47,930			—			12,477
Loss (gain) on early extinguishment of debt		66,019			—			(2,385	)
(Excess tax benefit) income tax payable increase relating to stock-based compensation expense		(5,290	)		(10,219	)		3,472
Other non-cash expenses, net		28,716			12,503			22,870
Changes in operating assets and liabilities, net of effects of acquisitions and divestitures:
Patient accounts receivable		(138,332	)		(27,049	)		58,390
Supplies, prepaid expenses and other current assets		(42,858	)		(39,904	)		(34,535	)
Accounts payable, accrued liabilities and income taxes		246,110			161,952			86,098
Other		(27,821	)		(2,982	)		(22,052	)
Net cash provided by operating activities		1,261,908			1,188,730			1,076,429
Cash flows from investing activities:
Acquisitions of facilities and other related equipment		(415,360	)		(248,251	)		(263,773	)
Purchases of property and equipment		(776,713	)		(667,378	)		(576,888	)
Proceeds from disposition of hospitals and other ancillary operations		173,387			—			89,514
Proceeds from sale of property and equipment		11,160			8,401			4,019
Increase in other investments		(188,249	)		(137,082	)		(120,054	)
Net cash used in investing activities		(1,195,775	)		(1,044,310	)		(867,182	)
Cash flows from financing activities:
Proceeds from exercise of stock options		18,910			56,916			12,759
Repurchase of restricted stock shares for payroll tax withholding requirements		(13,311	)		—			—
Deferred financing costs		(19,352	)		(13,260	)		(82	)
Excess tax benefit (income tax payable increase) relating to stock-based compensation		5,290			10,219			(3,472	)
Stock buy-back		(85,790	)		(113,961	)		—
Proceeds from noncontrolling investors in joint ventures		1,229			7,201			29,838
Redemption of noncontrolling investments in joint ventures		(13,022	)		(7,318	)		(7,268	)
Distributions to noncontrolling investors in joint ventures		(56,094	)		(68,113	)		(58,963	)
Borrowings under credit agreement		578,236			—			200,000
Issuance of long-term debt		1,000,000			—			—
Repayments of long-term indebtedness		(1,651,533	)		(61,476	)		(258,173	)
Net cash used in financing activities		(235,437	)		(189,792	)		(85,361	)
Net change in cash and cash equivalents		(169,304	)		(45,372	)		123,886
Cash and cash equivalents at beginning of period		299,169			344,541			220,655
Cash and cash equivalents at end of period	$	129,865		$	299,169		$	344,541
Supplemental disclosure of cash flow information:
Interest payments	$	680,704		$	650,712		$	656,997
Income taxes paid, net	$	26,463		$	128,186		$	57,299

See notes to consolidated financial statements.

66

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1. Business and Summary of Significant Accounting Policies

Business. Community Health Systems, Inc. is a holding company and operates no business in its own name. On a consolidated basis, Community Health Systems, Inc. and its subsidiaries (collectively the “Company”) own, lease and operate acute care hospitals in non-urban and selected urban markets. As of December 31, 2011, the Company owned or leased 131 hospitals, including four stand-alone rehabilitation or psychiatric hospitals, licensed for 19,695 beds in 29 states. Throughout these notes to the consolidated financial statements, Community Health Systems, Inc. (the “Parent”) and its consolidated subsidiaries are referred to on a collective basis as the “Company.” This drafting style is not meant to indicate that the publicly-traded Parent or any subsidiary of the Parent owns or operates any asset, business, or property. The hospitals, operations and businesses described in this filing are owned and operated, and management services provided, by distinct and indirect subsidiaries of Community Health Systems, Inc.

As of December 31, 2011, Indiana, Texas and Pennsylvania represent the only areas of geographic concentration. Operating revenues, net of contractual allowances and discounts (but before the provision for bad debts) generated by the Company’s hospitals in Indiana, as a percentage of consolidated operating revenues, were 10.3% in 2011, 10.6% in 2010 and 11.2% in 2009. Operating revenues, net of contractual allowances and discounts (but before the provision for bad debts) generated by the Company’s hospitals in Texas, as a percentage of consolidated operating revenues, were 13.1% in 2011, 13.0% in 2010 and 13.2% in 2009. Operating revenues, net of contractual allowances and discounts (but before the provision for bad debts) generated by the Company’s hospitals in Pennsylvania, as a percentage of consolidated operating revenues, were 11.5% in 2011, 10.3% in 2010 and 10.2% in 2009.

Use of Estimates. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates under different assumptions or conditions.

Principles of Consolidation. The consolidated financial statements include the accounts of the Parent, its subsidiaries, all of which are controlled by the Parent through majority voting control, and variable interest entities for which the Company is the primary beneficiary. All significant intercompany accounts, profits and transactions have been eliminated. Noncontrolling interests in less-than-wholly-owned consolidated subsidiaries of the Parent are presented as a component of total equity to distinguish between the interests of the Parent and the interests of the noncontrolling owners. Revenues, expenses and income from continuing operations from these subsidiaries are included in the consolidated amounts as presented on the consolidated statements of income, along with a net income measure that separately presents the amounts attributable to the controlling interests and the amounts attributable to the noncontrolling interests for each of the periods presented. Noncontrolling interests that are redeemable or may become redeemable at a fixed or determinable price at the option of the holder or upon the occurrence of an event outside of the control of the Company are presented in mezzanine equity on the consolidated balance sheets.

Cost of Revenue. Substantially all of the Company’s operating expenses are “cost of revenue” items. Operating costs that could be classified as general and administrative by the Company would include the Company’s corporate office costs at its Franklin, Tennessee office, which were $183.4 million, $155.4 million and $157.9 million for the years ended December 31, 2011, 2010 and 2009, respectively. Included in these amounts is stock-based compensation of $42.5 million, $38.8 million and $44.5 million for the years ended December 31, 2011, 2010 and 2009, respectively.

Cash Equivalents. The Company considers highly liquid investments with original maturities of three months or less to be cash equivalents.

Supplies. Supplies, principally medical supplies, are stated at the lower of cost (first-in, first-out basis) or market.

67

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Marketable Securities. The Company’s marketable securities are classified as trading or available-for-sale. Available-for-sale securities are carried at fair value as determined by quoted market prices, with unrealized gains and losses reported as a separate component of stockholders’ equity. Trading securities are reported at fair value with unrealized gains and losses included in earnings. Interest and dividends on securities classified as available-for-sale or trading are included in net operating revenues and were not material in all periods presented. Accumulated other comprehensive income (loss) included an unrealized loss of $1.0 million and an unrealized gain of $3.7 million at December 31, 2011 and 2010, respectively, related to these available-for-sale securities.

Property and Equipment. Property and equipment are recorded at cost. Depreciation is recognized using the straight-line method over the estimated useful lives of the land and improvements (2 to 15 years; weighted-average useful life is 14 years), buildings and improvements (5 to 40 years; weighted-average useful life is 24 years) and equipment and fixtures (4 to 18 years; weighted-average useful life is 8 years). Costs capitalized as construction in progress were $397.2 million and $221.2 million at December 31, 2011 and 2010, respectively. Expenditures for renovations and other significant improvements are capitalized; however, maintenance and repairs which do not improve or extend the useful lives of the respective assets are charged to operations as incurred. Interest capitalized related to construction in progress was $21.4 million, $11.9 million and $16.7 million for the years ended December 31, 2011, 2010 and 2009, respectively. Purchases of property and equipment accrued in accounts payable and not yet paid were $94.2 million and $59.5 million at December 31, 2011 and 2010, respectively.

The Company also leases certain facilities and equipment under capital leases (see Note 9). Such assets are amortized on a straight-line basis over the lesser of the term of the lease or the remaining useful lives of the applicable assets.

Goodwill. Goodwill represents the excess of the fair value of the consideration conveyed in the acquisition over the fair value of net assets acquired. Goodwill arising from business combinations is not amortized. Goodwill is required to be evaluated for impairment at the same time every year and when an event occurs or circumstances change such that it is reasonably possible that an impairment may exist. The Company has selected September 30 as its annual testing date.

Other Assets. Other assets primarily consist of costs associated with the issuance of debt, which are included in interest expense over the life of the related debt using the effective interest method, and costs to recruit physicians to the Company’s markets, which are deferred and expensed over the term of the respective physician recruitment contract, which is generally three years, and included in amortization expense. Other assets also include capitalized internal-use software costs, which are expensed over the expected useful life, which is generally three years for routine software and eight years for major software projects, and included in amortization expense.

Third-Party Reimbursement. Net patient service revenue is reported at the estimated net realizable amount from patients, third-party payors and others for services rendered. Net operating revenues include amounts estimated by management to be reimbursable by Medicare and Medicaid under prospective payment systems, provisions of cost-reimbursement and other payment methods. Approximately 36.5%, 38.1% and 37.2% of operating revenues, net of contractual allowances and discounts (but before the provision for bad debts) for the years ended December 31, 2011, 2010 and 2009, respectively, are related to services rendered to patients covered by the Medicare and Medicaid programs. Revenues from Medicare outlier payments are included in the amounts received from Medicare and were approximately 0.42%, 0.43% and 0.43% of operating revenues, net of contractual allowances and discounts (but before the provision for bad debts) for the years ended December 31, 2011, 2010 and 2009, respectively. In addition, the Company is reimbursed by non-governmental payors using a variety of payment methodologies. Amounts received by the Company for treatment of patients covered by such programs are generally less than the standard billing rates. The differences between the estimated program reimbursement rates and the standard billing rates are accounted for as contractual adjustments, which are deducted from gross revenues to arrive at net operating revenues. These net operating revenues are an estimate of the net realizable amount due from these payors. The process of estimating contractual allowances requires the Company to estimate the amount expected to be received based on payor contract provisions. The key assumption in this process is the estimated contractual reimbursement percentage, which is based on payor classification and historical paid claims data. Due to the complexities involved in these estimates, actual payments the Company receives could be different from the amounts it estimates and records. Final settlements under some of these programs are subject to adjustment based on administrative review and audit by third parties. Adjustments to previous program reimbursement estimates are accounted for as contractual allowance adjustments and reported in the periods that such adjustments become

68

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

known. Contractual allowance adjustments related to final settlements and previous program reimbursement estimates impacted net operating revenues and net income by an insignificant amount in each of the years ended December 31, 2011, 2010 and 2009.

Amounts due to third-party payors were $66.0 million and $80.5 million as of December 31, 2011 and 2010, respectively, and are included in accrued liabilities-other in the accompanying consolidated balance sheets. Amounts due from third-party payors were $86.5 million and $118.7 million as of December 31, 2011 and 2010, respectively, and are included in other current assets in the accompanying consolidated balance sheets. Substantially all Medicare and Medicaid cost reports are final settled through 2006.

Net Operating Revenues. Net operating revenues are recorded net of provisions for contractual allowance of approximately $42.4 billion, $35.8 billion and $30.8 billion in 2011, 2010 and 2009, respectively. Net operating revenues are recognized when services are provided and are reported at the estimated net realizable amount from patients, third-party payors and others for services rendered. Also included in the provision for contractual allowance shown above is the value of administrative and other discounts provided to self-pay patients eliminated from net operating revenues which was $852.4 million, $689.4 million and $531.9 million for the years ended December 31, 2011, 2010 and 2009, respectively. In the ordinary course of business, the Company renders services to patients who are financially unable to pay for hospital care. Also, included in the provision for contractual allowance shown above is the value (at the Company’s standard charges) of these services to patients who are unable to pay that is eliminated from net operating revenues when it is determined they qualify under the Company’s charity care policy. The value of these services was $651.1 million, $512.4 million and $451.0 million for the years ended December 31, 2011, 2010 and 2009, respectively. The estimated cost incurred by the Company to provide these services to patients who are unable to pay was approximately $125.7 million, $105.5 million and $104.0 million for the years ended December 31, 2011, 2010 and 2009, respectively. The estimated cost of these charity care services was determined using a ratio of cost to gross charges and applying that ratio to the gross charges associated with providing care to charity patients for the period. Gross charges associated with providing care to charity patients includes only the related charges for those patients who are financially unable to pay and qualify under the Company’s charity care policy and that do not otherwise qualify for reimbursement from a governmental program.

Currently, several states utilize supplemental reimbursement programs for the purpose of providing reimbursement to providers to offset a portion of the cost of providing care to Medicaid and indigent patients. These programs are designed with input from Centers for Medicare and Medicaid Services and are funded with a combination of state and federal resources, including, in certain instances, fees or taxes levied on the providers. Similar programs are also being considered by other states. After these supplemental programs are signed into law, the Company recognizes revenue and related expenses in the period in which amounts are estimable and collection is reasonably assured. Reimbursement under these programs is reflected in net operating revenues and fees, taxes or other program-related costs are reflected in other operating costs and expenses.

Allowance for Doubtful Accounts. Accounts receivable are reduced by an allowance for amounts that could become uncollectible in the future. Substantially all of the Company’s receivables are related to providing healthcare services to its hospitals’ patients.

The Company estimates the allowance for doubtful accounts by reserving a percentage of all self-pay accounts receivable without regard to aging category, based on collection history, adjusted for expected recoveries and, if present, anticipated changes in trends. For all other non-self-pay payor categories, the Company reserves 100% of all accounts aging over 365 days from the date of discharge. The percentage used to reserve for all self-pay accounts is based on the Company’s collection history. The Company collects substantially all of its third-party insured receivables, which include receivables from governmental agencies.

Collections are impacted by the economic ability of patients to pay and the effectiveness of the Company’s collection efforts. Significant changes in payor mix, business office operations, economic conditions or trends in federal and state governmental healthcare coverage could affect the Company’s collection of accounts receivable and the estimates of the collectability of future accounts receivable. The process of estimating the allowance for doubtful accounts requires the Company to estimate the collectability of self-pay accounts receivable, which is primarily based on its collection history, adjusted for expected recoveries and, if available, anticipated changes in collection trends. The Company also continually reviews its overall reserve adequacy by monitoring historical cash

69

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

collections as a percentage of trailing net revenue less provision for bad debts, as well as by analyzing current period net revenue and admissions by payor classification, aged accounts receivable by payor, days revenue outstanding, and the impact of recent acquisitions and dispositions.

Operating revenues, net of contractual allowances and discounts (but before the provision for bad debts), recognized during the years ended December 31, 2011, 2010 and 2009, is as follows (in thousands):

	Year Ended December 31,
	2011		2010		2009
Medicare	$	3,654,247	$	3,464,117	$	3,212,424
Medicaid		1,318,756		1,345,315		1,146,033
Managed Care and other third-party payors		7,014,519		6,359,322		6,071,023
Self-pay		1,638,646		1,454,520		1,312,974
Total	$	13,626,168	$	12,623,274	$	11,742,454

Physician Income Guarantees. The Company enters into physician recruiting agreements under which it supplements physician income to a minimum amount over a period of time, typically one year, while the physicians establish themselves in the community. As part of the agreements, the physicians are committed to practice in the community for a period of time, typically three years, which extends beyond their income guarantee period. The Company records an asset and liability for the estimated fair value of minimum revenue guarantees on new agreements. Adjustments to the ultimate value of the guarantee paid to physicians are recognized in the period that the change in estimate is identified. The Company amortizes an asset over the life of the agreement. As of December 31, 2011 and 2010, the unamortized portion of these physician income guarantees was $33.0 million and $37.2 million, respectively.

Concentrations of Credit Risk. The Company grants unsecured credit to its patients, most of whom reside in the service area of the Company’s facilities and are insured under third-party payor agreements. Because of the economic diversity of the Company’s facilities and non-governmental third-party payors, Medicare represents the only significant concentration of credit risk from payors. Accounts receivable, net of contractual allowances, from Medicare were $250.8 million and $270.8 million as of December 31, 2011 and 2010, respectively, representing 6.7% and 8.1% of consolidated net accounts receivable, before allowance for doubtful accounts, as of December 31, 2011 and 2010, respectively.

Professional Liability Claims. The Company accrues for estimated losses resulting from professional liability. The accrual, which includes an estimate for incurred but not reported claims, is based on historical loss patterns and actuarially-determined projections and is discounted to its net present value. To the extent that subsequent claims information varies from management’s estimates, the liability is adjusted when such information becomes available.

Accounting for the Impairment or Disposal of Long-Lived Assets. Whenever events or changes in circumstances indicate that the carrying values of certain long-lived assets may be impaired, the Company projects the undiscounted cash flows expected to be generated by these assets. If the projections indicate that the reported amounts are not expected to be recovered, such amounts are reduced to their estimated fair value based on a quoted market price, if available, or an estimate based on valuation techniques available in the circumstances.

Income Taxes. The Company accounts for income taxes under the asset and liability method, in which deferred income tax assets and liabilities are recognized for the tax consequences of “temporary differences” by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying amounts and the tax bases of existing assets and liabilities. The effect on deferred taxes of a change in tax rates is recognized in the consolidated statement of income during the period in which the tax rate change becomes law.

Comprehensive Income (Loss). Comprehensive income (loss) is the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources.

70

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Accumulated Other Comprehensive Income (Loss) consisted of the following (in thousands):

	Change in Fair Value of Interest Rate Swaps			Change in Fair Value of Available for Sale Securities			Change in Unrecognized Pension Cost Components			Accumulated Other Comprehensive Income (Loss)
Balance as of December 31, 2009	$	(202,260	)	$	(1,180	)	$	(17,945	)	$	(221,385	)
2010 Activity, net of tax		(15,676	)		3,716			2,418			(9,542	)
Balance as of December 31, 2010		(217,936	)		2,536			(15,527	)		(230,927	)
2011 Activity, net of tax		55,145			(960	)		(7,737	)		46,448
Balance as of December 31, 2011	$	(162,791	)	$	1,576		$	(23,264	)	$	(184,479	)

Segment Reporting. A public company is required to report annual and interim financial and descriptive information about its reportable operating segments. Operating segments, as defined, are components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. Aggregation of similar operating segments into a single reportable operating segment is permitted if the businesses have similar economic characteristics and meet the criteria established by U.S. GAAP.

The Company operates in three distinct operating segments, represented by the hospital operations (which includes the Company’s acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services), the home care agencies operations (which provide in-home outpatient care), and the hospital management services business (which provides executive management and consulting services to non-affiliated general acute care hospitals). U.S. GAAP requires (1) that financial information be disclosed for operating segments that meet a 10% quantitative threshold of the consolidated totals of net revenue, profit or loss, or total assets; and (2) that the individual reportable segments disclosed contribute at least 75% of total consolidated net revenue. Based on these measures, only the hospital operations segment meets the criteria as a separate reportable segment. Financial information for the home care agencies and hospital management services segments do not meet the quantitative thresholds and are therefore combined with corporate into the all other reportable segment.

Derivative Instruments and Hedging Activities. The Company records derivative instruments on the consolidated balance sheet as either an asset or liability measured at its fair value. Changes in a derivative’s fair value are recorded each period in earnings or other comprehensive income (“OCI”), depending on whether the derivative is designated and is effective as a hedged transaction, and on the type of hedge transaction. Changes in the fair value of derivative instruments recorded to OCI are reclassified to earnings in the period affected by the underlying hedged item. Any portion of the fair value of a derivative instrument determined to be ineffective under the standard is recognized in current earnings.

The Company has entered into several interest rate swap agreements. See Note 7 for further discussion about the swap transactions.

New Accounting Pronouncements. In August 2010, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2010-24, which provides clarification to companies in the healthcare industry on the accounting for professional liability insurance. This ASU states that receivables related to insurance recoveries should not be netted against the related claim liability and such claim liabilities should be determined without considering insurance recoveries. This ASU is effective for fiscal years beginning after December 15, 2010 and was adopted prospectively by the Company on January 1, 2011. The adoption of this ASU increased other current assets by $5.3 million, other assets, net by $36.9 million and long-term liabilities by $42.2 million in the consolidated balance sheet at December 31, 2011 and had no impact to the consolidated statement of income for the year ended December 31, 2011.

In June 2011, the FASB issued ASU 2011-05, which eliminates the option to present components of other comprehensive income as part of the statement of changes in stockholders’ equity. Instead, ASU 2011-05 requires that all nonowner changes in stockholders’ equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. In December 2011, the FASB issued ASU 2011-12, which amends ASU 2011-05 to defer the requirement to measure and present reclassification adjustments from accumulated other comprehensive income to net income by income statement line item in net income and also

71

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

in other comprehensive income. ASU 2011-05, as amended by ASU 2011-12, is required to be applied retrospectively and is effective for fiscal years beginning after December 15, 2011, and has been reflected in the accompanying consolidated financial statements for all periods presented. The adoption of ASU 2011-05, as amended by ASU 2011-12, has not impacted the Company’s consolidated financial position, results of operations or cash flows.

In July 2011, the FASB issued ASU 2011-07, which requires healthcare organizations that perform services for patients for which the ultimate collection of all or a portion of the amounts billed or billable cannot be determined at the time services are rendered to present all bad debt expense associated with such patient service revenue as an offset to the patient service revenue line item in the statement of operations. The ASU also requires qualitative disclosures about the Company’s policy for recognizing revenue and bad debt expense for patient service transactions and quantitative information about the effects of changes in the assessment of collectability of patient service revenue. This ASU is effective for fiscal years beginning after December 15, 2011, and has been reflected in the accompanying consolidated financial statements for all periods presented.

In September 2011, the FASB issued ASU 2011-08, which simplifies how entities test goodwill for impairment. Previous guidance required an entity to perform a two-step goodwill impairment test at least annually by comparing the fair value of a reporting unit with its carrying amount, including goodwill, and recording an impairment loss if the fair value is less than the carrying amount. This ASU allows an entity to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If an entity determines after that assessment that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the two-step impairment test is not required. ASU 2011-08 is required to be applied to interim and annual goodwill impairment tests performed for fiscal years beginning after December 15, 2011, and will be adopted by the Company in 2012. The adoption of ASU 2011-08 is not expected to impact the Company’s consolidated financial position, results of operations or cash flows.

2. Accounting for Stock-Based Compensation

Stock-based compensation awards are granted under the Community Health Systems, Inc. Amended and Restated 2000 Stock Option and Award Plan, amended and restated as of March 24, 2009 (the “2000 Plan”), and the Community Health Systems, Inc. 2009 Stock Option and Award Plan, amended and restated as of March 18, 2011 (the “2009 Plan”).

The 2000 Plan allows for the grant of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code (“IRC”), as well as stock options which do not so qualify, stock appreciation rights, restricted stock, restricted stock units, performance-based shares or units and other share awards. Prior to being amended in 2009, the 2000 Plan also allowed for the grant of phantom stock. Persons eligible to receive grants under the 2000 Plan include the Company’s directors, officers, employees and consultants. To date, all options granted under the 2000 Plan have been “nonqualified” stock options for tax purposes. Generally, vesting of these granted options occurs in one-third increments on each of the first three anniversaries of the award date. Options granted prior to 2005 have a 10-year contractual term, options granted in 2005 through 2007 have an eight-year contractual term and options granted in 2008 or later have a 10-year contractual term. As of December 31, 2011, 332,747 shares of unissued common stock were reserved for future grants under the 2000 Plan.

The 2009 Plan provides for the grant of incentive stock options intended to qualify under Section 422 of the IRC and for the grant of stock options which do not so qualify, stock appreciation rights, restricted stock, restricted stock units, performance-based shares or units and other share awards. Persons eligible to receive grants under the 2009 Plan include the Company’s directors, officers, employees and consultants. To date, all options granted under the 2009 Plan have been “nonqualified” stock options for tax purposes. Options granted in 2011 have a 10-year contractual term. As of December 31, 2011, 2,773,489 shares of unissued common stock were reserved for future grants under the 2009 Plan.

72

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

The exercise price of all options granted is equal to the fair value of the Company’s common stock on the option grant date.

73

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

The following table reflects the impact of total compensation expense related to stock-based equity plans on the reported operating results for the respective periods (in thousands):

	Year Ended December 31,
	2011			2010			2009
Effect on income from continuing operations before income taxes	$	(42,542	)	$	(38,779	)	$	(44,501	)
Effect on net income	$	(27,014	)	$	(24,625	)	$	(26,986	)

At December 31, 2011, $59.0 million of unrecognized stock-based compensation expense was expected to be recognized over a weighted-average period of 22 months. Of that amount, $13.1 million relates to outstanding unvested stock options expected to be recognized over a weighted-average period of 22 months and $45.9 million relates to outstanding unvested restricted stock, restricted stock units and phantom shares expected to be recognized over a weighted-average period of 22 months. There were no modifications to awards during the years ended December 31, 2011, 2010 and 2009.

The fair value of stock options was estimated using the Black-Scholes option pricing model with the following assumptions during the years ended December 31, 2011, 2010 and 2009:

	Year Ended December 31,
	2011			2010			2009
Expected volatility		33.8	%		33.7	%		40.7	%
Expected dividends		0			0			0
Expected term		4 years			3.1 years			4 years
Risk-free interest rate		1.63	%		1.41	%		1.64	%

In determining the expected term, the Company examined concentrations of option holdings and historical patterns of option exercises and forfeitures, as well as forward-looking factors, in an effort to determine if there were any discernable employee populations. From this analysis, the Company identified two primary employee populations, one consisting of certain senior executives and the other consisting of substantially all other recipients.

The expected volatility rate was estimated based on historical volatility. In determining expected volatility, the Company also reviewed the market-based implied volatility of actively traded options of its common stock and determined that historical volatility utilized to estimate the expected volatility rate did not differ significantly from the implied volatility.

The expected term computation is based on historical exercise and cancellation patterns and forward-looking factors, where present, for each population identified. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of the grant. The pre-vesting forfeiture rate is based on historical rates and forward-looking factors for each population identified. The Company adjusts the estimated forfeiture rate to its actual experience.

74

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Options outstanding and exercisable under the 2000 Plan and 2009 Plan as of December 31, 2011, and changes during each of the years in the three-year period ended December 31, 2011 were as follows (in thousands, except share and per share data):

	Shares			Weighted - Average Exercise Price		Weighted - Average Remaining Contractual Term		Aggregate Intrinsic Value as of December 31, 2011
Outstanding at December 31, 2008		8,764,084		$	30.97
Granted		1,313,000			19.43
Exercised		(680,898	)		18.74
Forfeited and cancelled		(442,105	)		31.27
Outstanding at December 31, 2009		8,954,081			30.19
Granted		1,447,500			33.89
Exercised		(2,194,862	)		25.88
Forfeited and cancelled		(372,387	)		29.80
Outstanding at December 31, 2010		7,834,332			32.08
Granted		1,505,000			35.87
Exercised		(623,341	)		30.34
Forfeited and cancelled		(326,849	)		33.69
Outstanding at December 31, 2011		8,389,142		$	32.83		5.3 years	$	120
Exercisable at December 31, 2011		5,884,262		$	32.74		3.9 years	$	74

The weighted-average grant date fair value of stock options granted during the years ended December 31, 2011, 2010 and 2009, was $10.07, $8.47 and $6.61, respectively. The aggregate intrinsic value (the number of in-the-money stock options multiplied by the difference between the Company’s closing stock price on the last trading day of the reporting period ($17.45) and the exercise price of the respective stock options) in the table above represents the amount that would have been received by the option holders had all option holders exercised their options on December 31, 2011. This amount changes based on the market value of the Company’s common stock. The aggregate intrinsic value of options exercised during the years ended December 31, 2011, 2010 and 2009 was $6.1 million, $28.9 million and $7.6 million, respectively. The aggregate intrinsic value of options vested and expected to vest approximates that of the outstanding options.

The Company has also awarded restricted stock under the 2000 Plan and the 2009 Plan to its directors and employees of certain subsidiaries. The restrictions on these shares generally lapse in one-third increments on each of the first three anniversaries of the award date. Certain of the restricted stock awards granted to the Company’s senior executives contain a performance objective that must be met in addition to any vesting requirements. If the performance objective is not attained, the awards will be forfeited in their entirety. Once the performance objective has been attained, restrictions will lapse in one-third increments on each of the first three anniversaries of the award date. Notwithstanding the above-mentioned performance objectives and vesting requirements, the restrictions will lapse earlier in the event of death, disability or termination of employment by the Company for any reason other than for cause of the holder of the restricted stock, or change in control of the Company. Restricted stock awards subject to performance standards are not considered outstanding for purposes of determining earnings per share until the performance objectives have been satisfied.

75

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Restricted stock outstanding under the 2000 Plan and the 2009 Plan as of December 31, 2011, and changes during each of the years in the three-year period ended December 31, 2011 was as follows:

	Shares			Weighted - Average Grant Date Fair Value
Unvested at December 31, 2008		1,684,207		$	35.57
Granted		1,188,814			18.45
Vested		(965,478	)		37.08
Forfeited		(10,002	)		32.52
Unvested at December 31, 2009		1,897,541			24.09
Granted		1,099,000			33.83
Vested		(860,749	)		27.04
Forfeited		(10,501	)		27.84
Unvested at December 31, 2010		2,125,291			27.92
Granted		1,109,949			37.57
Vested		(1,009,959	)		27.40
Forfeited		(17,669	)		35.68
Unvested at December 31, 2011		2,207,612			32.95

Phantom stock and restricted stock units (“RSUs”) have been granted to the Company’s outside directors under the 2000 Plan and the 2009 Plan. On February 25, 2009, each of the Company’s outside directors received a grant under the 2000 Plan of 7,151 shares of phantom stock. On May 19, 2009, the newly elected outside director received a grant under the 2000 Plan of 7,151 RSUs. On February 24, 2010, six of the Company’s seven outside directors each received a grant under the 2000 Plan of 4,130 RSUs and one outside director, who did not stand for reelection in 2010, did not receive such a grant. On February 23, 2011, each of the Company’s outside directors received a grant under the 2009 Plan of 3,688 RSUs. Vesting of these shares of phantom stock and RSUs occurs in one-third increments on each of the first three anniversaries of the award date.

76

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Phantom stock and RSUs outstanding as of December 31, 2011, and changes during each of the years in the three-year period ended December 31, 2011 were as follows:

	Shares			Weighted - Average Grant Date Fair Value
Unvested at December 31, 2008		—		$	—
Phantom Stock Granted February 25, 2009		42,906			18.18
RSUs Granted May 19, 2009		7,151			25.27
Vested		—			—
Forfeited		—			—
Unvested at December 31, 2009		50,057			19.19
RSUs Granted February 24, 2010		24,780			33.90
Vested		(21,449	)		18.97
Forfeited		—			—
Unvested at December 31, 2010		53,388			26.11
RSUs Granted February 23, 2011		22,128			37.96
Vested		(22,560	)		24.68
Forfeited		—			—
Unvested at December 31, 2011		52,956			31.67

Under the Directors’ Fees Deferral Plan, the Company’s outside directors may elect to receive share equivalent units in lieu of cash for their directors’ fees. These share equivalent units are held in the plan until the director electing to receive the share equivalent units retires or otherwise terminates his/her directorship with the Company. Share equivalent units are converted to shares of common stock of the Company at the time of distribution based on the closing market price of the Company’s common stock on that date. The following table represents the amount of directors’ fees which were deferred during each of the respective periods, and the number of share equivalent units into which such directors’ fees would have converted had each of the directors who had deferred such fees retired or terminated his/her directorship with the Company as of the end of the respective periods (in thousands, except share equivalent units):

	Year Ended December 31,
	2011		2010		2009
Directors’ fees earned and deferred into plan	$	220	$	180	$	80
Share equivalent units		9,974		5,207		3,284

At December 31, 2011, a total of 28,775 share equivalent units were deferred in the plan with an aggregate fair value of $0.5 million, based on the closing market price of the Company’s common stock at December 31, 2011 of $17.45.

77

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

3. Acquisitions and Divestitures

Acquisitions

The Company accounts for all transactions that represent business combinations after January 1, 2009 using the acquisition method of accounting, where the identifiable assets acquired, the liabilities assumed and any noncontrolling interest in the acquired entity are recognized and measured at their fair values on the date the Company obtains control in the acquiree. Such fair values that are not finalized for reporting periods following the acquisition date are estimated and recorded as provisional amounts. Adjustments to these provisional amounts during the measurement period (defined as the date through which all information required to identify and measure the consideration transferred, the assets acquired, the liabilities assumed and any noncontrolling interests has been obtained, limited to one year from the acquisition date) are recorded as of the date of acquisition. Any material impact to comparative information for periods after acquisition, but before the period in which adjustments are identified, is reflected in those prior periods as if the adjustments were considered as of the acquisition date. Goodwill is determined as the excess of the fair value of the consideration conveyed in the acquisition over the fair value of the net assets acquired.

Effective October 1, 2011, one or more subsidiaries of the Company completed the acquisition of Tomball Regional Hospital (358 licensed beds) located in Tomball, Texas. The total cash consideration paid for fixed assets and working capital was approximately $192.0 million and $17.5 million, respectively, with additional consideration of $15.8 million assumed in liabilities, for a total consideration of $225.3 million. Based upon the Company’s preliminary purchase price allocation relating to this acquisition as of December 31, 2011, approximately $30.8 million of goodwill has been recorded. The preliminary allocation of the purchase price has been determined by the Company based on available information and is subject to settling amounts related to purchased working capital and final appraisals of tangible and intangible assets. Adjustments to the purchase price allocation are not expected to be material.

Effective May 1, 2011, one or more subsidiaries of the Company completed the acquisition of Mercy Health Partners based in Scranton, Pennsylvania, which is a healthcare system comprised of two acute care hospitals, a long-term acute care facility and other healthcare providers. This healthcare system includes Regional Hospital of Scranton (198 licensed beds) located in Scranton, Pennsylvania, and Tyler Memorial Hospital (48 licensed beds) located in Tunkhannock, Pennsylvania. This healthcare system also includes a long-term acute care facility, Special Care Hospital (67 licensed beds) located in Nanticoke, Pennsylvania, as well as several outpatient clinics and other ancillary facilities. The total cash consideration paid for fixed assets was approximately $150.8 million, with additional consideration of $12.3 million assumed in liabilities as well as a credit applied at closing of $2.1 million for negative acquired working capital, for a total consideration of $161.0 million. Based upon the Company’s final purchase price allocation relating to this acquisition, as of December 31, 2011 approximately $43.1 million of goodwill has been recorded.

Effective October 1, 2010, one or more subsidiaries of the Company completed the acquisition of Forum Health based in Youngstown, Ohio, a healthcare system of two acute care hospitals, a rehabilitation hospital and other healthcare providers. This healthcare system includes Northside Medical Center (355 licensed beds) located in Youngstown, Ohio, and Trumbull Memorial Hospital (311 licensed beds) located in Warren, Ohio. This healthcare system also includes Hillside Rehabilitation Hospital (69 licensed beds) located in Warren, Ohio, as well as several outpatient clinics and other ancillary facilities. The total cash consideration paid for fixed assets and working capital was approximately $93.4 million and $27.8 million, respectively, with additional consideration of $40.3 million assumed in liabilities, for a total consideration of $161.5 million. Based upon the Company’s final purchase price allocation relating to this acquisition, as of December 31, 2011 approximately $8.1 million of goodwill has been recorded.

Effective October 1, 2010, one or more subsidiaries of the Company completed the acquisition of Bluefield Regional Medical Center (240 licensed beds) located in Bluefield, West Virginia. The total cash consideration paid for fixed assets was approximately $35.4 million, with additional consideration of $8.9 million assumed in liabilities as well as a credit applied at closing of $1.8 million for negative acquired working capital, for a total consideration of $42.5 million. Based upon the Company’s final purchase price allocation relating to this acquisition, as of December 31, 2011 approximately $2.4 million of goodwill has been recorded.

78

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Effective July 7, 2010, one or more subsidiaries of the Company completed the acquisition of Marion Regional Healthcare System located in Marion, South Carolina. This healthcare system includes Marion Regional Hospital (124 licensed beds), an acute care hospital, along with a related skilled nursing facility and other ancillary services. The total cash consideration paid for fixed assets and working capital was approximately $18.6 million and $5.8 million, respectively, with additional consideration of $3.9 million assumed in liabilities, for a total consideration of $28.3 million. Based upon the Company’s final purchase price allocation relating to this acquisition, as of December 31, 2011 no goodwill has been recorded.

On December 31, 2009, one or more subsidiaries of the Company completed an affiliation transaction providing $54.2 million of financing to Rockwood Clinic, P.S., a multi-specialty clinic with 32 locations across the inland northwest region of eastern Washington and western Idaho. This transaction was accounted for as a purchase business combination.

Effective June 1, 2009, one or more subsidiaries of the Company acquired from Akron General Medical Center the remaining 20% noncontrolling interest in Massillon Community Health System, LLC not then owned by a subsidiary of the Company. This entity indirectly owns and operates Affinity Medical Center of Massillon, Ohio. The purchase price for this noncontrolling interest was $1.1 million in cash. Affinity Medical Center is now wholly-owned by these subsidiaries of the Company.

Effective April 30, 2009, one or more subsidiaries of the Company acquired Wyoming Valley Health Care System in Wilkes-Barre, Pennsylvania. This healthcare system includes Wilkes-Barre General Hospital (392 licensed beds), an acute care hospital located in Wilkes-Barre, Pennsylvania, and First Hospital Wyoming Valley, a behavioral health facility located in Kingston, Pennsylvania, as well as other outpatient and ancillary services. The total consideration for fixed assets and working capital of Wyoming Valley Health Care System was approximately $133.7 million and $30.0 million, respectively, with additional consideration of $25.4 million assumed in liabilities and net of $14.2 million of cash in acquired bank accounts, for a total consideration of $174.9 million. Based upon the Company’s final purchase price allocation relating to this acquisition, as of December 31, 2011 no goodwill has been recorded.

Effective April 1, 2009, one or more subsidiaries of the Company acquired from Share Foundation the remaining 50% equity interest in MCSA L.L.C., an entity in which one or more subsidiaries of the Company previously had a 50% unconsolidated noncontrolling interest. One or more subsidiaries of the Company provided MCSA L.L.C. certain management services. This acquisition resulted in these subsidiaries of the Company owning a 100% equity interest in that entity. MCSA L.L.C. owns and operates Medical Center of South Arkansas (166 licensed beds) in El Dorado, Arkansas. The purchase price was $26.0 million in cash. As of the acquisition date, one or more subsidiaries of the Company had a liability to MCSA L.L.C. of $14.1 million, as a result of a cash management agreement previously entered into with the hospital. Upon completion of the acquisition, this liability was eliminated in consolidation.

Effective February 1, 2009, one or more subsidiaries of the Company completed the acquisition of Siloam Springs Memorial Hospital (73 licensed beds), located in Siloam Springs, Arkansas, from the City of Siloam Springs. The total consideration for this hospital consisted of approximately $0.1 million paid in cash for working capital and approximately $1.0 million of assumed liabilities. In connection with this acquisition, a subsidiary of the Company entered into a lease agreement for the existing hospital and agreed to build a replacement facility at this location, with construction required to commence by February 2011 and be completed by February 2013. As security for this obligation, a subsidiary of the Company deposited $1.6 million into an escrow account at closing and agreed to deposit an additional $1.6 million by February 1, 2010, which the Company’s subsidiary deposited in January 2010. If the construction of the replacement facility is not completed within the agreed time frame, the escrow balance will be remitted to the City of Siloam Springs. If the construction of the replacement facility is completed by February 2013 as planned, the escrow balance will be returned to the Company’s subsidiary.

Approximately $16.0 million, $8.9 million and $6.7 million of acquisition costs related to prospective and closed acquisitions were expensed during the years ended December 31, 2011, 2010 and 2009, respectively.

79

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

The table below summarizes the allocations of the purchase price (including assumed liabilities) for the above acquisition transactions (in thousands):

	2011		2010
Current assets	$	26,017	$	46,842
Property and equipment		280,639		169,209
Goodwill		73,923		10,537
Intangible assets		2,260		1,730
Other long-term assets		3,497		—
Liabilities		28,089		51,124

The operating results of the foregoing transactions have been included in the consolidated statements of income from their respective dates of acquisition, including operating revenues, net of contractual allowances and discounts (but before the provision for bad debts) of $169.7 million for the year ended December 31, 2011 from hospital acquisitions that closed during 2011 and $139.0 million for the year ended December 31, 2010 from hospital acquisitions that closed during 2010. The following pro forma combined summary of operations of the Company gives effect to using historical information of the operations of the acquisitions in 2011 and 2010 discussed above as if the transactions had occurred as of January 1, 2010 (in thousands, except per share data):

	Year Ended December 31,
	2011		2010
	(Unaudited)
Pro forma net operating revenues	$	12,180,247	$	11,792,639
Pro forma net income		173,697		259,978
Pro forma net income per share:
Basic	$	1.93	$	2.83
Diluted	$	1.92	$	2.80

Pro forma adjustments to net income include adjustments to depreciation and amortization expense, net of the related tax effect, based on the estimated fair value assigned to the long-lived assets acquired, and to interest expense, net of the related tax effect, assuming the increase in long-term debt used to fund the acquisitions had occurred as of January 1, 2010. These pro forma results are not necessarily indicative of the actual results of operations.

Additionally, during 2011, the Company paid approximately $57.9 million to acquire the operating assets and related businesses of certain physician practices, clinics and other ancillary businesses that operate within the communities served by its hospitals. In connection with these acquisitions, the Company allocated approximately $13.1 million of the consideration paid to property and equipment, $2.9 million to net working capital, $1.6 million to other intangible assets and the remainder, approximately $40.3 million consisting of intangible assets that do not qualify for separate recognition, was allocated to goodwill. These acquisition transactions were accounted for as purchase business combinations.

During 2010, the Company paid approximately $67.4 million to acquire the operating assets and related businesses of certain physician practices, clinics and other ancillary businesses that operate within the communities served by its hospitals. In connection with these acquisitions, the Company allocated approximately $35.6 million of the consideration paid to property and equipment and the remainder, approximately $35.4 million consisting of intangible assets that do not qualify for separate recognition, was allocated to goodwill. These acquisition transactions were accounted for as purchase business combinations.

80

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Discontinued Operations

Effective February 1, 2011, the Company sold Willamette Community Medical Group, which is a physician clinic operating as Oregon Medical Group, located in Springfield, Oregon, to Oregon Healthcare Resources, LLC, for $14.6 million in cash; this business had a carrying amount of net assets, including an allocation of reporting unit goodwill, of $19.7 million.

Effective September 1, 2011, the Company sold Southcrest Hospital, located in Tulsa, Oklahoma, Claremore Regional Hospital, located in Claremore, Oklahoma, and other related healthcare assets affiliated with those hospitals to Hillcrest Healthcare System, part of Ardent Health Services, for approximately $154.2 million in cash. The carrying amount of the net assets sold in this transaction, including an allocation of reporting unit goodwill, was approximately $193.0 million.

Effective October 22, 2011, the Company sold Cleveland Regional Medical Center, located in Cleveland, Texas, and other related healthcare assets affiliated with the hospital to New Directions Health Systems, LLC for approximately $0.9 million in cash. The carrying amount of the net assets sold in this transaction, including an allocation of reporting unit goodwill, was approximately $14.2 million.

Effective March 31, 2009, the Company, through its subsidiaries Triad-Denton Hospital LLC and Triad-Denton Hospital LP, completed the settlement of pending litigation, which resulted in the sale of its ownership interest in a partnership, which owned and operated Presbyterian Hospital of Denton (255 licensed beds) in Denton, Texas, to Texas Health Resources for $103.0 million in cash. Also as part of the settlement, these subsidiaries transferred certain hospital related assets to Texas Health Resources.

In connection with management’s decision to sell the previously mentioned facilities, the Company has classified the results of operations of the above mentioned hospitals as discontinued operations in the accompanying consolidated statements of income. As of December 31, 2011, no hospitals are held for sale.

Net operating revenues and income from discontinued operations for the respective periods are as follows (in thousands):

	Year Ended December 31,
	2011			2010			2009
Net operating revenues	$	144,546		$	305,562		$	348,796
(Loss) income from operations of entities sold before income taxes		(12,390	)		(10,460	)		1,492
Impairment of hospitals sold		(51,695	)		—			—
Loss on sale, net		(4,301	)		—			(644	)
(Loss) income from discontinued operations before income taxes		(68,386	)		(10,460	)		848
(Benefit from) provision for income taxes		(10,115	)		(3,688	)		282
(Loss) income from discontinued operations, net of taxes	$	(58,271	)	$	(6,772	)	$	566

Interest expense was allocated to discontinued operations based on sales proceeds available for debt repayment.

The long-lived assets and allocated goodwill at December 31, 2010 of the hospitals and physician clinic sold during the year ended December 31, 2011 totaled approximately $182.7 million, and are included in the accompanying consolidated balance sheet in other assets, net.

81

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

4. Goodwill and Other Intangible Assets

The changes in the carrying amount of goodwill are as follows (in thousands):

	Year Ended December 31,
	2011		2010
Balance, beginning of year	$	4,150,247	$	4,157,927
Goodwill acquired as part of acquisitions during the year		114,473		45,975
Consideration adjustments and purchase price allocation adjustments for prior year’s acquisitions		125		(3,997	)
Goodwill related to the hospital operations reporting unit assigned to the disposal group classified as held for sale in 2011		—		(49,658	)
Balance, end of year	$	4,264,845	$	4,150,247

Goodwill is allocated to each identified reporting unit, which is defined as an operating segment or one level below the operating segment (referred to as a component of the entity). Management has determined that the Company’s operating segments meet the criteria to be classified as reporting units. At December 31, 2011, the hospital operations reporting unit, the home care agency operations reporting unit and the hospital management services reporting unit had approximately $4.2 billion, $40.5 million and $33.3 million, respectively, of goodwill. At December 31, 2010, the hospital operations reporting unit, the home care agency operations reporting unit and the hospital management services reporting unit had approximately $4.1 billion, $35.9 million and $33.3 million, respectively, of goodwill.

Goodwill is evaluated for impairment at the same time every year and when an event occurs or circumstances change that, more likely than not, reduce the fair value of the reporting unit below its carrying value. There is a two-step method for determining goodwill impairment. Step one is to compare the fair value of the reporting unit with the unit’s carrying amount, including goodwill. If this test indicates the fair value is less than the carrying value, then step two is required to compare the implied fair value of the reporting unit’s goodwill with the carrying value of the reporting unit’s goodwill. The Company has selected September 30 as its annual testing date. The Company performed its last annual goodwill evaluation as of September 30, 2011, which evaluation took place during the fourth quarter of 2011. No impairment was indicated by this evaluation.

The Company estimates the fair value of the related reporting units using both a discounted cash flow model as well as an EBITDA multiple model. The cash flow forecasts are adjusted by an appropriate discount rate based on the Company’s estimate of a market participant’s weighted-average cost of capital. These models are both based on the Company’s best estimate of future revenues and operating costs and are reconciled to the Company’s consolidated market capitalization, with consideration of the amount a potential acquirer would be required to pay, in the form of a control premium, in order to gain sufficient ownership to set policies, direct operations and control management decisions.

Approximately $3.8 million of intangible assets other than goodwill were acquired during the year ended December 31, 2011. The gross carrying amount of the Company’s other intangible assets subject to amortization was $60.0 million and $60.5 million at December 31, 2011 and 2010, respectively, and the net carrying amount was $30.6 million and $36.1 million at December 31, 2011 and 2010, respectively. The carrying amount of the Company’s other intangible assets not subject to amortization was $46.9 million and $44.4 million at December 31, 2011 and 2010. Other intangible assets are included in other assets, net on the Company’s consolidated balance sheets. Substantially all of the Company’s intangible assets are contract-based intangible assets related to operating licenses, management contracts, or non-compete agreements entered into in connection with prior acquisitions.

The weighted-average amortization period for the intangible assets subject to amortization is approximately nine years. There are no expected residual values related to these intangible assets. Amortization expense on these intangible assets was $8.1 million, $12.2 million and $13.0 million during the years ended December 31, 2011, 2010 and 2009, respectively. Amortization expense on intangible assets is estimated to be $7.4 million in 2012, $4.7 million in 2013, $2.9 million in 2014, $2.5 million in 2015, $2.3 million in 2016 and $10.8 million thereafter.

82

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

The gross carrying amount of capitalized software for internal use was approximately $451.0 million and $356.5 million at December 31, 2011 and 2010, respectively, and the net carrying amount considering accumulated amortization was approximately $241.3 million and $209.4 million at December 31, 2011 and 2010, respectively. The estimated amortization period for capitalized internal-use software is generally three years, except for capitalized costs related to significant system conversions, which is generally eight years. There is no expected residual value for capitalized internal-use software. At December 31, 2011, there was approximately $109.3 million of capitalized costs for internal-use software that will begin amortization once the software project is complete and ready for its intended use. Amortization expense for capitalized internal-use software was $70.5 million, $48.2 million and $32.5 million during the years ended December 31, 2011, 2010 and 2009, respectively. Amortization expense for capitalized internal-use software is estimated to be $81.0 million in 2012, $70.8 million in 2013, $35.1 million in 2014, $17.3 million in 2015, $15.4 million in 2016 and $21.7 million thereafter.

5. Income Taxes

The provision for income taxes for income from continuing operations consists of the following (in thousands):

	Year Ended December 31,
	2011		2010		2009
Current:
Federal	$	23,020	$	54,986	$	93,543
State		7,601		11,208		13,577
		30,621		66,194		107,120
Deferred:
Federal		105,771		92,628		16,012
State		1,261		4,859		18,719
		107,032		97,487		34,731
Total provision for income taxes for income from continuing operations	$	137,653	$	163,681	$	141,851

The following table reconciles the differences between the statutory federal income tax rate and the effective tax rate (dollars in thousands):

	Year Ended December 31,
	2011						2010						2009
	Amount			%			Amount			%			Amount			%
Provision for income taxes at statutory federal rate	$	165,741			35.0	%	$	181,474			35.0	%	$	156,682			35.0	%
State income taxes, net of federal income tax benefit		8,212			1.7			8,847			1.7			9,080			2.0
Release of unrecognized tax benefit		(6,509	)		(1.3	)		—			—			—			—
Net income attributable to noncontrolling interests		(26,486	)		(5.6	)		(23,960	)		(4.6	)		(22,006	)		(4.9	)
Change in valuation allowance		—			0.0			(910	)		(0.2	)		1,113			0.3
Federal and state tax credits		(3,788	)		(0.8	)		(2,246	)		(0.4	)		(4,241	)		(0.9	)
Deferred tax revaluation		—			—			—			—			(2,996	)		(0.7	)
Other		483			0.1			476			0.1			4,219			0.9
Provision for income taxes and effective tax rate for income from continuing operations	$	137,653			29.1	%	$	163,681			31.6	%	$	141,851			31.7	%

83

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Deferred income taxes are based on the estimated future tax effects of differences between the financial statement and tax bases of assets and liabilities under the provisions of the enacted tax laws. Deferred income taxes as of December 31, 2011 and 2010 consist of (in thousands):

	December 31,
	2011					2010
	Assets			Liabilities		Assets			Liabilities
Net operating loss and credit carryforwards	$	140,825		$	—	$	131,093		$	—
Property and equipment		—			727,366		—			685,089
Self-insurance liabilities		113,640			—		91,246			—
Intangibles		—			201,396		—			169,860
Investments in unconsolidated affiliates		—			62,112		—			48,353
Other liabilities		—			22,050		—			27,045
Long-term debt and interest		—			24,115		—			29,191
Accounts receivable		11,435			—		60,026			—
Accrued expenses		49,575			—		53,842			—
Other comprehensive income		128,170			—		156,597			—
Stock-based compensation		28,894			—		25,472			—
Deferred compensation		42,668			—		41,703			—
Other		57,158			—		24,963			—
		572,365			1,037,039		584,942			959,538
Valuation allowance		(150,254	)		—		(126,644	)		—
Total deferred income taxes	$	422,111		$	1,037,039	$	458,298		$	959,538

The Company’s deferred tax assets and liabilities have been adjusted in 2010 for the effects of its filed 2009 tax return, having the effect of increasing total deferred tax assets by $12.5 million, increasing total deferred tax liabilities by $11.4 million, and decreasing prepaid income taxes by $1.1 million. The effects of the adjustments did not impact income tax expense, and their effects on previously issued consolidated financial statements were not material.

The Company believes that the net deferred tax assets will ultimately be realized, except as noted below. Its conclusion is based on its estimate of future taxable income and the expected timing of temporary difference reversals. The Company has state net operating loss carry forwards of approximately $3.3 billion, which expire from 2012 to 2031. The Company also has unrecognized deferred tax assets primarily related to interest expense that are included in other comprehensive income. If recognized, additional state net operating losses will be created which the Company does not expect to be able to utilize prior to the expiration of the carryforward period. A valuation allowance of approximately $24.9 million has been recognized for those items. With respect to the deferred tax liability pertaining to intangibles, as included above, goodwill purchased in connection with certain of the Company’s business acquisitions is amortizable for income tax reporting purposes. However, for financial reporting purposes, there is no corresponding amortization allowed with respect to such purchased goodwill.

The valuation allowance increased by $23.6 million during the year ended December 31, 2011 and increased by $11.5 million during the year ended December 31, 2010. In addition to amounts previously discussed, the change in valuation allowance relates to a redetermination of the amount of, and realizability of, net operating losses in certain state income tax jurisdictions.

84

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

The total amount of unrecognized benefit that would impact the effective tax rate, if recognized, was approximately $0.8 million as of December 31, 2011. A total of approximately $0.3 million of interest and penalties is included in the amount of liability for uncertain tax positions at December 31, 2011. During the year ended December 31, 2011, the Company decreased liabilities for uncertain tax positions by $5.4 million, including the favorable resolution of an issue on appeal with the IRS related to its tax examination of Triad tax returns, and decreased interest and penalties by approximately $1.1 million. It is the Company’s policy to recognize interest and penalties related to unrecognized benefits in its consolidated statements of income as income tax expense. During the year ended December 31, 2011, the Company released $2.3 million for income taxes and $0.7 million for accrued interest of its liability for uncertain tax positions, as a result of the expiration of the statute of limitations pertaining to tax positions taken in prior years.

It is possible the amount of unrecognized tax benefit could change in the next twelve months as a result of a lapse of the statute of limitations and settlements with taxing authorities; however, the Company does not anticipate the change will have a material impact on its consolidated results of operations or consolidated financial position.

The following is a tabular reconciliation of the total amount of unrecognized tax benefit for the years ended December 31, 2011, 2010 and 2009 (in thousands):

	Year Ended December 31,
	2011			2010			2009
Unrecognized tax benefit, beginning of year	$	7,458		$	9,234		$	15,630
Gross (decreases) increases — purchase business combination		—			—			(4,173	)
Gross increases — tax positions in prior period		349			70			—
Reductions — tax positions in prior period		(3,469	)		(1,833	)		—
Lapse of statute of limitations		(3,575	)		—			(663	)
Settlements		(134	)		(13	)		(1,560	)
Unrecognized tax benefit, end of year	$	629		$	7,458		$	9,234

The Company, or one of its subsidiaries, files income tax returns in the United States federal jurisdiction and various state jurisdictions. The Company has extended the federal statute of limitations for Triad for the tax periods ended December 31, 1999, December 31, 2000, April 30, 2001, June 30, 2001, December 31, 2001, December 31, 2002 and December 31, 2003. The IRS has concluded its examination of the federal tax return of Triad for the tax periods ended December 31, 2004, December 31, 2005, December 31, 2006 and July 25, 2007. In September 2011, the Company reached a favorable resolution of an issue on appeal with the IRS related to its examination of Triad’s tax returns. As a result, the Company recognized a tax benefit of $4.0 million, which is reflected in the accompanying consolidated statement of income for the year ended December 31, 2011. With few exceptions, the Company is no longer subject to state income tax examinations for years prior to 2008 and federal income tax examinations with respect to Community Health Systems, Inc. federal returns for years prior to 2007. The Company’s federal income tax returns for the 2007 and 2008 tax years are currently under examination by the IRS. The Company believes the results of this examination will not be material to its consolidated results of operations or consolidated financial position. In connection with the Company’s 2007 and 2008 IRS examinations, the IRS has taken exception to the timing of the Company’s malpractice expense deductions. Management believes that the Company’s deduction timing is appropriate, and will work to resolve this item over the next 24 months. If management is unable to sustain the current timing of the Company’s deduction, then it would be subject to interest and penalty costs. Management does not consider this matter to have met the recognition criteria to be considered an uncertain tax position for which a reserve is necessary.

The Company paid income taxes, net of refunds received, of $26.5 million, $128.2 million and $57.3 million during the years ended December 31, 2011, 2010 and 2009.

85

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

6. Long-Term Debt

Long-term debt consists of the following (in thousands):

	December 31,
	2011			2010
Credit Facility:
Term loans	$	5,949,383		$	5,999,337
Revolving credit loans		30,000			—
8 7/8% Senior Notes due 2015		1,777,617			2,784,331
8% Senior Notes due 2019		1,000,000			—
Capital lease obligations (see Note 9)		48,361			51,731
Other		41,143			36,122
Total debt		8,846,504			8,871,521
Less current maturities		(63,706	)		(63,139	)
Total long-term debt	$	8,782,798		$	8,808,382

Credit Facility

In connection with the consummation of the acquisition of Triad in July 2007, the Company’s wholly-owned subsidiary CHS/Community Health Systems, Inc. (“CHS”) obtained approximately $7.2 billion of senior secured financing under a new credit facility (the “Credit Facility”) with a syndicate of financial institutions led by Credit Suisse, as administrative agent and collateral agent, and issued approximately $3.0 billion aggregate principal amount of 8 ⁷/8% senior notes due 2015 (the “ 8 ⁷/8% Senior Notes”). The Company used the net proceeds of $3.0 billion from the 8 ⁷/8% Senior Notes offering and the net proceeds of approximately $6.1 billion of term loans under the Credit Facility to acquire the outstanding shares of Triad, to refinance certain of Triad’s indebtedness and the Company’s indebtedness, to complete certain related transactions, to pay certain costs and expenses of the transactions and for general corporate uses. Specifically, the Company repaid its outstanding debt under the previously outstanding credit facility, the 6.50% senior subordinated notes due 2012 and certain of Triad’s existing indebtedness.

The Credit Facility consisted of an approximately $6.1 billion funded term loan facility with a maturity of seven years, a $400 million delayed draw term loan facility with a maturity of seven years and a $750 million revolving credit facility with a maturity of six years. As of December 31, 2007, the $400 million delayed draw term loan facility had been reduced to $300 million at the request of CHS. During the fourth quarter of 2008, $100 million of the delayed draw term loan was drawn by CHS, reducing the delayed draw term loan availability to $200 million at December 31, 2008. In January 2009, CHS drew down the remaining $200 million of the delayed draw term loan. The revolving credit facility also includes a subfacility for letters of credit and a swingline subfacility. The Credit Facility requires quarterly amortization payments of each term loan facility equal to 0.25% of the outstanding amount of the term loans. On November 5, 2010, CHS entered into an amendment and restatement of its existing Credit Facility. The amendment extended by two and a half years, until January 25, 2017, the maturity date of $1.5 billion of the existing term loans under the Credit Facility and increased the pricing on these term loans to LIBOR plus 350 basis points. If more than $50 million of the 8 ⁷/8% Senior Notes remain outstanding on April 15, 2015, without having been refinanced, then the maturity date for the extended term loans will be accelerated to April 15, 2015. The amendment also increases CHS’s ability to issue additional indebtedness under the uncommitted incremental facility to $1.0 billion from $600 million, permits CHS to issue Term A term loans under the incremental facility, and provides up to $2.0 billion of borrowing capacity from receivable transactions, an increase of $0.5 billion, of which $1.7 billion would be required to be used for repayment of existing term loans. In addition, effective February 2, 2012, the Company completed an additional amendment and restatement of the Credit Facility, which extended by two and a half years, until January 25, 2017, the maturity date of an additional $1.6 billion of the existing non-extended term loans under the Credit Facility and increased the pricing on the newly extended term loans by 125 basis points. The maturity date of the balance of the term loans of approximately $2.9 billion remained unchanged at July 25, 2014.

86

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

The term loan facility must be prepaid in an amount equal to (1) 100% of the net cash proceeds of certain asset sales and dispositions by the Company and its subsidiaries, subject to certain exceptions and reinvestment rights, (2) 100% of the net cash proceeds of issuances of certain debt obligations or receivables based financing by the Company and its subsidiaries, subject to certain exceptions, and (3) 50%, subject to reduction to a lower percentage based on the Company’s leverage ratio (as defined in the Credit Facility generally as the ratio of total debt on the date of determination to the Company’s EBITDA, as defined, for the four quarters most recently ended prior to such date), of excess cash flow (as defined) for any year, commencing in 2008, subject to certain exceptions. Voluntary prepayments and commitment reductions are permitted in whole or in part, without any premium or penalty, subject to minimum prepayment or reduction requirements.

The obligor under the Credit Facility is CHS. All of the obligations under the Credit Facility are unconditionally guaranteed by the Company and certain existing and subsequently acquired or organized domestic subsidiaries. All obligations under the Credit Facility and the related guarantees are secured by a perfected first priority lien or security interest in substantially all of the assets of the Company, CHS and each subsidiary guarantor, including equity interests held by the Company, CHS or any subsidiary guarantor, but excluding, among others, the equity interests of non-significant subsidiaries, syndication subsidiaries, securitization subsidiaries and joint venture subsidiaries.

The loans under the Credit Facility bear interest on the outstanding unpaid principal amount at a rate equal to an applicable percentage plus, at CHS’s option, either (a) an Alternate Base Rate (as defined) determined by reference to the greater of (1) the Prime Rate (as defined) announced by Credit Suisse or (2) the Federal Funds Effective Rate (as defined) plus one-half of 1.0% or (3) the adjusted London Interbank Offered Rate (“LIBOR”) on such day for a three-month interest period commencing on the second business day after such day plus 1%, or (b) a reserve adjusted LIBOR for dollars (Eurodollar rate) (as defined). The applicable percentage for Alternate Base Rate loans is 1.25% for term loans due 2014 and is 2.25% for term loans due 2017. The applicable percentage for Eurodollar rate loans is 2.25% for term loans due 2014 and 3.5% for term loans due 2017. The applicable percentage for revolving loans is 1.25% for Alternate Base Rate revolving loans and 2.25% for Eurodollar revolving loans, in each case subject to reduction based on the Company’s leverage ratio. Loans under the swingline subfacility bear interest at the rate applicable to Alternate Base Rate loans under the revolving credit facility.

CHS has agreed to pay letter of credit fees equal to the applicable percentage then in effect with respect to Eurodollar rate loans under the revolving credit facility times the maximum aggregate amount available to be drawn under all letters of credit outstanding under the subfacility for letters of credit. The issuer of any letter of credit issued under the subfacility for letters of credit will also receive a customary fronting fee and other customary processing charges. CHS was initially obligated to pay commitment fees of 0.50% per annum (subject to reduction based upon the Company’s leverage ratio) on the unused portion of the revolving credit facility. For purposes of this calculation, swingline loans are not treated as usage of the revolving credit facility. With respect to the delayed draw term loan facility, CHS was also obligated to pay commitment fees of 0.50% per annum for the first nine months after the closing of the Credit Facility, 0.75% per annum for the next three months after such nine-month period and thereafter, 1.0% per annum. In each case, the commitment fee was paid on the unused amount of the delayed draw term loan facility. After the draw down of the remaining $200 million of the delayed draw term loan in January 2009, CHS no longer pays any commitment fees for the delayed draw term loan facility. CHS paid arrangement fees on the closing of the Credit Facility and pays an annual administrative agent fee.

The Credit Facility contains customary representations and warranties, subject to limitations and exceptions, and customary covenants restricting the Company’s and its subsidiaries’ ability, subject to certain exceptions, to, among other things (1) declare dividends, make distributions or redeem or repurchase capital stock, (2) prepay, redeem or repurchase other debt, (3) incur liens or grant negative pledges, (4) make loans and investments and enter into acquisitions and joint ventures, (5) incur additional indebtedness or provide certain guarantees, (6) make capital expenditures, (7) engage in mergers, acquisitions and asset sales, (8) conduct transactions with affiliates, (9) alter the nature of the Company’s businesses, (10) grant certain guarantees with respect to physician practices, (11) engage in sale and leaseback transactions or (12) change the Company’s fiscal year. The Company is also required to comply with specified financial covenants (consisting of a leverage ratio and an interest coverage ratio) and various affirmative covenants.

87

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Events of default under the Credit Facility include, but are not limited to, (1) CHS’s failure to pay principal, interest, fees or other amounts under the credit agreement when due (taking into account any applicable grace period), (2) any representation or warranty proving to have been materially incorrect when made, (3) covenant defaults subject, with respect to certain covenants, to a grace period, (4) bankruptcy events, (5) a cross default to certain other debt, (6) certain undischarged judgments (not paid within an applicable grace period), (7) a change of control, (8) certain ERISA-related defaults and (9) the invalidity or impairment of specified security interests, guarantees or subordination provisions in favor of the administrative agent or lenders under the Credit Facility.

On April 2, 2009, the Company paid down $110.4 million of its term loans under the Credit Facility. Of this amount, $85.0 million was paid down as required under the terms of the Credit Facility with the net proceeds received from the sale of the ownership interest in the partnership that owned and operated Presbyterian Hospital of Denton. This resulted in a loss from early extinguishment of debt of $1.1 million with an after-tax impact of $0.7 million recorded in discontinued operations for the year ended December 31, 2009. The remaining $25.4 million was paid on the term loans as required under the terms of the Credit Facility with the net proceeds received from the sale of various other assets. This resulted in a loss from early extinguishment of debt of $0.3 million with an after-tax impact of $0.2 million recorded in continuing operations for the year ended December 31, 2009.

As of December 31, 2011, a $750 million revolving credit facility was available to the Company for working capital and general corporate purposes under the Credit Facility, with $37.7 million of the revolving credit facility being set aside for outstanding letters of credit and $30.0 million outstanding at December 31, 2011. CHS has the ability to amend the Credit Facility to provide for one or more tranches of term loans in an aggregate principal amount of $1.0 billion, which CHS has not yet accessed. CHS also has the ability to add up to $300 million of borrowing capacity from receivable transactions (including securitizations) under the Credit Facility, which has not yet been accessed. As of December 31, 2011, the weighted-average interest rate under the Credit Facility, excluding swaps, was 3.5%.

The term loans are scheduled to be paid with principal payments for future years as follows (in thousands):

Year	Amount
2012	$	49,874
2013		49,874
2014		4,413,385
2015		15,000
2016		15,000
Thereafter		1,406,250
Total	$	5,949,383

As of December 31, 2011 and 2010, the Company had letters of credit issued, primarily in support of potential insurance-related claims and certain bonds, of approximately $37.7 million and $81.9 million, respectively.

8  ⁷/8% Senior Notes due 2015

The 8 ⁷/8% Senior Notes were issued by CHS in connection with the Triad acquisition in the principal amount of approximately $3.0 billion. The 8 ⁷/8% Senior Notes will mature on July 15, 2015. The 8 ⁷/8% Senior Notes bear interest at the rate of 8.875% per annum, payable semiannually in arrears on January 15 and July 15, commencing January 15, 2008. Interest on the 8 ⁷/8% Senior Notes accrues from the date of original issuance. Interest is calculated on the basis of a 360-day year comprised of twelve 30-day months.

88

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

On and after July 15, 2011, CHS is entitled, at its option, to redeem all or a portion of the 8 ⁷/8% Senior Notes upon not less than 30 nor more than 60 days’ notice, at the redemption prices (expressed as a percentage of principal amount on the redemption date), plus accrued and unpaid interest, if any, to the redemption date (subject to the right of holders of record on the relevant record date to receive interest due on the relevant interest payment date), if redeemed during the 12-month period commencing on July 15 of the years set forth below:

Period	Redemption Price
2012		102.219	%
2013 and thereafter		100.000	%

Pursuant to a registration rights agreement entered into at the time of the issuance of the 8 ⁷/8% Senior Notes, as a result of an exchange offer made by CHS, substantially all of the 8 ⁷/8% Senior Notes issued in July 2007 were exchanged in November 2007 for new notes (the “Exchange Notes”) having terms substantially identical in all material respects to the 8 ⁷/8% Senior Notes (except that the Exchange Notes were issued under a registration statement pursuant to the 1933 Act). References to the 8 ⁷/8% Senior Notes shall also be deemed to include the Exchange Notes unless the context provides otherwise.

On December 7, 2011, CHS completed the cash tender offer for $1.0 billion of the $2.8 billion aggregate principal amount of 8 ⁷/8% Senior Notes due 2015. This resulted in a loss from early extinguishment of debt of $66.0 million with an after-tax impact of $42.0 million recorded in continuing operations for the year ended December 31, 2011.

8% Senior Notes due 2019

On November 22, 2011, CHS completed its offering of $1.0 billion aggregate principal amount of 8% Senior Notes due 2019 (the “8% Senior Notes”), which were issued in a private placement. The net proceeds from this issuance, together with available cash on hand, were used to finance the purchase of $1.0 billion aggregate principal amount of CHS’ outstanding 8 ⁷/8% Senior Notes due 2015 and related fees and expenses. The 8% Senior Notes bear interest at 8% per annum, payable semiannually in arrears on May 15 and November 15, commencing May 15, 2012. Interest on the 8% Senior Notes accrues from the date of original issuance. Interest is calculated on the basis of a 360-day year comprised of twelve 30-day months.

Except as set forth below, CHS is not entitled to redeem the 8% Senior Notes prior to November 15, 2015.

On and after November 15, 2015, CHS is entitled, at its option, to redeem all or a portion of the 8% Senior Notes upon not less than 30 nor more than 60 days’ notice, at the redemption prices (expressed as a percentage of principal amount on the redemption date), plus accrued and unpaid interest, if any, to the redemption date (subject to the right of holders of record on the relevant record date to receive interest due on the relevant interest payment date), if redeemed during the 12-month period commencing on November 15 of the years set forth below:

Period	Redemption Price
2015		104.000	%
2016		102.000	%
2017 and thereafter		100.000	%

89

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

In addition, any time prior to November 15, 2014, CHS is entitled, at its option, on one or more occasions to redeem the 8% Senior Notes (which include additional 8% Senior Notes, if any) in an aggregate principal amount not to exceed 35% of the aggregate principal amount of the 8% Senior Notes (which includes additional 8% Senior Notes, if any) originally issued at a redemption price (expressed as a percentage of principal amount) of 108.000%, plus accrued and unpaid interest to the redemption date, with the Net Cash Proceeds (as defined in the indenture governing the 8% Senior Notes) from one or more Public Equity Offerings (as defined in the indenture governing the 8% Senior Notes) (provided that if the Public Equity Offering is an offering by the Company, a portion of the Net Cash Proceeds thereof equal to the amount required to redeem any such 8% Senior Notes is contributed to the equity capital of CHS); provided, however, that:

1) at least 65% of such aggregate principal amount of 8% Senior Notes originally issued remains outstanding immediately after the occurrence of each such redemption (other than the 8% Senior Notes held, directly or indirectly, by the Company or its subsidiaries); and

2) each such redemption occurs within 180 days after the date of the related Public Equity Offering.

CHS is entitled, at its option, to redeem the 8% Senior Notes, in whole or in part, at any time prior to November 15, 2015, upon not less than 30 or more than 60 days notice, at a redemption price equal to 100% of the principal amount of 8% Senior Notes redeemed plus the Applicable Premium (as defined), and accrued and unpaid interest, if any, as of the applicable redemption date.

Other Debt. As of December 31, 2011, other debt consisted primarily of the mortgage obligation on the Company’s corporate headquarters and other obligations maturing in various installments through 2020.

To limit the effect of changes in interest rates on a portion of the Company’s long-term borrowings, the Company is a party to 34 separate interest swap agreements in effect at December 31, 2011, with an aggregate notional amount of approximately $4.9 billion. On each of these swaps, the Company receives a variable rate of interest based on the three-month LIBOR in exchange for the payment of a fixed rate of interest. The Company currently pays, on a quarterly basis, a margin above LIBOR of 225 basis points for the outstanding balance of revolver loans and term loans due in 2014 and 350 basis points for term loans due in 2017 under the Credit Facility. See Note 7 for additional information regarding these swaps.

As of December 31, 2011, the scheduled maturities of long-term debt outstanding, including capital lease obligations for each of the next five years and thereafter are as follows (in thousands):

Year	Amount
2012	$	63,706
2013		87,993
2014		4,417,745
2015		1,796,304
2016		18,644
Thereafter		2,462,112
Total	$	8,846,504

The Company paid interest of $680.7 million, $650.7 million and $657.0 million on borrowings during the years ended December 31, 2011, 2010 and 2009, respectively.

90

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

7. Fair Values of Financial Instruments

The fair value of financial instruments has been estimated by the Company using available market information as of December 31, 2011 and 2010, and valuation methodologies considered appropriate. The estimates presented are not necessarily indicative of amounts the Company could realize in a current market exchange (in thousands):

	December 31,
	2011				2010
	Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value
Assets:
Cash and cash equivalents	$	129,865	$	129,865	$	299,169	$	299,169
Available-for-sale securities		31,582		31,582		31,570		31,570
Trading securities		30,486		30,486		35,092		35,092
Liabilities:
Credit Facility		5,979,383		5,780,877		5,999,337		5,882,124
8 7/8% Senior Notes		1,777,617		1,842,322		2,784,331		2,923,548
8% Senior Notes		1,000,000		995,000		—		—
Other debt		41,143		41,143		36,122		36,122

Cash and cash equivalents. The carrying amount approximates fair value due to the short-term maturity of these instruments (less than three months).

Available-for-sale securities. Estimated fair value is based on closing price as quoted in public markets.

Trading securities. Estimated fair value is based on closing price as quoted in public markets.

Credit Facility. Estimated fair value is based on information from the Company’s bankers regarding relevant pricing for trading activity among the Company’s lending institutions.

8 ⁷/8% Senior Notes. Estimated fair value is based on the average bid and ask price as quoted by the bank who served as underwriters in the sale of these notes.

8% Senior notes. Estimated fair value is based on the average bid and ask price as quoted by the bank who served as underwriters in the sale of these notes.

91

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Other debt. The carrying amount of all other debt approximates fair value due to the nature of these obligations.

Interest rate swaps. The fair value of interest rate swap agreements is the amount at which they could be settled, based on estimates calculated by the Company using a discounted cash flow analysis based on observable market inputs and validated by comparison to estimates obtained from the counterparty. The Company incorporates credit valuation adjustments (“CVAs”) to appropriately reflect both its own nonperformance or credit risk and the respective counterparty’s nonperformance or credit risk in the fair value measurements. In adjusting the fair value of its interest rate swap agreements for the effect of nonperformance or credit risk, the Company has considered the impact of any netting features included in the agreements.

The Company assesses the effectiveness of its hedge instruments on a quarterly basis. For the years ended December 31, 2011 and 2010, the Company completed an assessment of the cash flow hedge instruments and determined the hedges to be highly effective. The Company has also determined that the ineffective portion of the hedges do not have a material effect on the Company’s consolidated financial position, operations or cash flows. The counterparties to the interest rate swap agreements expose the Company to credit risk in the event of nonperformance. However, at December 31, 2011, each swap agreement entered into by the Company was in a net liability position so that the Company would be required to make the net settlement payments to the counterparties; the Company does not anticipate nonperformance by those counterparties. The Company does not hold or issue derivative financial instruments for trading purposes.

92

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Interest rate swaps consisted of the following at December 31, 2011:

Swap #	Notional Amount (in 000’s)		Fixed Interest Rate			Termination Date		Fair Value of Liability (in 000’s)
1		100,000		3.8470	%		January 4, 2012		30
2		100,000		3.8510	%		January 4, 2012		30
3		100,000		3.8560	%		January 4, 2012		30
4		200,000		3.7260	%		January 8, 2012		152
5		200,000		3.5065	%		January 16, 2012		281
6		250,000		5.0185	%		May 30, 2012		4,509
7		150,000		5.0250	%		May 30, 2012		2,709
8		200,000		4.6845	%		September 11, 2012		5,574
9		100,000		3.3520	%		October 23, 2012		2,161
10		125,000		4.3745	%		November 23, 2012		4,104
11		75,000		4.3800	%		November 23, 2012		2,466
12		150,000		5.0200	%		November 30, 2012		5,900
13		200,000		2.2420	%		February 28, 2013		3,550
14		100,000		5.0230	%		May 30, 2013		5,952
15		300,000		5.2420	%		August 6, 2013		21,085
16		100,000		5.0380	%		August 30, 2013		6,967
17		50,000		3.5860	%		October 23, 2013		2,505
18		50,000		3.5240	%		October 23, 2013		2,451
19		100,000		5.0500	%		November 30, 2013		7,948
20		200,000		2.0700	%		December 19, 2013		5,080
21		100,000		5.2310	%		July 25, 2014		10,706
22		100,000		5.2310	%		July 25, 2014		10,707
23		200,000		5.1600	%		July 25, 2014		21,073
24		75,000		5.0405	%		July 25, 2014		7,685
25		125,000		5.0215	%		July 25, 2014		12,752
26		100,000		2.6210	%		July 25, 2014		4,436
27		100,000		3.1100	%		July 25, 2014		5,612
28		100,000		3.2580	%		July 25, 2014		5,968
29		200,000		2.6930	%		October 26, 2014		9,916
30		300,000		3.4470	%		August 8, 2016		27,728
31		200,000		3.4285	%		August 19, 2016		18,401
32		100,000		3.4010	%		August 19, 2016		9,099
33		200,000		3.5000	%		August 30, 2016		19,048
34		100,000		3.0050	%		November 30, 2016		7,613

93

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

The Company is exposed to certain risks relating to its ongoing business operations. The risk managed by using derivative instruments is interest rate risk. Interest rate swaps are entered into to manage interest rate fluctuation risk associated with the term loans in the Credit Facility. Companies are required to recognize all derivative instruments as either assets or liabilities at fair value in the consolidated statement of financial position. The Company designates its interest rate swaps as cash flow hedges. For derivative instruments that are designated and qualify as cash flow hedges, the effective portion of the gain or loss on the derivative is reported as a component of OCI and reclassified into earnings in the same period or periods during which the hedged transactions affect earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current earnings.

Assuming no change in December 31, 2011 interest rates, approximately $131.8 million of interest expense resulting from the spread between the fixed and floating rates defined in each interest rate swap agreement will be recognized during the next 12 months. If interest rate swaps do not remain highly effective as a cash flow hedge, the derivatives’ gains or losses resulting from the change in fair value reported through OCI will be reclassified into earnings.

The following tabular disclosure provides the amount of pre-tax loss recognized in the consolidated balance sheets as a component of OCI during the years ended December 31, 2011 and 2010 (in thousands):

Derivatives in Cash Flow Hedging Relationships	Amount of Pre-Tax Loss Recognized in OCI on Derivative (Effective Portion) Year Ended December 31,
	2011			2010
Interest rate swaps	($	122,686	)	($	239,893	)

The following tabular disclosure provides the location of the effective portion of the pre-tax loss reclassified from accumulated other comprehensive loss (“AOCL”) into interest expense on the consolidated statements of income during the years ended December 31, 2011 and 2010 (in thousands):

	Amount of Pre-Tax Loss Reclassified from AOCL into Income (Effective Portion) Year Ended December 31,
Location of Loss Reclassified from AOCL into Income (Effective Portion)	2011		2010
Interest expense, net	$	208,985	$	215,399

The fair values of derivative instruments in the consolidated balance sheets as of December 31, 2011 and 2010 were as follows (in thousands):

Asset Derivatives

Liability Derivatives

December 31, 2011

December 31, 2010

December 31, 2011

December 31, 2010

Balance Sheet Location

Fair Value

Balance Sheet Location

Fair Value

Balance Sheet Location

Fair Value

Balance Sheet Location

Fair Value

Other Derivatives designated as hedging instruments

Other assets, net

$

—

Other assets, net

$

—

Other long-term liabilities

$

254,228

Other long-term liabilities

$

340,526

94

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

8. Fair Value

Fair Value Hierarchy

Fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, the Company utilizes the U.S. GAAP fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumption about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).

The inputs used to measure fair value are classified into the following fair value hierarchy:

Level 1: Quoted market prices in active markets for identical assets or liabilities.

Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.

Level 3: Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities. Level 3 includes values determined using pricing models, discounted cash flow methodologies, or similar techniques reflecting the Company’s own assumptions.

In instances where the determination of the fair value hierarchy measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment of factors specific to the asset or liability.

The following table sets forth, by level within the fair value hierarchy, the financial assets and liabilities recorded at fair value on a recurring basis as of December 31, 2011 and 2010 (in thousands):

	December 31, 2011		Level 1		Level 2		Level 3
Available-for-sale securities	$	31,582	$	31,582	$	—	$	—
Trading securities		30,486		30,486		—		—
Total assets	$	62,068	$	62,068	$	—	$	—
Fair value of interest rate swap agreements	$	254,228	$	—	$	254,228	$	—
Total liabilities	$	254,228	$	—	$	254,228	$	—
	December 31, 2010		Level 1		Level 2		Level 3
Available-for-sale securities	$	31,570	$	31,570	$	—	$	—
Trading securities		35,092		35,092		—		—
Total assets	$	66,662	$	66,662	$	—	$	—
Fair value of interest rate swap agreements	$	340,526	$	—	$	340,526	$	—
Total liabilities	$	340,526	$	—	$	340,526	$	—

Available-for-sale securities and trading securities classified as Level 1 are measured using quoted market prices.

95

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

The valuation of the Company’s interest rate swap agreements is determined using market valuation techniques, including discounted cash flow analysis on the expected cash flows of each agreement. This analysis reflects the contractual terms of the agreement, including the period to maturity, and uses observable market-based inputs, including forward interest rate curves. The fair value of interest rate swap agreements are determined by netting the discounted future fixed cash payments and the discounted expected variable cash receipts. The variable cash receipts are based on the expectation of future interest rates based on observable market forward interest rate curves and the notional amount being hedged.

The Company incorporates CVAs to appropriately reflect both its own nonperformance or credit risk and the respective counterparty’s nonperformance or credit risk in the fair value measurements. In adjusting the fair value of its interest rate swap agreements for the effect of nonperformance or credit risk, the Company has considered the impact of any netting features included in the agreements. The CVA on the Company’s interest rate swap agreements at December 31, 2011 resulted in a decrease in the fair value of the related liability of $21.7 million and an after-tax adjustment of $13.9 million to OCI. The CVA on the Company’s interest rate swap agreements at December 31, 2010 resulted in a decrease in the fair value of the related liability of $3.9 million and an after-tax adjustment of $2.5 million to OCI.

The majority of the inputs used to value its interest rate swap agreements, including the forward interest rate curves and market perceptions of the Company’s credit risk used in the CVAs, are observable inputs available to a market participant. As a result, the Company has determined that the interest rate swap valuations are classified in Level 2 of the fair value hierarchy.

9. Leases

The Company leases hospitals, medical office buildings, and certain equipment under capital and operating lease agreements. During 2011, 2010 and 2009, the Company entered into capital lease obligations of $3.0 million, $22.7 million and $3.3 million, respectively. All lease agreements generally require the Company to pay maintenance, repairs, property taxes and insurance costs.

During 2010, the Company entered into an agreement with the lessor of Cleveland Regional Medical Center (“Cleveland Regional”), its leased facility in Cleveland, TX, to exchange its ownership interest in certain real estate at Hill Regional Medical Center (“Hill Regional”), in Hillsboro, TX for the lessor’s ownership interest in the real estate at Cleveland Regional. The related lease agreement was amended to incorporate Hill Regional as a leased asset with no change to the remaining lease term or payment schedule. No monetary consideration was exchanged in this transaction, and the transaction qualifies as a non-taxable, like-kind exchange under the regulations in Section 1031 of the Internal Revenue Code. The assets of Cleveland Regional were recorded in the consolidated balance sheet at fair value on the date of this transaction; however, as a result of the Company’s continuing involvement in the Hill Regional assets, the exchange with the lessor does not qualify for sale treatment under U.S. GAAP. Accordingly, the transaction has been accounted for as a financing obligation and the assets of Hill Regional will remain on the consolidated balance sheet as assets recorded under a financing obligation. Starting in the fourth quarter of 2010, future payments under the lease are amortized against the financing obligation rather than recorded as rent expense. The disclosures below for capital leases include the amounts related to the Hill Regional financing obligation.

96

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Commitments relating to noncancellable operating and capital leases for each of the next five years and thereafter are as follows (in thousands):

Year Ended December 31,	Operating (1)		Capital
2012	$	176,403	$	8,386
2013		149,460		7,216
2014		122,763		6,710
2015		98,543		6,005
2016		70,087		5,630
Thereafter		176,599		57,472
Total minimum future payments	$	793,855	$	91,419
Less imputed interest				(43,058	)
				48,361
Less current portion				(4,008	)
Long-term capital lease obligations			$	44,353

(1) Minimum lease payments have not been reduced by minimum sublease rentals due in the future of $21.3 million.

Assets capitalized under capital leases as reflected in the accompanying consolidated balance sheets were $27.9 million of land and improvements, $193.7 million of buildings and improvements and $69.3 million of equipment and fixtures as of December 31, 2011 and $27.9 million of land and improvements, $193.7 million of buildings and improvements and $76.7 million of equipment and fixtures as of December 31, 2010. The accumulated depreciation related to assets under capital leases was $119.3 million and $106.7 million as of December 31, 2011 and 2010, respectively. Depreciation of assets under capital leases is included in depreciation and amortization expense and amortization of debt discounts on capital lease obligations is included in interest expense in the consolidated statements of income.

10. Employee Benefit Plans

The Company maintains various benefit plans, including defined contribution plans, defined benefit plans and deferred compensation plans, for which the Company’s subsidiary, CHS, is the plan sponsor. On January 1, 2009, the plan sponsor merged the Triad Hospitals, Inc. Retirement Savings Plan, the Abilene Physicians Group 401(k) Plan and Trust and the Regional Employee Assistance Program 401(k) Plan with and into the CHS/Community Health Systems, Inc. 401(k) Plan. Contemporaneously, the plan sponsor also established the CHS/Community Health Systems, Inc. Retirement Savings Plan, and the accounts of substantially all participants in the CHS/Community Health Systems, Inc. 401(k) Plan were transferred subsequently to the CHS/Community Health Systems, Inc. Retirement Savings Plan. Employees of certain subsidiaries whose employment is covered by collective bargaining agreements have remained participants in the CHS/Community Health Systems, Inc. 401(k) Plan. The plan sponsor also established the CHS/Community Health Systems, Inc. Spokane 401(k) Plan on January 1, 2009 for the exclusive benefit of certain employees of the Deaconess Medical Center and Valley Hospital and Medical Center and their beneficiaries. Effective October 1, 2010, the plan sponsor established the CHS/Community Health Systems, Inc. Standard 401(k) Plan for the benefit of employees at the three hospitals acquired in Youngstown, Ohio and Warren, Ohio and their beneficiaries. Total expense to the Company under the 401(k) plans was $101.7 million, $95.8 million and $69.5 million for the years ended December 31, 2011, 2010 and 2009, respectively.

97

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

The Company maintains unfunded deferred compensation plans that allow participants to defer receipt of a portion of their compensation. The liability under the deferred compensation plans was $71.4 million and $73.2 million as of December 31, 2011 and 2010, respectively. The Company had assets of $72.5 million and $75.0 million as of December 31, 2011 and 2010, respectively, in a non-qualified plan trust generally designated to pay benefits of the deferred compensation plans, consisting of trading securities of $30.5 million and $35.1 million as of December 31, 2011 and 2010, respectively, and company-owned life insurance contracts of $42.0 million and $39.9 million as of December 31, 2011 and 2010, respectively.

The Company maintains the Community Health Systems Retirement Income Plan, which is a defined benefit, non-contributory pension plan that covers certain employees at three of its hospitals (“Pension Plan”). The Pension Plan provides benefits to covered individuals satisfying certain age and service requirements. Employer contributions to the Pension Plan are in accordance with the minimum funding requirements of the Employee Retirement Income Security Act of 1974, as amended. The Company expects to contribute $2.7 million to the Pension Plan in 2012. The Company also provides an unfunded Supplemental Executive Retirement Plan (“SERP”) for certain members of its executive management. The Company uses a December 31 measurement date for the benefit obligations and a January 1 measurement date for its net periodic costs for both the Pension Plan and SERP. Variances from actuarially assumed rates will result in increases or decreases in benefit obligations, net periodic cost and funding requirements in future periods. The Company had available-for-sale securities in a rabbi trust generally designated to pay benefits of the SERP in the amounts of $31.6 million at both December 31, 2011 and 2010. These amounts are included in other assets, net on the consolidated balance sheets.

A summary of the benefit obligations and funded status for the Company’s Pension and SERP Plans at December 31, 2011 and 2010 follows (in thousands):

	Pension Plan						SERP
	2011			2010			2011			2010
Change in benefit obligation:
Benefit obligation, beginning of year	$	39,682		$	42,245		$	73,840		$	61,079
Service cost		1,315			1,169			5,197			4,661
Interest cost		2,159			2,051			3,434			3,728
Curtailment		—			(7,407	)		—			—
Plan amendment		—			—			—			(24	)
Actuarial loss		8,480			2,082			5,225			4,396
Benefits paid		(524	)		(458	)		(1,546	)		—
Benefit obligation, end of year		51,112			39,682			86,150			73,840
Change in plan assets:
Fair value of assets, beginning of year		34,354			28,583			—			—
Actual return on plan assets		(536	)		3,895			—			—
Employer contributions		1,758			2,334			—			—
Benefits paid		(524	)		(458	)		—			—
Fair value of assets, end of year		35,052			34,354			—			—
Unfunded status	$	(16,060	)	$	(5,328	)	$	(86,150	)	$	(73,840	)

98

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

A summary of the amounts recognized in the accompanying consolidated balance sheets at December 31, 2011 and 2010 follows (in thousands):

	Pension Plan						SERP
	2011			2010			2011			2010
Noncurrent asset	$	—		$	—		$	—		$	—
Current liability		—			—			(1,191	)		(1,546	)
Noncurrent liability		(16,060	)		(5,328	)		(84,959	)		(72,294	)
Net amount recognized in the consolidated balance sheets	$	(16,060	)	$	(5,328	)	$	(86,150	)	$	(73,840	)

A summary of the amounts recognized in AOCL at December 31, 2011 and 2010 follows (in thousands):

	Pension Plan						SERP
	2011			2010			2011		2010
Prior service (credit) cost	$	(1,076	)	$	(1,217	)	$	7,084	$	8,781
Net actuarial loss		13,260			1,474			23,779		20,087
Total amount recognized in AOCL	$	12,184		$	257		$	30,863	$	28,868

A summary of the plans’ benefit obligation in excess of the fair value of plan assets at December 31, 2011 and 2010 follows (in thousands):

	Pension Plan				SERP
	2011		2010		2011		2010
Projected benefit obligation	$	51,112	$	39,682	$	86,150	$	73,840
Accumulated benefit obligation		50,745		39,380		66,172		47,304
Fair value of plan assets		35,052		34,354		—		—

A summary of the weighted-average assumptions used by the Company to determine benefit obligations as of December 31 follows:

	Pension Plan						SERP
	2011			2010			2011			2010
Discount rate		4.33	%		5.50	%		4.00	%		4.75	%
Annual salary increases		4.50	%		4.50	%		4.00	%		4.00	%

99

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

A summary of net periodic cost and other amounts recognized in OCI for the years ended December 31, 2011, 2010 and 2009 follows (in thousands):

	Pension Plan									SERP
	2011			2010			2009			2011			2010			2009
Service cost	$	1,315		$	1,169		$	3,886		$	5,197		$	4,661		$	4,437
Interest cost		2,159			2,051			2,200			3,434			3,728			2,469
Expected return on plan assets		(2,771	)		(2,497	)		(1,683	)		—			—			—
Amortization of unrecognized prior service (credit) cost		(141	)		(38	)		689			1,696			1,697			1,704
Amortization of net loss		—			—			426			1,533			1,459			1
Curtailment credit		—			(1,910	)		—			—			—			—
Net periodic cost		562			(1,225	)		5,518			11,860			11,545			8,611
Prior service (credit) cost arising during period		—			(2,770	)		—			—			(24	)		—
Net (gain) loss arising during period		11,787			(2,044	)		(4,595	)		5,225			4,396			13,028
Amortization of:
Prior service cost (credit)		141			38			(689	)		(1,696	)		(1,697	)		(1,704	)
Net actuarial gain		—			—			(426	)		(1,533	)		(1,459	)		(1	)
Total amount recognized in OCI		11,928			(4,776	)		(5,710	)		1,996			1,216			11,323
Total recognized in net periodic cost and OCI	$	12,490		$	(6,001	)	$	(192	)	$	13,856		$	12,761		$	19,934

A summary of the expected amortization amounts to be included in net periodic cost for 2012 are as follows (in thousands):

	Pension Plan			SERP
Prior service (credit) cost	$	(141	)	$	1,696
Actuarial loss		978			2,028

A summary of the weighted-average assumptions used by the Company to determine net periodic cost for the years ended December 31, 2011, 2010 and 2009 follows:

	Pension Plan									SERP
	2011			2010			2009			2011			2010			2009
Discount rate		5.50	%		5.99	%		5.96	%		4.75	%		6.00	%		6.00	%
Rate of compensation increase		4.50	%		4.50	%		4.00	%		4.00	%		5.00	%		5.00	%
Expected long term rate of return on assets		8.00	%		8.50	%		8.50	%		N/A			N/A			N/A

The Company’s weighted-average asset allocations by asset category at December 31, 2011 and 2010 follows:

	Pension Plan						SERP
	2011			2010			2011	2010
Equity securities		100	%		100	%	N/A	N/A
Debt securities		0	%		0	%	N/A	N/A
Total		100	%		100	%	N/A	N/A

The Pension Plan assets are invested in mutual funds with an underlying investment allocation of 60% equity securities and 40% debt securities. All assets are measured at fair value using quoted prices in active markets and therefore are classified as Level 1 measurements in the fair value hierarchy. The expected long-term rate of return for the Pension Plan assets is based on current expected long-term inflation and historical rates of return on equities and fixed income securities, taking into account the investment policy under the plan. The expected long-term rate of return is weighted based on the target allocation for each asset category. Equity securities are expected to return between 7% and 11% and debt securities are expected to return between 3% and 6%. The Company expects the Pension Plan asset managers will provide a premium of approximately 0% to 1.5% per annum to the respective market benchmark indices.

100

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

The Company’s investment policy related to the Pension Plan is to provide for growth of capital with a moderate level of volatility by investing in accordance with the target asset allocations stated above. The Company reviews its investment policy, including its target asset allocations, on a semi-annual basis to determine whether any changes in market conditions or amendments to its pension plans require a revision to its investment policy.

The estimated future benefit payments reflecting future service as of December 31, 2011 for the Pension Plan and SERP plan follows (in thousands):

Year Ending	Pension Plan		SERP
2012	$	1,236	$	1,191
2013		1,511		1,392
2014		1,701		10,782
2015		1,820		3,365
2016		2,237		44,737
2017-2021		15,115		40,072

11. Stockholders’ Equity

Authorized capital shares of the Company include 400,000,000 shares of capital stock consisting of 300,000,000 shares of common stock and 100,000,000 shares of preferred stock. Each of the aforementioned classes of capital stock has a par value of $0.01 per share. Shares of preferred stock, none of which were outstanding as of December 31, 2011, may be issued in one or more series having such rights, preferences and other provisions as determined by the Board of Directors without approval by the holders of common stock.

On December 14, 2011, the Company adopted a new open market repurchase program for up to 4,000,000 shares of the Company’s common stock, not to exceed $100 million in repurchases. The new repurchase program will conclude at the earliest of three years, when the maximum number of shares has been repurchased, or when the maximum dollar amount has been reached. Through December 31, 2011, no shares have been purchased and retired under this program.

On September 15, 2010, the Company commenced an open market repurchase program for up to 4,000,000 shares of the Company’s common stock, not to exceed $100 million in repurchases. This program will conclude at the earliest of three years from the commencement date, when the maximum number of shares has been repurchased or when the maximum dollar amount has been expended. During the year ended December 31, 2010, the Company repurchased and retired 451,272 shares at a weighted-average price of $30.81 per share. During the year ended December 31, 2011, the Company repurchased and retired 3,469,866 shares at a weighted-average price of $24.68 per share. The cumulative number of shares that have been repurchased and retired under this program through December 31, 2011 is 3,921,138 shares at a weighted-average price of $25.39 per share.

On December 9, 2009, the Company commenced the predecessor open market repurchase program for up to 3,000,000 shares of the Company’s common stock, not to exceed $100 million in repurchases. This program concluded in September 2010 when purchases approximately totaled the permitted maximum dollar amount. During the year ended December 31, 2010, the Company repurchased and retired 2,964,528 shares at a weighted-average price of $33.69 per share, which is the cumulative number of shares that were repurchased under this program.

The Credit Facility limits the Company’s ability to pay dividends and/or repurchase stock to an amount not to exceed $50 million in the aggregate after November 5, 2010, the date of the initial amendment and restatement of the Credit Facility. In addition, the Credit Facility allows the Company to repurchase stock in an amount not to exceed the aggregate amount of proceeds from the exercise of stock options. The indentures governing the 8 ⁷/8% Senior Notes and the 8% Senior Notes (collectively, the “Senior Notes”) also limit the Company’s ability to pay dividends and/or repurchase stock. As of December 31, 2011, under the most restrictive test under these agreements, the Company has approximately $30.1 million remaining available with which to pay permitted dividends and/or make stock and Senior Notes repurchases.

101

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

The following schedule discloses the effects of changes in the Company’s ownership interest in its less-than-wholly-owned subsidiaries on Community Health Systems, Inc. stockholders’ equity (in thousands):

	Year Ended December 31,
	2011			2010			2009
Net income attributable to Community Health Systems, Inc.	$	201,948		$	279,983		$	243,150
Transfers (to) from the noncontrolling interests:
Net (decrease) increase in Community Health Systems, Inc. paid-in capital for purchase of subsidiary partnership interests		(4,556	)		(3,529	)		3,106
Net transfers (to) from the noncontrolling interests		(4,556	)		(3,529	)		3,106
Change to Community Health Systems, Inc. stockholders’ equity from net income attributable to Community Health Systems, Inc. and transfers (to) from noncontrolling interests	$	197,392		$	276,454		$	246,256

12. Earnings Per Share

The following table sets forth the components of the numerator and denominator for the computation of basic and diluted earnings per share for income from continuing operations, discontinued operations and net income attributable to Community Health Systems, Inc. common stockholders (in thousands, except share data):

	Year Ended December 31,
	2011			2010			2009
Numerator:
Income from continuing operations, net of taxes	$	335,894		$	355,213		$	305,811
Less: Income from continuing operations attributable to noncontrolling interests, net of taxes		75,675			68,577			62,948
Income from continuing operations attributable to Community Health
Systems, Inc. common stockholders — basic and diluted	$	260,219		$	286,636		$	242,863
(Loss) income from discontinued operations, net of taxes	$	(58,271	)	$	(6,772	)	$	566
Less: (Loss) income from discontinued operations attributable to noncontrolling interests, net of taxes		—			(119	)		279
Loss from discontinued operations attributable to Community Health Systems, Inc. common stockholders - basic and diluted	$	(58,271	)	$	(6,653	)	$	287
Denominator:
Weighted-average number of shares outstanding – basic		89,966,933			91,718,791			90,614,886
Effect of dilutive securities:
Restricted stock awards		327,652			542,488			469,134
Employee stock options		361,554			667,606			422,637
Other equity-based awards		10,209			17,163			10,617
Weighted-average number of shares outstanding – diluted		90,666,348			92,946,048			91,517,274
Dilutive securities outstanding not included in the computation of earnings per share because their effect is antidilutive:
Employee stock options		6,432,281			4,882,338			6,820,393

102

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

13. Equity Investments

As of December 31, 2011, the Company owned equity interests of 27.5% in four hospitals in Las Vegas, Nevada, and 26.1% in one hospital in Las Vegas, Nevada, in which Universal Health Systems, Inc. owns the majority interest, and an equity interest of 38.0% in three hospitals in Macon, Georgia, in which HCA Inc. (“HCA”) owns the majority interest.

Summarized combined financial information for the unconsolidated entities in which the Company owns an equity interest is as follows (in thousands):

	December 31,
	2011		2010
Current assets	$	233,496	$	220,881
Noncurrent assets		790,125		771,646
Total assets	$	1,023,621	$	992,527
Current liabilities	$	82,687	$	83,985
Noncurrent liabilities		2,094		2,198
Members’ equity		938,672		905,006
Noncontrolling interests		168		1,338
Total liabilities and equity	$	1,023,621	$	992,527

	Year Ended December 31,
	2011		2010		2009
Net operating revenues	$	1,230,146	$	1,195,108	$	1,181,334
Operating costs and expenses	$	1,068,212	$	1,044,751	$	1,032,953
Income from continuing operations before taxes	$	162,124	$	150,640	$	148,343

The summarized financial information was derived from the financial information provided to the Company by those unconsolidated entities.

The Company’s investment in all of its unconsolidated affiliates was $422.2 million and $409.5 million at December 31, 2011 and 2010, respectively, and is included in other assets, net in the accompanying consolidated balance sheets. Included in the Company’s results of operations is the Company’s equity in pre-tax earnings from all of its investments in unconsolidated affiliates, which was $49.5 million, $45.4 million and $36.5 million for the years ended December 31, 2011, 2010 and 2009, respectively.

103

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

14. Segment Information

The Company operates in three distinct operating segments, represented by hospital operations (which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services), home care agency operations (which provide in-home outpatient care), and hospital management services (which provides executive management and consulting services to non-affiliated acute care hospitals). Only the hospital operations segment meets the criteria as a separate reportable segment. The financial information for the home care agencies and hospital management services segments do not meet the quantitative thresholds for a separate identifiable reportable segment and are combined into the corporate and all other reportable segment.

The accounting policies of the segments are the same as those described in the summary of significant accounting policies in Note 1. Expenditures for segment assets are reported on an accrual basis, which includes amounts that are reflected in accounts payable. Substantially all depreciation and amortization as reflected in the consolidated statements of income relates to the hospital operations segment.

The distribution between reportable segments of the Company’s net operating revenues, income from continuing operations before income taxes, expenditures for segment assets and total assets is summarized in the following tables (in thousands):

	Year Ended December 31,
	2011			2010			2009
Net operating revenues:
Hospital operations	$	11,631,382		$	10,813,383		$	10,065,457
Corporate and all other		274,830			279,039			268,044
	$	11,906,212		$	11,092,422		$	10,333,501
Income from continuing operations before income taxes:
Hospital operations	$	720,215		$	662,303		$	590,389
Corporate and all other		(246,668	)		(143,409	)		(142,727	)
	$	473,547		$	518,894		$	447,662
Expenditures for segment assets:
Hospital operations	$	737,391		$	646,509		$	543,969
Corporate and all other		39,322			20,869			15,105
	$	776,713		$	667,378		$	559,074
	December 31,
	2011			2010
Total assets:
Hospital operations	$	13,984,964		$	13,398,314
Corporate and all other		1,223,876			1,299,809
	$	15,208,840		$	14,698,123

15. Commitments and Contingencies

Construction and Other Capital Commitments. Pursuant to hospital purchase agreements in effect as of December 31, 2011, and where final certificate of need approval has been obtained, the Company is required to build replacement facilities. As required by an amendment to a lease agreement entered into in 2005, the Company agreed to build a replacement facility at its Barstow, California location with an aggregate estimated construction cost, including equipment costs, of approximately $73.5 million. Of this amount, approximately $49.3 million has been expended through December 31, 2011. This project is expected to be completed in 2012. The Company has agreed, as part of an acquisition in 2007, to build a replacement hospital in Valparaiso, Indiana with an aggregate estimated construction cost, including equipment costs, of approximately $208.7 million. Of this amount, approximately $137.0 million has been expended through December 31, 2011. This project is expected to be completed in 2012. The Company has agreed, as part of an acquisition in 2009, to build a replacement hospital in Siloam Springs, Arkansas with an aggregate estimated construction cost, including equipment costs, of approximately $35.0 million. Of this amount, approximately $24.0 million has been expended through December

104

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

31, 2011. This project is required to be completed in 2013. In October 2008, after the purchase of the noncontrolling owner’s interest in the Company’s Birmingham, Alabama facility, the Company initiated the purchase of a site, which includes a partially constructed hospital structure, for a potential replacement for the existing Birmingham facility. In September 2010, the Company received approval of its request for a certificate of need from the Alabama Certificate of Need Review Board; however, this certificate of need remains subject to an appeal process. The Company’s estimated construction costs, including the acquisition of the site and equipment costs, are approximately $280.0 million for the Birmingham replacement facility. Of this amount, approximately $3.5 million has been expended through December 31, 2011. In addition, under other purchase agreements outstanding at December 31, 2011, the Company has committed to spend approximately $652.5 million for costs such as capital improvements, equipment, selected leases and physician recruiting. These commitments are required to be fulfilled generally over a five to seven year period after acquisition. Through December 31, 2011, the Company has spent approximately $247.8 million related to these commitments.

Physician Recruiting Commitments. As part of its physician recruitment strategy, the Company provides income guarantee agreements to certain physicians who agree to relocate to its communities and commit to remain in practice there. Under such agreements, the Company is required to make payments to the physicians in excess of the amounts they earned in their practice up to the amount of the income guarantee. These income guarantee periods are typically for 12 months. Such payments are recoverable by the Company from physicians who do not fulfill their commitment period, which is typically three years, to the respective community. At December 31, 2011, the maximum potential amount of future payments under these guarantees in excess of the liability recorded is $27.4 million.

Professional Liability Claims. As part of the Company’s business of owning and operating hospitals, it is subject to legal actions alleging liability on its part. The Company accrues for losses resulting from such liability claims, as well as loss adjustment expenses that are out-of-pocket and directly related to such liability claims. These direct out-of-pocket expenses include fees of outside counsel and experts. The Company does not accrue for costs that are part of corporate overhead, such as the costs of in-house legal and risk management departments. The losses resulting from professional liability claims primarily consist of estimates for known claims, as well as estimates for incurred but not reported claims. The estimates are based on specific claim facts, historical claim reporting and payment patterns, the nature and level of hospital operations and actuarially determined projections. The actuarially determined projections are based on the Company’s actual claim data, including historic reporting and payment patterns which have been gathered over an approximate 20-year period. As discussed below, since the Company purchases excess insurance on a claims-made basis that transfers risk to third-party insurers, the liability it accrues does include an amount for the losses covered by its excess insurance. The Company also records a receivable for the expected reimbursement of losses covered by excess insurance. Since the Company believes that the amount and timing of its future claims payments are reliably determinable, it discounts the amount accrued for losses resulting from professional liability claims using the risk-free interest rate corresponding to the timing of expected payments.

The net present value of the projected payments was discounted using a weighted-average risk-free rate of 1.2%, 1.3% and 1.4% in 2011, 2010 and 2009, respectively. This liability is adjusted for new claims information in the period such information becomes known. The Company’s estimated liability for the self-insured portion of professional and general liability claims was $567.8 million and $489.2 million as of December 31, 2011 and 2010, respectively. The estimated undiscounted claims liability was $595.7 million and $513.2 million as of December 31, 2011 and 2010, respectively. The current portion of the liability for self-insured portion of professional and general liability claims was $98.1 million and $82.9 million as of December 31, 2011 and 2010, respectively, and is included in other accrued liabilities in the accompanying consolidated balance sheets. Professional malpractice expense includes the losses resulting from professional liability claims and loss adjustment expense, as well as paid excess insurance premiums, and is presented within other operating expenses in the accompanying consolidated statements of income.

105

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

The Company’s processes for obtaining and analyzing claims and incident data are standardized across all of its hospitals and have been consistent for many years. The Company monitors the outcomes of the medical care services that it provides and for each reported claim, the Company obtains various information concerning the facts and circumstances related to that claim. In addition, the Company routinely monitors current key statistics and volume indicators in its assessment of utilizing historical trends. The average lag period between claim occurrence and payment of a final settlement is between four and five years, although the facts and circumstances of individual claims could result in the timing of such payments being different from this average. Since claims are paid promptly after settlement with the claimant is reached, settled claims represent less than 1.0% of the total liability at the end of any period.

For purposes of estimating its individual claim accruals, the Company utilizes specific claim information, including the nature of the claim, the expected claim amount, the year in which the claim occurred and the laws of the jurisdiction in which the claim occurred. Once the case accruals for known claims are determined, information is stratified by loss layers and retentions, accident years, reported years, geography and claims relating to the acquired Triad hospitals versus claims relating to the Company’s other hospitals. Several actuarial methods are used against this data to produce estimates of ultimate paid losses and reserves for incurred but not reported claims. Each of these methods uses company-specific historical claims data and other information. This company-specific data includes information regarding the Company’s business, including historical paid losses and loss adjustment expenses, historical and current case loss reserves, actual and projected hospital statistical data, a variety of hospital census information, employed physician information, professional liability retentions for each policy year, geographic information and other data.

Based on these analyses the Company determines its estimate of the professional liability claims. The determination of management’s estimate, including the preparation of the reserve analysis that supports such estimate, involves subjective judgment of the management. Changes in reserving data or the trends and factors that influence reserving data may signal fundamental shifts in the Company’s future claim development patterns or may simply reflect single-period anomalies. Even if a change reflects a fundamental shift, the full extent of the change may not become evident until years later. Moreover, since the Company’s methods and models use different types of data and the Company selects its liability from the results of all of these methods, it typically cannot quantify the precise impact of such factors on its estimates of the liability. Due to the Company’s standardized and consistent processes for handling claims and the long history and depth of company-specific data, the Company’s methodologies have produced reliably determinable estimates of ultimate paid losses.

The Company is primarily self-insured for these claims; however, the Company obtains excess insurance that transfers the risk of loss to a third-party insurer for claims in excess of self-insured retentions. The Company’s excess insurance is underwritten on a claims-made basis. For claims reported prior to June 1, 2002, substantially all of the Company’s professional and general liability risks were subject to a $0.5 million per occurrence self-insured retention and for claims reported from June 1, 2002 through June 1, 2003, these self-insured retentions were $2.0 million per occurrence. Substantially all claims reported after June 1, 2003 and before June 1, 2005 are self-insured up to $4 million per claim. Substantially all claims reported on or after June 1, 2005 are self-insured up to $5 million per claim. Management on occasion has selectively increased the insured risk at certain hospitals based upon insurance pricing and other factors and may continue that practice in the future. Excess insurance for all hospitals has been purchased through commercial insurance companies and generally covers the Company for liabilities in excess of the self-insured retentions. The excess coverage consists of multiple layers of insurance, the sum of which totals up to $95 million per occurrence and in the aggregate for claims reported on or after June 1, 2003 and up to $145 million per occurrence and in the aggregate for claims incurred and reported after January 1, 2008. For certain policy years, if the first aggregate layer of excess coverage becomes fully utilized, then the Company’s self-insured retention could increase to $10 million per claim for any subsequent claims in that policy year until the Company’s total aggregate coverage is met.

106

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Effective January 1, 2008, the former Triad hospitals are insured on a claims-made basis as described above and through commercial insurance companies as described above for substantially all claims occurring on or after January 1, 2002 and reported on or after January 1, 2008. Substantially all losses for the former Triad hospitals in periods prior to May 1999 were insured through a wholly-owned insurance subsidiary of HCA, Triad’s owner prior to that time, and excess loss policies maintained by HCA. HCA has agreed to indemnify the former Triad hospitals in respect of claims covered by such insurance policies arising prior to May 1999. After May 1999 through December 31, 2006, the former Triad hospitals obtained insurance coverage on a claims incurred basis from HCA’s wholly-owned insurance subsidiary, with excess coverage obtained from other carriers that is subject to certain deductibles. Effective for claims incurred after December 31, 2006, Triad began insuring its claims from $1 million to $5 million through its wholly-owned captive insurance company, replacing the coverage provided by HCA. Substantially all claims occurring during 2007 were self-insured up to $10 million per claim.

Legal Matters. The Company is a party to various legal proceedings incidental to its business. In the opinion of management, any ultimate liability with respect to these actions will not have a material adverse effect on the Company’s consolidated financial position, cash flows or results of operations. With respect to all litigation matters, the Company considers the likelihood of a negative outcome. If the Company determines the likelihood of a negative outcome is probable and the amount of the loss can be reasonably estimated, the Company records an estimated loss for the expected outcome of the litigation. If the likelihood of a negative outcome is reasonably possible and the Company is able to determine an estimate of the possible loss or a range of loss, the Company discloses that fact together with the estimate of the possible loss or range of loss. However, it is difficult to predict the outcome or estimate a possible loss or range of loss in some instances because litigation is subject to significant uncertainties.

Reasonably Possible Contingencies

For all of the legal matters below, the Company believes that a negative outcome is reasonably possible, but the Company is unable to determine an estimate of the possible loss or a range of loss.

On February 10, 2006, the Company received a letter from the Civil Division of the Department of Justice requesting documents in an investigation it was conducting involving the Company. The inquiry related to the way in which different state Medicaid programs apply to the federal government for matching or supplemental funds that are ultimately used to pay for a small portion of the services provided to Medicaid and indigent patients. These programs are referred to by different names, including “intergovernmental payments,” “upper payment limit programs,” and “Medicaid disproportionate share hospital payments.” The February 2006 letter focused on the Company’s hospitals in three states: Arkansas, New Mexico, and South Carolina. On August 31, 2006, the Company received a follow up letter from the Department of Justice requesting additional documents relating to the programs in New Mexico and the payments to the Company’s three hospitals in that state. Through the beginning of 2009, the Company provided the Department of Justice with requested documents, met with its personnel on numerous occasions, and otherwise cooperated in its investigation. During the course of the investigation, the Civil Division notified the Company that it believed that the Company and its three New Mexico hospitals caused the State of New Mexico to submit improper claims for federal funds, in violation of the Federal False Claims Act. At one point, the Civil Division calculated that the three hospitals received ineligible federal participation payments from August 2000 to June 2006 of approximately $27.5 million and said that if it proceeded to trial, it would seek treble damages plus an appropriate penalty for each of the violations of the Federal False Claims Act. This investigation has culminated in the federal government’s intervention in a qui tam lawsuit styled U.S. ex rel. Baker vs. Community Health Systems, Inc., pending in the United States District Court for the District of New Mexico. The federal government filed its complaint in intervention on June 30, 2009. The relator filed a second amended complaint on July 1, 2009. Both of these complaints expand the time period during which alleged improper payments were made. The Company filed motions to dismiss all of the federal government’s and the relator’s claims on August 28, 2009. On March 19, 2010, the court granted in part and denied in part the Company’s motion to dismiss as to the relator’s complaint. On July 7, 2010, the court denied the Company’s motion to dismiss the federal government’s complaint in intervention. On July 21, 2010, the Company filed its answer and pretrial discovery began. On June 2, 2011, the relator filed a Third Amended Complaint adding subsidiaries Community Health Systems Professional Services Corporation and CHS/Community Health Systems, Inc. as defendants. On June 6, 2011, the government filed its First Amended Complaint in intervention adding Community Health Systems Professional Services Corporation as a defendant. Discovery is closed. The deadline for filing of Motions for Summary Judgment is March 27, 2012 and there is currently no trial date set. The Company is vigorously defending this action.

107

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

On June 12, 2008, two of the Company’s hospitals received letters from the United States Attorney’s Office for the Western District of New York requesting documents in an investigation it is conducting into billing practices with respect to kyphoplasty procedures performed during the period January 1, 2002, through June 9, 2008. On September 16, 2008, one of the Company’s hospitals in South Carolina also received an inquiry. Kyphoplasty is a surgical spine procedure that returns a compromised vertebrae (either from trauma or osteoporotic disease process) to its previous height, reducing or eliminating severe pain. The Company has been informed that similar investigations have been initiated at unaffiliated facilities in Alabama, South Carolina, Indiana and other states. The Company believes that this investigation is related to a qui tam settlement between the same United States Attorney’s office and the manufacturer and distributor of the Kyphon product, which is used in performing the kyphoplasty procedure. The Company is cooperating with the investigation and continuing to evaluate and discuss this matter with the federal government.

Matters for which an Outcome Cannot be Assessed

For all of the legal matters below, the Company cannot at this time assess what the outcome may be and is further unable to determine any estimate of loss or range of loss. Because the investigations are at a very preliminary stage, there are not sufficient facts available to make these assessments.

On April 8, 2011, the Company received a document subpoena, dated March 31, 2011, from the United States Department of Health and Human Services, Office of Inspector General (the “OIG”), in connection with an investigation of possible improper claims submitted to Medicare and Medicaid. The subpoena, issued from the OIG’s Chicago, Illinois office, requested documents from all of the Company’s hospitals and appears to concern emergency department processes and procedures, including the Company’s hospitals’ use of the Pro-MED Clinical Information System, which is a third-party software system that assists with the management of patient care and provides operational support and data collection for emergency department management and has the ability to track discharge, transfer and admission recommendations of emergency department physicians. The subpoena also requested other information about the Company’s relationships with emergency department physicians, including financial arrangements. The subpoena’s requests were very similar to those contained in the Civil Investigative Demands received by the Company’s Texas hospitals from the Office of the Attorney General of the State of Texas on November 15, 2010. The Company is continuing to cooperate with the government (including production of documents and interviews with witnesses) in this investigation.

On April 11, 2011, Tenet Healthcare Corporation (“Tenet”) filed suit against the Company, Wayne T. Smith and W. Larry Cash in the United States District Court for the Northern District of Texas. The suit alleged the Company committed violations of certain federal securities laws by making certain statements in various proxy materials filed with the SEC in connection with the Company’s offer to purchase Tenet. Tenet alleged that the Company engaged in a practice to under-utilize observation status and over-utilize inpatient admission status and asserts that by doing so, the Company created undisclosed financial and legal liability to federal, state and private payors. The suit seeks declaratory and injunctive relief and Tenet’s costs. On April 19, 2011, the Company filed a motion to dismiss the complaint. On April 28, 2011, the Company responded to the allegations during its earnings release conference call as discussed in the Company’s Form 8-K furnished on April 28, 2011. On May 16, 2011, Tenet filed an amended complaint. On June 29, 2011, the Company filed a motion to dismiss the amended complaint. A hearing on the Company’s motion to dismiss occurred on September 8, 2011. The court took this matter under advisement. The Company will continue to vigorously defend this suit.

On April 22, 2011, a joint motion was filed by the relator and the United States Department of Justice in the case styled United States ex rel. and Reuille vs. Community Health Systems Professional Services Corporation and Lutheran Musculoskeletal Center, LLC d/b/a Lutheran Hospital, in the United States District Court for the Northern District of Indiana, Fort Wayne Division. The lawsuit was originally filed under seal on January 7, 2009. The suit is brought under the False Claims Act and alleges that Lutheran Hospital of Indiana billed the Medicare program for (a) false 23 hour observation after outpatient surgeries and procedures, and (b) intentional assignment of inpatient status to one-day stays for cases that do not meet Medicare criteria for inpatient intensity of service or severity of illness. The relator had worked in the case management department of Lutheran Hospital of Indiana but was

108

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

reassigned to another department in the fall of 2006. This facility was acquired by the Company as part of the July 25, 2007 merger transaction with Triad. The complaint also includes allegations of age discrimination in Ms. Reuille’s 2006 reassignment and retaliation in connection with her resignation on October 1, 2008. The Company had cooperated fully with the government in its investigation of this matter, but had been unaware of the exact nature of the allegations in the complaint. On December 27, 2010, the government filed a notice that it declined to intervene in this suit. The motion contained additional information about how the government intended to proceed with an investigation regarding “allegations of improper billing for inpatient care at other hospitals associated with Community Health Systems, Inc. . . . asserted in other qui tam complaints in other jurisdictions.” The motion stated that the Department of Justice has “consolidated its investigations” of the Company and other related entities and that “the Civil Division of the Department of Justice, multiple United States Attorneys’ offices, and the Office of Inspector General for the Department of Health and Human Services (the “HHS”) are now closely coordinating their investigation of these overlapping allegations. The Attorney General of Texas has initiated an investigation; the United States intends to work cooperatively with Texas and any other States investigating these allegations.” The motion also stated that the Office of Audit Services for the Office of Investigations for HHS has been engaged to conduct a national audit of certain of the Company’s Medicare claims. The government confirmed that it considers the allegations made in the complaint styled Tenet Healthcare Corporation vs. Community Health Systems, Inc., et al. filed in the United States District Court for the Northern District of Texas, Dallas Division on April 11, 2011 to be related to the allegations in the qui tam and to what the government is now describing as a consolidated investigation. Because qui tam suits are filed “under seal,” no one but the relator and the government knows that the suit has been filed or what allegations are being made by the relator on behalf of the government. Initially, the government has 60 days to make a determination about whether to intervene in a case and to act as the plaintiff or to decline to intervene and allow the relator to act as the plaintiff in the suit, but extensions of time are frequently granted to allow the government additional time to investigate the allegations. Even if, in the course of an investigation, the court partially unseals a complaint to allow the government and a defendant to work to a resolution of the complaint’s allegations, the defendant is prohibited from revealing to anyone even that the partial unsealing has occurred. As the investigation proceeds, the Company may learn of additional qui tam suits filed against the Company or its affiliated hospitals or related entities, or that contact letters, document requests, or medical record requests the Company has received in the past from various governmental agencies are generated from qui tam cases filed under seal. The motion filed on April 22, 2011 concluded by requesting a stay of the litigation in the Reuille case for 180 days, and on April 25, 2011, the court granted the motion. The Company’s management company subsidiary, Community Health Systems Professional Services Corporation, the defendant in the Reuille case, consented to the request for the stay. On October 19, 2011, the government filed an application to transfer the Reuille case to the Middle District of Tennessee or for an extension of the stay for an additional 180 days. The Company agreed that a stay for an additional, but shorter period of time, 90 days, was appropriate, but did not consent to the transfer of the case. The Company’s response setting forth the Company’s legal arguments was filed on October 24, 2011. On November 1, 2011, the court denied the motion to transfer the matter and extended the stay until April 30, 2012. The Company is cooperating fully with the government in its investigations.

Three purported class action shareholder federal securities cases have been filed in the United States District Court for the Middle District of Tennessee; namely, Norfolk County Retirement System v. Community Health Systems, Inc., Wayne T. Smith and W. Larry Cash, filed May 5, 2011; De Zheng v. Community Health Systems, Inc., Wayne T. Smith and W. Larry Cash, filed May 12, 2011; and Minneapolis Firefighters Relief Association v. Community Health Systems, Inc., Wayne T. Smith, W. Larry Cash and Thomas Mark Buford, filed June 2, 2011. All three seek class certification on behalf of purchasers of the Company’s common stock between July 27, 2006 and April 11, 2011 and allege that misleading statements resulted in artificially inflated prices for the Company’s common stock. On September 20, 2011, all three were assigned to the same judge as related cases. On December 28, 2011, the court consolidated all three shareholder cases for pretrial purposes, selected NYC Funds as lead plaintiffs, and selected NYC Funds’ counsel as lead plaintiffs’ counsel. The parties are in the process of negotiating operative dates for these consolidated shareholder federal securities actions, including dates for the filing of an operative consolidated complaint and related briefing. Three purported shareholder derivative actions have also been filed in the United States District Court for the Middle District of Tennessee; Plumbers and Pipefitters Local Union No. 630 Pension Annuity Trust Fund v. Wayne T. Smith, W. Larry Cash, T. Mark Buford, John A. Clerico, James S. Ely III, John A. Fry, William Norris Jennings, Julia B. North and H. Mitchell Watson, Jr., filed May 24, 2011; Roofers Local No. 149 Pension Fund v. Wayne T. Smith, W. Larry Cash, John A. Clerico, James S. Ely, III, John A. Fry, William Norris Jennings, Julia B. North and H. Mitchell Watson, Jr., filed June 21, 2011; and Lambert Sweat v. Wayne T. Smith, W. Larry Cash, T. Mark Buford, John A. Clerico, James S. Ely, III, John A. Fry, William

109

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Norris Jennings, Julia B. North, H. Mitchell Watson, Jr. and Community Health Systems, Inc., filed October 5, 2011. These three cases allege breach of fiduciary duty arising out of allegedly improper inpatient admission practices, mismanagement, waste and unjust enrichment. On September 28, 2011, the court ordered that the Plumbers and Pipefitters Local Union No. 630 Pension Annuity Trust Fund action and the Roofers Local No. 149 Pension Fund action be consolidated for pretrial purposes, and appointed the derivative plaintiffs’ lead counsel. On November 29, 2011, the court ordered that the Lambert Sweat action be consolidated with the Plumbers and Roofers consolidated derivative actions. Plaintiffs are expected to file an operative amended derivative complaint in these three consolidated actions on or about March 15, 2012. The Company believes all of these matters are without merit and will vigorously defend them.

The Company incurred the following pre-tax charges in connection with the Tenet acquisition lawsuit, government investigations and shareholder lawsuits relating to possible improper claims submitted to Medicare and Medicaid (in thousands):

	Year Ended December 31,
	2011		2010		2009
Professional fees and other related costs	$	15,317	$	—	$	—

16. Subsequent Events

The Company evaluated all material events occurring subsequent to the balance sheet date for events requiring disclosure or recognition in the consolidated financial statements.

Effective January 1, 2012, one or more subsidiaries of the Company completed the acquisition of Moses Taylor Healthcare System, located in northeast Pennsylvania. This healthcare system includes Moses Taylor Hospital in Scranton, Pennsylvania (217 licensed beds) and Mid-Valley Hospital in Peckville, Pennsylvania (25 licensed beds). The total cash consideration paid at closing for long-lived assets was approximately $152.0 million and for preliminary net working capital was approximately $10.0 million.

On January 24, 2012, the Company announced that one or more subsidiaries of the Company have executed a definitive agreement to acquire substantially all of the assets of Memorial Health Systems in York, Pennsylvania. Memorial Health Systems includes 100-bed Memorial Hospital, the Surgical Center of York and other outpatient and ancillary services.

On February 2, 2012, the Company completed an additional amendment and restatement of the Credit Facility, which extended by two and a half years, until January 25, 2017, the maturity date of an additional $1.6 billion of the existing non-extended term loans under the Credit Facility and increased the pricing on the newly extended term loans by 125 basis points. The maturity date of the balance of the term loans of approximately $2.9 billion remained unchanged at July 25, 2014.

110

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

17. Quarterly Financial Data (Unaudited)

	Quarter
	1st			2nd			3rd			4th			Total
	(in thousands, except share and per share data)
Year ended December 31, 2011:
Net operating revenues(1)	$	2,954,083		$	3,000,827		$	2,945,477		$	3,005,825		$	11,906,212
Income from continuing operations before income taxes		135,697			137,695			132,517			67,638			473,547
Income from continuing operations		91,605			92,874			95,800			55,615			335,894
Loss from discontinued operations		(13,280	)		(39,327	)		(3,169	)		(2,495	)		(58,271	)
Net income attributable to Community Health Systems, Inc	$	61,324		$	35,389		$	74,304		$	30,931		$	201,948
Basic earnings per share attributable to Community Health Systems, Inc. common stockholders(2):
Continuing operations	$	0.82		$	0.82		$	0.87		$	0.38		$	2.89
Discontinued operations		(0.15	)		(0.43	)		(0.04	)		(0.03	)		(0.65	)
Net income	$	0.67		$	0.39		$	0.83		$	0.35		$	2.24
Diluted earnings per share attributable to Community Health Systems, Inc. common stockholders(2):
Continuing operations	$	0.81		$	0.81		$	0.86		$	0.38		$	2.87
Discontinued operations		(0.14	)		(0.43	)		(0.04	)		(0.03	)		(0.64	)
Net income	$	0.67		$	0.39		$	0.83		$	0.35		$	2.23
Weighted-average number of shares:
Basic		91,008,405			91,130,672			89,412,310			88,344,566			89,966,933
Diluted		92,136,819			91,783,725			89,857,583			88,913,813			90,666,348
Year ended December 31, 2010:
Net operating revenues	$	2,702,111		$	2,713,644		$	2,772,311		$	2,904,356		$	11,092,422
Income from continuing operations before taxes		123,906			131,140			131,328			132,520			518,894
Income from continuing operations		84,357			88,379			88,009			94,468			355,213
Gain (loss) from discontinued operations		639			(2,037	)		(3,155	)		(2,219	)		(6,772	)
Net income attributable to Community Health Systems, Inc	$	70,007		$	70,065		$	70,401		$	69,510		$	279,983
Basic earnings per share attributable to Community Health Systems, Inc. common stockholders(2):
Continuing operations	$	0.76		$	0.77		$	0.80		$	0.79		$	3.13
Discontinued operations		0.01			(0.02	)		(0.03	)		(0.02	)		(0.07	)
Net income	$	0.76		$	0.75		$	0.77		$	0.77		$	3.05
Diluted earnings per share attributable to Community Health Systems, Inc. common stockholders(2):
Continuing operations	$	0.75		$	0.76		$	0.80		$	0.78		$	3.08
Discontinued operations		0.01			(0.02	)		(0.03	)		(0.02	)		(0.07	)
Net income	$	0.75		$	0.74		$	0.76		$	0.76		$	3.01
Weighted-average number of shares:
Basic		91,615,275			93,358,771			91,484,466			90,422,331			91,718,791
Diluted		92,836,451			94,711,919			92,462,702			91,778,801			92,946,048

(1) Net operating revenues for the quarter ended September 30, 2011 have been restated to reflect the reclassification of electronic health records incentive reimbursement, which was changed during the fourth quarter of 2011 as a reduction of operating expenses. This reclassification decreased net operating revenues and operating expenses by $40.2 million, and had no impact on income from continuing operations or net income as previously reported. Management does not believe this reclassification is material.

(2) Total per share amounts may not add due to rounding.

111

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

18. Supplemental Condensed Consolidating Financial Information

In 2007, CHS issued the 8 ⁷/8% Senior Notes in the aggregate principal amount of approximately $3.0 billion. In 2011, CHS issued the 8% Senior Notes in the aggregate principal amount of $1.0 billion, the proceeds from which were used to purchase $1.0 billion of the 8 ⁷/8% Senior Notes. These 8 ⁷/8% Senior Notes and 8% Senior Notes are senior unsecured obligations of CHS and are guaranteed on a senior basis by the Company and by certain of its existing and subsequently acquired or organized 100% owned domestic subsidiaries.

Both the 8 ⁷/8% Senior Notes and the 8% Senior Notes are guaranteed on a joint and several basis, with limited exceptions considered customary for such guarantees, including the release of the guarantee when a subsidiary’s assets used in operations are sold. The following condensed consolidating financial statements present Community Health Systems, Inc. (as parent guarantor), CHS (as the issuer), the subsidiary guarantors, the subsidiary non-guarantors and eliminations. These condensed consolidating financial statements have been prepared and presented in accordance with SEC Regulation S-X Rule 3-10 “Financial Statements of Guarantors and Issuers of Guaranteed Securities Registered or Being Registered.”

The accounting policies used in the preparation of this financial information are consistent with those elsewhere in the consolidated financial statements of the Company, except as noted below:

• Intercompany receivables and payables are presented gross in the supplemental consolidating balance sheets.

• Cash flows from intercompany transactions are presented in cash flows from financing activities, as changes in intercompany balances with affiliates, net.

• Income tax expense is allocated from the parent guarantor to the income producing operations (other guarantors and non-guarantors) and the issuer through stockholders’ equity. As this approach represents an allocation, the income tax expense allocation is considered non-cash for statement of cash flow purposes.

• Interest expense, net has been presented to reflect net interest expense and interest income from outstanding long-term debt and intercompany balances.

The Company’s intercompany activity consists primarily of daily cash transfers for purposes of cash management, the allocation of certain expenses and expenditures paid for by the parent on behalf of its subsidiaries, and the push down of investment in its subsidiaries. The Company’s subsidiaries generally do not purchase services from one another; thus, the intercompany transactions do not represent revenue generating transactions. All intercompany transactions eliminate in consolidation.

From time to time, the Company sells and/or repurchases noncontrolling interests in consolidated subsidiaries, which may change subsidiaries between guarantors and non-guarantors. Amounts for prior periods are restated to reflect the status of guarantors or non-guarantors as of December 31, 2011.

112

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Condensed Consolidating Statement of Income

Year Ended December 31, 2011

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
	(In thousands)
Operating revenues (net of contractual allowances and discounts)	$	—		$	—		$	7,904,497		$	5,721,671		$	—		$	13,626,168
Provision for bad debts		—			—			1,003,252			716,704			—			1,719,956
Net operating revenues		—			—			6,901,245			5,004,967			—			11,906,212
Operating costs and expenses:
Salaries and benefits		—			—			3,065,753			2,512,172			—			5,577,925
Supplies		—			—			1,058,807			775,299			—			1,834,106
Other operating expenses		—			—			1,486,113			1,029,525			—			2,515,638
Electronic health records incentive reimbursement		—			—			(42,312	)		(21,085	)		—			(63,397	)
Rent		—			—			124,823			129,958			—			254,781
Depreciation and amortization		—			—			393,549			259,125			—			652,674
Total operating costs and expenses		—			—			6,086,733			4,684,994			—			10,771,727
Income from operations		—			—			814,512			319,973			—			1,134,485
Interest expense, net		—			87,095			495,258			62,057			—			644,410
Loss (gain) from early extinguishment of debt		—			66,019			—			—			—			66,019
Equity in earnings of unconsolidated affiliates		(201,948	)		(275,175	)		(101,101	)		—			528,733			(49,491	)
Income from continuing operations before income taxes		201,948			122,061			420,355			257,916			(528,733	)		473,547
Provision for (benefit from) income taxes		—			(79,887	)		151,748			65,792			—			137,653
Income from continuing operations		201,948			201,948			268,607			192,124			(528,733	)		335,894
Discontinued operations, net of taxes:
(Loss) income from operations of entities sold		—			—			—			(7,769	)		—			(7,769	)
Impairment of hospitals sold		—			—			—			(47,930	)		—			(47,930	)
Loss on sale, net		—			—			—			(2,572	)		—			(2,572	)
(Loss) income from discontinued operations, net of taxes		—			—			—			(58,271	)		—			(58,271	)
Net income		201,948			201,948			268,607			133,853			(528,733	)		277,623
Less: Net income attributable to noncontrolling interests		—			—			—			75,675			—			75,675
Net income attributable to Community Health Systems, Inc.	$	201,948		$	201,948		$	268,607		$	58,178		$	(528,733	)	$	201,948

113

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Condensed Consolidating Statement of Income Year Ended December 31, 2010
	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
	(In thousands)
Operating revenues (net of contractual allowances and discounts)	$	—		$	—		$	7,271,078		$	5,352,196		$	—		$	12,623,274
Provision for bad debts		—			—			901,580			629,272			—			1,530,852
Net operating revenues		—			—			6,369,498			4,722,924			—			11,092,422
Operating costs and expenses:
Salaries and benefits		—			—			2,792,543			2,301,224			—			5,093,767
Supplies		—			—			989,241			748,847			—			1,738,088
Other operating expenses		—			—			1,295,527			1,000,536			—			2,296,063
Electronic health records incentive reimbursement		—			—			—			—			—			—
Rent		—			—			118,215			130,248			—			248,463
Depreciation and amortization		—			—			348,037			246,960			—			594,997
Total operating costs and expenses		—			—			5,543,563			4,427,815			—			9,971,378
Income from operations		—			—			825,935			295,109			—			1,121,044
Interest expense, net		—			113,464			477,418			56,711			—			647,593
Loss (gain) from early extinguishment of debt		—			—			—			—			—			—
Equity in earnings of unconsolidated affiliates		(279,983	)		(312,730	)		(142,174	)		—			689,444			(45,443	)
Income from continuing operations before income taxes		279,983			199,266			490,691			238,398			(689,444	)		518,894
Provision for (benefit from) income taxes		—			(80,717	)		180,574			63,824			—			163,681
Income from continuing operations		279,983			279,983			310,117			174,574			(689,444	)		355,213
Discontinued operations, net of taxes:
(Loss) income from operations of entities sold		—			—			—			(6,772	)		—			(6,772	)
Impairment of hospitals sold		—			—			—			—			—			—
Loss on sale, net		—			—			—			—			—			—
(Loss) income from discontinued operations, net of taxes		—			—			—			(6,772	)		—			(6,772	)
Net income		279,983			279,983			310,117			167,802			(689,444	)		348,441
Less: Net income attributable to noncontrolling interests		—			—			—			68,458			—			68,458
Net income attributable to Community Health Systems, Inc.	$	279,983		$	279,983		$	310,117		$	99,344		$	(689,444	)	$	279,983

114

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Condensed Consolidating Statement of Income Year Ended December 31, 2009
	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
	(In thousands)
Operating revenues (net of contractual allowances and discounts)	$	—		$	—		$	6,763,647		$	4,978,807		$	—		$	11,742,454
Provision for bad debts		—			—			841,342			567,611			—			1,408,953
Net operating revenues		—			—			5,922,305			4,411,196			—			10,333,501
Operating costs and expenses:
Salaries and benefits		—			—			2,630,349			2,070,882			—			4,701,231
Supplies		—			—			933,730			716,049			—			1,649,779
Other operating expenses		—			—			1,169,896			959,185			—			2,129,081
Electronic health records incentive reimbursement		—			—			—			—			—			—
Rent		—			—			113,407			124,129			—			237,536
Depreciation and amortization		—			—			324,018			227,025			—			551,043
Total operating costs and expenses		—			—			5,171,400			4,097,270			—			9,268,670
Income from operations		—			—			750,905			313,926			—			1,064,831
Interest expense, net		—			110,507			479,458			53,643			—			643,608
Loss (gain) from early extinguishment of debt		—			(2,385	)		—			—			—			(2,385	)
Equity in earnings of unconsolidated affiliates		(243,150	)		(259,270	)		(157,491	)		—			623,380			(36,531	)
Impairment of long-lived and other assets		—			—			12,477			—			—			12,477
Income from continuing operations before income taxes		243,150			151,148			416,461			260,283			(623,380	)		447,662
Provision for (benefit from) income taxes		—			(92,002	)		159,921			73,932			—			141,851
Income from continuing operations		243,150			243,150			256,540			186,351			(623,380	)		305,811
Discontinued operations, net of taxes:
(Loss) income from operations of entities sold		—			—			(50	)		1,021			—			971
Impairment of hospitals sold		—			—			—			—			—			—
Loss on sale, net		—			—			—			(405	)		—			(405	)
(Loss) income from discontinued operations, net of taxes		—			—			(50	)		616			—			566
Net income		243,150			243,150			256,490			186,967			(623,380	)		306,377
Less: Net income attributable to noncontrolling interests		—			—			—			63,227			—			63,227
Net income attributable to Community Health Systems, Inc.	$	243,150		$	243,150		$	256,490		$	123,740		$	(623,380	)	$	243,150

115

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Condensed Consolidating Statement of Comprehensive Income
Year Ended December 31, 2011
	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors		Eliminations			Consolidated
	(In thousands)
Net income	$	201,948		$	201,948		$	268,607		$	133,853	$	(528,733	)	$	277,623
Other comprehensive income, net of taxes
Net change in fair value of interest rate swaps		55,145			55,145			—			—		(55,145	)		55,145
Net change in fair value of available-for-sale securities		(960	)		(960	)		(960	)		—		1,920			(960	)
Amortization and recognition of unrecognized pension cost components		(7,737	)		(7,737	)		(7,737	)		—		15,474			(7,737	)
Other comprehensive income		46,448			46,448			(8,697	)		—		(37,751	)		46,448
Comprehensive income		248,396			248,396			259,910			133,853		(566,484	)		324,071
Less: Comprehensive income attributable to noncontrolling interests		—			—			—			75,675		—			75,675
Comprehensive income attributable to Community Health Systems, Inc.	$	248,396		$	248,396		$	259,910		$	58,178	$	(566,484	)	$	248,396

116

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Condensed Consolidating Statement of Comprehensive Income
Year Ended December 31, 2010
	Parent Guarantor			Issuer			Other Guarantors		Non- Guarantors		Eliminations			Consolidated
	(In thousands)
Net income	$	279,983		$	279,983		$	310,117	$	167,802	$	(689,444	)	$	348,441
Other comprehensive income, net of taxes
Net change in fair value of interest rate swaps		(15,676	)		(15,676	)		—		—		15,676			(15,676	)
Net change in fair value of available-for-sale securities		3,716			3,716			3,716		—		(7,432	)		3,716
Amortization and recognition of unrecognized pension cost components		2,418			2,418			2,418		—		(4,836	)		2,418
Other comprehensive income		(9,542	)		(9,542	)		6,134		—		3,408			(9,542	)
Comprehensive income		270,441			270,441			316,251		167,802		(686,036	)		338,899
Less: Comprehensive income attributable to noncontrolling interests		—			—			—		68,458		—			68,458
Comprehensive income attributable to Community Health Systems, Inc.	$	270,441		$	270,441		$	316,251	$	99,344	$	(686,036	)	$	270,441

117

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Condensed Consolidating Statement of Comprehensive Income
Year Ended December 31, 2009
	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors		Eliminations			Consolidated
	(In thousands)
Net income	$	243,150		$	243,150		$	256,490		$	186,967	$	(623,380	)	$	306,377
Other comprehensive income, net of taxes
Net change in fair value of interest rate swaps		76,225			76,225			—			—		(76,225	)		76,225
Net change in fair value of available-for-sale securities		412			412			412			—		(824	)		412
Amortization and recognition of unrecognized pension cost components		(2,447	)		(2,447	)		(2,447	)		—		4,894			(2,447	)
Other comprehensive income		74,190			74,190			(2,035	)		—		(72,155	)		74,190
Comprehensive income		317,340			317,340			254,455			186,967		(695,535	)		380,567
Less: Comprehensive income attributable to noncontrolling interests		—			—			—			63,227		—			63,227
Comprehensive income attributable to Community Health Systems, Inc.	$	317,340		$	317,340		$	254,455		$	123,740	$	(695,535	)	$	317,340

118

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Condensed Consolidating Balance Sheet

December 31, 2011

	Parent						Other			Non-
	Guarantor			Issuer			Guarantors			Guarantors		Eliminations			Consolidated
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	—		$	—		$	14,536		$	115,329	$	—		$	129,865
Patient accounts receivable, net of allowance for doubtful accounts		—			—			1,088,121			746,046		—			1,834,167
Supplies		—			—			215,203			131,408		—			346,611
Deferred income taxes		89,797			—			—			—		—			89,797
Prepaid expenses and taxes		101,389			117			83,983			28,513		—			214,002
Other current assets		—			10,235			141,192			80,220		—			231,647
Total current assets		191,186			10,352			1,543,035			1,101,516		—			2,846,089
Intercompany receivable		1,160,785			9,294,295			1,741,928			1,672,003		(13,869,011	)		—
Property and equipment, net		—			—			4,395,498			2,460,478		—			6,855,976
Goodwill		—			—			2,412,517			1,852,328		—			4,264,845
Other assets, net of accumulated amortization		—			99,521			523,645			618,764		—			1,241,930
Net investment in subsidiaries		1,758,458			6,413,757			2,450,625			—		(10,622,840	)		—
Total assets	$	3,110,429		$	15,817,925		$	13,067,248		$	7,705,089	$	(24,491,851	)	$	15,208,840
LIABILITIES AND EQUITY
Current liabilities:
Current maturities of long-term debt	$	—		$	49,954		$	9,625		$	4,127	$	—		$	63,706
Accounts payable		—			345			511,145			237,507		—			748,997
Deferred income taxes		—			—			—			—		—			—
Accrued interest		—			109,984			131			6		—			110,121
Accrued liabilities		7,580			567			662,746			317,422		—			988,315
Total current liabilities		7,580			160,850			1,183,647			559,062		—			1,911,139
Long-term debt		—			8,707,805			49,184			25,809		—			8,782,798
Intercompany payable		—			4,936,587			9,290,461			6,229,469		(20,456,517	)		—
Deferred income taxes		704,725			—			—			—		—			704,725
Other long-term liabilities		1,028			254,228			433,119			261,615		—			949,990
Total liabilities		713,333			14,059,470			10,956,411			7,075,955		(20,456,517	)		12,348,652
Redeemable noncontrolling interests in equity of consolidated subsidiaries		—			—			—			395,743		—			395,743
Equity:
Community Health Systems, Inc. stockholders’ equity:
Preferred stock		—			—			—			—		—			—
Common stock		915			—			1			2		(3	)		915
Additional paid-in capital		1,086,008			701,399			769,841			59,941		(1,531,181	)		1,086,008
Treasury stock, at cost		(6,678	)		—			—			—		—			(6,678	)
Accumulated other comprehensive (loss) income		(184,479	)		(184,479	)		(21,687	)		—		206,166			(184,479	)
Retained earnings		1,501,330			1,241,535			1,362,682			106,099		(2,710,316	)		1,501,330
Total Community Health Systems, Inc. stockholders’ equity		2,397,096			1,758,455			2,110,837			166,042		(4,035,334	)		2,397,096
Noncontrolling interests in equity of consolidated subsidiaries		—			—			—			67,349		—			67,349
Total equity		2,397,096			1,758,455			2,110,837			233,391		(4,035,334	)		2,464,445
Total liabilities and equity	$	3,110,429		$	15,817,925		$	13,067,248		$	7,705,089	$	(24,491,851	)	$	15,208,840

119

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Condensed Consolidating Balance Sheet

December 31, 2010

	Parent						Other			Non-
	Guarantor			Issuer			Guarantors			Guarantors		Eliminations			Consolidated
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	—		$	—		$	213,117		$	86,052	$	—		$	299,169
Patient accounts receivable, net of allowance for doubtful accounts		—			—			969,928			744,614		—			1,714,542
Supplies		—			—			193,902			135,212		—			329,114
Deferred income taxes		115,819			—			—			—		—			115,819
Prepaid expenses and taxes		118,464			116			88,647			11,991		—			219,218
Other current assets		—			41			137,113			56,177		—			193,331
Total current assets		234,283			157			1,602,707			1,034,046		—			2,871,193
Intercompany receivable		1,079,294			9,002,158			1,424,734			1,370,494		(12,876,680	)		—
Property and equipment, net		—			—			3,889,651			2,434,786		—			6,324,437
Goodwill		—			—			2,331,452			1,818,795		—			4,150,247
Other assets, net of accumulated amortization		—			131,352			438,131			782,763		—			1,352,246
Net investment in subsidiaries		1,510,063			5,267,860			1,944,795			—		(8,722,718	)		—
Total assets	$	2,823,640		$	14,401,527		$	11,631,470		$	7,440,884	$	(21,599,398	)	$	14,698,123
LIABILITIES AND EQUITY
Current liabilities:
Current maturities of long-term debt	$	—		$	49,953		$	11,070		$	2,116	$	—		$	63,139
Accounts payable		—			—			361,088			165,250		—			526,338
Deferred income taxes		8,882			—			—			—		—			8,882
Accrued interest		—			146,297			116			2		—			146,415
Accrued liabilities		7,595			567			567,101			322,003		—			897,266
Total current liabilities		16,477			196,817			939,375			489,371		—			1,642,040
Long-term debt		—			8,734,473			44,831			29,078		—			8,808,382
Intercompany payable		—			3,619,651			8,424,670			6,086,227		(18,130,548	)		—
Deferred income taxes		608,177			—			—			—		—			608,177
Other long-term liabilities		9,522			340,526			371,667			279,960		—			1,001,675
Total liabilities		634,176			12,891,467			9,780,543			6,884,636		(18,130,548	)		12,060,274
Redeemable noncontrolling interests in equity of consolidated subsidiaries		—			—			—			387,472		—			387,472
Equity:
Community Health Systems, Inc. stockholders’ equity:
Preferred stock		—			—			—			—		—			—
Common stock		936			—			1			2		(3	)		936
Additional paid-in capital		1,126,751			640,683			685,921			39,693		(1,366,297	)		1,126,751
Treasury stock, at cost		(6,678	)		—			—			—		—			(6,678	)
Accumulated other comprehensive (loss) income		(230,927	)		(230,927	)		(12,990	)		—		243,917			(230,927	)
Retained earnings		1,299,382			1,100,304			1,177,995			68,169		(2,346,468	)		1,299,382
Total Community Health Systems, Inc. stockholders’ equity		2,189,464			1,510,060			1,850,927			107,864		(3,468,851	)		2,189,464
Noncontrolling interests in equity of consolidated subsidiaries		—			—			—			60,913		—			60,913
Total equity		2,189,464			1,510,060			1,850,927			168,777		(3,468,851	)		2,250,377
Total liabilities and equity	$	2,823,640		$	14,401,527		$	11,631,470		$	7,440,885	$	(21,599,399	)	$	14,698,123

120

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

Condensed Consolidating Statement of Cash Flows

Year Ended December 31, 2011

	Parent						Other			Non-
	Guarantor			Issuer			Guarantors			Guarantors			Eliminations			Consolidated
	(In thousands)
Net cash (used in) provided by operating activities	$	(41,780	)	$	(111,011	)	$	840,582		$	574,117		$	—		$	1,261,908
Cash flows from investing activities:
Acquisitions of facilities and other related equipment		—			—			(370,243	)		(45,117	)		—			(415,360	)
Purchases of property and equipment		—			—			(440,754	)		(335,959	)		—			(776,713	)
Proceeds from disposition of hospitals and other ancillary operations		—			—			—			173,387			—			173,387
Proceeds from sale of property and equipment		—			—			2,283			8,877			—			11,160
Increase in other investments		—			(10,000	)		(129,852	)		(48,397	)		—			(188,249	)
Net cash used in investing activities		—			(10,000	)		(938,566	)		(247,209	)		—			(1,195,775	)
Cash flows from financing activities:
Proceeds from exercise of stock options		18,910			—			—			—			—			18,910
Repurchase of restricted stock shares for payroll tax withholding requirements		(13,311	)		—			—			—			—			(13,311	)
Deferred financing costs		—			(19,352	)		—			—			—			(19,352	)
Excess tax benefit (income tax payable increase) relating to stock-based compensation		5,290			—			—			—			—			5,290
Stock buy-back		(85,790	)		—			—			—			—			(85,790	)
Proceeds from noncontrolling investors in joint ventures		—			—			—			1,229			—			1,229
Redemption of noncontrolling investments in joint ventures		—			—			—			(13,022	)		—			(13,022	)
Distributions to noncontrolling investors in joint ventures		—			—			—			(56,094	)		—			(56,094	)
Changes in intercompany balances with affiliates, net		116,681			209,066			(95,945	)		(229,802	)		—			—
Borrowings under credit agreement		—			560,000			18,236			2,145			(2,145	)		578,236
Issuance of long-term debt		—			1,000,000			—			—			—			1,000,000
Repayments of long-term indebtedness		—			(1,628,703	)		(22,888	)		(2,087	)		2,145			(1,651,533	)
Net cash provided by (used in) financing activities		41,780			121,011			(100,597	)		(297,631	)		—			(235,437	)
Net change in cash and cash equivalents		—			—			(198,581	)		29,277			—			(169,304	)
Cash and cash equivalents at beginning of period		—			—			213,117			86,052			—			299,169
Cash and cash equivalents at end of period	$	—		$	—		$	14,536		$	115,329		$	—		$	129,865

121

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Condensed Consolidating Statement of Cash Flows

Year Ended December 31, 2010

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations		Consolidated
	(In thousands)
Net cash (used in) provided by operating activities	$	(154,101	)	$	(87,018	)	$	782,993		$	646,856		$	—	$	1,188,730
Cash flows from investing activities:
Acquisitions of facilities and other related equipment		—			—			(204,773	)		(43,478	)		—		(248,251	)
Purchases of property and equipment		—			—			(342,735	)		(324,643	)		—		(667,378	)
Proceeds from disposition of hospitals and other ancillary operations		—			—			—			—			—		—
Proceeds from sale of property and equipment		—			—			8,140			261			—		8,401
Increase in other investments		—			—			(112,587	)		(24,495	)		—		(137,082	)
Net cash used in investing activities		—			—			(651,955	)		(392,355	)		—		(1,044,310	)
Cash flows from financing activities:
Proceeds from exercise of stock options		56,916			—			—			—			—		56,916
Repurchase of restricted stock shares for payroll tax withholding requirements		—			—			—			—			—		—
Deferred financing costs		—			(13,260	)		—			—			—		(13,260	)
Excess tax benefit (income tax payable increase) relating to stock-based compensation		10,219			—			—			—			—		10,219
Stock buy-back		(113,961	)		—			—			—			—		(113,961	)
Proceeds from noncontrolling investors in joint ventures		—			—			—			7,201			—		7,201
Redemption of noncontrolling investments in joint ventures		—			—			—			(7,318	)		—		(7,318	)
Distributions to noncontrolling investors in joint ventures		—			—			—			(68,113	)		—		(68,113	)
Changes in intercompany balances with affiliates, net		200,927			144,788			(142,864	)		(202,851	)		—		—
Borrowings under credit agreement					—			—			—			—		—
Issuance of long-term debt		—			—			—			—			—		—
Repayments of long-term indebtedness		—			(44,510	)		(13,507	)		(3,459	)		—		(61,476	)
Net cash provided by (used in) financing activities		154,101			87,018			(156,371	)		(274,540	)		—		(189,792	)
Net change in cash and cash equivalents		—			—			(25,333	)		(20,039	)		—		(45,372	)
Cash and cash equivalents at beginning of period		—			—			238,450			106,091			—		344,541
Cash and cash equivalents at end of period	$	—		$	—		$	213,117		$	86,052		$	—	$	299,169

122

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Condensed Consolidating Statement of Cash Flows

Year Ended December 31, 2009

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
	(In thousands)
Net cash (used in) provided by operating activities	$	(62,883	)	$	(88,486	)	$	671,528		$	556,270		$	—		$	1,076,429
Cash flows from investing activities:
Acquisitions of facilities and other related equipment		—			—			(199,363	)		(64,410	)		—			(263,773	)
Purchases of property and equipment		—			—			(368,408	)		(208,480	)		—			(576,888	)
Proceeds from disposition of hospitals and other ancillary operations		—			—			—			89,514			—			89,514
Proceeds from sale of property and equipment		—			—			824			3,195			—			4,019
Increase in other investments		—			—			(115,799	)		(4,255	)		—			(120,054	)
Net cash used in investing activities		—			—			(682,746	)		(184,436	)		—			(867,182	)
Cash flows from financing activities:
Proceeds from exercise of stock options		12,759			—			—			—			—			12,759
Repurchase of restricted stock shares for payroll tax withholding requirements		—			—			—			—			—			—
Deferred financing costs		—			(82	)		—			—			—			(82	)
Excess tax benefit (income tax payable increase) relating to stock-based compensation		(3,472	)		—			—			—			—			(3,472	)
Stock buy-back		—			—			—			—			—			—
Proceeds from noncontrolling investors in joint ventures		—			—			—			29,838			—			29,838
Redemption of noncontrolling investments in joint ventures		—			—			—			(7,268	)		—			(7,268	)
Distributions to noncontrolling investors in joint ventures		—			—			—			(58,963	)		—			(58,963	)
Changes in intercompany balances with affiliates, net		53,596			135,518			100,944			(290,058	)		—			—
Borrowings under credit agreement		—			200,000			4,045			2,570			(6,615	)		200,000
Issuance of long-term debt		—			—			—			—			—			—
Repayments of long-term indebtedness		—			(246,950	)		(13,853	)		(3,985	)		6,615			(258,173	)
Net cash provided by (used in) financing activities		62,883			88,486			91,136			(327,866	)		—			(85,361	)
Net change in cash and cash equivalents		—			—			79,918			43,968			—			123,886
Cash and cash equivalents at beginning of period		—			—			158,532			62,123			—			220,655
Cash and cash equivalents at end of period	$	—		$	—		$	238,450		$	106,091		$	—		$	344,541

123

PART IV

Item 15. Exhibits and Financial Statement Schedules

Item 15(a) 1. Financial Statements

Reference is made to the index of financial statements and supplementary data under Item 8 in Part II.

Item 15(a) 2. Financial Statement Schedules

The following financial statement schedule was previously filed as a part of the Annual Report on Form 10-K:

Schedule II — Valuation and Qualifying Accounts

All other schedules are omitted since the required information is not present or is not present in amounts sufficient to require submission of the schedule, or because the information required is included in the consolidated financial statements and notes thereto.

124

XML

Stockholders' Equity (Tables)

12 Months Ended

Dec. 31, 2011

Stockholders' Equity [Abstract]

Effects of changes in the ownership interest in less-than-wholly-owned subsidiaries

The following schedule discloses the effects of changes in the Company’s ownership interest in its less-than-wholly-owned subsidiaries on Community Health Systems, Inc. stockholders’ equity (in thousands):

	Year Ended December 31,
	2011			2010			2009
Net income attributable to Community Health Systems, Inc.	$	201,948		$	279,983		$	243,150
Transfers (to) from the noncontrolling interests:
Net (decrease) increase in Community Health Systems, Inc. paid-in capital for purchase of subsidiary partnership interests		(4,556	)		(3,529	)		3,106
Net transfers (to) from the noncontrolling interests		(4,556	)		(3,529	)		3,106
Change to Community Health Systems, Inc. stockholders’ equity from net income attributable to Community Health Systems, Inc. and transfers (to) from noncontrolling interests	$	197,392		$	276,454		$	246,256

XML

Accounting for Stock-Based Compensation (Details 5) (USD $) In Thousands, except Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Deferred Director's Fee
Directors' fees earned and deferred into plan	$ 220	$ 180	$ 80
Share equivalent units	9,974	5,207	3,284

XML

Business and Summary of Significant Accounting Policies (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2011 Bed Hospital State	Dec. 31, 2010	Dec. 31, 2009
Accounts, Notes, Loans and Financing Receivable [Line Items]
Patient accounts receivable, net of allowance for doubtful accounts	$ 1,834,167,000	$ 1,714,542,000
Business and Summary of Significant Accounting Policies (Textual) [Abstract]
Number of hospitals owned and leased by the Company	131
Number of stand alone rehabilitation or Psychiatric hospitals	4
Number of beds for which license is obtained	19,695
Number of states in which hospitals are owned or leased	29
Corporate office costs included in general and administrative expenses	183,400,000	155,400,000	157,900,000
Accumulated other comprehensive income (loss) including unrealized gain	(960,000)	3,716,000	412,000
Construction in Progress, Gross	397,200,000	221,200,000
Interest Capitalized Related to Construction in Progress	21,400,000	11,900,000	16,700,000
Purchases of property and equipment accrued in accounts payable	94,200,000	59,500,000
Annual testing date for goodwill to be evaluated for impairments	September 30th
Term of physician recruitment contract	3 years
Percentage of net operating revenues related to services rendered to patients covered by the Medicare and Medicaid programs	36.50%	38.10%	37.20%
Percentage of revenues from Medicare outlier payments included in received from Medicare	0.42%	0.43%	0.43%
Amounts due to third party payors	66,000,000	80,500,000
Amounts due from third party payors	86,500,000	118,700,000
Charity Care, Methodology	The estimated cost of these charity care services was determined using a ratio of cost to gross charges and applying that ratio to the gross charges associated with providing care to charity patients for the period.
Provision for contractual allowance included in net operating revenue	42,400,000,000	35,800,000,000	30,800,000,000
Value of administrative and other discounts provided to self-pay patients	852,400,000	689,400,000	531,900,000
Value of charity care services at the Company's standard charges	651,100,000	512,400,000	451,000,000
Estimated cost incurred to provide charity care services	125,700,000	105,500,000	104,000,000
Percentage reserved for all non-self-pay payors accounts aging over 365 days from the date of discharge	100.00%
Physicians recruitment agreement period	1 year
Period for physicians committed to practice in community	3 years
Unamortized portion of physicians income guarantee	33,000,000	37,200,000
Percentage of quantitative threshold under condition one to disclose financial information for operating segment	10.00%
Percentage of consolidated net revenue for disclosing individual reportable segments	75.00%
Increase in Other Current Assets	5,300,000
Increase in Other Assets	36,900,000
Increase in Long Term Liabilities	42,200,000
Effect on income statement with adoption of ASU	0
Medicare [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable, net of contractual allowances, from Medicare	250,800,000	270,800,000
Accounts receivable, net of contractual allowances, from Medicare as a percentage of consolidated net accounts receivable, before allowance for doubtful accounts	6.70%	8.10%
Routine Software [Member]
Finite-Lived Intangible Assets [Line Items]
Expected useful life (in years)	3
Major Software [Member]
Finite-Lived Intangible Assets [Line Items]
Expected useful life (in years)	8
Land and Improvements [Member]
Property Plant and Equipment [Line Items]
Estimated useful lives (in years), minimum	2
Estimated useful lives (in years), maximum	15
Weighted-average useful life (in years)	14
Building and Improvements [Member]
Property Plant and Equipment [Line Items]
Estimated useful lives (in years), minimum	5
Estimated useful lives (in years), maximum	40
Weighted-average useful life (in years)	24
Equipment and Fixtures [Member]
Property Plant and Equipment [Line Items]
Estimated useful lives (in years), minimum	4
Estimated useful lives (in years), maximum	18
Weighted-average useful life (in years)	8
General and Administrative Expense [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation costs included in general and administrative expenses	$ 42,500,000	$ 38,800,000	$ 44,500,000
Indiana [Member] | Geographic Concentration Risk [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Operating revenues, net of contractual allowances and discounts (but before the provision for bad debts) as a percentage of consolidated operating revenues	10.30%	10.60%	11.20%
Texas [Member] | Geographic Concentration Risk [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Operating revenues, net of contractual allowances and discounts (but before the provision for bad debts) as a percentage of consolidated operating revenues	13.10%	13.00%	13.20%
Pennsylvania [Member] | Geographic Concentration Risk [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Operating revenues, net of contractual allowances and discounts (but before the provision for bad debts) as a percentage of consolidated operating revenues	11.50%	10.30%	10.20%

XML

Long-Term Debt (Details 4) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2011
Scheduled maturities of long-term debt outstanding
2012	$ 63,706
2013	87,993
2014	4,417,745
2015	1,796,304
2016	18,644
Thereafter	2,462,112
Total	$ 8,846,504

XML

Accounting for Stock-Based Compensation (Details Textual) (USD $) In Millions, except Share data, unless otherwise specified	12 Months Ended				12 Months Ended							12 Months Ended
	Dec. 31, 2011 M	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008	Dec. 31, 2011 Contractual term of option granted prior to 2005 [Member]	Dec. 31, 2011 Contractual term of option granted from 2005 through 2007 [Member]	Dec. 31, 2011 Contractual term of option granted from 2008 through 2011 [Member]	Dec. 31, 2011 Plan 2000 [Member]	Dec. 31, 2011 Plan 2009 [Member]	Dec. 31, 2011 Employee Stock Option [Member]	Dec. 31, 2011 Restricted Stock Restricted Stock Units and Phantom Shares [Member]	Dec. 31, 2011 Phantom Stock and Restricted Stock Units [Member]	Dec. 31, 2010 Phantom Stock and Restricted Stock Units [Member]	Dec. 31, 2009 Phantom Stock and Restricted Stock Units [Member]	Dec. 31, 2008 Phantom Stock and Restricted Stock Units [Member]	Feb. 24, 2010 Phantom Stock and Restricted Stock Units [Member] Plan 2000 [Member]	Feb. 25, 2009 Phantom Stock and Restricted Stock Units [Member] Plan 2000 [Member]	Feb. 19, 2009 Phantom Stock and Restricted Stock Units [Member] Plan 2000 [Member]	Feb. 23, 2011 Phantom Stock and Restricted Stock Units [Member] Plan 2009 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unissued common stock reserved for grants								332,747	2,773,489
Employee Service Share-based Compensation, Unrecognized Compensation Costs on Nonvested Awards	$ 59.0									$ 13.1	$ 45.9
Closing price of Company's common stock	$ 17.45
Number of shares received by Director.																4,130	7,151	7,151
Grant received by director																			3,688
Total shares of phantom stock	1,109,949	1,099,000	1,188,814
Shares vested at weighted-average grant date	1,009,959	860,749	965,478									22,560	21,449
Weighted-average grant date fair value, Vested	$ 27.40	$ 27.04	$ 37.08									$ 24.68	$ 18.97
Phantom stock and restricted stock units unvested	2,207,612	2,125,291	1,897,541	1,684,207								52,956	53,388	50,057
Weighted-average grant date fair value, Vested	$ 32.95	$ 27.92	$ 24.09	$ 35.57								$ 31.67	$ 26.11	$ 19.19
Contractual term of option granted					10 years	8 years	10 years
Accounting for Stock Based Compensation (Textual) [Abstract]
Weighted Average Period in months	22
Weighted-average grant date fair value of stock options	$ 10.07	$ 8.47	$ 6.61
Aggregate intrinsic value of options exercised	6.1	28.9	7.6
Share equivalent units, Deferred in the plan	28,775
Aggregate fair value, Deferred in the plan	$ 0.5
Valuation method used to estimate the fair value of stock options	Black Scholes option pricing model

XML

Fair Value (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010
Financial assets and liabilities recorded at fair value on a recurring basis
Available-for-sale securities, fair value disclosure	$ 31,582	$ 31,570
Trading securities, fair value disclosure	30,486	35,092
Fair Value, Measurements, Recurring [Member]
Financial assets and liabilities recorded at fair value on a recurring basis
Available-for-sale securities, fair value disclosure	31,582	31,570
Trading securities, fair value disclosure	30,486	35,092
Total assets	62,068	66,662
Fair value of interest rate swap agreements	254,228	340,526
Total liabilities	254,228	340,526
Level 1 [Member] | Fair Value, Measurements, Recurring [Member]
Financial assets and liabilities recorded at fair value on a recurring basis
Available-for-sale securities, fair value disclosure	31,582	31,570
Trading securities, fair value disclosure	30,486	35,092
Total assets	62,068	66,662
Fair value of interest rate swap agreements	0	0
Total liabilities	0	0
Level 2 [Member] | Fair Value, Measurements, Recurring [Member]
Financial assets and liabilities recorded at fair value on a recurring basis
Available-for-sale securities, fair value disclosure	0	0
Trading securities, fair value disclosure	0	0
Total assets	0	0
Fair value of interest rate swap agreements	254,228	340,526
Total liabilities	254,228	340,526
Level 3 [Member] | Fair Value, Measurements, Recurring [Member]
Financial assets and liabilities recorded at fair value on a recurring basis
Available-for-sale securities, fair value disclosure	0	0
Trading securities, fair value disclosure	0	0
Total assets	0	0
Fair value of interest rate swap agreements	0	0
Total liabilities	$ 0	$ 0

XML

Supplemental Condensed Consolidating Financial Information (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Consolidated Statements of Income
Operating revenues (net of contractual allowances and discounts)									$ 13,626,168	$ 12,623,274	$ 11,742,454
Provision for bad debts									1,719,956	1,530,852	1,408,953
Net operating revenues	3,005,825	2,945,477	3,000,827	2,954,083	2,904,356	2,772,311	2,713,644	2,702,111	11,906,212	11,092,422	10,333,501
Operating Costs and Expenses [Abstract]
Salaries and benefits									5,577,925	5,093,767	4,701,231
Supplies									1,834,106	1,738,088	1,649,779
Other operating expenses									2,515,638	2,296,063	2,129,081
Electronic health records incentive reimbursement									(63,397)
Rent									254,781	248,463	237,536
Depreciation and amortization									652,674	594,997	551,043
Total operating costs and expenses									10,771,727	9,971,378	9,268,670
Income from operations									1,134,485	1,121,044	1,064,831
Interest expense, net									644,410	647,593	643,608
Loss (gain) from early extinguishment of debt									66,019		(2,385)
Equity in earnings of unconsolidated affiliates									(49,491)	(45,443)	(36,531)
Impairment of long-lived and other assets									0		12,477
Income from continuing operations before income taxes	67,638	132,517	137,695	135,697	132,520	131,328	131,140	123,906	473,547	518,894	447,662
Provision for (benefit from) income taxes									137,653	163,681	141,851
Income from continuing operations	55,615	95,800	92,874	91,605	94,468	88,009	88,379	84,357	335,894	355,213	305,811
Discontinued operations, net of taxes:
(Loss) income from operations of entities sold									(7,769)	(6,772)	971
Impairment of hospitals sold									(47,930)
Loss on sale, net									(2,572)		(405)
(Loss) income from discontinued operations, net of taxes	(2,495)	(3,169)	(39,327)	(13,280)	(2,219)	(3,155)	(2,037)	639	(58,271)	(6,772)	566
Net income									277,623	348,441	306,377
Less: Net income attributable to noncontrolling interests									75,675	68,458	63,227
Net income attributable to Community Health Systems, Inc.	30,931	74,304	35,389	61,324	69,510	70,401	70,065	70,007	201,948	279,983	243,150
Parent Guarantor [Member]
Operating Costs and Expenses [Abstract]
Equity in earnings of unconsolidated affiliates									(201,948)	(279,983)	(243,150)
Income from continuing operations before income taxes									201,948	279,983	243,150
Income from continuing operations									201,948	279,983	243,150
Discontinued operations, net of taxes:
Net income									201,948	279,983	243,150
Net income attributable to Community Health Systems, Inc.									201,948	279,983	243,150
Issuer [Member]
Operating Costs and Expenses [Abstract]
Interest expense, net									87,095	113,464	110,507
Loss (gain) from early extinguishment of debt									66,019		(2,385)
Equity in earnings of unconsolidated affiliates									(275,175)	(312,730)	(259,270)
Income from continuing operations before income taxes									122,061	199,266	151,148
Provision for (benefit from) income taxes									(79,887)	(80,717)	(92,002)
Income from continuing operations									201,948	279,983	243,150
Discontinued operations, net of taxes:
Net income									201,948	279,983	243,150
Net income attributable to Community Health Systems, Inc.									201,948	279,983	243,150
Other Guarantors [Member]
Consolidated Statements of Income
Operating revenues (net of contractual allowances and discounts)									7,904,497	7,271,078	6,763,647
Provision for bad debts									1,003,252	901,580	841,342
Net operating revenues									6,901,245	6,369,498	5,922,305
Operating Costs and Expenses [Abstract]
Salaries and benefits									3,065,753	2,792,543	2,630,349
Supplies									1,058,807	989,241	933,730
Other operating expenses									1,486,113	1,295,527	1,169,896
Electronic health records incentive reimbursement									(42,312)
Rent									124,823	118,215	113,407
Depreciation and amortization									393,549	348,037	324,018
Total operating costs and expenses									6,086,733	5,543,563	5,171,400
Income from operations									814,512	825,935	750,905
Interest expense, net									495,258	477,418	479,458
Equity in earnings of unconsolidated affiliates									(101,101)	(142,174)	(157,491)
Impairment of long-lived and other assets											12,477
Income from continuing operations before income taxes									420,355	490,691	416,461
Provision for (benefit from) income taxes									151,748	180,574	159,921
Income from continuing operations									268,607	310,117	256,540
Discontinued operations, net of taxes:
(Loss) income from operations of entities sold											(50)
(Loss) income from discontinued operations, net of taxes											(50)
Net income									268,607	310,117	256,490
Net income attributable to Community Health Systems, Inc.									268,607	310,117	256,490
Non-Guarantors [Member]
Consolidated Statements of Income
Operating revenues (net of contractual allowances and discounts)									5,721,671	5,352,196	4,978,807
Provision for bad debts									716,704	629,272	567,611
Net operating revenues									5,004,967	4,722,924	4,411,196
Operating Costs and Expenses [Abstract]
Salaries and benefits									2,512,172	2,301,224	2,070,882
Supplies									775,299	748,847	716,049
Other operating expenses									1,029,525	1,000,536	959,185
Electronic health records incentive reimbursement									(21,085)
Rent									129,958	130,248	124,129
Depreciation and amortization									259,125	246,960	227,025
Total operating costs and expenses									4,684,994	4,427,815	4,097,270
Income from operations									319,973	295,109	313,926
Interest expense, net									62,057	56,711	53,643
Income from continuing operations before income taxes									257,916	238,398	260,283
Provision for (benefit from) income taxes									65,792	63,824	73,932
Income from continuing operations									192,124	174,574	186,351
Discontinued operations, net of taxes:
(Loss) income from operations of entities sold									(7,769)	(6,772)	1,021
Impairment of hospitals sold									(47,930)
Loss on sale, net									(2,572)		(405)
(Loss) income from discontinued operations, net of taxes									(58,271)	(6,772)	616
Net income									133,853	167,802	186,967
Less: Net income attributable to noncontrolling interests									75,675	68,458	63,227
Net income attributable to Community Health Systems, Inc.									58,178	99,344	123,740
Eliminations [Member]
Operating Costs and Expenses [Abstract]
Equity in earnings of unconsolidated affiliates									528,733	689,444	623,380
Income from continuing operations before income taxes									(528,733)	(689,444)	(623,380)
Income from continuing operations									(528,733)	(689,444)	(623,380)
Discontinued operations, net of taxes:
Net income									(528,733)	(689,444)	(623,380)
Net income attributable to Community Health Systems, Inc.									$ (528,733)	$ (689,444)	$ (623,380)

XML

Business and Summary of Significant Accounting Policies (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Health Care Organization Receivable and Revenue Disclosures [Line Items]
Total	$ 13,626,168	$ 12,623,274	$ 11,742,454
Medicare [Member]
Health Care Organization Receivable and Revenue Disclosures [Line Items]
Total	3,654,247	3,464,117	3,212,424
Medicaid [Member]
Health Care Organization Receivable and Revenue Disclosures [Line Items]
Total	1,318,756	1,345,315	1,146,033
Managed Care and other third-party payors [Member]
Health Care Organization Receivable and Revenue Disclosures [Line Items]
Total	7,014,519	6,359,322	6,071,023
Self-pay [Member]
Health Care Organization Receivable and Revenue Disclosures [Line Items]
Total	$ 1,638,646	$ 1,454,520	$ 1,312,974

XML

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2011

Income Taxes [Abstract]

Provision for income taxes for income from continuing operations

The provision for income taxes for income from continuing operations consists of the following (in thousands):

	Year Ended December 31,
	2011		2010		2009
Current:
Federal	$	23,020	$	54,986	$	93,543
State		7,601		11,208		13,577
		30,621		66,194		107,120
Deferred:
Federal		105,771		92,628		16,012
State		1,261		4,859		18,719
		107,032		97,487		34,731
Total provision for income taxes for income from continuing operations	$	137,653	$	163,681	$	141,851

Differences between the statutory federal income tax rate and the effective tax rate

The following table reconciles the differences between the statutory federal income tax rate and the effective tax rate (dollars in thousands):

	Year Ended December 31,
	2011						2010						2009
	Amount			%			Amount			%			Amount			%
Provision for income taxes at statutory federal rate	$	165,741			35.0	%	$	181,474			35.0	%	$	156,682			35.0	%
State income taxes, net of federal income tax benefit		8,212			1.7			8,847			1.7			9,080			2.0
Release of unrecognized tax benefit		(6,509	)		(1.3	)		—			—			—			—
Net income attributable to noncontrolling interests		(26,486	)		(5.6	)		(23,960	)		(4.6	)		(22,006	)		(4.9	)
Change in valuation allowance		—			0.0			(910	)		(0.2	)		1,113			0.3
Federal and state tax credits		(3,788	)		(0.8	)		(2,246	)		(0.4	)		(4,241	)		(0.9	)
Deferred tax revaluation		—			—			—			—			(2,996	)		(0.7	)
Other		483			0.1			476			0.1			4,219			0.9
Provision for income taxes and effective tax rate for income from continuing operations	$	137,653			29.1	%	$	163,681			31.6	%	$	141,851			31.7	%

Components of deferred income taxes

	December 31,
	2011					2010
	Assets			Liabilities		Assets			Liabilities
Net operating loss and credit carryforwards	$	140,825		$	—	$	131,093		$	—
Property and equipment		—			727,366		—			685,089
Self-insurance liabilities		113,640			—		91,246			—
Intangibles		—			201,396		—			169,860
Investments in unconsolidated affiliates		—			62,112		—			48,353
Other liabilities		—			22,050		—			27,045
Long-term debt and interest		—			24,115		—			29,191
Accounts receivable		11,435			—		60,026			—
Accrued expenses		49,575			—		53,842			—
Other comprehensive income		128,170			—		156,597			—
Stock-based compensation		28,894			—		25,472			—
Deferred compensation		42,668			—		41,703			—
Other		57,158			—		24,963			—
		572,365			1,037,039		584,942			959,538
Valuation allowance		(150,254	)		—		(126,644	)		—
Total deferred income taxes	$	422,111		$	1,037,039	$	458,298		$	959,538

Reconciliation of the total amount of unrecognized tax benefit

The following is a tabular reconciliation of the total amount of unrecognized tax benefit for the years ended December 31, 2011, 2010 and 2009 (in thousands):

	Year Ended December 31,
	2011			2010			2009
Unrecognized tax benefit, beginning of year	$	7,458		$	9,234		$	15,630
Gross (decreases) increases — purchase business combination		—			—			(4,173	)
Gross increases — tax positions in prior period		349			70			—
Reductions — tax positions in prior period		(3,469	)		(1,833	)		—
Lapse of statute of limitations		(3,575	)		—			(663	)
Settlements		(134	)		(13	)		(1,560	)
Unrecognized tax benefit, end of year	$	629		$	7,458		$	9,234

XML

Fair Value (Details Textual) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Fair Value (Textual) [Abstract]
Decrease in fair value of liability related to interest rate swap agreements	$ 21.7	$ 3.9
After tax adjustment to other comprehensive due to interest rate swap agreement	$ 13.9	$ 2.5

XML

Fair Value of Financial Instruments (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008
Assets:
Cash and cash equivalents	$ 129,865	$ 299,169	$ 344,541	$ 220,655
Cash and cash equivalents, fair value disclosure	129,865	299,169
Available-for-sale securities	31,582	31,570
Available-for-sale securities, fair value disclosure	31,582	31,570
Trading securities	30,486	35,092
Trading securities, fair value disclosure	30,486	35,092
Liabilities:
Credit facilities	5,979,383	5,999,337
Credit facilities, fair value disclosure	5,780,877	5,882,124
Other debt	41,143	36,122
Other debt, fair value disclosure	41,143	36,122
8.875% Senior Notes [Member]
Liabilities:
Senior notes	1,777,617	2,784,331
Senior notes, fair value disclosure	1,842,322	2,923,548
8% Senior Notes [Member]
Liabilities:
Senior notes	1,000,000	0
Senior notes, fair value disclosure	$ 995,000	$ 0

XML

Employee Benefit Plans (Details 7)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Pension Plan [Member]
Weighted-average assumptions to determine net periodic cost
Discount rate	5.50%	5.99%	5.96%
Rate of compensation increase	4.50%	4.50%	4.00%
Expected long term rate of return on assets	8.00%	8.50%	8.50%
SERP [Member]
Weighted-average assumptions to determine net periodic cost
Discount rate	4.75%	6.00%	6.00%
Rate of compensation increase	4.00%	5.00%	5.00%

XML

Acquisitions and Divestitures (Details 1) (USD $) In Thousands, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Net operating revenues and income from discontinued operations
Net operating revenues									$ 144,546	$ 305,562	$ 348,796
(Loss) income from operations of entities sold before income taxes									(12,390)	(10,460)	1,492
Impairment of hospitals sold									(51,695)
Loss on sale, net									(4,301)		(644)
(Loss) income from discontinued operations before income taxes									(68,386)	(10,460)	848
(Benefit from) provision for income taxes									(10,115)	(3,688)	282
(Loss) income from discontinued operations, net of taxes	$ (2,495)	$ (3,169)	$ (39,327)	$ (13,280)	$ (2,219)	$ (3,155)	$ (2,037)	$ 639	$ (58,271)	$ (6,772)	$ 566

XML

Fair Value of Financial Instruments (Details 3) (Derivatives designated as hedging instruments [Member], USD $) In Thousands, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010
Other assets, net [Member]
Fair value of derivative instruments in the condensed consolidated balance sheets
Derivatives assets designated as hedging instruments	$ 0	$ 0
Other long-term liabilities [Member]
Fair value of derivative instruments in the condensed consolidated balance sheets
Derivatives liabilities designated as hedging instruments	$ 254,228	$ 340,526

XML

Employee Benefit Plans (Details 4)	Dec. 31, 2011	Dec. 31, 2010
Pension Plan [Member]
Weighted-average assumptions to determine benefit obligations
Discount rate	4.33%	5.50%
Annual salary increases	4.50%	4.50%
SERP [Member]
Weighted-average assumptions to determine benefit obligations
Discount rate	4.00%	4.75%
Annual salary increases	4.00%	4.00%

XML

Leases (Details Textual) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Lease (Additional Textual) [Abstract]
Capital lease obligation	$ 3.0	$ 22.7	$ 3.3
Minimum sublease rentals due in future	21.3
Accumulated depreciation related to assets under capital lease	119.3	106.7
Land and Land Improvements [Member]
Assets capitalized under capital lease
Assets capitalized under capital lease	27.9	27.9
Building and Improvements [Member]
Assets capitalized under capital lease
Assets capitalized under capital lease	193.7	193.7
Equipment and Fixture [Member]
Assets capitalized under capital lease
Assets capitalized under capital lease	$ 69.3	$ 76.7

XML

Employee Benefit Plans (Details 5) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Pension Plan [Member]
Net periodic cost and other amounts recognized in OCI
Service cost	$ 1,315	$ 1,169	$ 3,886
Interest cost	2,159	2,051	2,200
Expected return on plan assets	(2,771)	(2,497)	(1,683)
Amortization of unrecognized prior service (credit) cost	(141)	(38)	689
Amortization of net loss			426
Curtailment credit		(1,910)
Net periodic cost	562	(1,225)	5,518
Prior service (credit) cost arising during period	0	(2,770)
Net gain loss arising during period	11,787	(2,044)	(4,595)
Amortization of:
Prior service cost (credit)	141	38	(689)
Net actuarial gain	0		(426)
Total amount recognized in OCI	11,928	(4,776)	(5,710)
Total recognized in net periodic cost and OCI	12,490	(6,001)	(192)
SERP [Member]
Net periodic cost and other amounts recognized in OCI
Service cost	5,197	4,661	4,437
Interest cost	3,434	3,728	2,469
Expected return on plan assets	0
Amortization of unrecognized prior service (credit) cost	1,696	1,697	1,704
Amortization of net loss	1,533	1,459	1
Curtailment credit
Net periodic cost	11,860	11,545	8,611
Prior service (credit) cost arising during period	0	(24)
Net gain loss arising during period	5,225	4,396	13,028
Amortization of:
Prior service cost (credit)	(1,696)	(1,697)	(1,704)
Net actuarial gain	(1,533)	(1,459)	(1)
Total amount recognized in OCI	1,996	1,216	11,323
Total recognized in net periodic cost and OCI	$ 13,856	$ 12,761	$ 19,934

XML

Fair Value of Financial Instruments (Details Textual) (USD $) In Millions, unless otherwise specified	Dec. 31, 2011
Fair Value of Financial Instruments (Textual) [Abstract]
Interest expenses due to spread between fixed and floating rates	$ 131.8

XML

Long-Term Debt (Details Textual) (USD $)	12 Months Ended					12 Months Ended			12 Months Ended								12 Months Ended			1 Months Ended	12 Months Ended				1 Months Ended	12 Months Ended		12 Months Ended		3 Months Ended			3 Months Ended		1 Months Ended	3 Months Ended	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009	Feb. 02, 2012	Nov. 05, 2010	Dec. 31, 2011 Senior Notes 8.875% Due 2015 [Member]	Dec. 31, 2007 Senior Notes 8.875% Due 2015 [Member]	Jul. 25, 2007 Senior Notes 8.875% Due 2015 [Member]	Dec. 31, 2011 8% Senior Notes Due 2019 [Member]	Jul. 25, 2007 8% Senior Notes Due 2019 [Member]	Dec. 31, 2011 1.25% term loan due 2014 [Member]	Dec. 31, 2011 2.25% term loan due 2014 [Member]	Dec. 31, 2011 2.25% term loan due 2017 [Member]	Dec. 31, 2011 3.5% term loan due 2017 [Member]	Dec. 31, 2011 Alternate Base Rate Revolving Loan [Member]	Dec. 31, 2011 Eurodollar Revolving Loan [Member]	Dec. 31, 2011 First Nine Months [Member]	Dec. 31, 2011 Next Three Months [Member]	Dec. 31, 2011 One Year Onward [Member]	Apr. 30, 2009 Term Loan One [Member]	Dec. 31, 2009 Term Loan One [Member]	Dec. 31, 2009 Term Loan Two [Member]	Feb. 02, 2012 July 25, 2014 maturity term loans [Member]	Feb. 02, 2012 Amended credit agreement [Member]	Jan. 31, 2009 Community Health System [Member]	Dec. 31, 2011 Community Health System [Member]	Jul. 25, 2007 Community Health System [Member]	Dec. 31, 2011 Community Health System [Member] Senior 6.50% Subordinated Notes Due 2012 [Member]	Jul. 25, 2007 Community Health System [Member] Senior 6.50% Subordinated Notes Due 2012 [Member]	Sep. 30, 2007 Community Health System [Member] Senior Notes 8.875% Due 2015 [Member]	Dec. 31, 2007 Community Health System [Member] Senior Notes 8.875% Due 2015 [Member]	Jul. 25, 2007 Community Health System [Member] Senior Notes 8.875% Due 2015 [Member]	Sep. 30, 2007 Community Health System [Member] Funded Term Loan Facility [Member]	Dec. 31, 2011 Community Health System [Member] Funded Term Loan Facility [Member]	Jan. 31, 2009 Community Health System [Member] Delayed Draw Term Loan Facility [Member]	Dec. 31, 2008 Community Health System [Member] Delayed Draw Term Loan Facility [Member]	Dec. 31, 2011 Community Health System [Member] Delayed Draw Term Loan Facility [Member]	Dec. 31, 2007 Community Health System [Member] Delayed Draw Term Loan Facility [Member]
Long-Term Debt (Textual) [Abstract]
Senior secured financing under a new credit facility																											$ 7,200,000,000
Principal amount of senior notes issued									1,000,000,000																						3,000,000,000	3,000,000,000
Applicable percentage for rate loan				1.25%							1.25%	2.25%	2.25%	3.50%	1.25%	2.25%
Percentage of interest rate							8.875%	8.875%	8.00%	8.00%																			6.50%
Net proceeds from the notes offering																														3,000,000,000
Issuance of long-term debt	1,000,000,000																																6,100,000,000
Debt instrument maximum borrowing capacity																																		0			400,000,000	300,000,000
Maturity period of debt instrument																																		7 years			7 years
Drawn of delayed draw term loan																																			200,000,000	100,000,000
Amortization term loan facility as percentage of outstanding term loan																									0.25%
Quarterly amortization payments of each term loan facility																									0.25% of the outstanding amount of the term loans
Condition for amended maturity date	If more than $50 million of the Notes remain outstanding on April 15, 2015, without having been refinanced, then the maturity date for the extended term loans will be accelerated to April 15, 2015
Amended maximum borrowing capacity under uncommitted incremental facility	1,000,000,000
Original maximum borrowing capacity under uncommitted incremental facility	600,000,000
Amended borrowing capacity from receivable transactions	2,000,000,000
Increase in borrowing capacity from receivable transactions	500,000,000
Amount of borrowing from receivable transactions to be used for repayment of existing term loans	1,700,000,000
Prepaid amount of term loan																										equal to (1) 100% of the net cash proceeds of certain asset sales and dispositions by the Company and its subsidiaries, subject to certain exceptions and reinvestment rights, (2) 100% of the net cash proceeds of issuances of certain debt obligations or receivables based financing by the Company and its subsidiaries, subject to certain exceptions, and (3) 50%, subject to reduction to a lower percentage based on the Company’s leverage ratio (as defined in the Credit Facility generally as the ratio of total debt on the date of determination to the Company’s EBITDA, as defined, for the four quarters most recently ended prior to such date), of excess cash flow (as defined) for any year, commencing in 2008, subject to certain exceptions.
Loans under the Credit Facility interest rate description																										Rate equal to an applicable percentage plus, at CHS’s option, either (a) an Alternate Base Rate (as defined) determined by reference to the greater of (1) the Prime Rate (as defined) announced by Credit Suisse or (2) the Federal Funds Effective Rate (as defined) plus one-half of 1.0% or (3) the adjusted London Interbank Offered Rate (“LIBOR”) on such day for a three-month interest period commencing on the second business day after such day plus 1%, or (b) a reserve adjusted LIBOR for dollars (Eurodollar rate) (as defined). The applicable percentage for Alternate Base Rate loans is 1.25% for term loans due 2014 and is 2.25% for term loans due 2017. The applicable percentage for Eurodollar rate loans is 2.25% for term loans due 2014 and 3.5% for term loans due 2017. The applicable percentage for revolving loans is 1.25% for Alternate Base Rate revolving loans and 2.25% for Eurodollar revolving loans, in each case subject to reduction based on the Company’s leverage ratio.
Maturity period of senior notes						July 15, 2015																						2015
Aggregate principal amount	8,846,504,000					2,800,000,000
Percentage payment of commitment fees per annum																										0.50%
Percentage payment of commitment fees Description																																					0.50% per annum for the first nine months after the closing of the Credit Facility, 0.75% per annum for the next three months after such nine-month period and thereafter, 1.0% per annum.
Frequency of payment						semiannually
Date of commencing interest payment	May 15, 2012					January 15, 2008
Base for calculation of Interest	360-day year comprised of twelve 30-day months					360-day year comprised of twelve 30-day months
Payments made for term loan under Credit Facility	1,651,533,000	61,476,000	258,173,000
Principle amount of term loans to tranches																																		1,000,000,000
Interest paid on borrowings	680,704,000	650,712,000	656,997,000
Extended maturity date for term loans with minimum specified amount						Apr. 15, 2015
Obligation to pay commitment fees																	0.50%	0.75%	1.00%
Period for calculation of interest rate	360 days
Frequency of interest	30 days					30 days
Minimum period for redemption of notes	30 days					30 days
Maximum period for redemption of notes	60 days					60 days
Period of redemption commencing on scheduled date						12 months
Percentage of Redemption price equal to principal amount of Notes redeemed	35.00%
Percentage of principal amount of notes redeemed									108.00%
Minimum amount of notes without having been refinanced outstanding on specified date						50,000,000
Term loan under Credit facility paid by the Company																				110,400,000
Repayment of term loan with net proceeds received from sale of ownership interest in partnership																					85,000,000
Extinguishment of Debt	1,000,000,000					1,000,000,000
Percentage of aggregate principal amount	65.00%
Loss from early extinguishment of debt from sale of ownership interest in partnership with an after tax impact																					700,000	200,000
Net gain from early extinguishment of debt net of tax						42,000,000
Loss (gain) from early extinguishment of debt	66,019,000		(2,385,000)			66,000,000															(1,100,000)
Remaining amount paid with net proceeds received from the sale of various other assets																						25,400,000
Loss from early extinguishment of debt from sale of various other assets																						300,000
Balance of term loans	8,782,798,000	8,808,382,000																					2,900,000,000
Non-extended term loans under the Credit Facility																								1,600,000,000
Long Term Debt (Additional Textual) [Abstract]
Equivalent percentage of term loan facility related to net cash proceeds of certain asset sales and dispositions by Company and its subsidiaries	100.00%
Equivalent percentage of term loan facility related to net cash proceeds of Issuances of certain debt obligations or receivables based financing by Company and its subsidiaries	100.00%
Increase the pricing of term loans	LIBOR plus 350 basis points
Equivalent percentage of term loan facility related to reduction to lower percentage based on company's leverage ratio	50.00%
Addition to federal effective rate under credit facility	0.50%
Percentage above LIBOR Rate	1.00%
Amended maximum borrowing capacity under uncommitted incremental facility	1,000,000,000
Original maximum borrowing capacity under uncommitted incremental facility	600,000,000
Amended borrowing capacity from receivable transactions	2,000,000,000
Increase in borrowing capacity from receivable transactions	500,000,000
Amount of borrowing from receivable transactions to be used for repayment of existing term loans	1,700,000,000
Maximum period for redemption of senior notes from public equity offering	180 days
Condition for amended maturity date	If more than $50 million of the Notes remain outstanding on April 15, 2015, without having been refinanced, then the maturity date for the extended term loans will be accelerated to April 15, 2015
Existing term loans under the Credit Facility					$ 1,500,000,000

XML

Subsequent Events

12 Months Ended

Dec. 31, 2011

Subsequent Events [Abstract]

Subsequent Events

16. Subsequent Events

The Company evaluated all material events occurring subsequent to the balance sheet date for events requiring disclosure or recognition in the consolidated financial statements.

Effective January 1, 2012, one or more subsidiaries of the Company completed the acquisition of Moses Taylor Healthcare System, located in northeast Pennsylvania. This healthcare system includes Moses Taylor Hospital in Scranton, Pennsylvania (217 licensed beds) and Mid-Valley Hospital in Peckville, Pennsylvania (25 licensed beds). The total cash consideration paid at closing for long-lived assets was approximately $152.0 million and for preliminary net working capital was approximately $10.0 million.

On January 24, 2012, the Company announced that one or more subsidiaries of the Company have executed a definitive agreement to acquire substantially all of the assets of Memorial Health Systems in York, Pennsylvania. Memorial Health Systems includes 100-bed Memorial Hospital, the Surgical Center of York and other outpatient and ancillary services.

On February 2, 2012, the Company completed an additional amendment and restatement of the Credit Facility, which extended by two and a half years, until January 25, 2017, the maturity date of an additional $1.6 billion of the existing non-extended term loans under the Credit Facility and increased the pricing on the newly extended term loans by 125 basis points. The maturity date of the balance of the term loans of approximately $2.9 billion remained unchanged at July 25, 2014.

XML

Accounting for Stock-Based Compensation (Details 1) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011 Y	Dec. 31, 2010 Y	Dec. 31, 2009 Y
Fair value of stock options
Expected volatility	33.80%	33.70%	40.70%
Expected dividends	$ 0	$ 0	$ 0
Expected term	4	3.1	4
Risk-free interest rate	1.63%	1.41%	1.64%

XML

Segment Information (Tables)

12 Months Ended

Dec. 31, 2011

Segment Information [Abstract]

Revenues and Income from continuing operations before income taxes

The distribution between reportable segments of the Company’s net operating revenues, income from continuing operations before income taxes, expenditures for segment assets and total assets is summarized in the following tables (in thousands):

	Year Ended December 31,
	2011			2010			2009
Net operating revenues:
Hospital operations	$	11,631,382		$	10,813,383		$	10,065,457
Corporate and all other		274,830			279,039			268,044
	$	11,906,212		$	11,092,422		$	10,333,501
Income from continuing operations before income taxes:
Hospital operations	$	720,215		$	662,303		$	590,389
Corporate and all other		(246,668	)		(143,409	)		(142,727	)
	$	473,547		$	518,894		$	447,662
Expenditures for segment assets:
Hospital operations	$	737,391		$	646,509		$	543,969
Corporate and all other		39,322			20,869			15,105
	$	776,713		$	667,378		$	559,074
	December 31,
	2011			2010
Total assets:
Hospital operations	$	13,984,964		$	13,398,314
Corporate and all other		1,223,876			1,299,809
	$	15,208,840		$	14,698,123

XML

Fair Value of Financial Instruments (Details 2) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Interest expense, net [Member]
Effective portion of the pre-tax loss reclassified from accumulated other comprehensive loss ("OCL') into interest expense on the condensed consolidated statements of income
Amount of Pre-Tax Loss Reclassified from AOCL into Income (Effective Portion)	$ 208,985	$ 215,399
Derivatives in Cash Flow Hedging Relationships [Member] | Interest rate swaps [Member]
Amount of pre-tax loss recognized in the condensed consolidated balance sheets as a component of other comprehensive income
Amount of Pre-Tax Gain (Loss) Recognized in OCI on Derivative (Effective Portion)	$ (122,686)	$ (239,893)

XML

Equity Investments (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Summarized combined financial information of entities in which Company owns equity interest
Current assets	$ 233,496	$ 220,881
Noncurrent assets	790,125	771,646
Total assets	1,023,621	992,527
Current liabilities	82,687	83,985
Noncurrent liabilities	2,094	2,198
Members' equity	938,672	905,006
Noncontrolling interests	168	1,338
Total liabilities and equity	1,023,621	992,527
Net operating revenues	1,230,146	1,195,108	1,181,334
Operating costs and expenses	1,068,212	1,044,751	1,032,953
Income from continuing operations before taxes	$ 162,124	$ 150,640	$ 148,343

XML

Leases (Tables)

12 Months Ended

Dec. 31, 2011

Leases [Abstract]

Schedule of future minimum lease payments for operating and capital leases

Commitments relating to noncancellable operating and capital leases for each of the next five years and thereafter are as follows (in thousands):

Year Ended December 31,	Operating (1)		Capital
2012	$	176,403	$	8,386
2013		149,460		7,216
2014		122,763		6,710
2015		98,543		6,005
2016		70,087		5,630
Thereafter		176,599		57,472
Total minimum future payments	$	793,855	$	91,419
Less imputed interest				(43,058	)
				48,361
Less current portion				(4,008	)
Long-term capital lease obligations			$	44,353

(1) Minimum lease payments have not been reduced by minimum sublease rentals due in the future of $21.3 million.

XML

Accounting for Stock-Based Compensation (Details 3) (USD $)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Restricted stock outstanding
Beginning Balance, Shares	2,125,291	1,897,541	1,684,207
Granted, Shares	1,109,949	1,099,000	1,188,814
Vested, Shares	(1,009,959)	(860,749)	(965,478)
Forfeited, Shares	(17,669)	(10,501)	(10,002)
Ending Balance, Shares	2,207,612	2,125,291	1,897,541
Beginning of Period, Weighted Average Grant Date Fair Value	$ 27.92	$ 24.09	$ 35.57
Granted, Weighted Average Grant Date Fair Value	$ 37.57	$ 33.83	$ 18.45
Vested, Weighted Average Grant Date Fair Value	$ 27.40	$ 27.04	$ 37.08
Forfeited, Weighted Average Grant Date Fair Value	$ 35.68	$ 27.84	$ 32.52
End of Period, Weighted Average Grant Date Fair Value	$ 32.95	$ 27.92	$ 24.09

XML

Long-Term Debt (Details 1) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2011
Principal payments
2012	$ 63,706
2013	87,993
2014	4,417,745
2015	1,796,304
2016	18,644
Thereafter	2,462,112
Total	8,846,504
Term Loans [Member]
Principal payments
2012	49,874
2013	49,874
2014	4,413,385
2015	15,000
2016	15,000
Thereafter	1,406,250
Total	$ 5,949,383

XML

Income Taxes (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Current:
Federal	$ 23,020	$ 54,986	$ 93,543
State	7,601	11,208	13,577
Total, Current	30,621	66,194	107,120
Deferred:
Federal	105,771	92,628	16,012
State	1,261	4,859	18,719
Total, Deferred	107,032	97,370	34,268
Total provision for income taxes for income from continuing operations	$ 137,653	$ 163,681	$ 141,851

XML

Business and Summary of Significant Accounting Policies (Details 1) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Accumulated Other Comprehensive Income (Loss)
Change in Fair Value of Interest Rate Swaps, Beginning Balance	$ (217,936)	$ (202,260)
Change in Fair Value of Interest Rate Swaps, Activity during year, net of tax	55,145	(15,676)
Change in Fair Value of Interest Rate Swaps, Ending Balance	(162,791)	(217,936)
Change in Fair Value of Sale Securities, Beginning Balance	2,536	(1,180)
Change in Fair Value of Sale Securities, Activity during year, net of tax	(960)	3,716
Change in Fair Value of Sale Securities, Ending Balance	1,576	2,536
Change in Unrecognized Pension Cost Components, Beginning balance	(15,527)	(17,945)
Change in Unrecognized Pension Cost Components, Activity during year, net of tax	(7,737)	2,418
Change in Unrecognized Pension Cost Components, Ending balance	(23,264)	(15,527)
Accumulated Other Comprehensive Income (Loss), Beginning Balance	(230,927)	(221,385)
Accumulated Other Comprehensive Income (Loss), Activity during year, net of tax	46,448	(9,542)
Accumulated Other Comprehensive Income (Loss), Ending Balance	$ (184,479)	$ (230,927)

XML

Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Cash flows from operating activities:
Net income	$ 277,623	$ 348,441	$ 306,377
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	657,665	609,839	566,543
Deferred income taxes	107,032	97,370	34,268
Stock-based compensation expense	42,542	38,779	44,501
Loss on sale, net	2,572		405
Impairment of hospitals sold and other long-lived assets	47,930		12,477
Loss (gain) from early extinguishment of debt	66,019		(2,385)
(Excess tax benefit) income tax payable increase relating to stock-based compensation expense	(5,290)	(10,219)	3,472
Other non-cash expenses, net	28,716	12,503	22,870
Changes in operating assets and liabilities, net of effects of acquisitions and divestitures:
Patient accounts receivable	(138,332)	(27,049)	58,390
Supplies, prepaid expenses and other current assets	(42,858)	(39,904)	(34,535)
Accounts payable, accrued liabilities and income taxes	246,110	161,952	86,098
Other	(27,821)	(2,982)	(22,052)
Net cash provided by operating activities	1,261,908	1,188,730	1,076,429
Cash flows from investing activities:
Acquisitions of facilities and other related equipment	(415,360)	(248,251)	(263,773)
Purchases of property and equipment	(776,713)	(667,378)	(576,888)
Proceeds from disposition of hospitals and other ancillary operations	173,387		89,514
Proceeds from sale of property and equipment	11,160	8,401	4,019
Increase in other investments	(188,249)	(137,082)	(120,054)
Net cash used in investing activities	(1,195,775)	(1,044,310)	(867,182)
Cash flows from financing activities:
Proceeds from exercise of stock options	18,910	56,916	12,759
Repurchase of restricted stock shares for payroll tax withholding requirements	(13,311)
Deferred financing costs	(19,352)	(13,260)	(82)
Excess tax benefit (income tax payable increase) relating to stock-based compensation	5,290	10,219	(3,472)
Stock buy-back	(85,790)	(113,961)
Proceeds from noncontrolling investors in joint ventures	1,229	7,201	29,838
Redemption of noncontrolling investments in joint ventures	(13,022)	(7,318)	(7,268)
Distributions to noncontrolling investors in joint ventures	(56,094)	(68,113)	(58,963)
Borrowings under credit agreement	578,236		200,000
Issuance of long-term debt	1,000,000
Repayments of long-term indebtedness	(1,651,533)	(61,476)	(258,173)
Net cash used in financing activities	(235,437)	(189,792)	(85,361)
Net change in cash and cash equivalents	(169,304)	(45,372)	123,886
Cash and cash equivalents at beginning of period	299,169	344,541	220,655
Cash and cash equivalents at end of period	129,865	299,169	344,541
Supplemental disclosure of cash flow information:
Interest payments	680,704	650,712	656,997
Income taxes paid, net	$ 26,463	$ 128,186	$ 57,299

XML

Income Taxes (Details 1) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Differences between the statutory federal income tax rate and the effective tax rate
Provision for income taxes at statutory federal rate, Amount	$ 165,741	$ 181,474	$ 156,682
Provision for income taxes at statutory federal rate, Percentage	35.00%	35.00%	35.00%
State income taxes, net of federal income tax benefit, Amount	8,212	8,847	9,080
State income taxes, net of federal income tax benefit, Percentage	1.70%	1.70%	2.00%
Release of unrecognized tax benefit, amount	(6,509)
Release of unrecognized tax benefit, percentage	(1.30%)
Net income attributable to noncontrolling interests, Amount	(26,486)	(23,960)	(22,006)
Net income attributable to noncontrolling interests, Percentage	(5.60%)	(4.60%)	(4.90%)
Change in valuation allowance, Amount	0	(910)	1,113
Change in valuation allowance, Percentage	0.00%	(0.20%)	0.30%
Federal and state tax credits, Amount	(3,788)	(2,246)	(4,241)
Federal and state tax credits, Percentage	(0.80%)	(0.40%)	(0.90%)
Deferred tax revaluation, Amount			(2,996)
Deferred tax revaluation, Percentage			(0.70%)
Other, Amount	483	476	4,219
Other, Percentage	0.10%	0.10%	0.90%
Provision for income taxes and effective tax rate for income from continuing operations, Amount	$ 137,653	$ 163,681	$ 141,851
Provision for income taxes and effective tax rate for income from continuing operations, Percentage	29.10%	31.60%	31.70%

XML

Commitments and Contingencies (Tables)

12 Months Ended

Dec. 31, 2011

Commitments and Contingencies [Abstract]

Pre tax charges in connection with lawsuits

The Company incurred the following pre-tax charges in connection with the Tenet acquisition lawsuit, government investigations and shareholder lawsuits relating to possible improper claims submitted to Medicare and Medicaid (in thousands):

	Year Ended December 31,
	2011		2010		2009
Professional fees and other related costs	$	15,317	$	—	$	—

XML

Business and Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2011

Business and Summary of Significant Accounting Policies [Abstract]

Operating revenue, net of contractual allowances and discounts (but before the provision for bad debts),

Operating revenues, net of contractual allowances and discounts (but before the provision for bad debts), recognized during the years ended December 31, 2011, 2010 and 2009, is as follows (in thousands):

	Year Ended December 31,
	2011		2010		2009
Medicare	$	3,654,247	$	3,464,117	$	3,212,424
Medicaid		1,318,756		1,345,315		1,146,033
Managed Care and other third-party payors		7,014,519		6,359,322		6,071,023
Self-pay		1,638,646		1,454,520		1,312,974
Total	$	13,626,168	$	12,623,274	$	11,742,454

Accumulated Other Comprehensive Income (Loss)

	Change in Fair Value of Interest Rate Swaps			Change in Fair Value of Available for Sale Securities			Change in Unrecognized Pension Cost Components			Accumulated Other Comprehensive Income (Loss)
Balance as of December 31, 2009	$	(202,260	)	$	(1,180	)	$	(17,945	)	$	(221,385	)
2010 Activity, net of tax		(15,676	)		3,716			2,418			(9,542	)
Balance as of December 31, 2010		(217,936	)		2,536			(15,527	)		(230,927	)
2011 Activity, net of tax		55,145			(960	)		(7,737	)		46,448
Balance as of December 31, 2011	$	(162,791	)	$	1,576		$	(23,264	)	$	(184,479	)

XML

Business and Summary of Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2011

Business and Summary of Significant Accounting Policies [Abstract]

Use of Estimates

Use of Estimates. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates under different assumptions or conditions.

Principles of Consolidation

Principles of Consolidation. The consolidated financial statements include the accounts of the Parent, its subsidiaries, all of which are controlled by the Parent through majority voting control, and variable interest entities for which the Company is the primary beneficiary. All significant intercompany accounts, profits and transactions have been eliminated. Noncontrolling interests in less-than-wholly-owned consolidated subsidiaries of the Parent are presented as a component of total equity to distinguish between the interests of the Parent and the interests of the noncontrolling owners. Revenues, expenses and income from continuing operations from these subsidiaries are included in the consolidated amounts as presented on the consolidated statements of income, along with a net income measure that separately presents the amounts attributable to the controlling interests and the amounts attributable to the noncontrolling interests for each of the periods presented. Noncontrolling interests that are redeemable or may become redeemable at a fixed or determinable price at the option of the holder or upon the occurrence of an event outside of the control of the Company are presented in mezzanine equity on the consolidated balance sheets.

Cost of Revenue

Cost of Revenue. Substantially all of the Company’s operating expenses are “cost of revenue” items. Operating costs that could be classified as general and administrative by the Company would include the Company’s corporate office costs at its Franklin, Tennessee office, which were $183.4 million, $155.4 million and $157.9 million for the years ended December 31, 2011, 2010 and 2009, respectively. Included in these amounts is stock-based compensation of $42.5 million, $38.8 million and $44.5 million for the years ended December 31, 2011, 2010 and 2009, respectively.

Cash Equivalents

Cash Equivalents. The Company considers highly liquid investments with original maturities of three months or less to be cash equivalents.

Supplies

Supplies. Supplies, principally medical supplies, are stated at the lower of cost (first-in, first-out basis) or market.

Marketable Securities

Marketable Securities. The Company’s marketable securities are classified as trading or available-for-sale. Available-for-sale securities are carried at fair value as determined by quoted market prices, with unrealized gains and losses reported as a separate component of stockholders’ equity. Trading securities are reported at fair value with unrealized gains and losses included in earnings. Interest and dividends on securities classified as available-for-sale or trading are included in net operating revenues and were not material in all periods presented. Accumulated other comprehensive income (loss) included an unrealized loss of $1.0 million and an unrealized gain of $3.7 million at December 31, 2011 and 2010, respectively, related to these available-for-sale securities.

Property and Equipment

Property and Equipment. Property and equipment are recorded at cost. Depreciation is recognized using the straight-line method over the estimated useful lives of the land and improvements (2 to 15 years; weighted-average useful life is 14 years), buildings and improvements (5 to 40 years; weighted-average useful life is 24 years) and equipment and fixtures (4 to 18 years; weighted-average useful life is 8 years). Costs capitalized as construction in progress were $397.2 million and $221.2 million at December 31, 2011 and 2010, respectively. Expenditures for renovations and other significant improvements are capitalized; however, maintenance and repairs which do not improve or extend the useful lives of the respective assets are charged to operations as incurred. Interest capitalized related to construction in progress was $21.4 million, $11.9 million and $16.7 million for the years ended December 31, 2011, 2010 and 2009, respectively. Purchases of property and equipment accrued in accounts payable and not yet paid were $94.2 million and $59.5 million at December 31, 2011 and 2010, respectively.

The Company also leases certain facilities and equipment under capital leases (see Note 9). Such assets are amortized on a straight-line basis over the lesser of the term of the lease or the remaining useful lives of the applicable assets.

Goodwill

Goodwill. Goodwill represents the excess of the fair value of the consideration conveyed in the acquisition over the fair value of net assets acquired. Goodwill arising from business combinations is not amortized. Goodwill is required to be evaluated for impairment at the same time every year and when an event occurs or circumstances change such that it is reasonably possible that an impairment may exist. The Company has selected September 30 as its annual testing date.

Other Assets

Other Assets. Other assets primarily consist of costs associated with the issuance of debt, which are included in interest expense over the life of the related debt using the effective interest method, and costs to recruit physicians to the Company’s markets, which are deferred and expensed over the term of the respective physician recruitment contract, which is generally three years, and included in amortization expense. Other assets also include capitalized internal-use software costs, which are expensed over the expected useful life, which is generally three years for routine software and eight years for major software projects, and included in amortization expense.

Third-Party Reimbursement

Third-Party Reimbursement. Net patient service revenue is reported at the estimated net realizable amount from patients, third-party payors and others for services rendered. Net operating revenues include amounts estimated by management to be reimbursable by Medicare and Medicaid under prospective payment systems, provisions of cost-reimbursement and other payment methods. Approximately 36.5%, 38.1% and 37.2% of operating revenues, net of contractual allowances and discounts (but before the provision for bad debts) for the years ended December 31, 2011, 2010 and 2009, respectively, are related to services rendered to patients covered by the Medicare and Medicaid programs. Revenues from Medicare outlier payments are included in the amounts received from Medicare and were approximately 0.42%, 0.43% and 0.43% of operating revenues, net of contractual allowances and discounts (but before the provision for bad debts) for the years ended December 31, 2011, 2010 and 2009, respectively. In addition, the Company is reimbursed by non-governmental payors using a variety of payment methodologies. Amounts received by the Company for treatment of patients covered by such programs are generally less than the standard billing rates. The differences between the estimated program reimbursement rates and the standard billing rates are accounted for as contractual adjustments, which are deducted from gross revenues to arrive at net operating revenues. These net operating revenues are an estimate of the net realizable amount due from these payors. The process of estimating contractual allowances requires the Company to estimate the amount expected to be received based on payor contract provisions. The key assumption in this process is the estimated contractual reimbursement percentage, which is based on payor classification and historical paid claims data. Due to the complexities involved in these estimates, actual payments the Company receives could be different from the amounts it estimates and records. Final settlements under some of these programs are subject to adjustment based on administrative review and audit by third parties. Adjustments to previous program reimbursement estimates are accounted for as contractual allowance adjustments and reported in the periods that such adjustments become known. Contractual allowance adjustments related to final settlements and previous program reimbursement estimates impacted net operating revenues and net income by an insignificant amount in each of the years ended December 31, 2011, 2010 and 2009.

Amounts due to third-party payors were $66.0 million and $80.5 million as of December 31, 2011 and 2010, respectively, and are included in accrued liabilities-other in the accompanying consolidated balance sheets. Amounts due from third-party payors were $86.5 million and $118.7 million as of December 31, 2011 and 2010, respectively, and are included in other current assets in the accompanying consolidated balance sheets. Substantially all Medicare and Medicaid cost reports are final settled through 2006.

Net Operating Revenues

Net Operating Revenues. Net operating revenues are recorded net of provisions for contractual allowance of approximately $42.4 billion, $35.8 billion and $30.8 billion in 2011, 2010 and 2009, respectively. Net operating revenues are recognized when services are provided and are reported at the estimated net realizable amount from patients, third-party payors and others for services rendered. Also included in the provision for contractual allowance shown above is the value of administrative and other discounts provided to self-pay patients eliminated from net operating revenues which was $852.4 million, $689.4 million and $531.9 million for the years ended December 31, 2011, 2010 and 2009, respectively.

Charity Care

In the ordinary course of business, the Company renders services to patients who are financially unable to pay for hospital care. Also, included in the provision for contractual allowance shown above is the value (at the Company’s standard charges) of these services to patients who are unable to pay that is eliminated from net operating revenues when it is determined they qualify under the Company’s charity care policy. The value of these services was $651.1 million, $512.4 million and $451.0 million for the years ended December 31, 2011, 2010 and 2009, respectively. The estimated cost incurred by the Company to provide these services to patients who are unable to pay was approximately $125.7 million, $105.5 million and $104.0 million for the years ended December 31, 2011, 2010 and 2009, respectively. The estimated cost of these charity care services was determined using a ratio of cost to gross charges and applying that ratio to the gross charges associated with providing care to charity patients for the period. Gross charges associated with providing care to charity patients includes only the related charges for those patients who are financially unable to pay and qualify under the Company’s charity care policy and that do not otherwise qualify for reimbursement from a governmental program.

Allowance for Doubtful Accounts

Allowance for Doubtful Accounts. Accounts receivable are reduced by an allowance for amounts that could become uncollectible in the future. Substantially all of the Company’s receivables are related to providing healthcare services to its hospitals’ patients.

The Company estimates the allowance for doubtful accounts by reserving a percentage of all self-pay accounts receivable without regard to aging category, based on collection history, adjusted for expected recoveries and, if present, anticipated changes in trends. For all other non-self-pay payor categories, the Company reserves 100% of all accounts aging over 365 days from the date of discharge. The percentage used to reserve for all self-pay accounts is based on the Company’s collection history. The Company collects substantially all of its third-party insured receivables, which include receivables from governmental agencies.

Collections are impacted by the economic ability of patients to pay and the effectiveness of the Company’s collection efforts. Significant changes in payor mix, business office operations, economic conditions or trends in federal and state governmental healthcare coverage could affect the Company’s collection of accounts receivable and the estimates of the collectability of future accounts receivable. The process of estimating the allowance for doubtful accounts requires the Company to estimate the collectability of self-pay accounts receivable, which is primarily based on its collection history, adjusted for expected recoveries and, if available, anticipated changes in collection trends. The Company also continually reviews its overall reserve adequacy by monitoring historical cash collections as a percentage of trailing net revenue less provision for bad debts, as well as by analyzing current period net revenue and admissions by payor classification, aged accounts receivable by payor, days revenue outstanding, and the impact of recent acquisitions and dispositions.

Physician Income Guarantees

Physician Income Guarantees. The Company enters into physician recruiting agreements under which it supplements physician income to a minimum amount over a period of time, typically one year, while the physicians establish themselves in the community. As part of the agreements, the physicians are committed to practice in the community for a period of time, typically three years, which extends beyond their income guarantee period. The Company records an asset and liability for the estimated fair value of minimum revenue guarantees on new agreements. Adjustments to the ultimate value of the guarantee paid to physicians are recognized in the period that the change in estimate is identified. The Company amortizes an asset over the life of the agreement. As of December 31, 2011 and 2010, the unamortized portion of these physician income guarantees was $33.0 million and $37.2 million, respectively.

Concentration of Credit Risk

Concentrations of Credit Risk. The Company grants unsecured credit to its patients, most of whom reside in the service area of the Company’s facilities and are insured under third-party payor agreements. Because of the economic diversity of the Company’s facilities and non-governmental third-party payors, Medicare represents the only significant concentration of credit risk from payors. Accounts receivable, net of contractual allowances, from Medicare were $250.8 million and $270.8 million as of December 31, 2011 and 2010, respectively, representing 6.7% and 8.1% of consolidated net accounts receivable, before allowance for doubtful accounts, as of December 31, 2011 and 2010, respectively.

Professional Liability Claims

Professional Liability Claims. The Company accrues for estimated losses resulting from professional liability. The accrual, which includes an estimate for incurred but not reported claims, is based on historical loss patterns and actuarially-determined projections and is discounted to its net present value. To the extent that subsequent claims information varies from management’s estimates, the liability is adjusted when such information becomes available.

Accounting for the Impairment or Disposal of Long-Lived Assets

Accounting for the Impairment or Disposal of Long-Lived Assets. Whenever events or changes in circumstances indicate that the carrying values of certain long-lived assets may be impaired, the Company projects the undiscounted cash flows expected to be generated by these assets. If the projections indicate that the reported amounts are not expected to be recovered, such amounts are reduced to their estimated fair value based on a quoted market price, if available, or an estimate based on valuation techniques available in the circumstances.

Income Taxes

Income Taxes. The Company accounts for income taxes under the asset and liability method, in which deferred income tax assets and liabilities are recognized for the tax consequences of “temporary differences” by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying amounts and the tax bases of existing assets and liabilities. The effect on deferred taxes of a change in tax rates is recognized in the consolidated statement of income during the period in which the tax rate change becomes law.

Comprehensive Income (Loss)

Comprehensive Income (Loss). Comprehensive income (loss) is the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources.

Segment Reporting

Segment Reporting. A public company is required to report annual and interim financial and descriptive information about its reportable operating segments. Operating segments, as defined, are components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. Aggregation of similar operating segments into a single reportable operating segment is permitted if the businesses have similar economic characteristics and meet the criteria established by U.S. GAAP.

The Company operates in three distinct operating segments, represented by the hospital operations (which includes the Company’s acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services), the home care agencies operations (which provide in-home outpatient care), and the hospital management services business (which provides executive management and consulting services to non-affiliated general acute care hospitals). U.S. GAAP requires (1) that financial information be disclosed for operating segments that meet a 10% quantitative threshold of the consolidated totals of net revenue, profit or loss, or total assets; and (2) that the individual reportable segments disclosed contribute at least 75% of total consolidated net revenue. Based on these measures, only the hospital operations segment meets the criteria as a separate reportable segment. Financial information for the home care agencies and hospital management services segments do not meet the quantitative thresholds and are therefore combined with corporate into the all other reportable segment.

Derivative Instruments and Hedging Activities

Derivative Instruments and Hedging Activities. The Company records derivative instruments on the consolidated balance sheet as either an asset or liability measured at its fair value. Changes in a derivative’s fair value are recorded each period in earnings or other comprehensive income (“OCI”), depending on whether the derivative is designated and is effective as a hedged transaction, and on the type of hedge transaction. Changes in the fair value of derivative instruments recorded to OCI are reclassified to earnings in the period affected by the underlying hedged item. Any portion of the fair value of a derivative instrument determined to be ineffective under the standard is recognized in current earnings.

The Company has entered into several interest rate swap agreements. See Note 7 for further discussion about the swap transactions.

New Accounting Pronouncements

New Accounting Pronouncements. In August 2010, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2010-24, which provides clarification to companies in the healthcare industry on the accounting for professional liability insurance. This ASU states that receivables related to insurance recoveries should not be netted against the related claim liability and such claim liabilities should be determined without considering insurance recoveries. This ASU is effective for fiscal years beginning after December 15, 2010 and was adopted prospectively by the Company on January 1, 2011. The adoption of this ASU increased other current assets by $5.3 million, other assets, net by $36.9 million and long-term liabilities by $42.2 million in the consolidated balance sheet at December 31, 2011 and had no impact to the consolidated statement of income for the year ended December 31, 2011.

In June 2011, the FASB issued ASU 2011-05, which eliminates the option to present components of other comprehensive income as part of the statement of changes in stockholders’ equity. Instead, ASU 2011-05 requires that all nonowner changes in stockholders’ equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. In December 2011, the FASB issued ASU 2011-12, which amends ASU 2011-05 to defer the requirement to measure and present reclassification adjustments from accumulated other comprehensive income to net income by income statement line item in net income and also in other comprehensive income. ASU 2011-05, as amended by ASU 2011-12, is required to be applied retrospectively and is effective for fiscal years beginning after December 15, 2011, and has been reflected in the accompanying consolidated financial statements for all periods presented. The adoption of ASU 2011-05, as amended by ASU 2011-12, has not impacted the Company’s consolidated financial position, results of operations or cash flows.

In July 2011, the FASB issued ASU 2011-07, which requires healthcare organizations that perform services for patients for which the ultimate collection of all or a portion of the amounts billed or billable cannot be determined at the time services are rendered to present all bad debt expense associated with such patient service revenue as an offset to the patient service revenue line item in the statement of operations. The ASU also requires qualitative disclosures about the Company’s policy for recognizing revenue and bad debt expense for patient service transactions and quantitative information about the effects of changes in the assessment of collectability of patient service revenue. This ASU is effective for fiscal years beginning after December 15, 2011, and has been reflected in the accompanying consolidated financial statements for all periods presented.

In September 2011, the FASB issued ASU 2011-08, which simplifies how entities test goodwill for impairment. Previous guidance required an entity to perform a two-step goodwill impairment test at least annually by comparing the fair value of a reporting unit with its carrying amount, including goodwill, and recording an impairment loss if the fair value is less than the carrying amount. This ASU allows an entity to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If an entity determines after that assessment that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the two-step impairment test is not required. ASU 2011-08 is required to be applied to interim and annual goodwill impairment tests performed for fiscal years beginning after December 15, 2011, and will be adopted by the Company in 2012. The adoption of ASU 2011-08 is not expected to impact the Company’s consolidated financial position, results of operations or cash flows.

Fair Values of Financial Instruments

Cash and cash equivalents. The carrying amount approximates fair value due to the short-term maturity of these instruments (less than three months).

Available-for-sale securities. Estimated fair value is based on closing price as quoted in public markets.

Trading securities. Estimated fair value is based on closing price as quoted in public markets.

Credit Facility. Estimated fair value is based on information from the Company’s bankers regarding relevant pricing for trading activity among the Company’s lending institutions.

8 ⁷ /8% Senior Notes. Estimated fair value is based on the average bid and ask price as quoted by the bank who served as underwriters in the sale of these notes.

8% Senior notes. Estimated fair value is based on the average bid and ask price as quoted by the bank who served as underwriters in the sale of these notes.

Other debt. The carrying amount of all other debt approximates fair value due to the nature of these obligations.

Interest rate swaps. The fair value of interest rate swap agreements is the amount at which they could be settled, based on estimates calculated by the Company using a discounted cash flow analysis based on observable market inputs and validated by comparison to estimates obtained from the counterparty. The Company incorporates credit valuation adjustments (“CVAs”) to appropriately reflect both its own nonperformance or credit risk and the respective counterparty’s nonperformance or credit risk in the fair value measurements. In adjusting the fair value of its interest rate swap agreements for the effect of nonperformance or credit risk, the Company has considered the impact of any netting features included in the agreements.

The Company assesses the effectiveness of its hedge instruments on a quarterly basis. For the years ended December 31, 2011 and 2010, the Company completed an assessment of the cash flow hedge instruments and determined the hedges to be highly effective. The Company has also determined that the ineffective portion of the hedges do not have a material effect on the Company’s consolidated financial position, operations or cash flows. The counterparties to the interest rate swap agreements expose the Company to credit risk in the event of nonperformance. However, at December 31, 2011, each swap agreement entered into by the Company was in a net liability position so that the Company would be required to make the net settlement payments to the counterparties; the Company does not anticipate nonperformance by those counterparties. The Company does not hold or issue derivative financial instruments for trading purposes.

Condensed consolidating financial information

The accounting policies used in the preparation of this financial information are consistent with those elsewhere in the consolidated financial statements of the Company, except as noted below:

• Intercompany receivables and payables are presented gross in the supplemental consolidating balance sheets.

• Cash flows from intercompany transactions are presented in cash flows from financing activities, as changes in intercompany balances with affiliates, net.

• Income tax expense is allocated from the parent guarantor to the income producing operations (other guarantors and non-guarantors) and the issuer through stockholders’ equity. As this approach represents an allocation, the income tax expense allocation is considered non-cash for statement of cash flow purposes.

• Interest expense, net has been presented to reflect net interest expense and interest income from outstanding long-term debt and intercompany balances.

The Company’s intercompany activity consists primarily of daily cash transfers for purposes of cash management, the allocation of certain expenses and expenditures paid for by the parent on behalf of its subsidiaries, and the push down of investment in its subsidiaries. The Company’s subsidiaries generally do not purchase services from one another; thus, the intercompany transactions do not represent revenue generating transactions. All intercompany transactions eliminate in consolidation.

From time to time, the Company sells and/or repurchases noncontrolling interests in consolidated subsidiaries, which may change subsidiaries between guarantors and non-guarantors. Amounts for prior periods are restated to reflect the status of guarantors or non-guarantors as of December 31, 2011.

XML

Commitments and Contingencies (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011
Pre tax charges in connection with lawsuits
Professional fees and other related costs	$ 15,317

XML

Acquisitions and Divestitures (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Allocation of Purchase Price for business acquisition transactions
Current assets	$ 26,017	$ 46,842
Property and equipment	280,639	169,209
Goodwill	73,923	10,537
Intangible assets	2,260	1,730
Other long-term assets	3,497
Liabilities	28,089	51,124
Summary of business acquisition operation
Pro forma net operating revenues	12,180,247	11,792,639
Pro forma net income	$ 173,697	$ 259,978
Pro forma net income per share:
Basic	$ 1.93	$ 2.83
Diluted	$ 1.92	$ 2.80

XML

Quarterly Financial Data (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2011

Quarterly Financial Data (Unaudited) [Abstract]

Quarterly Financial Data (Unaudited)

	Quarter
	1st			2nd			3rd			4th			Total
	(in thousands, except share and per share data)
Year ended December 31, 2011:
Net operating revenues(1)	$	2,954,083		$	3,000,827		$	2,945,477		$	3,005,825		$	11,906,212
Income from continuing operations before income taxes		135,697			137,695			132,517			67,638			473,547
Income from continuing operations		91,605			92,874			95,800			55,615			335,894
Loss from discontinued operations		(13,280	)		(39,327	)		(3,169	)		(2,495	)		(58,271	)
Net income attributable to Community Health Systems, Inc	$	61,324		$	35,389		$	74,304		$	30,931		$	201,948
Basic earnings per share attributable to Community Health Systems, Inc. common stockholders(2):
Continuing operations	$	0.82		$	0.82		$	0.87		$	0.38		$	2.89
Discontinued operations		(0.15	)		(0.43	)		(0.04	)		(0.03	)		(0.65	)
Net income	$	0.67		$	0.39		$	0.83		$	0.35		$	2.24
Diluted earnings per share attributable to Community Health Systems, Inc. common stockholders(2):
Continuing operations	$	0.81		$	0.81		$	0.86		$	0.38		$	2.87
Discontinued operations		(0.14	)		(0.43	)		(0.04	)		(0.03	)		(0.64	)
Net income	$	0.67		$	0.39		$	0.83		$	0.35		$	2.23
Weighted-average number of shares:
Basic		91,008,405			91,130,672			89,412,310			88,344,566			89,966,933
Diluted		92,136,819			91,783,725			89,857,583			88,913,813			90,666,348
Year ended December 31, 2010:
Net operating revenues	$	2,702,111		$	2,713,644		$	2,772,311		$	2,904,356		$	11,092,422
Income from continuing operations before taxes		123,906			131,140			131,328			132,520			518,894
Income from continuing operations		84,357			88,379			88,009			94,468			355,213
Gain (loss) from discontinued operations		639			(2,037	)		(3,155	)		(2,219	)		(6,772	)
Net income attributable to Community Health Systems, Inc	$	70,007		$	70,065		$	70,401		$	69,510		$	279,983
Basic earnings per share attributable to Community Health Systems, Inc. common stockholders(2):
Continuing operations	$	0.76		$	0.77		$	0.80		$	0.79		$	3.13
Discontinued operations		0.01			(0.02	)		(0.03	)		(0.02	)		(0.07	)
Net income	$	0.76		$	0.75		$	0.77		$	0.77		$	3.05
Diluted earnings per share attributable to Community Health Systems, Inc. common stockholders(2):
Continuing operations	$	0.75		$	0.76		$	0.80		$	0.78		$	3.08
Discontinued operations		0.01			(0.02	)		(0.03	)		(0.02	)		(0.07	)
Net income	$	0.75		$	0.74		$	0.76		$	0.76		$	3.01
Weighted-average number of shares:
Basic		91,615,275			93,358,771			91,484,466			90,422,331			91,718,791
Diluted		92,836,451			94,711,919			92,462,702			91,778,801			92,946,048

(1) Net operating revenues for the quarter ended September 30, 2011 have been restated to reflect the reclassification of electronic health records incentive reimbursement, which was changed during the fourth quarter of 2011 as a reduction of operating expenses. This reclassification decreased net operating revenues and operating expenses by $40.2 million, and had no impact on income from continuing operations or net income as previously reported. Management does not believe this reclassification is material.

(2) Total per share amounts may not add due to rounding.

XML

Accounting for Stock-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2011

Accounting for Stock-Based Compensation [Abstract]

Impact of Total Compensation Expense

The following table reflects the impact of total compensation expense related to stock-based equity plans on the reported operating results for the respective periods (in thousands):

	Year Ended December 31,
	2011			2010			2009
Effect on income from continuing operations before income taxes	$	(42,542	)	$	(38,779	)	$	(44,501	)
Effect on net income	$	(27,014	)	$	(24,625	)	$	(26,986	)

Fair value of stock options

The fair value of stock options was estimated using the Black-Scholes option pricing model with the following assumptions during the years ended December 31, 2011, 2010 and 2009:

	Year Ended December 31,
	2011			2010			2009
Expected volatility		33.8	%		33.7	%		40.7	%
Expected dividends		0			0			0
Expected term		4 years			3.1 years			4 years
Risk-free interest rate		1.63	%		1.41	%		1.64	%

Options outstanding and exercisable

	Shares			Weighted - Average Exercise Price		Weighted - Average Remaining Contractual Term		Aggregate Intrinsic Value as of December 31, 2011
Outstanding at December 31, 2008		8,764,084		$	30.97
Granted		1,313,000			19.43
Exercised		(680,898	)		18.74
Forfeited and cancelled		(442,105	)		31.27
Outstanding at December 31, 2009		8,954,081			30.19
Granted		1,447,500			33.89
Exercised		(2,194,862	)		25.88
Forfeited and cancelled		(372,387	)		29.80
Outstanding at December 31, 2010		7,834,332			32.08
Granted		1,505,000			35.87
Exercised		(623,341	)		30.34
Forfeited and cancelled		(326,849	)		33.69
Outstanding at December 31, 2011		8,389,142		$	32.83		5.3 years	$	120
Exercisable at December 31, 2011		5,884,262		$	32.74		3.9 years	$	74

Restricted stock outstanding

Restricted stock outstanding under the 2000 Plan and the 2009 Plan as of December 31, 2011, and changes during each of the years in the three-year period ended December 31, 2011 was as follows:

	Shares			Weighted - Average Grant Date Fair Value
Unvested at December 31, 2008		1,684,207		$	35.57
Granted		1,188,814			18.45
Vested		(965,478	)		37.08
Forfeited		(10,002	)		32.52
Unvested at December 31, 2009		1,897,541			24.09
Granted		1,099,000			33.83
Vested		(860,749	)		27.04
Forfeited		(10,501	)		27.84
Unvested at December 31, 2010		2,125,291			27.92
Granted		1,109,949			37.57
Vested		(1,009,959	)		27.40
Forfeited		(17,669	)		35.68
Unvested at December 31, 2011		2,207,612			32.95

Phantom stock and restricted stock

Phantom stock and RSUs outstanding as of December 31, 2011, and changes during each of the years in the three-year period ended December 31, 2011 were as follows:

	Shares			Weighted - Average Grant Date Fair Value
Unvested at December 31, 2008		—		$	—
Phantom Stock Granted February 25, 2009		42,906			18.18
RSUs Granted May 19, 2009		7,151			25.27
Vested		—			—
Forfeited		—			—
Unvested at December 31, 2009		50,057			19.19
RSUs Granted February 24, 2010		24,780			33.90
Vested		(21,449	)		18.97
Forfeited		—			—
Unvested at December 31, 2010		53,388			26.11
RSUs Granted February 23, 2011		22,128			37.96
Vested		(22,560	)		24.68
Forfeited		—			—
Unvested at December 31, 2011		52,956			31.67

Deferred Director's Fee

	Year Ended December 31,
	2011		2010		2009
Directors’ fees earned and deferred into plan	$	220	$	180	$	80
Share equivalent units		9,974		5,207		3,284

XML

Acquisitions and Divestitures (Tables)

12 Months Ended

Dec. 31, 2011

Acquisitions and Divestitures [Abstract]

Allocation of Purchase Price for business acquisition transactions

The table below summarizes the allocations of the purchase price (including assumed liabilities) for the above acquisition transactions (in thousands):

	2011		2010
Current assets	$	26,017	$	46,842
Property and equipment		280,639		169,209
Goodwill		73,923		10,537
Intangible assets		2,260		1,730
Other long-term assets		3,497		—
Liabilities		28,089		51,124

Summary of business acquisition operation

	Year Ended December 31,
	2011		2010
	(Unaudited)
Pro forma net operating revenues	$	12,180,247	$	11,792,639
Pro forma net income		173,697		259,978
Pro forma net income per share:
Basic	$	1.93	$	2.83
Diluted	$	1.92	$	2.80

Net operating revenues and income from discontinued operations

Net operating revenues and income from discontinued operations for the respective periods are as follows (in thousands):

	Year Ended December 31,
	2011			2010			2009
Net operating revenues	$	144,546		$	305,562		$	348,796
(Loss) income from operations of entities sold before income taxes		(12,390	)		(10,460	)		1,492
Impairment of hospitals sold		(51,695	)		—			—
Loss on sale, net		(4,301	)		—			(644	)
(Loss) income from discontinued operations before income taxes		(68,386	)		(10,460	)		848
(Benefit from) provision for income taxes		(10,115	)		(3,688	)		282
(Loss) income from discontinued operations, net of taxes	$	(58,271	)	$	(6,772	)	$	566

XML

Consolidated Statements of Stockholders' Equity (Parenthetical) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Tax provision (benefit) related to change in fair value of interest rate swap	$ 31,154	$ (8,818)	$ 42,876
Tax provision (benefit) related to amortization and recognition of unrecognized pension cost components	(4,754)	1,142	(3,262)
Accumulated Other Comprehensive Income (Loss)
Tax provision (benefit) related to change in fair value of interest rate swap	31,154	(8,818)	42,876
Tax provision (benefit) related to amortization and recognition of unrecognized pension cost components	$ (4,754)	$ 1,142	$ (3,262)

XML

Goodwill and Other Intangibles Assets (Tables)

12 Months Ended

Dec. 31, 2011

Goodwill and Other Intangible Assets [Abstract]

Carrying amount of goodwill

The changes in the carrying amount of goodwill are as follows (in thousands):

	Year Ended December 31,
	2011		2010
Balance, beginning of year	$	4,150,247	$	4,157,927
Goodwill acquired as part of acquisitions during the year		114,473		45,975
Consideration adjustments and purchase price allocation adjustments for prior year’s acquisitions		125		(3,997	)
Goodwill related to the hospital operations reporting unit assigned to the disposal group classified as held for sale in 2011		—		(49,658	)
Balance, end of year	$	4,264,845	$	4,150,247

XML

Employee Benefit Plans (Details 1) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010
Pension Plan [Member]
Summary of consolidated balance sheets
Noncurrent asset	$ 0	$ 0
Current liability	0	0
Noncurrent liability	(16,060)	(5,328)
Net amount recognized in the consolidated balance sheets	(16,060)	(5,328)
SERP [Member]
Summary of consolidated balance sheets
Noncurrent asset	0	0
Current liability	(1,191)	(1,546)
Noncurrent liability	(84,959)	(72,294)
Net amount recognized in the consolidated balance sheets	$ (86,150)	$ (73,840)

XML

Earnings per Share (Tables)

12 Months Ended

Dec. 31, 2011

Earnings per Share [Abstract]

Components for computation of basic and diluted earnings per share

The following table sets forth the components of the numerator and denominator for the computation of basic and diluted earnings per share for income from continuing operations, discontinued operations and net income attributable to Community Health Systems, Inc. common stockholders (in thousands, except share data):

	Year Ended December 31,
	2011			2010			2009
Numerator:
Income from continuing operations, net of taxes	$	335,894		$	355,213		$	305,811
Less: Income from continuing operations attributable to noncontrolling interests, net of taxes		75,675			68,577			62,948
Income from continuing operations attributable to Community Health
Systems, Inc. common stockholders — basic and diluted	$	260,219		$	286,636		$	242,863
(Loss) income from discontinued operations, net of taxes	$	(58,271	)	$	(6,772	)	$	566
Less: (Loss) income from discontinued operations attributable to noncontrolling interests, net of taxes		—			(119	)		279
Loss from discontinued operations attributable to Community Health Systems, Inc. common stockholders - basic and diluted	$	(58,271	)	$	(6,653	)	$	287
Denominator:
Weighted-average number of shares outstanding – basic		89,966,933			91,718,791			90,614,886
Effect of dilutive securities:
Restricted stock awards		327,652			542,488			469,134
Employee stock options		361,554			667,606			422,637
Other equity-based awards		10,209			17,163			10,617
Weighted-average number of shares outstanding – diluted		90,666,348			92,946,048			91,517,274

Dilutive securities outstanding not included in the computation of earnings per share because their effect is antidilutive

Dilutive securities outstanding not included in the computation of earnings per share because their effect is antidilutive:
Employee stock options	6,432,281	4,882,338	6,820,393

XML

Accounting For Stock Based Compensation (Details 4) (USD $)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]
Beginning Balance, Shares	2,125,291	1,897,541	1,684,207
Granted, Shares	1,109,949	1,099,000	1,188,814
Vested, Shares	(1,009,959)	(860,749)	(965,478)
Forfeited, Shares	17,669	10,501	10,002
Ending Balance, Shares	2,207,612	2,125,291	1,897,541
Beginning of Period, Weighted Average Grant Date Fair Value	$ 27.92	$ 24.09	$ 35.57
Granted, Weighted Average Grant Date Fair Value	$ 37.57	$ 33.83	$ 18.45
Vested, Weighted Average Grant Date Fair Value	$ 27.40	$ 27.04	$ 37.08
Forfeited, Weighted Average Grant Date Fair Value	$ 35.68	$ 27.84	$ 32.52
End of Period, Weighted Average Grant Date Fair Value	$ 32.95	$ 27.92	$ 24.09
Phantom Stock and Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]
Beginning Balance, Shares	53,388	50,057
Vested, Shares	(22,560)	(21,449)
Forfeited, Shares
Ending Balance, Shares	52,956	53,388	50,057
Beginning of Period, Weighted Average Grant Date Fair Value	$ 26.11	$ 19.19
Vested, Weighted Average Grant Date Fair Value	$ 24.68	$ 18.97
Forfeited, Weighted Average Grant Date Fair Value
End of Period, Weighted Average Grant Date Fair Value	$ 31.67	$ 26.11	$ 19.19
Phantom stock [Member] | Phantom Stock and Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]
Granted, Shares			42,906
Granted, Weighted Average Grant Date Fair Value			$ 18.18
Restricted Stock Units [Member] | Phantom Stock and Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]
Granted, Shares	22,128	24,780	7,151
Granted, Weighted Average Grant Date Fair Value	$ 37.96	$ 33.90	$ 25.27

XML

Long-Term Debt (Details Textual 1) (USD $)		12 Months Ended				12 Months Ended
	Dec. 31, 2011	Dec. 31, 2011 Community Health System [Member]	Dec. 31, 2011 Interest rate swaps [Member] Agreement	Dec. 31, 2011 Letter of Credit [Member]	Dec. 31, 2010 Letter of Credit [Member]	Dec. 31, 2011 Revolving Credit Facility [Member] Community Health System [Member]	Dec. 31, 2011 Line of Credit [Member]	Dec. 31, 2011 Line of Credit [Member] Community Health System [Member]
Additional Long-Term Debt (Textual) [Abstract]
Revolving credit facility						$ 750,000,000
Maturity period of revolving credit facility						6 years
Debt instrument unused borrowing capacity amount								750,000,000
Amount of borrowing capacity from receivable transactions including securitizations								300,000,000
Weighted-average interest rate under the Credit Facility, excluding swaps								3.50%
Letters of Credit outstanding				37,700,000	81,900,000		37,700,000
Line of Credit Facility, Amount Outstanding	30,000,000
Extended period of amendment for existing Credit Facility		2 years 6 months
Maturity date of existing term loans under Credit Facility						Jan. 25, 2017
Amount related to separate interest swap agreements with aggregate notional amount			$ 4,900,000,000
Number of separate interest rate swap agreement			34

XML

Consolidated Statements of Income (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2011		Dec. 31, 2010		Dec. 31, 2009
Consolidated Statements of Income [Abstract]
Operating revenues (net of contractual allowances and discounts)									$ 13,626,168		$ 12,623,274		$ 11,742,454
Provision for bad debts									1,719,956		1,530,852		1,408,953
Net operating revenues	3,005,825	2,945,477	3,000,827	2,954,083	2,904,356	2,772,311	2,713,644	2,702,111	11,906,212		11,092,422		10,333,501
Operating costs and expenses:
Salaries and benefits									5,577,925		5,093,767		4,701,231
Supplies									1,834,106		1,738,088		1,649,779
Other operating expenses									2,515,638		2,296,063		2,129,081
Electronic health records incentive reimbursement									(63,397)
Rent									254,781		248,463		237,536
Depreciation and amortization									652,674		594,997		551,043
Total operating costs and expenses									10,771,727		9,971,378		9,268,670
Income from operations									1,134,485		1,121,044		1,064,831
Interest expense, net of interest income of $4,650, $1,757 and $3,561 in 2011, 2010, and 2009, respectively									644,410		647,593		643,608
Loss (gain) from early extinguishment of debt									66,019				(2,385)
Equity in earnings of unconsolidated affiliates									(49,491)		(45,443)		(36,531)
Impairment of long-lived and other assets									0				12,477
Income from continuing operations before income taxes	67,638	132,517	137,695	135,697	132,520	131,328	131,140	123,906	473,547		518,894		447,662
Provision for income taxes									137,653		163,681		141,851
Income from continuing operations	55,615	95,800	92,874	91,605	94,468	88,009	88,379	84,357	335,894		355,213		305,811
Discontinued operations, net of taxes:
(Loss) income from operations of entities sold									(7,769)		(6,772)		971
Impairment of hospitals sold									(47,930)
Loss on sale, net									(2,572)				(405)
(Loss) income from discontinued operations, net of taxes	(2,495)	(3,169)	(39,327)	(13,280)	(2,219)	(3,155)	(2,037)	639	(58,271)		(6,772)		566
Net income									277,623		348,441		306,377
Less: Net income attributable to noncontrolling interests									75,675		68,458		63,227
Net income attributable to Community Health Systems, Inc.	$ 30,931	$ 74,304	$ 35,389	$ 61,324	$ 69,510	$ 70,401	$ 70,065	$ 70,007	$ 201,948		$ 279,983		$ 243,150
Basic earnings per share attributable to Community Health Systems, Inc. common stockholders:
Continuing operations	$ 0.38	$ 0.87	$ 0.82	$ 0.82	$ 0.79	$ 0.80	$ 0.77	$ 0.76	$ 2.89	[1]	$ 3.13	[1]	$ 2.68	[1]
Discontinued operations	$ (0.03)	$ (0.04)	$ (0.43)	$ (0.15)	$ (0.02)	$ (0.03)	$ (0.02)	$ 0.01	$ (0.65)	[1]	$ (0.07)	[1]
Net income	$ 0.35	$ 0.83	$ 0.39	$ 0.67	$ 0.77	$ 0.77	$ 0.75	$ 0.76	$ 2.24	[1]	$ 3.05	[1]	$ 2.68	[1]
Diluted earnings per share attributable to Community Health Systems, Inc. common stockholders:
Continuing operations	$ 0.38	$ 0.86	$ 0.81	$ 0.81	$ 0.78	$ 0.80	$ 0.76	$ 0.75	$ 2.87	[1]	$ 3.08	[1]	$ 2.65	[1]
Discontinued operations	$ (0.03)	$ (0.04)	$ (0.43)	$ (0.14)	$ (0.02)	$ (0.03)	$ (0.02)	$ 0.01	$ (0.64)	[1]	$ (0.07)	[1]
Net income	$ 0.35	$ 0.83	$ 0.39	$ 0.67	$ 0.76	$ 0.76	$ 0.74	$ 0.75	$ 2.23	[1]	$ 3.01	[1]	$ 2.66	[1]
Weighted-average number of shares outstanding:
Basic	88,344,566	89,412,310	91,130,672	91,008,405	90,422,331	91,484,466	93,358,771	91,615,275	89,966,933		91,718,791		90,614,886
Diluted	88,913,813	89,857,583	91,783,725	92,136,819	91,778,801	92,462,702	94,711,919	92,836,451	90,666,348		92,946,048		91,517,274

[1] Total per share amounts may not add due to rounding.

XML

Supplemental Condensed Consolidating Financial Information (Tables)

12 Months Ended

Dec. 31, 2011

Supplemental Financial Information [Abstract]

Condensed Consolidating Statement of Income

Condensed Consolidating Statement of Income

Year Ended December 31, 2011

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
	(In thousands)
Operating revenues (net of contractual allowances and discounts)	$	—		$	—		$	7,904,497		$	5,721,671		$	—		$	13,626,168
Provision for bad debts		—			—			1,003,252			716,704			—			1,719,956
Net operating revenues		—			—			6,901,245			5,004,967			—			11,906,212
Operating costs and expenses:
Salaries and benefits		—			—			3,065,753			2,512,172			—			5,577,925
Supplies		—			—			1,058,807			775,299			—			1,834,106
Other operating expenses		—			—			1,486,113			1,029,525			—			2,515,638
Electronic health records incentive reimbursement		—			—			(42,312	)		(21,085	)		—			(63,397	)
Rent		—			—			124,823			129,958			—			254,781
Depreciation and amortization		—			—			393,549			259,125			—			652,674
Total operating costs and expenses		—			—			6,086,733			4,684,994			—			10,771,727
Income from operations		—			—			814,512			319,973			—			1,134,485
Interest expense, net		—			87,095			495,258			62,057			—			644,410
Loss (gain) from early extinguishment of debt		—			66,019			—			—			—			66,019
Equity in earnings of unconsolidated affiliates		(201,948	)		(275,175	)		(101,101	)		—			528,733			(49,491	)
Income from continuing operations before income taxes		201,948			122,061			420,355			257,916			(528,733	)		473,547
Provision for (benefit from) income taxes		—			(79,887	)		151,748			65,792			—			137,653
Income from continuing operations		201,948			201,948			268,607			192,124			(528,733	)		335,894
Discontinued operations, net of taxes:
(Loss) income from operations of entities sold		—			—			—			(7,769	)		—			(7,769	)
Impairment of hospitals sold		—			—			—			(47,930	)		—			(47,930	)
Loss on sale, net		—			—			—			(2,572	)		—			(2,572	)
(Loss) income from discontinued operations, net of taxes		—			—			—			(58,271	)		—			(58,271	)
Net income		201,948			201,948			268,607			133,853			(528,733	)		277,623
Less: Net income attributable to noncontrolling interests		—			—			—			75,675			—			75,675
Net income attributable to Community Health Systems, Inc.	$	201,948		$	201,948		$	268,607		$	58,178		$	(528,733	)	$	201,948

Condensed Consolidating Statement of Income Year Ended December 31, 2010
	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
	(In thousands)
Operating revenues (net of contractual allowances and discounts)	$	—		$	—		$	7,271,078		$	5,352,196		$	—		$	12,623,274
Provision for bad debts		—			—			901,580			629,272			—			1,530,852
Net operating revenues		—			—			6,369,498			4,722,924			—			11,092,422
Operating costs and expenses:
Salaries and benefits		—			—			2,792,543			2,301,224			—			5,093,767
Supplies		—			—			989,241			748,847			—			1,738,088
Other operating expenses		—			—			1,295,527			1,000,536			—			2,296,063
Electronic health records incentive reimbursement		—			—			—			—			—			—
Rent		—			—			118,215			130,248			—			248,463
Depreciation and amortization		—			—			348,037			246,960			—			594,997
Total operating costs and expenses		—			—			5,543,563			4,427,815			—			9,971,378
Income from operations		—			—			825,935			295,109			—			1,121,044
Interest expense, net		—			113,464			477,418			56,711			—			647,593
Loss (gain) from early extinguishment of debt		—			—			—			—			—			—
Equity in earnings of unconsolidated affiliates		(279,983	)		(312,730	)		(142,174	)		—			689,444			(45,443	)
Income from continuing operations before income taxes		279,983			199,266			490,691			238,398			(689,444	)		518,894
Provision for (benefit from) income taxes		—			(80,717	)		180,574			63,824			—			163,681
Income from continuing operations		279,983			279,983			310,117			174,574			(689,444	)		355,213
Discontinued operations, net of taxes:
(Loss) income from operations of entities sold		—			—			—			(6,772	)		—			(6,772	)
Impairment of hospitals sold		—			—			—			—			—			—
Loss on sale, net		—			—			—			—			—			—
(Loss) income from discontinued operations, net of taxes		—			—			—			(6,772	)		—			(6,772	)
Net income		279,983			279,983			310,117			167,802			(689,444	)		348,441
Less: Net income attributable to noncontrolling interests		—			—			—			68,458			—			68,458
Net income attributable to Community Health Systems, Inc.	$	279,983		$	279,983		$	310,117		$	99,344		$	(689,444	)	$	279,983

Condensed Consolidating Statement of Income Year Ended December 31, 2009
	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
	(In thousands)
Operating revenues (net of contractual allowances and discounts)	$	—		$	—		$	6,763,647		$	4,978,807		$	—		$	11,742,454
Provision for bad debts		—			—			841,342			567,611			—			1,408,953
Net operating revenues		—			—			5,922,305			4,411,196			—			10,333,501
Operating costs and expenses:
Salaries and benefits		—			—			2,630,349			2,070,882			—			4,701,231
Supplies		—			—			933,730			716,049			—			1,649,779
Other operating expenses		—			—			1,169,896			959,185			—			2,129,081
Electronic health records incentive reimbursement		—			—			—			—			—			—
Rent		—			—			113,407			124,129			—			237,536
Depreciation and amortization		—			—			324,018			227,025			—			551,043
Total operating costs and expenses		—			—			5,171,400			4,097,270			—			9,268,670
Income from operations		—			—			750,905			313,926			—			1,064,831
Interest expense, net		—			110,507			479,458			53,643			—			643,608
Loss (gain) from early extinguishment of debt		—			(2,385	)		—			—			—			(2,385	)
Equity in earnings of unconsolidated affiliates		(243,150	)		(259,270	)		(157,491	)		—			623,380			(36,531	)
Impairment of long-lived and other assets		—			—			12,477			—			—			12,477
Income from continuing operations before income taxes		243,150			151,148			416,461			260,283			(623,380	)		447,662
Provision for (benefit from) income taxes		—			(92,002	)		159,921			73,932			—			141,851
Income from continuing operations		243,150			243,150			256,540			186,351			(623,380	)		305,811
Discontinued operations, net of taxes:
(Loss) income from operations of entities sold		—			—			(50	)		1,021			—			971
Impairment of hospitals sold		—			—			—			—			—			—
Loss on sale, net		—			—			—			(405	)		—			(405	)
(Loss) income from discontinued operations, net of taxes		—			—			(50	)		616			—			566
Net income		243,150			243,150			256,490			186,967			(623,380	)		306,377
Less: Net income attributable to noncontrolling interests		—			—			—			63,227			—			63,227
Net income attributable to Community Health Systems, Inc.	$	243,150		$	243,150		$	256,490		$	123,740		$	(623,380	)	$	243,150

Condensed Consolidating Statements of Comprehensive Income

Condensed Consolidating Statement of Comprehensive Income
Year Ended December 31, 2011
	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors		Eliminations			Consolidated
	(In thousands)
Net income	$	201,948		$	201,948		$	268,607		$	133,853	$	(528,733	)	$	277,623
Other comprehensive income, net of taxes
Net change in fair value of interest rate swaps		55,145			55,145			—			—		(55,145	)		55,145
Net change in fair value of available-for-sale securities		(960	)		(960	)		(960	)		—		1,920			(960	)
Amortization and recognition of unrecognized pension cost components		(7,737	)		(7,737	)		(7,737	)		—		15,474			(7,737	)
Other comprehensive income		46,448			46,448			(8,697	)		—		(37,751	)		46,448
Comprehensive income		248,396			248,396			259,910			133,853		(566,484	)		324,071
Less: Comprehensive income attributable to noncontrolling interests		—			—			—			75,675		—			75,675
Comprehensive income attributable to Community Health Systems, Inc.	$	248,396		$	248,396		$	259,910		$	58,178	$	(566,484	)	$	248,396

Condensed Consolidating Statement of Comprehensive Income
Year Ended December 31, 2010
	Parent Guarantor			Issuer			Other Guarantors		Non- Guarantors		Eliminations			Consolidated
	(In thousands)
Net income	$	279,983		$	279,983		$	310,117	$	167,802	$	(689,444	)	$	348,441
Other comprehensive income, net of taxes
Net change in fair value of interest rate swaps		(15,676	)		(15,676	)		—		—		15,676			(15,676	)
Net change in fair value of available-for-sale securities		3,716			3,716			3,716		—		(7,432	)		3,716
Amortization and recognition of unrecognized pension cost components		2,418			2,418			2,418		—		(4,836	)		2,418
Other comprehensive income		(9,542	)		(9,542	)		6,134		—		3,408			(9,542	)
Comprehensive income		270,441			270,441			316,251		167,802		(686,036	)		338,899
Less: Comprehensive income attributable to noncontrolling interests		—			—			—		68,458		—			68,458
Comprehensive income attributable to Community Health Systems, Inc.	$	270,441		$	270,441		$	316,251	$	99,344	$	(686,036	)	$	270,441

Condensed Consolidating Statement of Comprehensive Income
Year Ended December 31, 2009
	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors		Eliminations			Consolidated
	(In thousands)
Net income	$	243,150		$	243,150		$	256,490		$	186,967	$	(623,380	)	$	306,377
Other comprehensive income, net of taxes
Net change in fair value of interest rate swaps		76,225			76,225			—			—		(76,225	)		76,225
Net change in fair value of available-for-sale securities		412			412			412			—		(824	)		412
Amortization and recognition of unrecognized pension cost components		(2,447	)		(2,447	)		(2,447	)		—		4,894			(2,447	)
Other comprehensive income		74,190			74,190			(2,035	)		—		(72,155	)		74,190
Comprehensive income		317,340			317,340			254,455			186,967		(695,535	)		380,567
Less: Comprehensive income attributable to noncontrolling interests		—			—			—			63,227		—			63,227
Comprehensive income attributable to Community Health Systems, Inc.	$	317,340		$	317,340		$	254,455		$	123,740	$	(695,535	)	$	317,340

Condensed Consolidating Balance Sheet

Condensed Consolidating Balance Sheet

December 31, 2011

	Parent						Other			Non-
	Guarantor			Issuer			Guarantors			Guarantors		Eliminations			Consolidated
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	—		$	—		$	14,536		$	115,329	$	—		$	129,865
Patient accounts receivable, net of allowance for doubtful accounts		—			—			1,088,121			746,046		—			1,834,167
Supplies		—			—			215,203			131,408		—			346,611
Deferred income taxes		89,797			—			—			—		—			89,797
Prepaid expenses and taxes		101,389			117			83,983			28,513		—			214,002
Other current assets		—			10,235			141,192			80,220		—			231,647
Total current assets		191,186			10,352			1,543,035			1,101,516		—			2,846,089
Intercompany receivable		1,160,785			9,294,295			1,741,928			1,672,003		(13,869,011	)		—
Property and equipment, net		—			—			4,395,498			2,460,478		—			6,855,976
Goodwill		—			—			2,412,517			1,852,328		—			4,264,845
Other assets, net of accumulated amortization		—			99,521			523,645			618,764		—			1,241,930
Net investment in subsidiaries		1,758,458			6,413,757			2,450,625			—		(10,622,840	)		—
Total assets	$	3,110,429		$	15,817,925		$	13,067,248		$	7,705,089	$	(24,491,851	)	$	15,208,840
LIABILITIES AND EQUITY
Current liabilities:
Current maturities of long-term debt	$	—		$	49,954		$	9,625		$	4,127	$	—		$	63,706
Accounts payable		—			345			511,145			237,507		—			748,997
Deferred income taxes		—			—			—			—		—			—
Accrued interest		—			109,984			131			6		—			110,121
Accrued liabilities		7,580			567			662,746			317,422		—			988,315
Total current liabilities		7,580			160,850			1,183,647			559,062		—			1,911,139
Long-term debt		—			8,707,805			49,184			25,809		—			8,782,798
Intercompany payable		—			4,936,587			9,290,461			6,229,469		(20,456,517	)		—
Deferred income taxes		704,725			—			—			—		—			704,725
Other long-term liabilities		1,028			254,228			433,119			261,615		—			949,990
Total liabilities		713,333			14,059,470			10,956,411			7,075,955		(20,456,517	)		12,348,652
Redeemable noncontrolling interests in equity of consolidated subsidiaries		—			—			—			395,743		—			395,743
Equity:
Community Health Systems, Inc. stockholders’ equity:
Preferred stock		—			—			—			—		—			—
Common stock		915			—			1			2		(3	)		915
Additional paid-in capital		1,086,008			701,399			769,841			59,941		(1,531,181	)		1,086,008
Treasury stock, at cost		(6,678	)		—			—			—		—			(6,678	)
Accumulated other comprehensive (loss) income		(184,479	)		(184,479	)		(21,687	)		—		206,166			(184,479	)
Retained earnings		1,501,330			1,241,535			1,362,682			106,099		(2,710,316	)		1,501,330
Total Community Health Systems, Inc. stockholders’ equity		2,397,096			1,758,455			2,110,837			166,042		(4,035,334	)		2,397,096
Noncontrolling interests in equity of consolidated subsidiaries		—			—			—			67,349		—			67,349
Total equity		2,397,096			1,758,455			2,110,837			233,391		(4,035,334	)		2,464,445
Total liabilities and equity	$	3,110,429		$	15,817,925		$	13,067,248		$	7,705,089	$	(24,491,851	)	$	15,208,840

Condensed Consolidating Balance Sheet

December 31, 2010

	Parent						Other			Non-
	Guarantor			Issuer			Guarantors			Guarantors		Eliminations			Consolidated
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	—		$	—		$	213,117		$	86,052	$	—		$	299,169
Patient accounts receivable, net of allowance for doubtful accounts		—			—			969,928			744,614		—			1,714,542
Supplies		—			—			193,902			135,212		—			329,114
Deferred income taxes		115,819			—			—			—		—			115,819
Prepaid expenses and taxes		118,464			116			88,647			11,991		—			219,218
Other current assets		—			41			137,113			56,177		—			193,331
Total current assets		234,283			157			1,602,707			1,034,046		—			2,871,193
Intercompany receivable		1,079,294			9,002,158			1,424,734			1,370,494		(12,876,680	)		—
Property and equipment, net		—			—			3,889,651			2,434,786		—			6,324,437
Goodwill		—			—			2,331,452			1,818,795		—			4,150,247
Other assets, net of accumulated amortization		—			131,352			438,131			782,763		—			1,352,246
Net investment in subsidiaries		1,510,063			5,267,860			1,944,795			—		(8,722,718	)		—
Total assets	$	2,823,640		$	14,401,527		$	11,631,470		$	7,440,884	$	(21,599,398	)	$	14,698,123
LIABILITIES AND EQUITY
Current liabilities:
Current maturities of long-term debt	$	—		$	49,953		$	11,070		$	2,116	$	—		$	63,139
Accounts payable		—			—			361,088			165,250		—			526,338
Deferred income taxes		8,882			—			—			—		—			8,882
Accrued interest		—			146,297			116			2		—			146,415
Accrued liabilities		7,595			567			567,101			322,003		—			897,266
Total current liabilities		16,477			196,817			939,375			489,371		—			1,642,040
Long-term debt		—			8,734,473			44,831			29,078		—			8,808,382
Intercompany payable		—			3,619,651			8,424,670			6,086,227		(18,130,548	)		—
Deferred income taxes		608,177			—			—			—		—			608,177
Other long-term liabilities		9,522			340,526			371,667			279,960		—			1,001,675
Total liabilities		634,176			12,891,467			9,780,543			6,884,636		(18,130,548	)		12,060,274
Redeemable noncontrolling interests in equity of consolidated subsidiaries		—			—			—			387,472		—			387,472
Equity:
Community Health Systems, Inc. stockholders’ equity:
Preferred stock		—			—			—			—		—			—
Common stock		936			—			1			2		(3	)		936
Additional paid-in capital		1,126,751			640,683			685,921			39,693		(1,366,297	)		1,126,751
Treasury stock, at cost		(6,678	)		—			—			—		—			(6,678	)
Accumulated other comprehensive (loss) income		(230,927	)		(230,927	)		(12,990	)		—		243,917			(230,927	)
Retained earnings		1,299,382			1,100,304			1,177,995			68,169		(2,346,468	)		1,299,382
Total Community Health Systems, Inc. stockholders’ equity		2,189,464			1,510,060			1,850,927			107,864		(3,468,851	)		2,189,464
Noncontrolling interests in equity of consolidated subsidiaries		—			—			—			60,913		—			60,913
Total equity		2,189,464			1,510,060			1,850,927			168,777		(3,468,851	)		2,250,377
Total liabilities and equity	$	2,823,640		$	14,401,527		$	11,631,470		$	7,440,885	$	(21,599,399	)	$	14,698,123

Condensed Consolidating Statement of Cash Flows

Condensed Consolidating Statement of Cash Flows

Year Ended December 31, 2011

	Parent						Other			Non-
	Guarantor			Issuer			Guarantors			Guarantors			Eliminations			Consolidated
	(In thousands)
Net cash (used in) provided by operating activities	$	(41,780	)	$	(111,011	)	$	840,582		$	574,117		$	—		$	1,261,908
Cash flows from investing activities:
Acquisitions of facilities and other related equipment		—			—			(370,243	)		(45,117	)		—			(415,360	)
Purchases of property and equipment		—			—			(440,754	)		(335,959	)		—			(776,713	)
Proceeds from disposition of hospitals and other ancillary operations		—			—			—			173,387			—			173,387
Proceeds from sale of property and equipment		—			—			2,283			8,877			—			11,160
Increase in other investments		—			(10,000	)		(129,852	)		(48,397	)		—			(188,249	)
Net cash used in investing activities		—			(10,000	)		(938,566	)		(247,209	)		—			(1,195,775	)
Cash flows from financing activities:
Proceeds from exercise of stock options		18,910			—			—			—			—			18,910
Repurchase of restricted stock shares for payroll tax withholding requirements		(13,311	)		—			—			—			—			(13,311	)
Deferred financing costs		—			(19,352	)		—			—			—			(19,352	)
Excess tax benefit (income tax payable increase) relating to stock-based compensation		5,290			—			—			—			—			5,290
Stock buy-back		(85,790	)		—			—			—			—			(85,790	)
Proceeds from noncontrolling investors in joint ventures		—			—			—			1,229			—			1,229
Redemption of noncontrolling investments in joint ventures		—			—			—			(13,022	)		—			(13,022	)
Distributions to noncontrolling investors in joint ventures		—			—			—			(56,094	)		—			(56,094	)
Changes in intercompany balances with affiliates, net		116,681			209,066			(95,945	)		(229,802	)		—			—
Borrowings under credit agreement		—			560,000			18,236			2,145			(2,145	)		578,236
Issuance of long-term debt		—			1,000,000			—			—			—			1,000,000
Repayments of long-term indebtedness		—			(1,628,703	)		(22,888	)		(2,087	)		2,145			(1,651,533	)
Net cash provided by (used in) financing activities		41,780			121,011			(100,597	)		(297,631	)		—			(235,437	)
Net change in cash and cash equivalents		—			—			(198,581	)		29,277			—			(169,304	)
Cash and cash equivalents at beginning of period		—			—			213,117			86,052			—			299,169
Cash and cash equivalents at end of period	$	—		$	—		$	14,536		$	115,329		$	—		$	129,865

Condensed Consolidating Statement of Cash Flows

Year Ended December 31, 2010

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations		Consolidated
	(In thousands)
Net cash (used in) provided by operating activities	$	(154,101	)	$	(87,018	)	$	782,993		$	646,856		$	—	$	1,188,730
Cash flows from investing activities:
Acquisitions of facilities and other related equipment		—			—			(204,773	)		(43,478	)		—		(248,251	)
Purchases of property and equipment		—			—			(342,735	)		(324,643	)		—		(667,378	)
Proceeds from disposition of hospitals and other ancillary operations		—			—			—			—			—		—
Proceeds from sale of property and equipment		—			—			8,140			261			—		8,401
Increase in other investments		—			—			(112,587	)		(24,495	)		—		(137,082	)
Net cash used in investing activities		—			—			(651,955	)		(392,355	)		—		(1,044,310	)
Cash flows from financing activities:
Proceeds from exercise of stock options		56,916			—			—			—			—		56,916
Repurchase of restricted stock shares for payroll tax withholding requirements		—			—			—			—			—		—
Deferred financing costs		—			(13,260	)		—			—			—		(13,260	)
Excess tax benefit (income tax payable increase) relating to stock-based compensation		10,219			—			—			—			—		10,219
Stock buy-back		(113,961	)		—			—			—			—		(113,961	)
Proceeds from noncontrolling investors in joint ventures		—			—			—			7,201			—		7,201
Redemption of noncontrolling investments in joint ventures		—			—			—			(7,318	)		—		(7,318	)
Distributions to noncontrolling investors in joint ventures		—			—			—			(68,113	)		—		(68,113	)
Changes in intercompany balances with affiliates, net		200,927			144,788			(142,864	)		(202,851	)		—		—
Borrowings under credit agreement					—			—			—			—		—
Issuance of long-term debt		—			—			—			—			—		—
Repayments of long-term indebtedness		—			(44,510	)		(13,507	)		(3,459	)		—		(61,476	)
Net cash provided by (used in) financing activities		154,101			87,018			(156,371	)		(274,540	)		—		(189,792	)
Net change in cash and cash equivalents		—			—			(25,333	)		(20,039	)		—		(45,372	)
Cash and cash equivalents at beginning of period		—			—			238,450			106,091			—		344,541
Cash and cash equivalents at end of period	$	—		$	—		$	213,117		$	86,052		$	—	$	299,169

Condensed Consolidating Statement of Cash Flows

Year Ended December 31, 2009

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
	(In thousands)
Net cash (used in) provided by operating activities	$	(62,883	)	$	(88,486	)	$	671,528		$	556,270		$	—		$	1,076,429
Cash flows from investing activities:
Acquisitions of facilities and other related equipment		—			—			(199,363	)		(64,410	)		—			(263,773	)
Purchases of property and equipment		—			—			(368,408	)		(208,480	)		—			(576,888	)
Proceeds from disposition of hospitals and other ancillary operations		—			—			—			89,514			—			89,514
Proceeds from sale of property and equipment		—			—			824			3,195			—			4,019
Increase in other investments		—			—			(115,799	)		(4,255	)		—			(120,054	)
Net cash used in investing activities		—			—			(682,746	)		(184,436	)		—			(867,182	)
Cash flows from financing activities:
Proceeds from exercise of stock options		12,759			—			—			—			—			12,759
Repurchase of restricted stock shares for payroll tax withholding requirements		—			—			—			—			—			—
Deferred financing costs		—			(82	)		—			—			—			(82	)
Excess tax benefit (income tax payable increase) relating to stock-based compensation		(3,472	)		—			—			—			—			(3,472	)
Stock buy-back		—			—			—			—			—			—
Proceeds from noncontrolling investors in joint ventures		—			—			—			29,838			—			29,838
Redemption of noncontrolling investments in joint ventures		—			—			—			(7,268	)		—			(7,268	)
Distributions to noncontrolling investors in joint ventures		—			—			—			(58,963	)		—			(58,963	)
Changes in intercompany balances with affiliates, net		53,596			135,518			100,944			(290,058	)		—			—
Borrowings under credit agreement		—			200,000			4,045			2,570			(6,615	)		200,000
Issuance of long-term debt		—			—			—			—			—			—
Repayments of long-term indebtedness		—			(246,950	)		(13,853	)		(3,985	)		6,615			(258,173	)
Net cash provided by (used in) financing activities		62,883			88,486			91,136			(327,866	)		—			(85,361	)
Net change in cash and cash equivalents		—			—			79,918			43,968			—			123,886
Cash and cash equivalents at beginning of period		—			—			158,532			62,123			—			220,655
Cash and cash equivalents at end of period	$	—		$	—		$	238,450		$	106,091		$	—		$	344,541

XML

Earnings Per Share (Details 1)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Dilutive securities outstanding not included in the computation of earnings per share because their effect is antidilutive:
Employee stock options	6,432,281	4,882,338	6,820,393

XML

Consolidated Balance Sheets (Parenthetical) (USD $) In Thousands, except Share data, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010
Condensed Consolidated Balance Sheets [Abstract]
Allowance for doubtful patient accounts	$ 1,891,334	$ 1,639,198
Net of accumulated amortization	313,028	258,547
Long-lived assets held for sale	$ 0	$ 182,688
Preferred stock, par value per share	$ 0.01	$ 0.01
Preferred stock, shares authorized	100,000,000	100,000,000
Preferred stock, shares issued	0	0
Common stock, par value per share	$ 0.01	$ 0.01
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	91,547,079	93,644,862
Common stock, shares outstanding	90,571,530	92,669,313
Treasury stock, shares	975,549	975,549

XML

Stockholders' Equity (Details Textual) (USD $) In Millions, except Share data, unless otherwise specified	12 Months Ended		12 Months Ended		12 Months Ended			12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2011 New open market repurchase program [Member]	Dec. 14, 2011 New open market repurchase program [Member]	Dec. 31, 2011 Open Market Repurchase Program [Member]	Dec. 31, 2010 Open Market Repurchase Program [Member]	Sep. 15, 2010 Open Market Repurchase Program [Member]	Dec. 31, 2010 Predecessor open market repurchase program [Member]	Dec. 09, 2009 Predecessor open market repurchase program [Member]
Additional Stockholders' Equity (Textual) [Abstract]
Maximum Number of shares authorized for repurchase				4,000,000			4,000,000		3,000,000
Maximum amount of shares authorized under repurchase program				$ 100			$ 100		$ 100
Condition to conclude repurchase program				Earliest of three years, when the maximum number of shares has been repurchased, or when the maximum dollar amount has been reached.
Number of shares repurchased and retired			0		3,469,866	451,272		2,964,528
Weighted average price of repurchased and retired shares, per share					$ 24.68	$ 30.81		$ 33.69
Cumulative number of shares repurchased and retired					3,921,138
Cumulative weighted average price of repurchased and retired shares, per share					$ 25.39
Maximum amount of dividends and/or stock repurchases under credit facility	50
Amount available for dividend distribution for restrictions on dividends stock and notes repurchases	$ 30.1
Stockholders' Equity (Textual) [Abstract]
Total capital stock, shares authorized	400,000,000
Common stock, shares authorized	300,000,000	300,000,000
Preferred stock, shares authorized	100,000,000	100,000,000
Common stock, par value per share	$ 0.01	$ 0.01
Preferred stock, par value per share	$ 0.01	$ 0.01
Preferred stock, shares outstanding	0

XML

Goodwill and Other Intangible Assets (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Carrying amount of goodwill
Beginning Balance	$ 4,150,247	$ 4,157,927
Goodwill acquired as part of acquisitions during the year	114,473	45,975
Consideration adjustments and purchase price allocation adjustments for prior year's acquisitions	125	(3,997)
Goodwill related to hospital operations reporting unit assigned to the disposal group classified as held for sale in 2011		(49,658)
Ending Balance	$ 4,264,845	$ 4,150,247

XML

Segment Information (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Net operating revenues:
Net operating revenues	$ 3,005,825	$ 2,945,477	$ 3,000,827	$ 2,954,083	$ 2,904,356	$ 2,772,311	$ 2,713,644	$ 2,702,111	$ 11,906,212	$ 11,092,422	$ 10,333,501
Income from continuing operations before income taxes:
Income from continuing operations before income taxes	67,638	132,517	137,695	135,697	132,520	131,328	131,140	123,906	473,547	518,894	447,662
Expenditures for segment assets:
Total expenditures for segment assets									776,713	667,378	559,074
Assets:
Total assets	15,208,840				14,698,123				15,208,840	14,698,123
Hospital operations [Member]
Net operating revenues:
Net operating revenues									11,631,382	10,813,383	10,065,457
Income from continuing operations before income taxes:
Income from continuing operations before income taxes									720,215	662,303	590,389
Expenditures for segment assets:
Total expenditures for segment assets									737,391	646,509	543,969
Assets:
Total assets	13,984,964				13,398,314				13,984,964	13,398,314
Corporate and all other [Member]
Net operating revenues:
Net operating revenues									274,830	279,039	268,044
Income from continuing operations before income taxes:
Income from continuing operations before income taxes									(246,668)	(143,409)	(142,727)
Expenditures for segment assets:
Total expenditures for segment assets									39,322	20,869	15,105
Assets:
Total assets	$ 1,223,876				$ 1,299,809				$ 1,223,876	$ 1,299,809

XML

Fair Value of Financial Instruments (Tables)

12 Months Ended

Dec. 31, 2011

Fair Value of Financial Instruments [Abstract]

Estimated fair value of financial instruments

	December 31,
	2011				2010
	Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value
Assets:
Cash and cash equivalents	$	129,865	$	129,865	$	299,169	$	299,169
Available-for-sale securities		31,582		31,582		31,570		31,570
Trading securities		30,486		30,486		35,092		35,092
Liabilities:
Credit Facility		5,979,383		5,780,877		5,999,337		5,882,124
8 7/ 8% Senior Notes		1,777,617		1,842,322		2,784,331		2,923,548
8% Senior Notes		1,000,000		995,000		—		—
Other debt		41,143		41,143		36,122		36,122

Interest rate swaps

Interest rate swaps consisted of the following at December 31, 2011:

Swap #	Notional Amount (in 000’s)		Fixed Interest Rate			Termination Date		Fair Value of Liability (in 000’s)
1		100,000		3.8470	%		January 4, 2012		30
2		100,000		3.8510	%		January 4, 2012		30
3		100,000		3.8560	%		January 4, 2012		30
4		200,000		3.7260	%		January 8, 2012		152
5		200,000		3.5065	%		January 16, 2012		281
6		250,000		5.0185	%		May 30, 2012		4,509
7		150,000		5.0250	%		May 30, 2012		2,709
8		200,000		4.6845	%		September 11, 2012		5,574
9		100,000		3.3520	%		October 23, 2012		2,161
10		125,000		4.3745	%		November 23, 2012		4,104
11		75,000		4.3800	%		November 23, 2012		2,466
12		150,000		5.0200	%		November 30, 2012		5,900
13		200,000		2.2420	%		February 28, 2013		3,550
14		100,000		5.0230	%		May 30, 2013		5,952
15		300,000		5.2420	%		August 6, 2013		21,085
16		100,000		5.0380	%		August 30, 2013		6,967
17		50,000		3.5860	%		October 23, 2013		2,505
18		50,000		3.5240	%		October 23, 2013		2,451
19		100,000		5.0500	%		November 30, 2013		7,948
20		200,000		2.0700	%		December 19, 2013		5,080
21		100,000		5.2310	%		July 25, 2014		10,706
22		100,000		5.2310	%		July 25, 2014		10,707
23		200,000		5.1600	%		July 25, 2014		21,073
24		75,000		5.0405	%		July 25, 2014		7,685
25		125,000		5.0215	%		July 25, 2014		12,752
26		100,000		2.6210	%		July 25, 2014		4,436
27		100,000		3.1100	%		July 25, 2014		5,612
28		100,000		3.2580	%		July 25, 2014		5,968
29		200,000		2.6930	%		October 26, 2014		9,916
30		300,000		3.4470	%		August 8, 2016		27,728
31		200,000		3.4285	%		August 19, 2016		18,401
32		100,000		3.4010	%		August 19, 2016		9,099
33		200,000		3.5000	%		August 30, 2016		19,048
34		100,000		3.0050	%		November 30, 2016		7,613

Amount of pre-tax loss recognized in the consolidated balance sheets as a component of other comprehensive income

The following tabular disclosure provides the amount of pre-tax loss recognized in the consolidated balance sheets as a component of OCI during the years ended December 31, 2011 and 2010 (in thousands):

Derivatives in Cash Flow Hedging Relationships	Amount of Pre-Tax Loss Recognized in OCI on Derivative (Effective Portion) Year Ended December 31,
	2011			2010
Interest rate swaps	($	122,686	)	($	239,893	)

Effective portion of the pre-tax loss reclassified from accumulated other comprehensive loss ("OCL") into interest expense on the consolidated statements of income

The following tabular disclosure provides the location of the effective portion of the pre-tax loss reclassified from accumulated other comprehensive loss (“AOCL”) into interest expense on the consolidated statements of income during the years ended December 31, 2011 and 2010 (in thousands):

	Amount of Pre-Tax Loss Reclassified from AOCL into Income (Effective Portion) Year Ended December 31,
Location of Loss Reclassified from AOCL into Income (Effective Portion)	2011		2010
Interest expense, net	$	208,985	$	215,399

Fair value of derivative instruments in the consolidated balance sheets

The fair values of derivative instruments in the consolidated balance sheets as of December 31, 2011 and 2010 were as follows (in thousands):

Asset Derivatives

Liability Derivatives

December 31, 2011

December 31, 2010

December 31, 2011

December 31, 2010

Balance Sheet Location

Fair Value

Balance Sheet Location

Fair Value

Balance Sheet Location

Fair Value

Balance Sheet Location

Fair Value

Other Derivatives designated as hedging instruments

Other assets, net

$

—

Other assets, net

$

—

Other long-term liabilities

$

254,228

Other long-term liabilities

$

340,526

XML

Income Taxes (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Income Taxes (Textual) [Abstract]
Unrecognized benefit that would affect the effective tax rate	$ 800,000
Amount of interest and penalties included in liabilities	300,000
Cash paid for income tax	26,463,000	128,186,000	57,299,000
Adjustment of increased total deferred tax assets	12,500,000
Adjustment of increased total deferred tax liabilities	11,400,000
Decreasing prepaid income taxes	1,100,000
Net operating loss and credit carryforwards	3,300,000,000
Expiration date of net operating loss carry forwards	2012 to 2031
Valuation allowance increased	23,600,000	11,500,000
Operating Loss Carryforwards, Valuation Allowance	24,900,000
Reductions of tax positions in prior period	(3,469,000)	(1,833,000)
Reductions of tax positions in prior period total	5,400,000
Amount release for income taxes	2,300,000
Accrued interest of its liability for uncertain tax positions	700,000
Decrease in interest and penalties	1,100,000
Tax benefit recognized due to examination	$ 4,000,000
Income tax examination period	24 months

XML

Equity Investments

12 Months Ended

Dec. 31, 2011

Equity Investments [Abstract]

Equity Investments

13. Equity Investments

As of December 31, 2011, the Company owned equity interests of 27.5% in four hospitals in Las Vegas, Nevada, and 26.1% in one hospital in Las Vegas, Nevada, in which Universal Health Systems, Inc. owns the majority interest, and an equity interest of 38.0% in three hospitals in Macon, Georgia, in which HCA Inc. (“HCA”) owns the majority interest.

Summarized combined financial information for the unconsolidated entities in which the Company owns an equity interest is as follows (in thousands):

	December 31,
	2011		2010
Current assets	$	233,496	$	220,881
Noncurrent assets		790,125		771,646
Total assets	$	1,023,621	$	992,527
Current liabilities	$	82,687	$	83,985
Noncurrent liabilities		2,094		2,198
Members’ equity		938,672		905,006
Noncontrolling interests		168		1,338
Total liabilities and equity	$	1,023,621	$	992,527

	Year Ended December 31,
	2011		2010		2009
Net operating revenues	$	1,230,146	$	1,195,108	$	1,181,334
Operating costs and expenses	$	1,068,212	$	1,044,751	$	1,032,953
Income from continuing operations before taxes	$	162,124	$	150,640	$	148,343

The summarized financial information was derived from the financial information provided to the Company by those unconsolidated entities.

The Company’s investment in all of its unconsolidated affiliates was $422.2 million and $409.5 million at December 31, 2011 and 2010, respectively, and is included in other assets, net in the accompanying consolidated balance sheets. Included in the Company’s results of operations is the Company’s equity in pre-tax earnings from all of its investments in unconsolidated affiliates, which was $49.5 million, $45.4 million and $36.5 million for the years ended December 31, 2011, 2010 and 2009, respectively.

XML

Fair Value (Tables)

12 Months Ended

Dec. 31, 2011

Fair Value [Abstract]

Financial assets and liabilities recorded at fair value on a recurring basis

The following table sets forth, by level within the fair value hierarchy, the financial assets and liabilities recorded at fair value on a recurring basis as of December 31, 2011 and 2010 (in thousands):

	December 31, 2011		Level 1		Level 2		Level 3
Available-for-sale securities	$	31,582	$	31,582	$	—	$	—
Trading securities		30,486		30,486		—		—
Total assets	$	62,068	$	62,068	$	—	$	—
Fair value of interest rate swap agreements	$	254,228	$	—	$	254,228	$	—
Total liabilities	$	254,228	$	—	$	254,228	$	—
	December 31, 2010		Level 1		Level 2		Level 3
Available-for-sale securities	$	31,570	$	31,570	$	—	$	—
Trading securities		35,092		35,092		—		—
Total assets	$	66,662	$	66,662	$	—	$	—
Fair value of interest rate swap agreements	$	340,526	$	—	$	340,526	$	—
Total liabilities	$	340,526	$	—	$	340,526	$	—

XML

Equity Investments (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Additional Equity Investments (Textual) [Abstract]
Total company's investment	$ 422,200,000	$ 409,500,000
Income from equity methods investments	$ 49,491,000	$ 45,443,000	$ 36,531,000
Four Hospitals in Las Vegas, Nevada [Member]
Equity Investments (Textual) [Abstract]
Company owned equity interests	27.50%
One Hospital in Las Vegas, Nevada [Member]
Equity Investments (Textual) [Abstract]
Company owned equity interests	26.10%
Three Hospitals in Macon Georgia, [Member]
Equity Investments (Textual) [Abstract]
Company owned equity interests	38.00%

XML

Commitments and Contingencies

12 Months Ended

Dec. 31, 2011

Commitments and Contingencies [Abstract]

Commitments and Contingencies

15. Commitments and Contingencies

Construction and Other Capital Commitments. Pursuant to hospital purchase agreements in effect as of December 31, 2011, and where final certificate of need approval has been obtained, the Company is required to build replacement facilities. As required by an amendment to a lease agreement entered into in 2005, the Company agreed to build a replacement facility at its Barstow, California location with an aggregate estimated construction cost, including equipment costs, of approximately $73.5 million. Of this amount, approximately $49.3 million has been expended through December 31, 2011. This project is expected to be completed in 2012. The Company has agreed, as part of an acquisition in 2007, to build a replacement hospital in Valparaiso, Indiana with an aggregate estimated construction cost, including equipment costs, of approximately $208.7 million. Of this amount, approximately $137.0 million has been expended through December 31, 2011. This project is expected to be completed in 2012. The Company has agreed, as part of an acquisition in 2009, to build a replacement hospital in Siloam Springs, Arkansas with an aggregate estimated construction cost, including equipment costs, of approximately $35.0 million. Of this amount, approximately $24.0 million has been expended through December 31, 2011. This project is required to be completed in 2013. In October 2008, after the purchase of the noncontrolling owner’s interest in the Company’s Birmingham, Alabama facility, the Company initiated the purchase of a site, which includes a partially constructed hospital structure, for a potential replacement for the existing Birmingham facility. In September 2010, the Company received approval of its request for a certificate of need from the Alabama Certificate of Need Review Board; however, this certificate of need remains subject to an appeal process. The Company’s estimated construction costs, including the acquisition of the site and equipment costs, are approximately $280.0 million for the Birmingham replacement facility. Of this amount, approximately $3.5 million has been expended through December 31, 2011. In addition, under other purchase agreements outstanding at December 31, 2011, the Company has committed to spend approximately $652.5 million for costs such as capital improvements, equipment, selected leases and physician recruiting. These commitments are required to be fulfilled generally over a five to seven year period after acquisition. Through December 31, 2011, the Company has spent approximately $247.8 million related to these commitments.

Physician Recruiting Commitments. As part of its physician recruitment strategy, the Company provides income guarantee agreements to certain physicians who agree to relocate to its communities and commit to remain in practice there. Under such agreements, the Company is required to make payments to the physicians in excess of the amounts they earned in their practice up to the amount of the income guarantee. These income guarantee periods are typically for 12 months. Such payments are recoverable by the Company from physicians who do not fulfill their commitment period, which is typically three years, to the respective community. At December 31, 2011, the maximum potential amount of future payments under these guarantees in excess of the liability recorded is $27.4 million.

Professional Liability Claims. As part of the Company’s business of owning and operating hospitals, it is subject to legal actions alleging liability on its part. The Company accrues for losses resulting from such liability claims, as well as loss adjustment expenses that are out-of-pocket and directly related to such liability claims. These direct out-of-pocket expenses include fees of outside counsel and experts. The Company does not accrue for costs that are part of corporate overhead, such as the costs of in-house legal and risk management departments. The losses resulting from professional liability claims primarily consist of estimates for known claims, as well as estimates for incurred but not reported claims. The estimates are based on specific claim facts, historical claim reporting and payment patterns, the nature and level of hospital operations and actuarially determined projections. The actuarially determined projections are based on the Company’s actual claim data, including historic reporting and payment patterns which have been gathered over an approximate 20-year period. As discussed below, since the Company purchases excess insurance on a claims-made basis that transfers risk to third-party insurers, the liability it accrues does include an amount for the losses covered by its excess insurance. The Company also records a receivable for the expected reimbursement of losses covered by excess insurance. Since the Company believes that the amount and timing of its future claims payments are reliably determinable, it discounts the amount accrued for losses resulting from professional liability claims using the risk-free interest rate corresponding to the timing of expected payments.

The net present value of the projected payments was discounted using a weighted-average risk-free rate of 1.2%, 1.3% and 1.4% in 2011, 2010 and 2009, respectively. This liability is adjusted for new claims information in the period such information becomes known. The Company’s estimated liability for the self-insured portion of professional and general liability claims was $567.8 million and $489.2 million as of December 31, 2011 and 2010, respectively. The estimated undiscounted claims liability was $595.7 million and $513.2 million as of December 31, 2011 and 2010, respectively. The current portion of the liability for self-insured portion of professional and general liability claims was $98.1 million and $82.9 million as of December 31, 2011 and 2010, respectively, and is included in other accrued liabilities in the accompanying consolidated balance sheets. Professional malpractice expense includes the losses resulting from professional liability claims and loss adjustment expense, as well as paid excess insurance premiums, and is presented within other operating expenses in the accompanying consolidated statements of income.

The Company’s processes for obtaining and analyzing claims and incident data are standardized across all of its hospitals and have been consistent for many years. The Company monitors the outcomes of the medical care services that it provides and for each reported claim, the Company obtains various information concerning the facts and circumstances related to that claim. In addition, the Company routinely monitors current key statistics and volume indicators in its assessment of utilizing historical trends. The average lag period between claim occurrence and payment of a final settlement is between four and five years, although the facts and circumstances of individual claims could result in the timing of such payments being different from this average. Since claims are paid promptly after settlement with the claimant is reached, settled claims represent less than 1.0% of the total liability at the end of any period.

For purposes of estimating its individual claim accruals, the Company utilizes specific claim information, including the nature of the claim, the expected claim amount, the year in which the claim occurred and the laws of the jurisdiction in which the claim occurred. Once the case accruals for known claims are determined, information is stratified by loss layers and retentions, accident years, reported years, geography and claims relating to the acquired Triad hospitals versus claims relating to the Company’s other hospitals. Several actuarial methods are used against this data to produce estimates of ultimate paid losses and reserves for incurred but not reported claims. Each of these methods uses company-specific historical claims data and other information. This company-specific data includes information regarding the Company’s business, including historical paid losses and loss adjustment expenses, historical and current case loss reserves, actual and projected hospital statistical data, a variety of hospital census information, employed physician information, professional liability retentions for each policy year, geographic information and other data.

Based on these analyses the Company determines its estimate of the professional liability claims. The determination of management’s estimate, including the preparation of the reserve analysis that supports such estimate, involves subjective judgment of the management. Changes in reserving data or the trends and factors that influence reserving data may signal fundamental shifts in the Company’s future claim development patterns or may simply reflect single-period anomalies. Even if a change reflects a fundamental shift, the full extent of the change may not become evident until years later. Moreover, since the Company’s methods and models use different types of data and the Company selects its liability from the results of all of these methods, it typically cannot quantify the precise impact of such factors on its estimates of the liability. Due to the Company’s standardized and consistent processes for handling claims and the long history and depth of company-specific data, the Company’s methodologies have produced reliably determinable estimates of ultimate paid losses.

The Company is primarily self-insured for these claims; however, the Company obtains excess insurance that transfers the risk of loss to a third-party insurer for claims in excess of self-insured retentions. The Company’s excess insurance is underwritten on a claims-made basis. For claims reported prior to June 1, 2002, substantially all of the Company’s professional and general liability risks were subject to a $0.5 million per occurrence self-insured retention and for claims reported from June 1, 2002 through June 1, 2003, these self-insured retentions were $2.0 million per occurrence. Substantially all claims reported after June 1, 2003 and before June 1, 2005 are self-insured up to $4 million per claim. Substantially all claims reported on or after June 1, 2005 are self-insured up to $5 million per claim. Management on occasion has selectively increased the insured risk at certain hospitals based upon insurance pricing and other factors and may continue that practice in the future. Excess insurance for all hospitals has been purchased through commercial insurance companies and generally covers the Company for liabilities in excess of the self-insured retentions. The excess coverage consists of multiple layers of insurance, the sum of which totals up to $95 million per occurrence and in the aggregate for claims reported on or after June 1, 2003 and up to $145 million per occurrence and in the aggregate for claims incurred and reported after January 1, 2008. For certain policy years, if the first aggregate layer of excess coverage becomes fully utilized, then the Company’s self-insured retention could increase to $10 million per claim for any subsequent claims in that policy year until the Company’s total aggregate coverage is met.

Effective January 1, 2008, the former Triad hospitals are insured on a claims-made basis as described above and through commercial insurance companies as described above for substantially all claims occurring on or after January 1, 2002 and reported on or after January 1, 2008. Substantially all losses for the former Triad hospitals in periods prior to May 1999 were insured through a wholly-owned insurance subsidiary of HCA, Triad’s owner prior to that time, and excess loss policies maintained by HCA. HCA has agreed to indemnify the former Triad hospitals in respect of claims covered by such insurance policies arising prior to May 1999. After May 1999 through December 31, 2006, the former Triad hospitals obtained insurance coverage on a claims incurred basis from HCA’s wholly-owned insurance subsidiary, with excess coverage obtained from other carriers that is subject to certain deductibles. Effective for claims incurred after December 31, 2006, Triad began insuring its claims from $1 million to $5 million through its wholly-owned captive insurance company, replacing the coverage provided by HCA. Substantially all claims occurring during 2007 were self-insured up to $10 million per claim.

Legal Matters. The Company is a party to various legal proceedings incidental to its business. In the opinion of management, any ultimate liability with respect to these actions will not have a material adverse effect on the Company’s consolidated financial position, cash flows or results of operations. With respect to all litigation matters, the Company considers the likelihood of a negative outcome. If the Company determines the likelihood of a negative outcome is probable and the amount of the loss can be reasonably estimated, the Company records an estimated loss for the expected outcome of the litigation. If the likelihood of a negative outcome is reasonably possible and the Company is able to determine an estimate of the possible loss or a range of loss, the Company discloses that fact together with the estimate of the possible loss or range of loss. However, it is difficult to predict the outcome or estimate a possible loss or range of loss in some instances because litigation is subject to significant uncertainties.

Reasonably Possible Contingencies

For all of the legal matters below, the Company believes that a negative outcome is reasonably possible, but the Company is unable to determine an estimate of the possible loss or a range of loss.

On February 10, 2006, the Company received a letter from the Civil Division of the Department of Justice requesting documents in an investigation it was conducting involving the Company. The inquiry related to the way in which different state Medicaid programs apply to the federal government for matching or supplemental funds that are ultimately used to pay for a small portion of the services provided to Medicaid and indigent patients. These programs are referred to by different names, including “intergovernmental payments,” “upper payment limit programs,” and “Medicaid disproportionate share hospital payments.” The February 2006 letter focused on the Company’s hospitals in three states: Arkansas, New Mexico, and South Carolina. On August 31, 2006, the Company received a follow up letter from the Department of Justice requesting additional documents relating to the programs in New Mexico and the payments to the Company’s three hospitals in that state. Through the beginning of 2009, the Company provided the Department of Justice with requested documents, met with its personnel on numerous occasions, and otherwise cooperated in its investigation. During the course of the investigation, the Civil Division notified the Company that it believed that the Company and its three New Mexico hospitals caused the State of New Mexico to submit improper claims for federal funds, in violation of the Federal False Claims Act. At one point, the Civil Division calculated that the three hospitals received ineligible federal participation payments from August 2000 to June 2006 of approximately $27.5 million and said that if it proceeded to trial, it would seek treble damages plus an appropriate penalty for each of the violations of the Federal False Claims Act. This investigation has culminated in the federal government’s intervention in a qui tam lawsuit styled U.S. ex rel. Baker vs. Community Health Systems, Inc., pending in the United States District Court for the District of New Mexico. The federal government filed its complaint in intervention on June 30, 2009. The relator filed a second amended complaint on July 1, 2009. Both of these complaints expand the time period during which alleged improper payments were made. The Company filed motions to dismiss all of the federal government’s and the relator’s claims on August 28, 2009. On March 19, 2010, the court granted in part and denied in part the Company’s motion to dismiss as to the relator’s complaint. On July 7, 2010, the court denied the Company’s motion to dismiss the federal government’s complaint in intervention. On July 21, 2010, the Company filed its answer and pretrial discovery began. On June 2, 2011, the relator filed a Third Amended Complaint adding subsidiaries Community Health Systems Professional Services Corporation and CHS/Community Health Systems, Inc. as defendants. On June 6, 2011, the government filed its First Amended Complaint in intervention adding Community Health Systems Professional Services Corporation as a defendant. Discovery is closed. The deadline for filing of Motions for Summary Judgment is March 27, 2012 and there is currently no trial date set. The Company is vigorously defending this action.

On June 12, 2008, two of the Company’s hospitals received letters from the United States Attorney’s Office for the Western District of New York requesting documents in an investigation it is conducting into billing practices with respect to kyphoplasty procedures performed during the period January 1, 2002, through June 9, 2008. On September 16, 2008, one of the Company’s hospitals in South Carolina also received an inquiry. Kyphoplasty is a surgical spine procedure that returns a compromised vertebrae (either from trauma or osteoporotic disease process) to its previous height, reducing or eliminating severe pain. The Company has been informed that similar investigations have been initiated at unaffiliated facilities in Alabama, South Carolina, Indiana and other states. The Company believes that this investigation is related to a qui tam settlement between the same United States Attorney’s office and the manufacturer and distributor of the Kyphon product, which is used in performing the kyphoplasty procedure. The Company is cooperating with the investigation and continuing to evaluate and discuss this matter with the federal government.

Matters for which an Outcome Cannot be Assessed

For all of the legal matters below, the Company cannot at this time assess what the outcome may be and is further unable to determine any estimate of loss or range of loss. Because the investigations are at a very preliminary stage, there are not sufficient facts available to make these assessments.

On April 8, 2011, the Company received a document subpoena, dated March 31, 2011, from the United States Department of Health and Human Services, Office of Inspector General (the “OIG”), in connection with an investigation of possible improper claims submitted to Medicare and Medicaid. The subpoena, issued from the OIG’s Chicago, Illinois office, requested documents from all of the Company’s hospitals and appears to concern emergency department processes and procedures, including the Company’s hospitals’ use of the Pro-MED Clinical Information System, which is a third-party software system that assists with the management of patient care and provides operational support and data collection for emergency department management and has the ability to track discharge, transfer and admission recommendations of emergency department physicians. The subpoena also requested other information about the Company’s relationships with emergency department physicians, including financial arrangements. The subpoena’s requests were very similar to those contained in the Civil Investigative Demands received by the Company’s Texas hospitals from the Office of the Attorney General of the State of Texas on November 15, 2010. The Company is continuing to cooperate with the government (including production of documents and interviews with witnesses) in this investigation.

On April 11, 2011, Tenet Healthcare Corporation (“Tenet”) filed suit against the Company, Wayne T. Smith and W. Larry Cash in the United States District Court for the Northern District of Texas. The suit alleged the Company committed violations of certain federal securities laws by making certain statements in various proxy materials filed with the SEC in connection with the Company’s offer to purchase Tenet. Tenet alleged that the Company engaged in a practice to under-utilize observation status and over-utilize inpatient admission status and asserts that by doing so, the Company created undisclosed financial and legal liability to federal, state and private payors. The suit seeks declaratory and injunctive relief and Tenet’s costs. On April 19, 2011, the Company filed a motion to dismiss the complaint. On April 28, 2011, the Company responded to the allegations during its earnings release conference call as discussed in the Company’s Form 8-K furnished on April 28, 2011. On May 16, 2011, Tenet filed an amended complaint. On June 29, 2011, the Company filed a motion to dismiss the amended complaint. A hearing on the Company’s motion to dismiss occurred on September 8, 2011. The court took this matter under advisement. The Company will continue to vigorously defend this suit.

On April 22, 2011, a joint motion was filed by the relator and the United States Department of Justice in the case styled United States ex rel. and Reuille vs. Community Health Systems Professional Services Corporation and Lutheran Musculoskeletal Center, LLC d/b/a Lutheran Hospital, in the United States District Court for the Northern District of Indiana, Fort Wayne Division. The lawsuit was originally filed under seal on January 7, 2009. The suit is brought under the False Claims Act and alleges that Lutheran Hospital of Indiana billed the Medicare program for (a) false 23 hour observation after outpatient surgeries and procedures, and (b) intentional assignment of inpatient status to one-day stays for cases that do not meet Medicare criteria for inpatient intensity of service or severity of illness. The relator had worked in the case management department of Lutheran Hospital of Indiana but was reassigned to another department in the fall of 2006. This facility was acquired by the Company as part of the July 25, 2007 merger transaction with Triad. The complaint also includes allegations of age discrimination in Ms. Reuille’s 2006 reassignment and retaliation in connection with her resignation on October 1, 2008. The Company had cooperated fully with the government in its investigation of this matter, but had been unaware of the exact nature of the allegations in the complaint. On December 27, 2010, the government filed a notice that it declined to intervene in this suit. The motion contained additional information about how the government intended to proceed with an investigation regarding “allegations of improper billing for inpatient care at other hospitals associated with Community Health Systems, Inc. . . . asserted in other qui tam complaints in other jurisdictions.” The motion stated that the Department of Justice has “consolidated its investigations” of the Company and other related entities and that “the Civil Division of the Department of Justice, multiple United States Attorneys’ offices, and the Office of Inspector General for the Department of Health and Human Services (the “HHS”) are now closely coordinating their investigation of these overlapping allegations. The Attorney General of Texas has initiated an investigation; the United States intends to work cooperatively with Texas and any other States investigating these allegations.” The motion also stated that the Office of Audit Services for the Office of Investigations for HHS has been engaged to conduct a national audit of certain of the Company’s Medicare claims. The government confirmed that it considers the allegations made in the complaint styled Tenet Healthcare Corporation vs. Community Health Systems, Inc., et al. filed in the United States District Court for the Northern District of Texas, Dallas Division on April 11, 2011 to be related to the allegations in the qui tam and to what the government is now describing as a consolidated investigation. Because qui tam suits are filed “under seal,” no one but the relator and the government knows that the suit has been filed or what allegations are being made by the relator on behalf of the government. Initially, the government has 60 days to make a determination about whether to intervene in a case and to act as the plaintiff or to decline to intervene and allow the relator to act as the plaintiff in the suit, but extensions of time are frequently granted to allow the government additional time to investigate the allegations. Even if, in the course of an investigation, the court partially unseals a complaint to allow the government and a defendant to work to a resolution of the complaint’s allegations, the defendant is prohibited from revealing to anyone even that the partial unsealing has occurred. As the investigation proceeds, the Company may learn of additional qui tam suits filed against the Company or its affiliated hospitals or related entities, or that contact letters, document requests, or medical record requests the Company has received in the past from various governmental agencies are generated from qui tam cases filed under seal. The motion filed on April 22, 2011 concluded by requesting a stay of the litigation in the Reuille case for 180 days, and on April 25, 2011, the court granted the motion. The Company’s management company subsidiary, Community Health Systems Professional Services Corporation, the defendant in the Reuille case, consented to the request for the stay. On October 19, 2011, the government filed an application to transfer the Reuille case to the Middle District of Tennessee or for an extension of the stay for an additional 180 days. The Company agreed that a stay for an additional, but shorter period of time, 90 days, was appropriate, but did not consent to the transfer of the case. The Company’s response setting forth the Company’s legal arguments was filed on October 24, 2011. On November 1, 2011, the court denied the motion to transfer the matter and extended the stay until April 30, 2012. The Company is cooperating fully with the government in its investigations.

Three purported class action shareholder federal securities cases have been filed in the United States District Court for the Middle District of Tennessee; namely, Norfolk County Retirement System v. Community Health Systems, Inc., Wayne T. Smith and W. Larry Cash, filed May 5, 2011; De Zheng v. Community Health Systems, Inc., Wayne T. Smith and W. Larry Cash, filed May 12, 2011; and Minneapolis Firefighters Relief Association v. Community Health Systems, Inc., Wayne T. Smith, W. Larry Cash and Thomas Mark Buford, filed June 2, 2011. All three seek class certification on behalf of purchasers of the Company’s common stock between July 27, 2006 and April 11, 2011 and allege that misleading statements resulted in artificially inflated prices for the Company’s common stock. On September 20, 2011, all three were assigned to the same judge as related cases. On December 28, 2011, the court consolidated all three shareholder cases for pretrial purposes, selected NYC Funds as lead plaintiffs, and selected NYC Funds’ counsel as lead plaintiffs’ counsel. The parties are in the process of negotiating operative dates for these consolidated shareholder federal securities actions, including dates for the filing of an operative consolidated complaint and related briefing. Three purported shareholder derivative actions have also been filed in the United States District Court for the Middle District of Tennessee; Plumbers and Pipefitters Local Union No. 630 Pension Annuity Trust Fund v. Wayne T. Smith, W. Larry Cash, T. Mark Buford, John A. Clerico, James S. Ely III, John A. Fry, William Norris Jennings, Julia B. North and H. Mitchell Watson, Jr., filed May 24, 2011; Roofers Local No. 149 Pension Fund v. Wayne T. Smith, W. Larry Cash, John A. Clerico, James S. Ely, III, John A. Fry, William Norris Jennings, Julia B. North and H. Mitchell Watson, Jr., filed June 21, 2011; and Lambert Sweat v. Wayne T. Smith, W. Larry Cash, T. Mark Buford, John A. Clerico, James S. Ely, III, John A. Fry, William Norris Jennings, Julia B. North, H. Mitchell Watson, Jr. and Community Health Systems, Inc., filed October 5, 2011. These three cases allege breach of fiduciary duty arising out of allegedly improper inpatient admission practices, mismanagement, waste and unjust enrichment. On September 28, 2011, the court ordered that the Plumbers and Pipefitters Local Union No. 630 Pension Annuity Trust Fund action and the Roofers Local No. 149 Pension Fund action be consolidated for pretrial purposes, and appointed the derivative plaintiffs’ lead counsel. On November 29, 2011, the court ordered that the Lambert Sweat action be consolidated with the Plumbers and Roofers consolidated derivative actions. Plaintiffs are expected to file an operative amended derivative complaint in these three consolidated actions on or about March 15, 2012. The Company believes all of these matters are without merit and will vigorously defend them.

The Company incurred the following pre-tax charges in connection with the Tenet acquisition lawsuit, government investigations and shareholder lawsuits relating to possible improper claims submitted to Medicare and Medicaid (in thousands):

	Year Ended December 31,
	2011		2010		2009
Professional fees and other related costs	$	15,317	$	—	$	—

XML

Long-Term Debt (Details 2) (8.875% Senior Noted Due 2015 [Member])	12 Months Ended
	Dec. 31, 2011
8.875% Senior Noted Due 2015 [Member]
Redemption Price of 8.875 % Senior Notes in Long Term Debt
2012	102.219%
2013 and thereafter	100.00%

XML

Supplemental Condensed Consolidating Financial Information (Details Textual) (USD $) In Billions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2007	Jul. 25, 2007
Supplemental Condensed Consolidating Financial Information (Textual) [Abstract]
Percentage of owned domestic subsidiaries which guaranteed senior notes	100.00%
Senior Notes 8.875% Due 2015 [Member]
Supplemental Condensed Consolidating Financial Information (Textual) [Abstract]
Amount used to tender long term debt	$ 1.0
Percentage of interest rate		8.875%	8.875%
8% Senior Notes Due 2019 [Member]
Supplemental Condensed Consolidating Financial Information (Textual) [Abstract]
Principal amount of senior notes issued	1.0
Percentage of interest rate	8.00%		8.00%
Community Health System [Member] | Senior Notes 8.875% Due 2015 [Member]
Supplemental Condensed Consolidating Financial Information (Textual) [Abstract]
Principal amount of senior notes issued		3.0	3.0

XML

Consolidated Statements of Stockholders' Equity (USD $) In Thousands, except Share data, unless otherwise specified	Total	Redeemable Noncontrolling Interests	Common Stock	Additional Paid-in Capital	Treasury Stock	Accumulated Other Comprehensive Income (Loss)	Retained Earnings	Noncontrolling Interest
Beginning Balance at Dec. 31, 2008	$ 1,672,486	$ 348,816	$ 925	$ 1,136,108	$ (6,678)	$ (295,575)	$ 776,249	$ 61,457
Shares, Issued, Beginning Balance at Dec. 31, 2008			92,483,166		(975,549)
Comprehensive income (loss):
Net income	306,377	46,716					243,150	16,511
Net change in fair value of interest rate swaps, net of tax	76,225					76,225
Net change in fair value of available-for-sale securities	412					412
Amortization and recognition of unrecognized pension cost components, net of tax	(2,447)					(2,447)
Comprehensive income	380,567	46,716				74,190	243,150	16,511
Distributions to noncontrolling interests, net of contributions	(13,582)	(27,072)						(13,582)
Purchase of subsidiary shares from noncontrolling interests	3,502	(5,439)		3,106				396
Sale of less than wholly-owned subsidiaries		(21,691)
Adjustment to redemption value of redeemable noncontrolling interests	(27,527)	27,527		(27,527)
Issuance of common stock in connection with the exercise of stock options	12,767		7	12,760
Issuance of common stock in connection with the exercise of stock options, shares	680,898		680,898
Cancellation of restricted stock for tax withholdings on vested shares	(7,120)		(3)	(7,117)
Cancellation of restricted stock for tax withholdings on vested shares, shares			(328,470)
Excess tax benefit from exercise of stock options	(3,472)			(3,472)
Share-based compensation	44,512		11	44,501
Share-based compensation, shares			1,177,943
Ending Balance at Dec. 31, 2009	2,015,417	368,857	940	1,158,359	(6,678)	(221,385)	1,019,399	64,782
Shares, Issued, Ending Balance at Dec. 31, 2009			94,013,537		(975,549)
Comprehensive income (loss):
Net income	348,441	50,292					279,983	18,166
Net change in fair value of interest rate swaps, net of tax	(15,676)					(15,676)
Net change in fair value of available-for-sale securities	3,716					3,716
Amortization and recognition of unrecognized pension cost components, net of tax	2,418					2,418
Comprehensive income	338,899	50,292				(9,542)	279,983	18,166
Distributions to noncontrolling interests, net of contributions	(20,046)	(40,068)						(20,046)
Purchase of subsidiary shares from noncontrolling interests	(3,529)	(3,754)		(3,529)
Other reclassifications of noncontrolling interests	(1,989)	1,989						(1,989)
Adjustment to redemption value of redeemable noncontrolling interests	(10,156)	10,156		(10,156)
Issuance of common stock in connection with the exercise of stock options	56,938		22	56,916
Issuance of common stock in connection with the exercise of stock options, shares	2,194,862		2,194,862
Cancellation of restricted stock for tax withholdings on vested shares	(9,879)		(3)	(9,876)
Cancellation of restricted stock for tax withholdings on vested shares, shares			(295,171)
Repurchases of common stock	(113,995)		(34)	(113,961)
Repurchases of common stock, Shares			(3,415,800)
Excess tax benefit from exercise of stock options	10,219			10,219
Share-based compensation	38,790		11	38,779
Share-based compensation, shares			1,147,434
Ending Balance at Dec. 31, 2010	2,250,377	387,472	936	1,126,751	(6,678)	(230,927)	1,299,382	60,913
Shares, Issued, Ending Balance at Dec. 31, 2010			93,644,862		(975,549)
Comprehensive income (loss):
Net income	277,623	54,251					201,948	21,424
Net change in fair value of interest rate swaps, net of tax	55,145					55,145
Net change in fair value of available-for-sale securities	(960)					(960)
Amortization and recognition of unrecognized pension cost components, net of tax	(7,737)					(7,737)
Comprehensive income	324,071	54,251				46,448	201,948	21,424
Distributions to noncontrolling interests, net of contributions	(15,049)	(39,816)						(15,049)
Purchase of subsidiary shares from noncontrolling interests	(5,596)	(7,426)		(4,556)				(1,040)
Other reclassifications of noncontrolling interests	1,101	(2,099)						1,101
Adjustment to redemption value of redeemable noncontrolling interests	(3,361)	3,361		(3,361)
Issuance of common stock in connection with the exercise of stock options	18,916		6	18,910
Issuance of common stock in connection with the exercise of stock options, shares	623,341		623,341
Cancellation of restricted stock for tax withholdings on vested shares	(13,314)		(3)	(13,311)
Cancellation of restricted stock for tax withholdings on vested shares, shares			(346,419)
Repurchases of common stock	(85,825)		(35)	(85,790)
Repurchases of common stock, Shares			(3,469,099)
Excess tax benefit from exercise of stock options	4,823			4,823
Share-based compensation	42,553		11	42,542
Share-based compensation, shares			1,094,394
Ending Balance at Dec. 31, 2011	$ 2,464,445	$ 395,743	$ 915	$ 1,086,008	$ (6,678)	$ (184,479)	$ 1,501,330	$ 67,349
Shares, Issued, Ending Balance at Dec. 31, 2011			91,547,079		(975,549)

XML

Consolidated Statements of Income (Parenthetical) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Consolidated Statements of Income [Abstract]
Net of interest income	$ 4,650	$ 1,757	$ 3,561

XML

Fair Value

12 Months Ended

Dec. 31, 2011

Fair Value [Abstract]

Fair Value

8. Fair Value

Fair Value Hierarchy

Fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, the Company utilizes the U.S. GAAP fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumption about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).

The inputs used to measure fair value are classified into the following fair value hierarchy:

Level 1: Quoted market prices in active markets for identical assets or liabilities.

Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.

Level 3: Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities. Level 3 includes values determined using pricing models, discounted cash flow methodologies, or similar techniques reflecting the Company’s own assumptions.

In instances where the determination of the fair value hierarchy measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment of factors specific to the asset or liability.

The following table sets forth, by level within the fair value hierarchy, the financial assets and liabilities recorded at fair value on a recurring basis as of December 31, 2011 and 2010 (in thousands):

	December 31, 2011		Level 1		Level 2		Level 3
Available-for-sale securities	$	31,582	$	31,582	$	—	$	—
Trading securities		30,486		30,486		—		—
Total assets	$	62,068	$	62,068	$	—	$	—
Fair value of interest rate swap agreements	$	254,228	$	—	$	254,228	$	—
Total liabilities	$	254,228	$	—	$	254,228	$	—
	December 31, 2010		Level 1		Level 2		Level 3
Available-for-sale securities	$	31,570	$	31,570	$	—	$	—
Trading securities		35,092		35,092		—		—
Total assets	$	66,662	$	66,662	$	—	$	—
Fair value of interest rate swap agreements	$	340,526	$	—	$	340,526	$	—
Total liabilities	$	340,526	$	—	$	340,526	$	—

Available-for-sale securities and trading securities classified as Level 1 are measured using quoted market prices.

The valuation of the Company’s interest rate swap agreements is determined using market valuation techniques, including discounted cash flow analysis on the expected cash flows of each agreement. This analysis reflects the contractual terms of the agreement, including the period to maturity, and uses observable market-based inputs, including forward interest rate curves. The fair value of interest rate swap agreements are determined by netting the discounted future fixed cash payments and the discounted expected variable cash receipts. The variable cash receipts are based on the expectation of future interest rates based on observable market forward interest rate curves and the notional amount being hedged.

The Company incorporates CVAs to appropriately reflect both its own nonperformance or credit risk and the respective counterparty’s nonperformance or credit risk in the fair value measurements. In adjusting the fair value of its interest rate swap agreements for the effect of nonperformance or credit risk, the Company has considered the impact of any netting features included in the agreements. The CVA on the Company’s interest rate swap agreements at December 31, 2011 resulted in a decrease in the fair value of the related liability of $21.7 million and an after-tax adjustment of $13.9 million to OCI. The CVA on the Company’s interest rate swap agreements at December 31, 2010 resulted in a decrease in the fair value of the related liability of $3.9 million and an after-tax adjustment of $2.5 million to OCI.

The majority of the inputs used to value its interest rate swap agreements, including the forward interest rate curves and market perceptions of the Company’s credit risk used in the CVAs, are observable inputs available to a market participant. As a result, the Company has determined that the interest rate swap valuations are classified in Level 2 of the fair value hierarchy.

XML

Quarterly Financial Data Details (Unaudited) (USD $)	3 Months Ended								12 Months Ended
	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2011		Dec. 31, 2010		Dec. 31, 2009
Quarterly Financial Data (Unaudited)
Net operating revenues	$ 3,005,825,000	$ 2,945,477,000	$ 3,000,827,000	$ 2,954,083,000	$ 2,904,356,000	$ 2,772,311,000	$ 2,713,644,000	$ 2,702,111,000	$ 11,906,212,000		$ 11,092,422,000		$ 10,333,501,000
Income from continuing operations before income taxes	67,638,000	132,517,000	137,695,000	135,697,000	132,520,000	131,328,000	131,140,000	123,906,000	473,547,000		518,894,000		447,662,000
Income from continuing operations	55,615,000	95,800,000	92,874,000	91,605,000	94,468,000	88,009,000	88,379,000	84,357,000	335,894,000		355,213,000		305,811,000
Income from discontinued operations	(2,495,000)	(3,169,000)	(39,327,000)	(13,280,000)	(2,219,000)	(3,155,000)	(2,037,000)	639,000	(58,271,000)		(6,772,000)		566,000
Net income attributable to Community Health Systems, Inc.	30,931,000	74,304,000	35,389,000	61,324,000	69,510,000	70,401,000	70,065,000	70,007,000	201,948,000		279,983,000		243,150,000
Basic earnings per share attributable to Community Health Systems, Inc. common stockholders:
Continuing operations	$ 0.38	$ 0.87	$ 0.82	$ 0.82	$ 0.79	$ 0.80	$ 0.77	$ 0.76	$ 2.89	[1]	$ 3.13	[1]	$ 2.68	[1]
Discontinued operations	$ (0.03)	$ (0.04)	$ (0.43)	$ (0.15)	$ (0.02)	$ (0.03)	$ (0.02)	$ 0.01	$ (0.65)	[1]	$ (0.07)	[1]
Net income	$ 0.35	$ 0.83	$ 0.39	$ 0.67	$ 0.77	$ 0.77	$ 0.75	$ 0.76	$ 2.24	[1]	$ 3.05	[1]	$ 2.68	[1]
Diluted earnings per share attributable to Community Health Systems, Inc. common stockholders:
Continuing operations	$ 0.38	$ 0.86	$ 0.81	$ 0.81	$ 0.78	$ 0.80	$ 0.76	$ 0.75	$ 2.87	[1]	$ 3.08	[1]	$ 2.65	[1]
Discontinued operations	$ (0.03)	$ (0.04)	$ (0.43)	$ (0.14)	$ (0.02)	$ (0.03)	$ (0.02)	$ 0.01	$ (0.64)	[1]	$ (0.07)	[1]
Net income	$ 0.35	$ 0.83	$ 0.39	$ 0.67	$ 0.76	$ 0.76	$ 0.74	$ 0.75	$ 2.23	[1]	$ 3.01	[1]	$ 2.66	[1]
Weighted-average number of shares outstanding:
Basic	88,344,566	89,412,310	91,130,672	91,008,405	90,422,331	91,484,466	93,358,771	91,615,275	89,966,933		91,718,791		90,614,886
Diluted	88,913,813	89,857,583	91,783,725	92,136,819	91,778,801	92,462,702	94,711,919	92,836,451	90,666,348		92,946,048		91,517,274
Quarterly Financial Data (Textual) [Abstract]
Decreased net operating revenues and operating expenses due to reclassification of electronic health records incentive reimbursement		$ 40,200,000							$ 40,200,000

[1] Total per share amounts may not add due to rounding.

XML

Stockholders' Equity (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Effects of changes in the ownership interest in less-than-wholly-owned subsidiaries
Net income attributable to Community Health Systems, Inc.	$ 30,931	$ 74,304	$ 35,389	$ 61,324	$ 69,510	$ 70,401	$ 70,065	$ 70,007	$ 201,948	$ 279,983	$ 243,150
Transfers (to) from the noncontrolling interests:
Net (decrease) increase in Community Health Systems, Inc. paid-in capital for purchase of subsidiary partnership interests									(4,556)	(3,529)	3,106
Net transfers (to) from the noncontrolling interests									(4,556)	(3,529)	3,106
Change to Community Health Systems, Inc. stockholders' equity from net income attributable to Community Health Systems, Inc. and transfers (to) from noncontrolling interests									$ 197,392	$ 276,454	$ 246,256

XML

Employee Benefit Plans (Details 9) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2011
Pension Plan [Member]
Defined Benefit Plan, Estimated Future Benefit Payments [Abstract]
2012	$ 1,236
2013	1,511
2014	1,701
2015	1,820
2016	2,237
2017-2021	15,115
SERP [Member]
Defined Benefit Plan, Estimated Future Benefit Payments [Abstract]
2012	1,191
2013	1,392
2014	10,782
2015	3,365
2016	44,737
2017-2021	$ 40,072

XML

Document and Entity Information	12 Months Ended
	Dec. 31, 2011
Document and Entity Information [Abstract]
Entity Registrant Name	COMMUNITY HEALTH SYSTEMS INC
Entity Central Index Key	0001108109
Document Type	8-K
Document Period End Date	Dec. 31, 2011
Amendment Flag	false

XML

Leases

12 Months Ended

Dec. 31, 2011

Leases [Abstract]

Leases

9. Leases

The Company leases hospitals, medical office buildings, and certain equipment under capital and operating lease agreements. During 2011, 2010 and 2009, the Company entered into capital lease obligations of $3.0 million, $22.7 million and $3.3 million, respectively. All lease agreements generally require the Company to pay maintenance, repairs, property taxes and insurance costs.

During 2010, the Company entered into an agreement with the lessor of Cleveland Regional Medical Center (“Cleveland Regional”), its leased facility in Cleveland, TX, to exchange its ownership interest in certain real estate at Hill Regional Medical Center (“Hill Regional”), in Hillsboro, TX for the lessor’s ownership interest in the real estate at Cleveland Regional. The related lease agreement was amended to incorporate Hill Regional as a leased asset with no change to the remaining lease term or payment schedule. No monetary consideration was exchanged in this transaction, and the transaction qualifies as a non-taxable, like-kind exchange under the regulations in Section 1031 of the Internal Revenue Code. The assets of Cleveland Regional were recorded in the consolidated balance sheet at fair value on the date of this transaction; however, as a result of the Company’s continuing involvement in the Hill Regional assets, the exchange with the lessor does not qualify for sale treatment under U.S. GAAP. Accordingly, the transaction has been accounted for as a financing obligation and the assets of Hill Regional will remain on the consolidated balance sheet as assets recorded under a financing obligation. Starting in the fourth quarter of 2010, future payments under the lease are amortized against the financing obligation rather than recorded as rent expense. The disclosures below for capital leases include the amounts related to the Hill Regional financing obligation.

Commitments relating to noncancellable operating and capital leases for each of the next five years and thereafter are as follows (in thousands):

Year Ended December 31,	Operating (1)		Capital
2012	$	176,403	$	8,386
2013		149,460		7,216
2014		122,763		6,710
2015		98,543		6,005
2016		70,087		5,630
Thereafter		176,599		57,472
Total minimum future payments	$	793,855	$	91,419
Less imputed interest				(43,058	)
				48,361
Less current portion				(4,008	)
Long-term capital lease obligations			$	44,353

(1) Minimum lease payments have not been reduced by minimum sublease rentals due in the future of $21.3 million.

Assets capitalized under capital leases as reflected in the accompanying consolidated balance sheets were $27.9 million of land and improvements, $193.7 million of buildings and improvements and $69.3 million of equipment and fixtures as of December 31, 2011 and $27.9 million of land and improvements, $193.7 million of buildings and improvements and $76.7 million of equipment and fixtures as of December 31, 2010. The accumulated depreciation related to assets under capital leases was $119.3 million and $106.7 million as of December 31, 2011 and 2010, respectively. Depreciation of assets under capital leases is included in depreciation and amortization expense and amortization of debt discounts on capital lease obligations is included in interest expense in the consolidated statements of income.

XML

Leases (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2011
Commitments relating to noncancellable operating and capital leases
Operating Leases, Future Minimum Payments due, 2012	$ 176,403
Operating Leases, Future Minimum Payments due, 2013	149,460
Operating Leases, Future Minimum Payments due, 2014	122,763
Operating Leases, Future Minimum Payments due, 2015	98,543
Operating Leases, Future Minimum Payments due, 2016	70,087
Operating Leases, Future Minimum Payments due, Thereafter	176,599
Operating Leases total Future Minimum Payments	793,855
Capital Leases, Future Minimum Payments due, 2012	8,386
Capital Leases, Future Minimum Payments due, 2013	7,216
Capital Leases, Future Minimum Payments due, 2014	6,710
Capital Leases, Future Minimum Payments due, 2015	6,005
Capital Leases, Future Minimum Payments due, 2016	5,630
Capital Leases, Future Minimum Payments due, Thereafter	57,472
Capital Leases, total future minimum payments	91,419
Less imputed interest	(43,058)
Capital Leases, Net Future Minimum Payments	48,361
Less current portion	(4,008)
Long-term capital lease obligations	$ 44,353

XML

Employee Benefit Plans (Details 8) (Pension Plan [Member])	Dec. 31, 2011	Dec. 31, 2010
Pension Plan [Member]
Weighted-average asset allocations by asset category
Equity securities	100.00%	100.00%
Debt securities	0.00%	0.00%
Total	100.00%	100.00%

XML

Consolidated Statements of Comprehensive Income (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Condensed Consolidated Statements of Comprehensive Income [Abstract]
Net income	$ 277,623	$ 348,441	$ 306,377
Other comprehensive income, net of income taxes:
Net change in fair value of interest rate swaps	55,145	(15,676)	76,225
Net change in fair value of available-for-sale securities	(960)	3,716	412
Amortization and recognition of unrecognized pension cost components	(7,737)	2,418	(2,447)
Other comprehensive income	46,448	(9,542)	74,190
Comprehensive income	324,071	338,899	380,567
Less: Comprehensive income attributable to noncontrolling interests	75,675	68,458	63,227
Comprehensive income attributable to Community Health Systems, Inc.	$ 248,396	$ 270,441	$ 317,340

XML

Acquisitions and Divestitures

12 Months Ended

Dec. 31, 2011

Acquisitions and Divestitures [Abstract]

Acquisitions and Divestitures

3. Acquisitions and Divestitures

Acquisitions

The Company accounts for all transactions that represent business combinations after January 1, 2009 using the acquisition method of accounting, where the identifiable assets acquired, the liabilities assumed and any noncontrolling interest in the acquired entity are recognized and measured at their fair values on the date the Company obtains control in the acquiree. Such fair values that are not finalized for reporting periods following the acquisition date are estimated and recorded as provisional amounts. Adjustments to these provisional amounts during the measurement period (defined as the date through which all information required to identify and measure the consideration transferred, the assets acquired, the liabilities assumed and any noncontrolling interests has been obtained, limited to one year from the acquisition date) are recorded as of the date of acquisition. Any material impact to comparative information for periods after acquisition, but before the period in which adjustments are identified, is reflected in those prior periods as if the adjustments were considered as of the acquisition date. Goodwill is determined as the excess of the fair value of the consideration conveyed in the acquisition over the fair value of the net assets acquired.

Effective October 1, 2011, one or more subsidiaries of the Company completed the acquisition of Tomball Regional Hospital (358 licensed beds) located in Tomball, Texas. The total cash consideration paid for fixed assets and working capital was approximately $192.0 million and $17.5 million, respectively, with additional consideration of $15.8 million assumed in liabilities, for a total consideration of $225.3 million. Based upon the Company’s preliminary purchase price allocation relating to this acquisition as of December 31, 2011, approximately $30.8 million of goodwill has been recorded. The preliminary allocation of the purchase price has been determined by the Company based on available information and is subject to settling amounts related to purchased working capital and final appraisals of tangible and intangible assets. Adjustments to the purchase price allocation are not expected to be material.

Effective May 1, 2011, one or more subsidiaries of the Company completed the acquisition of Mercy Health Partners based in Scranton, Pennsylvania, which is a healthcare system comprised of two acute care hospitals, a long-term acute care facility and other healthcare providers. This healthcare system includes Regional Hospital of Scranton (198 licensed beds) located in Scranton, Pennsylvania, and Tyler Memorial Hospital (48 licensed beds) located in Tunkhannock, Pennsylvania. This healthcare system also includes a long-term acute care facility, Special Care Hospital (67 licensed beds) located in Nanticoke, Pennsylvania, as well as several outpatient clinics and other ancillary facilities. The total cash consideration paid for fixed assets was approximately $150.8 million, with additional consideration of $12.3 million assumed in liabilities as well as a credit applied at closing of $2.1 million for negative acquired working capital, for a total consideration of $161.0 million. Based upon the Company’s final purchase price allocation relating to this acquisition, as of December 31, 2011 approximately $43.1 million of goodwill has been recorded.

Effective October 1, 2010, one or more subsidiaries of the Company completed the acquisition of Forum Health based in Youngstown, Ohio, a healthcare system of two acute care hospitals, a rehabilitation hospital and other healthcare providers. This healthcare system includes Northside Medical Center (355 licensed beds) located in Youngstown, Ohio, and Trumbull Memorial Hospital (311 licensed beds) located in Warren, Ohio. This healthcare system also includes Hillside Rehabilitation Hospital (69 licensed beds) located in Warren, Ohio, as well as several outpatient clinics and other ancillary facilities. The total cash consideration paid for fixed assets and working capital was approximately $93.4 million and $27.8 million, respectively, with additional consideration of $40.3 million assumed in liabilities, for a total consideration of $161.5 million. Based upon the Company’s final purchase price allocation relating to this acquisition, as of December 31, 2011 approximately $8.1 million of goodwill has been recorded.

Effective October 1, 2010, one or more subsidiaries of the Company completed the acquisition of Bluefield Regional Medical Center (240 licensed beds) located in Bluefield, West Virginia. The total cash consideration paid for fixed assets was approximately $35.4 million, with additional consideration of $8.9 million assumed in liabilities as well as a credit applied at closing of $1.8 million for negative acquired working capital, for a total consideration of $42.5 million. Based upon the Company’s final purchase price allocation relating to this acquisition, as of December 31, 2011 approximately $2.4 million of goodwill has been recorded.

Effective July 7, 2010, one or more subsidiaries of the Company completed the acquisition of Marion Regional Healthcare System located in Marion, South Carolina. This healthcare system includes Marion Regional Hospital (124 licensed beds), an acute care hospital, along with a related skilled nursing facility and other ancillary services. The total cash consideration paid for fixed assets and working capital was approximately $18.6 million and $5.8 million, respectively, with additional consideration of $3.9 million assumed in liabilities, for a total consideration of $28.3 million. Based upon the Company’s final purchase price allocation relating to this acquisition, as of December 31, 2011 no goodwill has been recorded.

On December 31, 2009, one or more subsidiaries of the Company completed an affiliation transaction providing $54.2 million of financing to Rockwood Clinic, P.S., a multi-specialty clinic with 32 locations across the inland northwest region of eastern Washington and western Idaho. This transaction was accounted for as a purchase business combination.

Effective June 1, 2009, one or more subsidiaries of the Company acquired from Akron General Medical Center the remaining 20% noncontrolling interest in Massillon Community Health System, LLC not then owned by a subsidiary of the Company. This entity indirectly owns and operates Affinity Medical Center of Massillon, Ohio. The purchase price for this noncontrolling interest was $1.1 million in cash. Affinity Medical Center is now wholly-owned by these subsidiaries of the Company.

Effective April 30, 2009, one or more subsidiaries of the Company acquired Wyoming Valley Health Care System in Wilkes-Barre, Pennsylvania. This healthcare system includes Wilkes-Barre General Hospital (392 licensed beds), an acute care hospital located in Wilkes-Barre, Pennsylvania, and First Hospital Wyoming Valley, a behavioral health facility located in Kingston, Pennsylvania, as well as other outpatient and ancillary services. The total consideration for fixed assets and working capital of Wyoming Valley Health Care System was approximately $133.7 million and $30.0 million, respectively, with additional consideration of $25.4 million assumed in liabilities and net of $14.2 million of cash in acquired bank accounts, for a total consideration of $174.9 million. Based upon the Company’s final purchase price allocation relating to this acquisition, as of December 31, 2011 no goodwill has been recorded.

Effective April 1, 2009, one or more subsidiaries of the Company acquired from Share Foundation the remaining 50% equity interest in MCSA L.L.C., an entity in which one or more subsidiaries of the Company previously had a 50% unconsolidated noncontrolling interest. One or more subsidiaries of the Company provided MCSA L.L.C. certain management services. This acquisition resulted in these subsidiaries of the Company owning a 100% equity interest in that entity. MCSA L.L.C. owns and operates Medical Center of South Arkansas (166 licensed beds) in El Dorado, Arkansas. The purchase price was $26.0 million in cash. As of the acquisition date, one or more subsidiaries of the Company had a liability to MCSA L.L.C. of $14.1 million, as a result of a cash management agreement previously entered into with the hospital. Upon completion of the acquisition, this liability was eliminated in consolidation.

Effective February 1, 2009, one or more subsidiaries of the Company completed the acquisition of Siloam Springs Memorial Hospital (73 licensed beds), located in Siloam Springs, Arkansas, from the City of Siloam Springs. The total consideration for this hospital consisted of approximately $0.1 million paid in cash for working capital and approximately $1.0 million of assumed liabilities. In connection with this acquisition, a subsidiary of the Company entered into a lease agreement for the existing hospital and agreed to build a replacement facility at this location, with construction required to commence by February 2011 and be completed by February 2013. As security for this obligation, a subsidiary of the Company deposited $1.6 million into an escrow account at closing and agreed to deposit an additional $1.6 million by February 1, 2010, which the Company’s subsidiary deposited in January 2010. If the construction of the replacement facility is not completed within the agreed time frame, the escrow balance will be remitted to the City of Siloam Springs. If the construction of the replacement facility is completed by February 2013 as planned, the escrow balance will be returned to the Company’s subsidiary.

Approximately $16.0 million, $8.9 million and $6.7 million of acquisition costs related to prospective and closed acquisitions were expensed during the years ended December 31, 2011, 2010 and 2009, respectively.

The table below summarizes the allocations of the purchase price (including assumed liabilities) for the above acquisition transactions (in thousands):

	2011		2010
Current assets	$	26,017	$	46,842
Property and equipment		280,639		169,209
Goodwill		73,923		10,537
Intangible assets		2,260		1,730
Other long-term assets		3,497		—
Liabilities		28,089		51,124

The operating results of the foregoing transactions have been included in the consolidated statements of income from their respective dates of acquisition, including operating revenues, net of contractual allowances and discounts (but before the provision for bad debts) of $169.7 million for the year ended December 31, 2011 from hospital acquisitions that closed during 2011 and $139.0 million for the year ended December 31, 2010 from hospital acquisitions that closed during 2010. The following pro forma combined summary of operations of the Company gives effect to using historical information of the operations of the acquisitions in 2011 and 2010 discussed above as if the transactions had occurred as of January 1, 2010 (in thousands, except per share data):

	Year Ended December 31,
	2011		2010
	(Unaudited)
Pro forma net operating revenues	$	12,180,247	$	11,792,639
Pro forma net income		173,697		259,978
Pro forma net income per share:
Basic	$	1.93	$	2.83
Diluted	$	1.92	$	2.80

Pro forma adjustments to net income include adjustments to depreciation and amortization expense, net of the related tax effect, based on the estimated fair value assigned to the long-lived assets acquired, and to interest expense, net of the related tax effect, assuming the increase in long-term debt used to fund the acquisitions had occurred as of January 1, 2010. These pro forma results are not necessarily indicative of the actual results of operations.

Additionally, during 2011, the Company paid approximately $57.9 million to acquire the operating assets and related businesses of certain physician practices, clinics and other ancillary businesses that operate within the communities served by its hospitals. In connection with these acquisitions, the Company allocated approximately $13.1 million of the consideration paid to property and equipment, $2.9 million to net working capital, $1.6 million to other intangible assets and the remainder, approximately $40.3 million consisting of intangible assets that do not qualify for separate recognition, was allocated to goodwill. These acquisition transactions were accounted for as purchase business combinations.

During 2010, the Company paid approximately $67.4 million to acquire the operating assets and related businesses of certain physician practices, clinics and other ancillary businesses that operate within the communities served by its hospitals. In connection with these acquisitions, the Company allocated approximately $35.6 million of the consideration paid to property and equipment and the remainder, approximately $35.4 million consisting of intangible assets that do not qualify for separate recognition, was allocated to goodwill. These acquisition transactions were accounted for as purchase business combinations.

Discontinued Operations

Effective February 1, 2011, the Company sold Willamette Community Medical Group, which is a physician clinic operating as Oregon Medical Group, located in Springfield, Oregon, to Oregon Healthcare Resources, LLC, for $14.6 million in cash; this business had a carrying amount of net assets, including an allocation of reporting unit goodwill, of $19.7 million.

Effective September 1, 2011, the Company sold Southcrest Hospital, located in Tulsa, Oklahoma, Claremore Regional Hospital, located in Claremore, Oklahoma, and other related healthcare assets affiliated with those hospitals to Hillcrest Healthcare System, part of Ardent Health Services, for approximately $154.2 million in cash. The carrying amount of the net assets sold in this transaction, including an allocation of reporting unit goodwill, was approximately $193.0 million.

Effective October 22, 2011, the Company sold Cleveland Regional Medical Center, located in Cleveland, Texas, and other related healthcare assets affiliated with the hospital to New Directions Health Systems, LLC for approximately $0.9 million in cash. The carrying amount of the net assets sold in this transaction, including an allocation of reporting unit goodwill, was approximately $14.2 million.

Effective March 31, 2009, the Company, through its subsidiaries Triad-Denton Hospital LLC and Triad-Denton Hospital LP, completed the settlement of pending litigation, which resulted in the sale of its ownership interest in a partnership, which owned and operated Presbyterian Hospital of Denton (255 licensed beds) in Denton, Texas, to Texas Health Resources for $103.0 million in cash. Also as part of the settlement, these subsidiaries transferred certain hospital related assets to Texas Health Resources.

In connection with management’s decision to sell the previously mentioned facilities, the Company has classified the results of operations of the above mentioned hospitals as discontinued operations in the accompanying consolidated statements of income. As of December 31, 2011, no hospitals are held for sale.

Net operating revenues and income from discontinued operations for the respective periods are as follows (in thousands):

	Year Ended December 31,
	2011			2010			2009
Net operating revenues	$	144,546		$	305,562		$	348,796
(Loss) income from operations of entities sold before income taxes		(12,390	)		(10,460	)		1,492
Impairment of hospitals sold		(51,695	)		—			—
Loss on sale, net		(4,301	)		—			(644	)
(Loss) income from discontinued operations before income taxes		(68,386	)		(10,460	)		848
(Benefit from) provision for income taxes		(10,115	)		(3,688	)		282
(Loss) income from discontinued operations, net of taxes	$	(58,271	)	$	(6,772	)	$	566

Interest expense was allocated to discontinued operations based on sales proceeds available for debt repayment.

The long-lived assets and allocated goodwill at December 31, 2010 of the hospitals and physician clinic sold during the year ended December 31, 2011 totaled approximately $182.7 million, and are included in the accompanying consolidated balance sheet in other assets, net.

XML

Accounting for Stock-Based Compensation

12 Months Ended

Dec. 31, 2011

Accounting for Stock-Based Compensation [Abstract]

Accounting for Stock-Based Compensation

2. Accounting for Stock-Based Compensation

Stock-based compensation awards are granted under the Community Health Systems, Inc. Amended and Restated 2000 Stock Option and Award Plan, amended and restated as of March 24, 2009 (the “2000 Plan”), and the Community Health Systems, Inc. 2009 Stock Option and Award Plan, amended and restated as of March 18, 2011 (the “2009 Plan”).

The 2000 Plan allows for the grant of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code (“IRC”), as well as stock options which do not so qualify, stock appreciation rights, restricted stock, restricted stock units, performance-based shares or units and other share awards. Prior to being amended in 2009, the 2000 Plan also allowed for the grant of phantom stock. Persons eligible to receive grants under the 2000 Plan include the Company’s directors, officers, employees and consultants. To date, all options granted under the 2000 Plan have been “nonqualified” stock options for tax purposes. Generally, vesting of these granted options occurs in one-third increments on each of the first three anniversaries of the award date. Options granted prior to 2005 have a 10-year contractual term, options granted in 2005 through 2007 have an eight-year contractual term and options granted in 2008 or later have a 10-year contractual term. As of December 31, 2011, 332,747 shares of unissued common stock were reserved for future grants under the 2000 Plan.

The 2009 Plan provides for the grant of incentive stock options intended to qualify under Section 422 of the IRC and for the grant of stock options which do not so qualify, stock appreciation rights, restricted stock, restricted stock units, performance-based shares or units and other share awards. Persons eligible to receive grants under the 2009 Plan include the Company’s directors, officers, employees and consultants. To date, all options granted under the 2009 Plan have been “nonqualified” stock options for tax purposes. Options granted in 2011 have a 10-year contractual term. As of December 31, 2011, 2,773,489 shares of unissued common stock were reserved for future grants under the 2009 Plan.

The exercise price of all options granted is equal to the fair value of the Company’s common stock on the option grant date.

The following table reflects the impact of total compensation expense related to stock-based equity plans on the reported operating results for the respective periods (in thousands):

	Year Ended December 31,
	2011			2010			2009
Effect on income from continuing operations before income taxes	$	(42,542	)	$	(38,779	)	$	(44,501	)
Effect on net income	$	(27,014	)	$	(24,625	)	$	(26,986	)

At December 31, 2011, $59.0 million of unrecognized stock-based compensation expense was expected to be recognized over a weighted-average period of 22 months. Of that amount, $13.1 million relates to outstanding unvested stock options expected to be recognized over a weighted-average period of 22 months and $45.9 million relates to outstanding unvested restricted stock, restricted stock units and phantom shares expected to be recognized over a weighted-average period of 22 months. There were no modifications to awards during the years ended December 31, 2011, 2010 and 2009.

The fair value of stock options was estimated using the Black-Scholes option pricing model with the following assumptions during the years ended December 31, 2011, 2010 and 2009:

	Year Ended December 31,
	2011			2010			2009
Expected volatility		33.8	%		33.7	%		40.7	%
Expected dividends		0			0			0
Expected term		4 years			3.1 years			4 years
Risk-free interest rate		1.63	%		1.41	%		1.64	%

In determining the expected term, the Company examined concentrations of option holdings and historical patterns of option exercises and forfeitures, as well as forward-looking factors, in an effort to determine if there were any discernable employee populations. From this analysis, the Company identified two primary employee populations, one consisting of certain senior executives and the other consisting of substantially all other recipients.

The expected volatility rate was estimated based on historical volatility. In determining expected volatility, the Company also reviewed the market-based implied volatility of actively traded options of its common stock and determined that historical volatility utilized to estimate the expected volatility rate did not differ significantly from the implied volatility.

The expected term computation is based on historical exercise and cancellation patterns and forward-looking factors, where present, for each population identified. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of the grant. The pre-vesting forfeiture rate is based on historical rates and forward-looking factors for each population identified. The Company adjusts the estimated forfeiture rate to its actual experience.

Options outstanding and exercisable under the 2000 Plan and 2009 Plan as of December 31, 2011, and changes during each of the years in the three-year period ended December 31, 2011 were as follows (in thousands, except share and per share data):

	Shares			Weighted - Average Exercise Price		Weighted - Average Remaining Contractual Term		Aggregate Intrinsic Value as of December 31, 2011
Outstanding at December 31, 2008		8,764,084		$	30.97
Granted		1,313,000			19.43
Exercised		(680,898	)		18.74
Forfeited and cancelled		(442,105	)		31.27
Outstanding at December 31, 2009		8,954,081			30.19
Granted		1,447,500			33.89
Exercised		(2,194,862	)		25.88
Forfeited and cancelled		(372,387	)		29.80
Outstanding at December 31, 2010		7,834,332			32.08
Granted		1,505,000			35.87
Exercised		(623,341	)		30.34
Forfeited and cancelled		(326,849	)		33.69
Outstanding at December 31, 2011		8,389,142		$	32.83		5.3 years	$	120
Exercisable at December 31, 2011		5,884,262		$	32.74		3.9 years	$	74

The weighted-average grant date fair value of stock options granted during the years ended December 31, 2011, 2010 and 2009, was $10.07, $8.47 and $6.61, respectively. The aggregate intrinsic value (the number of in-the-money stock options multiplied by the difference between the Company’s closing stock price on the last trading day of the reporting period ($17.45) and the exercise price of the respective stock options) in the table above represents the amount that would have been received by the option holders had all option holders exercised their options on December 31, 2011. This amount changes based on the market value of the Company’s common stock. The aggregate intrinsic value of options exercised during the years ended December 31, 2011, 2010 and 2009 was $6.1 million, $28.9 million and $7.6 million, respectively. The aggregate intrinsic value of options vested and expected to vest approximates that of the outstanding options.

The Company has also awarded restricted stock under the 2000 Plan and the 2009 Plan to its directors and employees of certain subsidiaries. The restrictions on these shares generally lapse in one-third increments on each of the first three anniversaries of the award date. Certain of the restricted stock awards granted to the Company’s senior executives contain a performance objective that must be met in addition to any vesting requirements. If the performance objective is not attained, the awards will be forfeited in their entirety. Once the performance objective has been attained, restrictions will lapse in one-third increments on each of the first three anniversaries of the award date. Notwithstanding the above-mentioned performance objectives and vesting requirements, the restrictions will lapse earlier in the event of death, disability or termination of employment by the Company for any reason other than for cause of the holder of the restricted stock, or change in control of the Company. Restricted stock awards subject to performance standards are not considered outstanding for purposes of determining earnings per share until the performance objectives have been satisfied.

Restricted stock outstanding under the 2000 Plan and the 2009 Plan as of December 31, 2011, and changes during each of the years in the three-year period ended December 31, 2011 was as follows:

	Shares			Weighted - Average Grant Date Fair Value
Unvested at December 31, 2008		1,684,207		$	35.57
Granted		1,188,814			18.45
Vested		(965,478	)		37.08
Forfeited		(10,002	)		32.52
Unvested at December 31, 2009		1,897,541			24.09
Granted		1,099,000			33.83
Vested		(860,749	)		27.04
Forfeited		(10,501	)		27.84
Unvested at December 31, 2010		2,125,291			27.92
Granted		1,109,949			37.57
Vested		(1,009,959	)		27.40
Forfeited		(17,669	)		35.68
Unvested at December 31, 2011		2,207,612			32.95

Phantom stock and restricted stock units (“RSUs”) have been granted to the Company’s outside directors under the 2000 Plan and the 2009 Plan. On February 25, 2009, each of the Company’s outside directors received a grant under the 2000 Plan of 7,151 shares of phantom stock. On May 19, 2009, the newly elected outside director received a grant under the 2000 Plan of 7,151 RSUs. On February 24, 2010, six of the Company’s seven outside directors each received a grant under the 2000 Plan of 4,130 RSUs and one outside director, who did not stand for reelection in 2010, did not receive such a grant. On February 23, 2011, each of the Company’s outside directors received a grant under the 2009 Plan of 3,688 RSUs. Vesting of these shares of phantom stock and RSUs occurs in one-third increments on each of the first three anniversaries of the award date.

Phantom stock and RSUs outstanding as of December 31, 2011, and changes during each of the years in the three-year period ended December 31, 2011 were as follows:

	Shares			Weighted - Average Grant Date Fair Value
Unvested at December 31, 2008		—		$	—
Phantom Stock Granted February 25, 2009		42,906			18.18
RSUs Granted May 19, 2009		7,151			25.27
Vested		—			—
Forfeited		—			—
Unvested at December 31, 2009		50,057			19.19
RSUs Granted February 24, 2010		24,780			33.90
Vested		(21,449	)		18.97
Forfeited		—			—
Unvested at December 31, 2010		53,388			26.11
RSUs Granted February 23, 2011		22,128			37.96
Vested		(22,560	)		24.68
Forfeited		—			—
Unvested at December 31, 2011		52,956			31.67

Under the Directors’ Fees Deferral Plan, the Company’s outside directors may elect to receive share equivalent units in lieu of cash for their directors’ fees. These share equivalent units are held in the plan until the director electing to receive the share equivalent units retires or otherwise terminates his/her directorship with the Company. Share equivalent units are converted to shares of common stock of the Company at the time of distribution based on the closing market price of the Company’s common stock on that date. The following table represents the amount of directors’ fees which were deferred during each of the respective periods, and the number of share equivalent units into which such directors’ fees would have converted had each of the directors who had deferred such fees retired or terminated his/her directorship with the Company as of the end of the respective periods (in thousands, except share equivalent units):

	Year Ended December 31,
	2011		2010		2009
Directors’ fees earned and deferred into plan	$	220	$	180	$	80
Share equivalent units		9,974		5,207		3,284

At December 31, 2011, a total of 28,775 share equivalent units were deferred in the plan with an aggregate fair value of $0.5 million, based on the closing market price of the Company’s common stock at December 31, 2011 of $17.45.

XML

Segment Information

12 Months Ended

Dec. 31, 2011

Segment Information [Abstract]

Segment Information

14. Segment Information

The Company operates in three distinct operating segments, represented by hospital operations (which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services), home care agency operations (which provide in-home outpatient care), and hospital management services (which provides executive management and consulting services to non-affiliated acute care hospitals). Only the hospital operations segment meets the criteria as a separate reportable segment. The financial information for the home care agencies and hospital management services segments do not meet the quantitative thresholds for a separate identifiable reportable segment and are combined into the corporate and all other reportable segment.

The accounting policies of the segments are the same as those described in the summary of significant accounting policies in Note 1. Expenditures for segment assets are reported on an accrual basis, which includes amounts that are reflected in accounts payable. Substantially all depreciation and amortization as reflected in the consolidated statements of income relates to the hospital operations segment.

The distribution between reportable segments of the Company’s net operating revenues, income from continuing operations before income taxes, expenditures for segment assets and total assets is summarized in the following tables (in thousands):

	Year Ended December 31,
	2011			2010			2009
Net operating revenues:
Hospital operations	$	11,631,382		$	10,813,383		$	10,065,457
Corporate and all other		274,830			279,039			268,044
	$	11,906,212		$	11,092,422		$	10,333,501
Income from continuing operations before income taxes:
Hospital operations	$	720,215		$	662,303		$	590,389
Corporate and all other		(246,668	)		(143,409	)		(142,727	)
	$	473,547		$	518,894		$	447,662
Expenditures for segment assets:
Hospital operations	$	737,391		$	646,509		$	543,969
Corporate and all other		39,322			20,869			15,105
	$	776,713		$	667,378		$	559,074
	December 31,
	2011			2010
Total assets:
Hospital operations	$	13,984,964		$	13,398,314
Corporate and all other		1,223,876			1,299,809
	$	15,208,840		$	14,698,123

XML

Employee Benefit Plans

12 Months Ended

Dec. 31, 2011

Employee Benefit Plans [Abstract]

Employee Benefit Plans

10. Employee Benefit Plans

The Company maintains various benefit plans, including defined contribution plans, defined benefit plans and deferred compensation plans, for which the Company’s subsidiary, CHS, is the plan sponsor. On January 1, 2009, the plan sponsor merged the Triad Hospitals, Inc. Retirement Savings Plan, the Abilene Physicians Group 401(k) Plan and Trust and the Regional Employee Assistance Program 401(k) Plan with and into the CHS/Community Health Systems, Inc. 401(k) Plan. Contemporaneously, the plan sponsor also established the CHS/Community Health Systems, Inc. Retirement Savings Plan, and the accounts of substantially all participants in the CHS/Community Health Systems, Inc. 401(k) Plan were transferred subsequently to the CHS/Community Health Systems, Inc. Retirement Savings Plan. Employees of certain subsidiaries whose employment is covered by collective bargaining agreements have remained participants in the CHS/Community Health Systems, Inc. 401(k) Plan. The plan sponsor also established the CHS/Community Health Systems, Inc. Spokane 401(k) Plan on January 1, 2009 for the exclusive benefit of certain employees of the Deaconess Medical Center and Valley Hospital and Medical Center and their beneficiaries. Effective October 1, 2010, the plan sponsor established the CHS/Community Health Systems, Inc. Standard 401(k) Plan for the benefit of employees at the three hospitals acquired in Youngstown, Ohio and Warren, Ohio and their beneficiaries. Total expense to the Company under the 401(k) plans was $101.7 million, $95.8 million and $69.5 million for the years ended December 31, 2011, 2010 and 2009, respectively.

The Company maintains unfunded deferred compensation plans that allow participants to defer receipt of a portion of their compensation. The liability under the deferred compensation plans was $71.4 million and $73.2 million as of December 31, 2011 and 2010, respectively. The Company had assets of $72.5 million and $75.0 million as of December 31, 2011 and 2010, respectively, in a non-qualified plan trust generally designated to pay benefits of the deferred compensation plans, consisting of trading securities of $30.5 million and $35.1 million as of December 31, 2011 and 2010, respectively, and company-owned life insurance contracts of $42.0 million and $39.9 million as of December 31, 2011 and 2010, respectively.

The Company maintains the Community Health Systems Retirement Income Plan, which is a defined benefit, non-contributory pension plan that covers certain employees at three of its hospitals (“Pension Plan”). The Pension Plan provides benefits to covered individuals satisfying certain age and service requirements. Employer contributions to the Pension Plan are in accordance with the minimum funding requirements of the Employee Retirement Income Security Act of 1974, as amended. The Company expects to contribute $2.7 million to the Pension Plan in 2012. The Company also provides an unfunded Supplemental Executive Retirement Plan (“SERP”) for certain members of its executive management. The Company uses a December 31 measurement date for the benefit obligations and a January 1 measurement date for its net periodic costs for both the Pension Plan and SERP. Variances from actuarially assumed rates will result in increases or decreases in benefit obligations, net periodic cost and funding requirements in future periods. The Company had available-for-sale securities in a rabbi trust generally designated to pay benefits of the SERP in the amounts of $31.6 million at both December 31, 2011 and 2010. These amounts are included in other assets, net on the consolidated balance sheets.

A summary of the benefit obligations and funded status for the Company’s Pension and SERP Plans at December 31, 2011 and 2010 follows (in thousands):

	Pension Plan						SERP
	2011			2010			2011			2010
Change in benefit obligation:
Benefit obligation, beginning of year	$	39,682		$	42,245		$	73,840		$	61,079
Service cost		1,315			1,169			5,197			4,661
Interest cost		2,159			2,051			3,434			3,728
Curtailment		—			(7,407	)		—			—
Plan amendment		—			—			—			(24	)
Actuarial loss		8,480			2,082			5,225			4,396
Benefits paid		(524	)		(458	)		(1,546	)		—
Benefit obligation, end of year		51,112			39,682			86,150			73,840
Change in plan assets:
Fair value of assets, beginning of year		34,354			28,583			—			—
Actual return on plan assets		(536	)		3,895			—			—
Employer contributions		1,758			2,334			—			—
Benefits paid		(524	)		(458	)		—			—
Fair value of assets, end of year		35,052			34,354			—			—
Unfunded status	$	(16,060	)	$	(5,328	)	$	(86,150	)	$	(73,840	)

A summary of the amounts recognized in the accompanying consolidated balance sheets at December 31, 2011 and 2010 follows (in thousands):

	Pension Plan						SERP
	2011			2010			2011			2010
Noncurrent asset	$	—		$	—		$	—		$	—
Current liability		—			—			(1,191	)		(1,546	)
Noncurrent liability		(16,060	)		(5,328	)		(84,959	)		(72,294	)
Net amount recognized in the consolidated balance sheets	$	(16,060	)	$	(5,328	)	$	(86,150	)	$	(73,840	)

A summary of the amounts recognized in AOCL at December 31, 2011 and 2010 follows (in thousands):

	Pension Plan						SERP
	2011			2010			2011		2010
Prior service (credit) cost	$	(1,076	)	$	(1,217	)	$	7,084	$	8,781
Net actuarial loss		13,260			1,474			23,779		20,087
Total amount recognized in AOCL	$	12,184		$	257		$	30,863	$	28,868

A summary of the plans’ benefit obligation in excess of the fair value of plan assets at December 31, 2011 and 2010 follows (in thousands):

	Pension Plan				SERP
	2011		2010		2011		2010
Projected benefit obligation	$	51,112	$	39,682	$	86,150	$	73,840
Accumulated benefit obligation		50,745		39,380		66,172		47,304
Fair value of plan assets		35,052		34,354		—		—

A summary of the weighted-average assumptions used by the Company to determine benefit obligations as of December 31 follows:

	Pension Plan						SERP
	2011			2010			2011			2010
Discount rate		4.33	%		5.50	%		4.00	%		4.75	%
Annual salary increases		4.50	%		4.50	%		4.00	%		4.00	%

A summary of net periodic cost and other amounts recognized in OCI for the years ended December 31, 2011, 2010 and 2009 follows (in thousands):

	Pension Plan									SERP
	2011			2010			2009			2011			2010			2009
Service cost	$	1,315		$	1,169		$	3,886		$	5,197		$	4,661		$	4,437
Interest cost		2,159			2,051			2,200			3,434			3,728			2,469
Expected return on plan assets		(2,771	)		(2,497	)		(1,683	)		—			—			—
Amortization of unrecognized prior service (credit) cost		(141	)		(38	)		689			1,696			1,697			1,704
Amortization of net loss		—			—			426			1,533			1,459			1
Curtailment credit		—			(1,910	)		—			—			—			—
Net periodic cost		562			(1,225	)		5,518			11,860			11,545			8,611
Prior service (credit) cost arising during period		—			(2,770	)		—			—			(24	)		—
Net (gain) loss arising during period		11,787			(2,044	)		(4,595	)		5,225			4,396			13,028
Amortization of:
Prior service cost (credit)		141			38			(689	)		(1,696	)		(1,697	)		(1,704	)
Net actuarial gain		—			—			(426	)		(1,533	)		(1,459	)		(1	)
Total amount recognized in OCI		11,928			(4,776	)		(5,710	)		1,996			1,216			11,323
Total recognized in net periodic cost and OCI	$	12,490		$	(6,001	)	$	(192	)	$	13,856		$	12,761		$	19,934

A summary of the expected amortization amounts to be included in net periodic cost for 2012 are as follows (in thousands):

	Pension Plan			SERP
Prior service (credit) cost	$	(141	)	$	1,696
Actuarial loss		978			2,028

A summary of the weighted-average assumptions used by the Company to determine net periodic cost for the years ended December 31, 2011, 2010 and 2009 follows:

	Pension Plan									SERP
	2011			2010			2009			2011			2010			2009
Discount rate		5.50	%		5.99	%		5.96	%		4.75	%		6.00	%		6.00	%
Rate of compensation increase		4.50	%		4.50	%		4.00	%		4.00	%		5.00	%		5.00	%
Expected long term rate of return on assets		8.00	%		8.50	%		8.50	%		N/A			N/A			N/A

The Company’s weighted-average asset allocations by asset category at December 31, 2011 and 2010 follows:

	Pension Plan						SERP
	2011			2010			2011	2010
Equity securities		100	%		100	%	N/A	N/A
Debt securities		0	%		0	%	N/A	N/A
Total		100	%		100	%	N/A	N/A

The Pension Plan assets are invested in mutual funds with an underlying investment allocation of 60% equity securities and 40% debt securities. All assets are measured at fair value using quoted prices in active markets and therefore are classified as Level 1 measurements in the fair value hierarchy. The expected long-term rate of return for the Pension Plan assets is based on current expected long-term inflation and historical rates of return on equities and fixed income securities, taking into account the investment policy under the plan. The expected long-term rate of return is weighted based on the target allocation for each asset category. Equity securities are expected to return between 7% and 11% and debt securities are expected to return between 3% and 6%. The Company expects the Pension Plan asset managers will provide a premium of approximately 0% to 1.5% per annum to the respective market benchmark indices.

The Company’s investment policy related to the Pension Plan is to provide for growth of capital with a moderate level of volatility by investing in accordance with the target asset allocations stated above. The Company reviews its investment policy, including its target asset allocations, on a semi-annual basis to determine whether any changes in market conditions or amendments to its pension plans require a revision to its investment policy.

The estimated future benefit payments reflecting future service as of December 31, 2011 for the Pension Plan and SERP plan follows (in thousands):

Year Ending	Pension Plan		SERP
2012	$	1,236	$	1,191
2013		1,511		1,392
2014		1,701		10,782
2015		1,820		3,365
2016		2,237		44,737
2017-2021		15,115		40,072

XML

Employee Benefit Plans (Details 2) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010
Pension Plan [Member]
Summary of AOCL
Prior service (credit) cost	$ (1,076)	$ (1,217)
Net actuarial loss	13,260	1,474
Total amount recognized in AOCL	12,184	257
SERP [Member]
Summary of AOCL
Prior service (credit) cost	7,084	8,781
Net actuarial loss	23,779	20,087
Total amount recognized in AOCL	$ 30,863	$ 28,868

XML

Long-Term Debt

12 Months Ended

Dec. 31, 2011

Long-Term Debt [Abstract]

Long-Term Debt

6. Long-Term Debt

Long-term debt consists of the following (in thousands):

	December 31,
	2011			2010
Credit Facility:
Term loans	$	5,949,383		$	5,999,337
Revolving credit loans		30,000			—
8 7/ 8% Senior Notes due 2015		1,777,617			2,784,331
8% Senior Notes due 2019		1,000,000			—
Capital lease obligations (see Note 9)		48,361			51,731
Other		41,143			36,122
Total debt		8,846,504			8,871,521
Less current maturities		(63,706	)		(63,139	)
Total long-term debt	$	8,782,798		$	8,808,382

Credit Facility

In connection with the consummation of the acquisition of Triad in July 2007, the Company’s wholly-owned subsidiary CHS/Community Health Systems, Inc. (“CHS”) obtained approximately $7.2 billion of senior secured financing under a new credit facility (the “Credit Facility”) with a syndicate of financial institutions led by Credit Suisse, as administrative agent and collateral agent, and issued approximately $3.0 billion aggregate principal amount of 8 ⁷ /8% senior notes due 2015 (the “ 8 ⁷/8% Senior Notes”). The Company used the net proceeds of $3.0 billion from the 8 ⁷/8% Senior Notes offering and the net proceeds of approximately $6.1 billion of term loans under the Credit Facility to acquire the outstanding shares of Triad, to refinance certain of Triad’s indebtedness and the Company’s indebtedness, to complete certain related transactions, to pay certain costs and expenses of the transactions and for general corporate uses. Specifically, the Company repaid its outstanding debt under the previously outstanding credit facility, the 6.50% senior subordinated notes due 2012 and certain of Triad’s existing indebtedness.

The Credit Facility consisted of an approximately $6.1 billion funded term loan facility with a maturity of seven years, a $400 million delayed draw term loan facility with a maturity of seven years and a $750 million revolving credit facility with a maturity of six years. As of December 31, 2007, the $400 million delayed draw term loan facility had been reduced to $300 million at the request of CHS. During the fourth quarter of 2008, $100 million of the delayed draw term loan was drawn by CHS, reducing the delayed draw term loan availability to $200 million at December 31, 2008. In January 2009, CHS drew down the remaining $200 million of the delayed draw term loan. The revolving credit facility also includes a subfacility for letters of credit and a swingline subfacility. The Credit Facility requires quarterly amortization payments of each term loan facility equal to 0.25% of the outstanding amount of the term loans. On November 5, 2010, CHS entered into an amendment and restatement of its existing Credit Facility. The amendment extended by two and a half years, until January 25, 2017, the maturity date of $1.5 billion of the existing term loans under the Credit Facility and increased the pricing on these term loans to LIBOR plus 350 basis points. If more than $50 million of the 8 ⁷/8 % Senior Notes remain outstanding on April 15, 2015, without having been refinanced, then the maturity date for the extended term loans will be accelerated to April 15, 2015. The amendment also increases CHS’s ability to issue additional indebtedness under the uncommitted incremental facility to $1.0 billion from $600 million, permits CHS to issue Term A term loans under the incremental facility, and provides up to $2.0 billion of borrowing capacity from receivable transactions, an increase of $0.5 billion, of which $1.7 billion would be required to be used for repayment of existing term loans. In addition, effective February 2, 2012, the Company completed an additional amendment and restatement of the Credit Facility, which extended by two and a half years, until January 25, 2017, the maturity date of an additional $1.6 billion of the existing non-extended term loans under the Credit Facility and increased the pricing on the newly extended term loans by 125 basis points. The maturity date of the balance of the term loans of approximately $2.9 billion remained unchanged at July 25, 2014.

The term loan facility must be prepaid in an amount equal to (1) 100% of the net cash proceeds of certain asset sales and dispositions by the Company and its subsidiaries, subject to certain exceptions and reinvestment rights, (2) 100% of the net cash proceeds of issuances of certain debt obligations or receivables based financing by the Company and its subsidiaries, subject to certain exceptions, and (3) 50%, subject to reduction to a lower percentage based on the Company’s leverage ratio (as defined in the Credit Facility generally as the ratio of total debt on the date of determination to the Company’s EBITDA, as defined, for the four quarters most recently ended prior to such date), of excess cash flow (as defined) for any year, commencing in 2008, subject to certain exceptions. Voluntary prepayments and commitment reductions are permitted in whole or in part, without any premium or penalty, subject to minimum prepayment or reduction requirements.

The obligor under the Credit Facility is CHS. All of the obligations under the Credit Facility are unconditionally guaranteed by the Company and certain existing and subsequently acquired or organized domestic subsidiaries. All obligations under the Credit Facility and the related guarantees are secured by a perfected first priority lien or security interest in substantially all of the assets of the Company, CHS and each subsidiary guarantor, including equity interests held by the Company, CHS or any subsidiary guarantor, but excluding, among others, the equity interests of non-significant subsidiaries, syndication subsidiaries, securitization subsidiaries and joint venture subsidiaries.

The loans under the Credit Facility bear interest on the outstanding unpaid principal amount at a rate equal to an applicable percentage plus, at CHS’s option, either (a) an Alternate Base Rate (as defined) determined by reference to the greater of (1) the Prime Rate (as defined) announced by Credit Suisse or (2) the Federal Funds Effective Rate (as defined) plus one-half of 1.0% or (3) the adjusted London Interbank Offered Rate (“LIBOR”) on such day for a three-month interest period commencing on the second business day after such day plus 1%, or (b) a reserve adjusted LIBOR for dollars (Eurodollar rate) (as defined). The applicable percentage for Alternate Base Rate loans is 1.25% for term loans due 2014 and is 2.25% for term loans due 2017. The applicable percentage for Eurodollar rate loans is 2.25% for term loans due 2014 and 3.5% for term loans due 2017. The applicable percentage for revolving loans is 1.25% for Alternate Base Rate revolving loans and 2.25% for Eurodollar revolving loans, in each case subject to reduction based on the Company’s leverage ratio. Loans under the swingline subfacility bear interest at the rate applicable to Alternate Base Rate loans under the revolving credit facility.

CHS has agreed to pay letter of credit fees equal to the applicable percentage then in effect with respect to Eurodollar rate loans under the revolving credit facility times the maximum aggregate amount available to be drawn under all letters of credit outstanding under the subfacility for letters of credit. The issuer of any letter of credit issued under the subfacility for letters of credit will also receive a customary fronting fee and other customary processing charges. CHS was initially obligated to pay commitment fees of 0.50% per annum (subject to reduction based upon the Company’s leverage ratio) on the unused portion of the revolving credit facility. For purposes of this calculation, swingline loans are not treated as usage of the revolving credit facility. With respect to the delayed draw term loan facility, CHS was also obligated to pay commitment fees of 0.50% per annum for the first nine months after the closing of the Credit Facility, 0.75% per annum for the next three months after such nine-month period and thereafter, 1.0% per annum. In each case, the commitment fee was paid on the unused amount of the delayed draw term loan facility. After the draw down of the remaining $200 million of the delayed draw term loan in January 2009, CHS no longer pays any commitment fees for the delayed draw term loan facility. CHS paid arrangement fees on the closing of the Credit Facility and pays an annual administrative agent fee.

The Credit Facility contains customary representations and warranties, subject to limitations and exceptions, and customary covenants restricting the Company’s and its subsidiaries’ ability, subject to certain exceptions, to, among other things (1) declare dividends, make distributions or redeem or repurchase capital stock, (2) prepay, redeem or repurchase other debt, (3) incur liens or grant negative pledges, (4) make loans and investments and enter into acquisitions and joint ventures, (5) incur additional indebtedness or provide certain guarantees, (6) make capital expenditures, (7) engage in mergers, acquisitions and asset sales, (8) conduct transactions with affiliates, (9) alter the nature of the Company’s businesses, (10) grant certain guarantees with respect to physician practices, (11) engage in sale and leaseback transactions or (12) change the Company’s fiscal year. The Company is also required to comply with specified financial covenants (consisting of a leverage ratio and an interest coverage ratio) and various affirmative covenants.

Events of default under the Credit Facility include, but are not limited to, (1) CHS’s failure to pay principal, interest, fees or other amounts under the credit agreement when due (taking into account any applicable grace period), (2) any representation or warranty proving to have been materially incorrect when made, (3) covenant defaults subject, with respect to certain covenants, to a grace period, (4) bankruptcy events, (5) a cross default to certain other debt, (6) certain undischarged judgments (not paid within an applicable grace period), (7) a change of control, (8) certain ERISA-related defaults and (9) the invalidity or impairment of specified security interests, guarantees or subordination provisions in favor of the administrative agent or lenders under the Credit Facility.

On April 2, 2009, the Company paid down $110.4 million of its term loans under the Credit Facility. Of this amount, $85.0 million was paid down as required under the terms of the Credit Facility with the net proceeds received from the sale of the ownership interest in the partnership that owned and operated Presbyterian Hospital of Denton. This resulted in a loss from early extinguishment of debt of $1.1 million with an after-tax impact of $0.7 million recorded in discontinued operations for the year ended December 31, 2009. The remaining $25.4 million was paid on the term loans as required under the terms of the Credit Facility with the net proceeds received from the sale of various other assets. This resulted in a loss from early extinguishment of debt of $0.3 million with an after-tax impact of $0.2 million recorded in continuing operations for the year ended December 31, 2009.

As of December 31, 2011, a $750 million revolving credit facility was available to the Company for working capital and general corporate purposes under the Credit Facility, with $37.7 million of the revolving credit facility being set aside for outstanding letters of credit and $30.0 million outstanding at December 31, 2011. CHS has the ability to amend the Credit Facility to provide for one or more tranches of term loans in an aggregate principal amount of $1.0 billion, which CHS has not yet accessed. CHS also has the ability to add up to $300 million of borrowing capacity from receivable transactions (including securitizations) under the Credit Facility, which has not yet been accessed. As of December 31, 2011, the weighted-average interest rate under the Credit Facility, excluding swaps, was 3.5%.

The term loans are scheduled to be paid with principal payments for future years as follows (in thousands):

Year	Amount
2012	$	49,874
2013		49,874
2014		4,413,385
2015		15,000
2016		15,000
Thereafter		1,406,250
Total	$	5,949,383

As of December 31, 2011 and 2010, the Company had letters of credit issued, primarily in support of potential insurance-related claims and certain bonds, of approximately $37.7 million and $81.9 million, respectively.

8  ⁷/8% Senior Notes due 2015

The 8 ⁷/8% Senior Notes were issued by CHS in connection with the Triad acquisition in the principal amount of approximately $3.0 billion. The 8 ⁷/8 % Senior Notes will mature on July 15, 2015. The 8 ⁷/8% Senior Notes bear interest at the rate of 8.875% per annum, payable semiannually in arrears on January 15 and July 15, commencing January 15, 2008. Interest on the 8 ⁷ /8% Senior Notes accrues from the date of original issuance. Interest is calculated on the basis of a 360-day year comprised of twelve 30-day months.

On and after July 15, 2011, CHS is entitled, at its option, to redeem all or a portion of the 8 ⁷/8% Senior Notes upon not less than 30 nor more than 60 days’ notice, at the redemption prices (expressed as a percentage of principal amount on the redemption date), plus accrued and unpaid interest, if any, to the redemption date (subject to the right of holders of record on the relevant record date to receive interest due on the relevant interest payment date), if redeemed during the 12-month period commencing on July 15 of the years set forth below:

Period	Redemption Price
2012		102.219	%
2013 and thereafter		100.000	%

Pursuant to a registration rights agreement entered into at the time of the issuance of the 8  ⁷/8% Senior Notes, as a result of an exchange offer made by CHS, substantially all of the 8 ⁷/8% Senior Notes issued in July 2007 were exchanged in November 2007 for new notes (the “Exchange Notes”) having terms substantially identical in all material respects to the 8  ⁷/8% Senior Notes (except that the Exchange Notes were issued under a registration statement pursuant to the 1933 Act). References to the 8 ⁷/8 % Senior Notes shall also be deemed to include the Exchange Notes unless the context provides otherwise.

On December 7, 2011, CHS completed the cash tender offer for $1.0 billion of the $2.8 billion aggregate principal amount of 8 ⁷/8% Senior Notes due 2015. This resulted in a loss from early extinguishment of debt of $66.0 million with an after-tax impact of $42.0 million recorded in continuing operations for the year ended December 31, 2011.

8% Senior Notes due 2019

On November 22, 2011, CHS completed its offering of $1.0 billion aggregate principal amount of 8% Senior Notes due 2019 (the “8% Senior Notes”), which were issued in a private placement. The net proceeds from this issuance, together with available cash on hand, were used to finance the purchase of $1.0 billion aggregate principal amount of CHS’ outstanding 8  ⁷/8% Senior Notes due 2015 and related fees and expenses. The 8% Senior Notes bear interest at 8% per annum, payable semiannually in arrears on May 15 and November 15, commencing May 15, 2012. Interest on the 8% Senior Notes accrues from the date of original issuance. Interest is calculated on the basis of a 360-day year comprised of twelve 30-day months.

Except as set forth below, CHS is not entitled to redeem the 8% Senior Notes prior to November 15, 2015.

On and after November 15, 2015, CHS is entitled, at its option, to redeem all or a portion of the 8% Senior Notes upon not less than 30 nor more than 60 days’ notice, at the redemption prices (expressed as a percentage of principal amount on the redemption date), plus accrued and unpaid interest, if any, to the redemption date (subject to the right of holders of record on the relevant record date to receive interest due on the relevant interest payment date), if redeemed during the 12-month period commencing on November 15 of the years set forth below:

Period	Redemption Price
2015		104.000	%
2016		102.000	%
2017 and thereafter		100.000	%

In addition, any time prior to November 15, 2014, CHS is entitled, at its option, on one or more occasions to redeem the 8% Senior Notes (which include additional 8% Senior Notes, if any) in an aggregate principal amount not to exceed 35% of the aggregate principal amount of the 8% Senior Notes (which includes additional 8% Senior Notes, if any) originally issued at a redemption price (expressed as a percentage of principal amount) of 108.000%, plus accrued and unpaid interest to the redemption date, with the Net Cash Proceeds (as defined in the indenture governing the 8% Senior Notes) from one or more Public Equity Offerings (as defined in the indenture governing the 8% Senior Notes) (provided that if the Public Equity Offering is an offering by the Company, a portion of the Net Cash Proceeds thereof equal to the amount required to redeem any such 8% Senior Notes is contributed to the equity capital of CHS); provided, however, that:

1) at least 65% of such aggregate principal amount of 8% Senior Notes originally issued remains outstanding immediately after the occurrence of each such redemption (other than the 8% Senior Notes held, directly or indirectly, by the Company or its subsidiaries); and

2) each such redemption occurs within 180 days after the date of the related Public Equity Offering.

CHS is entitled, at its option, to redeem the 8% Senior Notes, in whole or in part, at any time prior to November 15, 2015, upon not less than 30 or more than 60 days notice, at a redemption price equal to 100% of the principal amount of 8% Senior Notes redeemed plus the Applicable Premium (as defined), and accrued and unpaid interest, if any, as of the applicable redemption date.

Other Debt. As of December 31, 2011, other debt consisted primarily of the mortgage obligation on the Company’s corporate headquarters and other obligations maturing in various installments through 2020.

To limit the effect of changes in interest rates on a portion of the Company’s long-term borrowings, the Company is a party to 34 separate interest swap agreements in effect at December 31, 2011, with an aggregate notional amount of approximately $4.9 billion. On each of these swaps, the Company receives a variable rate of interest based on the three-month LIBOR in exchange for the payment of a fixed rate of interest. The Company currently pays, on a quarterly basis, a margin above LIBOR of 225 basis points for the outstanding balance of revolver loans and term loans due in 2014 and 350 basis points for term loans due in 2017 under the Credit Facility. See Note 7 for additional information regarding these swaps.

As of December 31, 2011, the scheduled maturities of long-term debt outstanding, including capital lease obligations for each of the next five years and thereafter are as follows (in thousands):

Year	Amount
2012	$	63,706
2013		87,993
2014		4,417,745
2015		1,796,304
2016		18,644
Thereafter		2,462,112
Total	$	8,846,504

The Company paid interest of $680.7 million, $650.7 million and $657.0 million on borrowings during the years ended December 31, 2011, 2010 and 2009, respectively.

XML

Goodwill and Other Intangible Assets (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Goodwill [Line Items]
Goodwill	$ 4,264,845,000	$ 4,150,247,000	$ 4,157,927,000
Goodwill and Other Intangibles Assets (Textual) [Abstract]
Intangible assets acquired during the year	3,800,000
Gross, intangible asset subject to amortization	60,000,000	60,500,000
Net, intangible asset subject to amortization	30,600,000	36,100,000
Net, intangible asset not subject to amortization	46,900,000	44,400,000
Weighted-average amortization	9
Gross carrying amount of capitalized software	451,000,000	356,500,000
Net carrying amount considering accumulated amortization	241,300,000	209,400,000
Capitalized costs for internal-use software in development stage	109,300,000
Other Intangible Assets [Member]
Finite-Lived Intangible Assets [Line Items]
Amortization expense	8,100,000	12,200,000	13,000,000
Amortization expense for 2012	7,400,000
Amortization expense for 2013	4,700,000
Amortization expense for 2014	2,900,000
Amortization expense for 2015	2,500,000
Amortization expense for 2016	2,300,000
Amortization expense, thereafter	10,800,000
Significant system conversions [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated amortization period	8
Capitalized Internal Use Software [Member]
Finite-Lived Intangible Assets [Line Items]
Amortization expense	70,500,000	48,200,000	32,500,000
Amortization expense for 2012	81,000,000
Amortization expense for 2013	70,800,000
Amortization expense for 2014	35,100,000
Amortization expense for 2015	17,300,000
Amortization expense for 2016	15,400,000
Amortization expense, thereafter	21,700,000
Estimated amortization period	3
Hospital Operations Reporting Unit [Member]
Goodwill [Line Items]
Goodwill	4,200,000,000	4,100,000,000
Home Care Agency Operations Reporting Unit [Member]
Goodwill [Line Items]
Goodwill	40,500,000	35,900,000
Hospital Management Services Reporting Unit [Member]
Goodwill [Line Items]
Goodwill	$ 33,300,000	$ 33,300,000

XML

Goodwill and Other Intangible Assets

12 Months Ended

Dec. 31, 2011

Goodwill and Other Intangible Assets [Abstract]

Goodwill and Other Intangible Assets

4. Goodwill and Other Intangible Assets

The changes in the carrying amount of goodwill are as follows (in thousands):

	Year Ended December 31,
	2011		2010
Balance, beginning of year	$	4,150,247	$	4,157,927
Goodwill acquired as part of acquisitions during the year		114,473		45,975
Consideration adjustments and purchase price allocation adjustments for prior year’s acquisitions		125		(3,997	)
Goodwill related to the hospital operations reporting unit assigned to the disposal group classified as held for sale in 2011		—		(49,658	)
Balance, end of year	$	4,264,845	$	4,150,247

Goodwill is allocated to each identified reporting unit, which is defined as an operating segment or one level below the operating segment (referred to as a component of the entity). Management has determined that the Company’s operating segments meet the criteria to be classified as reporting units. At December 31, 2011, the hospital operations reporting unit, the home care agency operations reporting unit and the hospital management services reporting unit had approximately $4.2 billion, $40.5 million and $33.3 million, respectively, of goodwill. At December 31, 2010, the hospital operations reporting unit, the home care agency operations reporting unit and the hospital management services reporting unit had approximately $4.1 billion, $35.9 million and $33.3 million, respectively, of goodwill.

Goodwill is evaluated for impairment at the same time every year and when an event occurs or circumstances change that, more likely than not, reduce the fair value of the reporting unit below its carrying value. There is a two-step method for determining goodwill impairment. Step one is to compare the fair value of the reporting unit with the unit’s carrying amount, including goodwill. If this test indicates the fair value is less than the carrying value, then step two is required to compare the implied fair value of the reporting unit’s goodwill with the carrying value of the reporting unit’s goodwill. The Company has selected September 30 as its annual testing date. The Company performed its last annual goodwill evaluation as of September 30, 2011, which evaluation took place during the fourth quarter of 2011. No impairment was indicated by this evaluation.

The Company estimates the fair value of the related reporting units using both a discounted cash flow model as well as an EBITDA multiple model. The cash flow forecasts are adjusted by an appropriate discount rate based on the Company’s estimate of a market participant’s weighted-average cost of capital. These models are both based on the Company’s best estimate of future revenues and operating costs and are reconciled to the Company’s consolidated market capitalization, with consideration of the amount a potential acquirer would be required to pay, in the form of a control premium, in order to gain sufficient ownership to set policies, direct operations and control management decisions.

Approximately $3.8 million of intangible assets other than goodwill were acquired during the year ended December 31, 2011. The gross carrying amount of the Company’s other intangible assets subject to amortization was $60.0 million and $60.5 million at December 31, 2011 and 2010, respectively, and the net carrying amount was $30.6 million and $36.1 million at December 31, 2011 and 2010, respectively. The carrying amount of the Company’s other intangible assets not subject to amortization was $46.9 million and $44.4 million at December 31, 2011 and 2010. Other intangible assets are included in other assets, net on the Company’s consolidated balance sheets. Substantially all of the Company’s intangible assets are contract-based intangible assets related to operating licenses, management contracts, or non-compete agreements entered into in connection with prior acquisitions.

The weighted-average amortization period for the intangible assets subject to amortization is approximately nine years. There are no expected residual values related to these intangible assets. Amortization expense on these intangible assets was $8.1 million, $12.2 million and $13.0 million during the years ended December 31, 2011, 2010 and 2009, respectively. Amortization expense on intangible assets is estimated to be $7.4 million in 2012, $4.7 million in 2013, $2.9 million in 2014, $2.5 million in 2015, $2.3 million in 2016 and $10.8 million thereafter.

The gross carrying amount of capitalized software for internal use was approximately $451.0 million and $356.5 million at December 31, 2011 and 2010, respectively, and the net carrying amount considering accumulated amortization was approximately $241.3 million and $209.4 million at December 31, 2011 and 2010, respectively. The estimated amortization period for capitalized internal-use software is generally three years, except for capitalized costs related to significant system conversions, which is generally eight years. There is no expected residual value for capitalized internal-use software. At December 31, 2011, there was approximately $109.3 million of capitalized costs for internal-use software that will begin amortization once the software project is complete and ready for its intended use. Amortization expense for capitalized internal-use software was $70.5 million, $48.2 million and $32.5 million during the years ended December 31, 2011, 2010 and 2009, respectively. Amortization expense for capitalized internal-use software is estimated to be $81.0 million in 2012, $70.8 million in 2013, $35.1 million in 2014, $17.3 million in 2015, $15.4 million in 2016 and $21.7 million thereafter.

XML

Income Taxes

12 Months Ended

Dec. 31, 2011

Income Taxes [Abstract]

Income Taxes

5. Income Taxes

The provision for income taxes for income from continuing operations consists of the following (in thousands):

	Year Ended December 31,
	2011		2010		2009
Current:
Federal	$	23,020	$	54,986	$	93,543
State		7,601		11,208		13,577
		30,621		66,194		107,120
Deferred:
Federal		105,771		92,628		16,012
State		1,261		4,859		18,719
		107,032		97,487		34,731
Total provision for income taxes for income from continuing operations	$	137,653	$	163,681	$	141,851

The following table reconciles the differences between the statutory federal income tax rate and the effective tax rate (dollars in thousands):

	Year Ended December 31,
	2011						2010						2009
	Amount			%			Amount			%			Amount			%
Provision for income taxes at statutory federal rate	$	165,741			35.0	%	$	181,474			35.0	%	$	156,682			35.0	%
State income taxes, net of federal income tax benefit		8,212			1.7			8,847			1.7			9,080			2.0
Release of unrecognized tax benefit		(6,509	)		(1.3	)		—			—			—			—
Net income attributable to noncontrolling interests		(26,486	)		(5.6	)		(23,960	)		(4.6	)		(22,006	)		(4.9	)
Change in valuation allowance		—			0.0			(910	)		(0.2	)		1,113			0.3
Federal and state tax credits		(3,788	)		(0.8	)		(2,246	)		(0.4	)		(4,241	)		(0.9	)
Deferred tax revaluation		—			—			—			—			(2,996	)		(0.7	)
Other		483			0.1			476			0.1			4,219			0.9
Provision for income taxes and effective tax rate for income from continuing operations	$	137,653			29.1	%	$	163,681			31.6	%	$	141,851			31.7	%

Deferred income taxes are based on the estimated future tax effects of differences between the financial statement and tax bases of assets and liabilities under the provisions of the enacted tax laws. Deferred income taxes as of December 31, 2011 and 2010 consist of (in thousands):

	December 31,
	2011					2010
	Assets			Liabilities		Assets			Liabilities
Net operating loss and credit carryforwards	$	140,825		$	—	$	131,093		$	—
Property and equipment		—			727,366		—			685,089
Self-insurance liabilities		113,640			—		91,246			—
Intangibles		—			201,396		—			169,860
Investments in unconsolidated affiliates		—			62,112		—			48,353
Other liabilities		—			22,050		—			27,045
Long-term debt and interest		—			24,115		—			29,191
Accounts receivable		11,435			—		60,026			—
Accrued expenses		49,575			—		53,842			—
Other comprehensive income		128,170			—		156,597			—
Stock-based compensation		28,894			—		25,472			—
Deferred compensation		42,668			—		41,703			—
Other		57,158			—		24,963			—
		572,365			1,037,039		584,942			959,538
Valuation allowance		(150,254	)		—		(126,644	)		—
Total deferred income taxes	$	422,111		$	1,037,039	$	458,298		$	959,538

The Company’s deferred tax assets and liabilities have been adjusted in 2010 for the effects of its filed 2009 tax return, having the effect of increasing total deferred tax assets by $12.5 million, increasing total deferred tax liabilities by $11.4 million, and decreasing prepaid income taxes by $1.1 million. The effects of the adjustments did not impact income tax expense, and their effects on previously issued consolidated financial statements were not material.

The Company believes that the net deferred tax assets will ultimately be realized, except as noted below. Its conclusion is based on its estimate of future taxable income and the expected timing of temporary difference reversals. The Company has state net operating loss carry forwards of approximately $3.3 billion, which expire from 2012 to 2031. The Company also has unrecognized deferred tax assets primarily related to interest expense that are included in other comprehensive income. If recognized, additional state net operating losses will be created which the Company does not expect to be able to utilize prior to the expiration of the carryforward period. A valuation allowance of approximately $24.9 million has been recognized for those items. With respect to the deferred tax liability pertaining to intangibles, as included above, goodwill purchased in connection with certain of the Company’s business acquisitions is amortizable for income tax reporting purposes. However, for financial reporting purposes, there is no corresponding amortization allowed with respect to such purchased goodwill.

The valuation allowance increased by $23.6 million during the year ended December 31, 2011 and increased by $11.5 million during the year ended December 31, 2010. In addition to amounts previously discussed, the change in valuation allowance relates to a redetermination of the amount of, and realizability of, net operating losses in certain state income tax jurisdictions.

The total amount of unrecognized benefit that would impact the effective tax rate, if recognized, was approximately $0.8 million as of December 31, 2011. A total of approximately $0.3 million of interest and penalties is included in the amount of liability for uncertain tax positions at December 31, 2011. During the year ended December 31, 2011, the Company decreased liabilities for uncertain tax positions by $5.4 million, including the favorable resolution of an issue on appeal with the IRS related to its tax examination of Triad tax returns, and decreased interest and penalties by approximately $1.1 million. It is the Company’s policy to recognize interest and penalties related to unrecognized benefits in its consolidated statements of income as income tax expense. During the year ended December 31, 2011, the Company released $2.3 million for income taxes and $0.7 million for accrued interest of its liability for uncertain tax positions, as a result of the expiration of the statute of limitations pertaining to tax positions taken in prior years.

It is possible the amount of unrecognized tax benefit could change in the next twelve months as a result of a lapse of the statute of limitations and settlements with taxing authorities; however, the Company does not anticipate the change will have a material impact on its consolidated results of operations or consolidated financial position.

The following is a tabular reconciliation of the total amount of unrecognized tax benefit for the years ended December 31, 2011, 2010 and 2009 (in thousands):

	Year Ended December 31,
	2011			2010			2009
Unrecognized tax benefit, beginning of year	$	7,458		$	9,234		$	15,630
Gross (decreases) increases — purchase business combination		—			—			(4,173	)
Gross increases — tax positions in prior period		349			70			—
Reductions — tax positions in prior period		(3,469	)		(1,833	)		—
Lapse of statute of limitations		(3,575	)		—			(663	)
Settlements		(134	)		(13	)		(1,560	)
Unrecognized tax benefit, end of year	$	629		$	7,458		$	9,234

The Company, or one of its subsidiaries, files income tax returns in the United States federal jurisdiction and various state jurisdictions. The Company has extended the federal statute of limitations for Triad for the tax periods ended December 31, 1999, December 31, 2000, April 30, 2001, June 30, 2001, December 31, 2001, December 31, 2002 and December 31, 2003. The IRS has concluded its examination of the federal tax return of Triad for the tax periods ended December 31, 2004, December 31, 2005, December 31, 2006 and July 25, 2007. In September 2011, the Company reached a favorable resolution of an issue on appeal with the IRS related to its examination of Triad’s tax returns. As a result, the Company recognized a tax benefit of $4.0 million, which is reflected in the accompanying consolidated statement of income for the year ended December 31, 2011. With few exceptions, the Company is no longer subject to state income tax examinations for years prior to 2008 and federal income tax examinations with respect to Community Health Systems, Inc. federal returns for years prior to 2007. The Company’s federal income tax returns for the 2007 and 2008 tax years are currently under examination by the IRS. The Company believes the results of this examination will not be material to its consolidated results of operations or consolidated financial position. In connection with the Company’s 2007 and 2008 IRS examinations, the IRS has taken exception to the timing of the Company’s malpractice expense deductions. Management believes that the Company’s deduction timing is appropriate, and will work to resolve this item over the next 24 months. If management is unable to sustain the current timing of the Company’s deduction, then it would be subject to interest and penalty costs. Management does not consider this matter to have met the recognition criteria to be considered an uncertain tax position for which a reserve is necessary.

The Company paid income taxes, net of refunds received, of $26.5 million, $128.2 million and $57.3 million during the years ended December 31, 2011, 2010 and 2009.

XML

Fair Value of Financial Instruments

12 Months Ended

Dec. 31, 2011

Fair Value of Financial Instruments [Abstract]

Fair Values of Financial Instruments

7. Fair Values of Financial Instruments

The fair value of financial instruments has been estimated by the Company using available market information as of December 31, 2011 and 2010, and valuation methodologies considered appropriate. The estimates presented are not necessarily indicative of amounts the Company could realize in a current market exchange (in thousands):

	December 31,
	2011				2010
	Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value
Assets:
Cash and cash equivalents	$	129,865	$	129,865	$	299,169	$	299,169
Available-for-sale securities		31,582		31,582		31,570		31,570
Trading securities		30,486		30,486		35,092		35,092
Liabilities:
Credit Facility		5,979,383		5,780,877		5,999,337		5,882,124
8 7/ 8% Senior Notes		1,777,617		1,842,322		2,784,331		2,923,548
8% Senior Notes		1,000,000		995,000		—		—
Other debt		41,143		41,143		36,122		36,122

Cash and cash equivalents. The carrying amount approximates fair value due to the short-term maturity of these instruments (less than three months).

Available-for-sale securities. Estimated fair value is based on closing price as quoted in public markets.

Trading securities. Estimated fair value is based on closing price as quoted in public markets.

Credit Facility. Estimated fair value is based on information from the Company’s bankers regarding relevant pricing for trading activity among the Company’s lending institutions.

8 ⁷ /8% Senior Notes. Estimated fair value is based on the average bid and ask price as quoted by the bank who served as underwriters in the sale of these notes.

8% Senior notes. Estimated fair value is based on the average bid and ask price as quoted by the bank who served as underwriters in the sale of these notes.

Other debt. The carrying amount of all other debt approximates fair value due to the nature of these obligations.

Interest rate swaps. The fair value of interest rate swap agreements is the amount at which they could be settled, based on estimates calculated by the Company using a discounted cash flow analysis based on observable market inputs and validated by comparison to estimates obtained from the counterparty. The Company incorporates credit valuation adjustments (“CVAs”) to appropriately reflect both its own nonperformance or credit risk and the respective counterparty’s nonperformance or credit risk in the fair value measurements. In adjusting the fair value of its interest rate swap agreements for the effect of nonperformance or credit risk, the Company has considered the impact of any netting features included in the agreements.

The Company assesses the effectiveness of its hedge instruments on a quarterly basis. For the years ended December 31, 2011 and 2010, the Company completed an assessment of the cash flow hedge instruments and determined the hedges to be highly effective. The Company has also determined that the ineffective portion of the hedges do not have a material effect on the Company’s consolidated financial position, operations or cash flows. The counterparties to the interest rate swap agreements expose the Company to credit risk in the event of nonperformance. However, at December 31, 2011, each swap agreement entered into by the Company was in a net liability position so that the Company would be required to make the net settlement payments to the counterparties; the Company does not anticipate nonperformance by those counterparties. The Company does not hold or issue derivative financial instruments for trading purposes.

Interest rate swaps consisted of the following at December 31, 2011:

Swap #	Notional Amount (in 000’s)		Fixed Interest Rate			Termination Date		Fair Value of Liability (in 000’s)
1		100,000		3.8470	%		January 4, 2012		30
2		100,000		3.8510	%		January 4, 2012		30
3		100,000		3.8560	%		January 4, 2012		30
4		200,000		3.7260	%		January 8, 2012		152
5		200,000		3.5065	%		January 16, 2012		281
6		250,000		5.0185	%		May 30, 2012		4,509
7		150,000		5.0250	%		May 30, 2012		2,709
8		200,000		4.6845	%		September 11, 2012		5,574
9		100,000		3.3520	%		October 23, 2012		2,161
10		125,000		4.3745	%		November 23, 2012		4,104
11		75,000		4.3800	%		November 23, 2012		2,466
12		150,000		5.0200	%		November 30, 2012		5,900
13		200,000		2.2420	%		February 28, 2013		3,550
14		100,000		5.0230	%		May 30, 2013		5,952
15		300,000		5.2420	%		August 6, 2013		21,085
16		100,000		5.0380	%		August 30, 2013		6,967
17		50,000		3.5860	%		October 23, 2013		2,505
18		50,000		3.5240	%		October 23, 2013		2,451
19		100,000		5.0500	%		November 30, 2013		7,948
20		200,000		2.0700	%		December 19, 2013		5,080
21		100,000		5.2310	%		July 25, 2014		10,706
22		100,000		5.2310	%		July 25, 2014		10,707
23		200,000		5.1600	%		July 25, 2014		21,073
24		75,000		5.0405	%		July 25, 2014		7,685
25		125,000		5.0215	%		July 25, 2014		12,752
26		100,000		2.6210	%		July 25, 2014		4,436
27		100,000		3.1100	%		July 25, 2014		5,612
28		100,000		3.2580	%		July 25, 2014		5,968
29		200,000		2.6930	%		October 26, 2014		9,916
30		300,000		3.4470	%		August 8, 2016		27,728
31		200,000		3.4285	%		August 19, 2016		18,401
32		100,000		3.4010	%		August 19, 2016		9,099
33		200,000		3.5000	%		August 30, 2016		19,048
34		100,000		3.0050	%		November 30, 2016		7,613

The Company is exposed to certain risks relating to its ongoing business operations. The risk managed by using derivative instruments is interest rate risk. Interest rate swaps are entered into to manage interest rate fluctuation risk associated with the term loans in the Credit Facility. Companies are required to recognize all derivative instruments as either assets or liabilities at fair value in the consolidated statement of financial position. The Company designates its interest rate swaps as cash flow hedges. For derivative instruments that are designated and qualify as cash flow hedges, the effective portion of the gain or loss on the derivative is reported as a component of OCI and reclassified into earnings in the same period or periods during which the hedged transactions affect earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current earnings.

Assuming no change in December 31, 2011 interest rates, approximately $131.8 million of interest expense resulting from the spread between the fixed and floating rates defined in each interest rate swap agreement will be recognized during the next 12 months. If interest rate swaps do not remain highly effective as a cash flow hedge, the derivatives’ gains or losses resulting from the change in fair value reported through OCI will be reclassified into earnings.

The following tabular disclosure provides the amount of pre-tax loss recognized in the consolidated balance sheets as a component of OCI during the years ended December 31, 2011 and 2010 (in thousands):

Derivatives in Cash Flow Hedging Relationships	Amount of Pre-Tax Loss Recognized in OCI on Derivative (Effective Portion) Year Ended December 31,
	2011			2010
Interest rate swaps	($	122,686	)	($	239,893	)

The following tabular disclosure provides the location of the effective portion of the pre-tax loss reclassified from accumulated other comprehensive loss (“AOCL”) into interest expense on the consolidated statements of income during the years ended December 31, 2011 and 2010 (in thousands):

	Amount of Pre-Tax Loss Reclassified from AOCL into Income (Effective Portion) Year Ended December 31,
Location of Loss Reclassified from AOCL into Income (Effective Portion)	2011		2010
Interest expense, net	$	208,985	$	215,399

The fair values of derivative instruments in the consolidated balance sheets as of December 31, 2011 and 2010 were as follows (in thousands):

Asset Derivatives

Liability Derivatives

December 31, 2011

December 31, 2010

December 31, 2011

December 31, 2010

Balance Sheet Location

Fair Value

Balance Sheet Location

Fair Value

Balance Sheet Location

Fair Value

Balance Sheet Location

Fair Value

Other Derivatives designated as hedging instruments

Other assets, net

$

—

Other assets, net

$

—

Other long-term liabilities

$

254,228

Other long-term liabilities

$

340,526

XML

Income Taxes (Details 3) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Reconciliation of the total amount of unrecognized tax benefit
Unrecognized tax benefit, beginning of year	$ 7,458	$ 9,234	$ 15,630
Gross (decreases) increases purchase business combination	0		(4,173)
Gross increases in tax positions in prior period	349	70
Reductions of tax positions in prior period	(3,469)	(1,833)
Lapse of statute of limitations	(3,575)		(663)
Settlements	(134)	(13)	(1,560)
Unrecognized tax benefit, end of year	$ 629	$ 7,458	$ 9,234

XML

Employee Benefit Plans (Details 3) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010
Pension Plan [Member]
Plans' benefit obligation in excess of the fair value of plan assets
Projected benefit obligation	$ 51,112	$ 39,682
Accumulated benefit obligation	50,745	39,380
Fair value of plan assets	35,052	34,354
SERP [Member]
Plans' benefit obligation in excess of the fair value of plan assets
Projected benefit obligation	86,150	73,840
Accumulated benefit obligation	66,172	47,304
Fair value of plan assets	$ 0	$ 0

XML

Long-Term Debt (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010
Long Term Debt
Total debt	$ 8,846,504	$ 8,871,521
Less current maturities	(63,706)	(63,139)
Long-term debt	8,782,798	8,808,382
Term Loans [Member]
Long Term Debt
Total debt	5,949,383	5,999,337
Tax-exempt bonds [Member]
Long Term Debt
Total debt	30,000
Capital Lease Obligations [Member]
Long Term Debt
Total debt	48,361	51,731
Other [Member]
Long Term Debt
Total debt	41,143	36,122
8.875% Senior Noted Due 2015 [Member]
Long Term Debt
Total debt	1,777,617	2,784,331
8% Senior Notes Due 2019 [Member]
Long Term Debt
Total debt	$ 1,000,000

XML

Subsequent Events (Details) (USD $)				12 Months Ended
	Feb. 02, 2012	Feb. 02, 2012 Amended credit agreement [Member]	Dec. 31, 2011 Moses Taylor and Mid-Valley Hospital [Member]	Dec. 31, 2011 Moses Taylor Hospital [Member] Bed	Dec. 31, 2011 Mid-Valley Hospital [Member] Bed	Dec. 31, 2011 Memorial Health Systems Hospital [Member] Bed
Subsequent Events (Textual) [Abstract]
Cash paid for working capital			$ 10,000,000
Cash paid for long - lived assets			152,000,000
Number of licensed beds				217	25	100
Applicable percentage for rate loan	1.25%
Extension of term loan under credit agreement		1,600,000,000
Balance of term loans with unchanged maturity date	$ 2,900,000,000

XML

Income Taxes (Details 2) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010
Assets
Net operating loss and credit carryforwards	$ 140,825	$ 131,093
Self-insurance liabilities	113,640	91,246
Accounts receivable	11,435	60,026
Accrued expenses	49,575	53,842
Other comprehensive income	128,170	156,597
Stock-based compensation	28,894	25,472
Deferred compensation	42,668	41,703
Other	57,158	24,963
Deferred income tax assets, Gross	572,365	584,942
Valuation allowance	(150,254)	(126,644)
Total deferred income taxes, Assets	422,111	458,298
Liabilities
Property and equipment	727,366	685,089
Intangibles	201,396	169,860
Investments in unconsolidated affiliates	62,112	48,353
Other liabilities	22,050	27,045
Long-term debt and interest	24,115	29,191
Deferred income tax liabilities, gross	1,037,039	959,538
Valuation allowance	0	0
Total deferred income taxes, Liabilities	$ 1,037,039	$ 959,538

XML

Employee Benefit Plans (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2011 Hospital	Dec. 31, 2010	Dec. 31, 2009
Employee Benefit Plans (Textual)
Available-for-sale securities	$ 31,582,000	$ 31,570,000
Employee Benefit Plans (Additional Textual)
Total expense Community Health System plans	101,700,000	95,800,000	69,500,000
Liability under deferred compensation plans	71,400,000	73,200,000
Asset in non-qualified plan trust	72,500,000	75,000,000
Trading securities	30,486,000	35,092,000
Company owned life insurance contracts	42,000,000	39,900,000
Expected company contribution to Pension Plan in next year	2,700,000
Investment pattern of mutual funds, Equity securities	60.00%
Investment pattern of mutual funds, Debt	40.00%
Number of hospitals covering non contributory pension plan employees	3
Rabbi Trust [Member]
Employee Benefit Plans (Textual)
Available-for-sale securities	$ 31,600,000	$ 31,600,000
Minimum [Member]
Employee Benefit Plans (Textual)
Expected return on equity securities	7.00%
Expected return on debt securities	3.00%
Expected premium over benchmark indices	0.00%
Maximum [Member]
Employee Benefit Plans (Textual)
Expected return on equity securities	11.00%
Expected return on debt securities	6.00%
Expected premium over benchmark indices	1.50%

XML

Long-Term Debt (Tables)

12 Months Ended

Dec. 31, 2011

Long-Term Debt [Abstract]

Components of long term debt

Long-term debt consists of the following (in thousands):

	December 31,
	2011			2010
Credit Facility:
Term loans	$	5,949,383		$	5,999,337
Revolving credit loans		30,000			—
8 7/ 8% Senior Notes due 2015		1,777,617			2,784,331
8% Senior Notes due 2019		1,000,000			—
Capital lease obligations (see Note 9)		48,361			51,731
Other		41,143			36,122
Total debt		8,846,504			8,871,521
Less current maturities		(63,706	)		(63,139	)
Total long-term debt	$	8,782,798		$	8,808,382

Principal payment schedule for Term Loans

The term loans are scheduled to be paid with principal payments for future years as follows (in thousands):

Year	Amount
2012	$	49,874
2013		49,874
2014		4,413,385
2015		15,000
2016		15,000
Thereafter		1,406,250
Total	$	5,949,383

Redemption Price of 8.875 % Senior Notes in Long Term Debt

Period	Redemption Price
2012		102.219	%
2013 and thereafter		100.000	%

Redemption Price of 8 % Senior Notes in Long Term Debt

Period	Redemption Price
2015		104.000	%
2016		102.000	%
2017 and thereafter		100.000	%

Scheduled maturities of long-term debt outstanding, including capital lease

As of December 31, 2011, the scheduled maturities of long-term debt outstanding, including capital lease obligations for each of the next five years and thereafter are as follows (in thousands):

Year	Amount
2012	$	63,706
2013		87,993
2014		4,417,745
2015		1,796,304
2016		18,644
Thereafter		2,462,112
Total	$	8,846,504

XML

Accounting for Stock-Based Compensation (Details 2) (USD $) In Thousands, except Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2011 Y	Dec. 31, 2010	Dec. 31, 2009
Options outstanding and exercisable
Beginning Balance, shares	7,834,332	8,954,081	8,764,084
Granted, Shares	1,505,000	1,447,500	1,313,000
Exercised, Shares	(623,341)	(2,194,862)	(680,898)
Forfeited and cancelled, Shares	(326,849)	(372,387)	(442,105)
Ending Balance, shares	8,389,142	7,834,332	8,954,081
Beginning of Period, Weighted Average Exercise Price	$ 32.08	$ 30.19	$ 30.97
Granted, Weighted Average Exercise Price	$ 35.87	$ 33.89	$ 19.43
Exercised, Weighted Average Exercise Price	$ 30.34	$ 25.88	$ 18.74
Forfeited and cancelled, Weighted Average Exercise Price	$ 33.69	$ 29.80	$ 31.27
End of Period, Weighted Average Exercise Price	$ 32.83	$ 32.08	$ 30.19
Weighted Average Remaining Contractual Term	5.3
Aggregate Intrinsic Value	$ 120
Exercisable, Shares	5,884,262
Exercisable, Weighted Average Exercise Price	$ 32.74
Exercisable, Weighted Average Remaining Contractual Term	3.9
Exercisable, Intrinsic Value	$ 74

XML

Earnings per Share

12 Months Ended

Dec. 31, 2011

Earnings per Share [Abstract]

Earnings Per Share

12. Earnings Per Share

The following table sets forth the components of the numerator and denominator for the computation of basic and diluted earnings per share for income from continuing operations, discontinued operations and net income attributable to Community Health Systems, Inc. common stockholders (in thousands, except share data):

	Year Ended December 31,
	2011			2010			2009
Numerator:
Income from continuing operations, net of taxes	$	335,894		$	355,213		$	305,811
Less: Income from continuing operations attributable to noncontrolling interests, net of taxes		75,675			68,577			62,948
Income from continuing operations attributable to Community Health
Systems, Inc. common stockholders — basic and diluted	$	260,219		$	286,636		$	242,863
(Loss) income from discontinued operations, net of taxes	$	(58,271	)	$	(6,772	)	$	566
Less: (Loss) income from discontinued operations attributable to noncontrolling interests, net of taxes		—			(119	)		279
Loss from discontinued operations attributable to Community Health Systems, Inc. common stockholders - basic and diluted	$	(58,271	)	$	(6,653	)	$	287
Denominator:
Weighted-average number of shares outstanding – basic		89,966,933			91,718,791			90,614,886
Effect of dilutive securities:
Restricted stock awards		327,652			542,488			469,134
Employee stock options		361,554			667,606			422,637
Other equity-based awards		10,209			17,163			10,617
Weighted-average number of shares outstanding – diluted		90,666,348			92,946,048			91,517,274
Dilutive securities outstanding not included in the computation of earnings per share because their effect is antidilutive:
Employee stock options		6,432,281			4,882,338			6,820,393

XML

Quarterly Financial Data (Unaudited)

12 Months Ended

Dec. 31, 2011

Quarterly Financial Data (Unaudited) [Abstract]

Quarterly Financial Data (Unaudited)

17. Quarterly Financial Data (Unaudited)

	Quarter
	1st			2nd			3rd			4th			Total
	(in thousands, except share and per share data)
Year ended December 31, 2011:
Net operating revenues(1)	$	2,954,083		$	3,000,827		$	2,945,477		$	3,005,825		$	11,906,212
Income from continuing operations before income taxes		135,697			137,695			132,517			67,638			473,547
Income from continuing operations		91,605			92,874			95,800			55,615			335,894
Loss from discontinued operations		(13,280	)		(39,327	)		(3,169	)		(2,495	)		(58,271	)
Net income attributable to Community Health Systems, Inc	$	61,324		$	35,389		$	74,304		$	30,931		$	201,948
Basic earnings per share attributable to Community Health Systems, Inc. common stockholders(2):
Continuing operations	$	0.82		$	0.82		$	0.87		$	0.38		$	2.89
Discontinued operations		(0.15	)		(0.43	)		(0.04	)		(0.03	)		(0.65	)
Net income	$	0.67		$	0.39		$	0.83		$	0.35		$	2.24
Diluted earnings per share attributable to Community Health Systems, Inc. common stockholders(2):
Continuing operations	$	0.81		$	0.81		$	0.86		$	0.38		$	2.87
Discontinued operations		(0.14	)		(0.43	)		(0.04	)		(0.03	)		(0.64	)
Net income	$	0.67		$	0.39		$	0.83		$	0.35		$	2.23
Weighted-average number of shares:
Basic		91,008,405			91,130,672			89,412,310			88,344,566			89,966,933
Diluted		92,136,819			91,783,725			89,857,583			88,913,813			90,666,348
Year ended December 31, 2010:
Net operating revenues	$	2,702,111		$	2,713,644		$	2,772,311		$	2,904,356		$	11,092,422
Income from continuing operations before taxes		123,906			131,140			131,328			132,520			518,894
Income from continuing operations		84,357			88,379			88,009			94,468			355,213
Gain (loss) from discontinued operations		639			(2,037	)		(3,155	)		(2,219	)		(6,772	)
Net income attributable to Community Health Systems, Inc	$	70,007		$	70,065		$	70,401		$	69,510		$	279,983
Basic earnings per share attributable to Community Health Systems, Inc. common stockholders(2):
Continuing operations	$	0.76		$	0.77		$	0.80		$	0.79		$	3.13
Discontinued operations		0.01			(0.02	)		(0.03	)		(0.02	)		(0.07	)
Net income	$	0.76		$	0.75		$	0.77		$	0.77		$	3.05
Diluted earnings per share attributable to Community Health Systems, Inc. common stockholders(2):
Continuing operations	$	0.75		$	0.76		$	0.80		$	0.78		$	3.08
Discontinued operations		0.01			(0.02	)		(0.03	)		(0.02	)		(0.07	)
Net income	$	0.75		$	0.74		$	0.76		$	0.76		$	3.01
Weighted-average number of shares:
Basic		91,615,275			93,358,771			91,484,466			90,422,331			91,718,791
Diluted		92,836,451			94,711,919			92,462,702			91,778,801			92,946,048

(1) Net operating revenues for the quarter ended September 30, 2011 have been restated to reflect the reclassification of electronic health records incentive reimbursement, which was changed during the fourth quarter of 2011 as a reduction of operating expenses. This reclassification decreased net operating revenues and operating expenses by $40.2 million, and had no impact on income from continuing operations or net income as previously reported. Management does not believe this reclassification is material.

(2) Total per share amounts may not add due to rounding.

XML

Earnings per Share (Details) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Numerator:
Income from continuing operations, net of taxes	$ 55,615	$ 95,800	$ 92,874	$ 91,605	$ 94,468	$ 88,009	$ 88,379	$ 84,357	$ 335,894	$ 355,213	$ 305,811
Less: Income from continuing operations attributable to noncontrolling interests, net of taxes									75,675	68,577	62,948
Income from continuing operations attributable to Community Health Systems, Inc. common stockholders - basic and diluted									260,219	286,636	242,863
(Loss) Income from discontinued operations, net of taxes	(2,495)	(3,169)	(39,327)	(13,280)	(2,219)	(3,155)	(2,037)	639	(58,271)	(6,772)	566
Less: (loss) income from discontinued operations attributable to noncontrolling interests, net of taxes										(119)	279
Loss from discontinued operations attributable to Community Health Systems, Inc. common stockholders - basic and diluted									$ (58,271)	$ (6,653)	$ 287
Denominator:
Weighted-average number of shares outstanding - basic	88,344,566	89,412,310	91,130,672	91,008,405	90,422,331	91,484,466	93,358,771	91,615,275	89,966,933	91,718,791	90,614,886
Effect of dilutive securities:
Restricted stock awards									327,652	542,488	469,134
Employee stock options									361,554	667,606	422,637
Other equity-based awards									10,209	17,163	10,617
Weighted-average number of shares outstanding - diluted	88,913,813	89,857,583	91,783,725	92,136,819	91,778,801	92,462,702	94,711,919	92,836,451	90,666,348	92,946,048	91,517,274

XML

Accounting for Stock-Based Compensation (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Impact of Total Compensation Expense
Effect on income from continuing operations before income taxes	$ (42,542)	$ (38,779)	$ (44,501)
Effect on net income	$ (27,014)	$ (24,625)	$ (26,986)

XML

Supplemental Condensed Consolidating Financial Information (Details 1) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Condensed Consolidated Statements of Comprehensive Income [Abstract]
Net income	$ 277,623	$ 348,441	$ 306,377
Other comprehensive income, net of income taxes:
Net change in fair value of interest rate swaps	55,145	(15,676)	76,225
Net change in fair value of available-for-sale securities	(960)	3,716	412
Amortization and recognition of unrecognized pension cost components	(7,737)	2,418	(2,447)
Other comprehensive income	46,448	(9,542)	74,190
Comprehensive income	324,071	338,899	380,567
Less: Comprehensive income attributable to noncontrolling interests	75,675	68,458	63,227
Comprehensive income attributable to Community Health Systems, Inc.	248,396	270,441	317,340
Parent Guarantor [Member]
Condensed Consolidated Statements of Comprehensive Income [Abstract]
Net income	201,948	279,983	243,150
Other comprehensive income, net of income taxes:
Net change in fair value of interest rate swaps	55,145	(15,676)	76,225
Net change in fair value of available-for-sale securities	(960)	3,716	412
Amortization and recognition of unrecognized pension cost components	(7,737)	2,418	(2,447)
Other comprehensive income	46,448	(9,542)	74,190
Comprehensive income	248,396	270,441	317,340
Comprehensive income attributable to Community Health Systems, Inc.	248,396	270,441	317,340
Issuer [Member]
Condensed Consolidated Statements of Comprehensive Income [Abstract]
Net income	201,948	279,983	243,150
Other comprehensive income, net of income taxes:
Net change in fair value of interest rate swaps	55,145	(15,676)	76,225
Net change in fair value of available-for-sale securities	(960)	3,716	412
Amortization and recognition of unrecognized pension cost components	(7,737)	2,418	(2,447)
Other comprehensive income	46,448	(9,542)	74,190
Comprehensive income	248,396	270,441	317,340
Comprehensive income attributable to Community Health Systems, Inc.	248,396	270,441	317,340
Other Guarantors [Member]
Condensed Consolidated Statements of Comprehensive Income [Abstract]
Net income	268,607	310,117	256,490
Other comprehensive income, net of income taxes:
Net change in fair value of available-for-sale securities	(960)	3,716	412
Amortization and recognition of unrecognized pension cost components	(7,737)	2,418	(2,447)
Other comprehensive income	(8,697)	6,134	(2,035)
Comprehensive income	259,910	316,251	254,455
Comprehensive income attributable to Community Health Systems, Inc.	259,910	316,251	254,455
Non-Guarantors [Member]
Condensed Consolidated Statements of Comprehensive Income [Abstract]
Net income	133,853	167,802	186,967
Other comprehensive income, net of income taxes:
Comprehensive income	133,853	167,802	186,967
Less: Comprehensive income attributable to noncontrolling interests	75,675	68,458	63,227
Comprehensive income attributable to Community Health Systems, Inc.	58,178	99,344	123,740
Eliminations [Member]
Condensed Consolidated Statements of Comprehensive Income [Abstract]
Net income	(528,733)	(689,444)	(623,380)
Other comprehensive income, net of income taxes:
Net change in fair value of interest rate swaps	(55,145)	15,676	(76,225)
Net change in fair value of available-for-sale securities	1,920	(7,432)	(824)
Amortization and recognition of unrecognized pension cost components	15,474	(4,836)	4,894
Other comprehensive income	(37,751)	3,408	(72,155)
Comprehensive income	(566,484)	(686,036)	(695,535)
Comprehensive income attributable to Community Health Systems, Inc.	$ (566,484)	$ (686,036)	$ (695,535)

XML

Equity Investments (Tables)

12 Months Ended

Dec. 31, 2011

Equity Investments [Abstract]

Summarized combined financial information of entities in which Company owns equity interest

Summarized combined financial information for the unconsolidated entities in which the Company owns an equity interest is as follows (in thousands):

	December 31,
	2011		2010
Current assets	$	233,496	$	220,881
Noncurrent assets		790,125		771,646
Total assets	$	1,023,621	$	992,527
Current liabilities	$	82,687	$	83,985
Noncurrent liabilities		2,094		2,198
Members’ equity		938,672		905,006
Noncontrolling interests		168		1,338
Total liabilities and equity	$	1,023,621	$	992,527

	Year Ended December 31,
	2011		2010		2009
Net operating revenues	$	1,230,146	$	1,195,108	$	1,181,334
Operating costs and expenses	$	1,068,212	$	1,044,751	$	1,032,953
Income from continuing operations before taxes	$	162,124	$	150,640	$	148,343

XML

Supplemental Condensed Consolidating Financial Information (Details 3) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Cash flows from operating activities:
Net cash (used in) provided by operating activities	$ 1,261,908	$ 1,188,730	$ 1,076,429
Cash flows from investing activities:
Acquisitions of facilities and other related equipment	(415,360)	(248,251)	(263,773)
Purchases of property and equipment	(776,713)	(667,378)	(576,888)
Proceeds from disposition of hospitals and other ancillary operations	173,387		89,514
Proceeds from sale of property and equipment	11,160	8,401	4,019
Increase in other investments	(188,249)	(137,082)	(120,054)
Net cash used in investing activities	(1,195,775)	(1,044,310)	(867,182)
Cash flows from financing activities:
Proceeds from exercise of stock options	18,910	56,916	12,759
Repurchase of restricted stock shares for payroll tax withholding requirements	(13,311)
Deferred financing costs	(19,352)	(13,260)	(82)
Excess tax benefit (income tax payable increase) relating to stock-based compensation	5,290	10,219	(3,472)
Stock buy-back	(85,790)	(113,961)
Proceeds from noncontrolling investors in joint ventures	1,229	7,201	29,838
Redemption of noncontrolling investments in joint ventures	(13,022)	(7,318)	(7,268)
Distributions to noncontrolling investors in joint ventures	(56,094)	(68,113)	(58,963)
Borrowings under credit agreement	578,236		200,000
Issuance of long-term debt	1,000,000
Repayments of long-term indebtedness	(1,651,533)	(61,476)	(258,173)
Net cash used in financing activities	(235,437)	(189,792)	(85,361)
Net change in cash and cash equivalents	(169,304)	(45,372)	123,886
Cash and cash equivalents at beginning of period	299,169	344,541	220,655
Cash and cash equivalents at end of period	129,865	299,169	344,541
Parent Guarantor [Member]
Cash flows from operating activities:
Net cash (used in) provided by operating activities	(41,780)	(154,101)	(62,883)
Cash flows from financing activities:
Proceeds from exercise of stock options	18,910	56,916	12,759
Repurchase of restricted stock shares for payroll tax withholding requirements	(13,311)
Excess tax benefit (income tax payable increase) relating to stock-based compensation	5,290	10,219	(3,472)
Stock buy-back	(85,790)	(113,961)
Changes in intercompany balances with affiliates, net	116,681	200,927	53,596
Net cash used in financing activities	41,780	154,101	62,883
Issuer [Member]
Cash flows from operating activities:
Net cash (used in) provided by operating activities	(111,011)	(87,018)	(88,486)
Cash flows from investing activities:
Increase in other investments	(10,000)
Net cash used in investing activities	(10,000)
Cash flows from financing activities:
Deferred financing costs	(19,352)	(13,260)	(82)
Changes in intercompany balances with affiliates, net	209,066	144,788	135,518
Borrowings under credit agreement	859,000		200,000
Issuance of long-term debt	1,000,000
Repayments of long-term indebtedness	(1,628,703)	(44,510)	(246,950)
Net cash used in financing activities	121,011	87,018	88,486
Other Guarantors [Member]
Cash flows from operating activities:
Net cash (used in) provided by operating activities	840,582	782,993	671,528
Cash flows from investing activities:
Acquisitions of facilities and other related equipment	(370,243)	(204,773)	(199,363)
Purchases of property and equipment	(440,754)	(342,735)	(368,408)
Proceeds from sale of property and equipment	2,283	8,140	824
Increase in other investments	(129,852)	(112,587)	(115,799)
Net cash used in investing activities	(938,566)	(651,955)	(682,746)
Cash flows from financing activities:
Changes in intercompany balances with affiliates, net	(95,945)	(142,864)	100,944
Borrowings under credit agreement	18,236		4,045
Repayments of long-term indebtedness	(22,888)	(13,507)	(13,853)
Net cash used in financing activities	(100,597)	(156,371)	91,136
Net change in cash and cash equivalents	(198,581)	(25,333)	79,918
Cash and cash equivalents at beginning of period	213,117	238,450	158,532
Cash and cash equivalents at end of period	14,536	213,117	238,450
Non-Guarantors [Member]
Cash flows from operating activities:
Net cash (used in) provided by operating activities	574,117	646,856	556,270
Cash flows from investing activities:
Acquisitions of facilities and other related equipment	(45,117)	(43,478)	(64,410)
Purchases of property and equipment	(335,959)	(324,643)	(208,480)
Proceeds from disposition of hospitals and other ancillary operations	173,387		89,514
Proceeds from sale of property and equipment	8,877	261	3,195
Increase in other investments	(48,397)	(24,495)	(4,255)
Net cash used in investing activities	(247,209)	(392,355)	(184,436)
Cash flows from financing activities:
Proceeds from noncontrolling investors in joint ventures	1,229	7,201	29,838
Redemption of noncontrolling investments in joint ventures	(13,022)	(7,318)	(7,268)
Distributions to noncontrolling investors in joint ventures	(56,094)	(68,113)	(58,963)
Changes in intercompany balances with affiliates, net	(229,802)	(202,851)	(290,058)
Borrowings under credit agreement	2,145		2,570
Repayments of long-term indebtedness	(2,087)	(3,459)	(3,985)
Net cash used in financing activities	(297,631)	(274,540)	(327,866)
Net change in cash and cash equivalents	29,277	(20,039)	43,968
Cash and cash equivalents at beginning of period	86,052	106,091	62,123
Cash and cash equivalents at end of period	115,329	86,052	106,091
Eliminations [Member]
Cash flows from financing activities:
Borrowings under credit agreement	(2,145)		(6,615)
Repayments of long-term indebtedness	$ 2,145		$ 6,615

XML

Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010
Current assets:
Cash and cash equivalents	$ 129,865	$ 299,169
Patient accounts receivable, net of allowance for doubtful accounts of $1,891,334 and $1,639,198 at December 31, 2011 and December 31, 2010, respectively	1,834,167	1,714,542
Supplies	346,611	329,114
Prepaid income taxes	101,389	118,464
Deferred income taxes	89,797	115,819
Prepaid expenses and taxes	112,613	100,754
Other current assets	231,647	193,331
Total current assets	2,846,089	2,871,193
Property and equipment:
Land and improvements	591,457	538,496
Buildings and improvements	5,715,066	5,108,711
Equipment and fixtures	3,063,005	2,735,915
Property and equipment, gross	9,369,528	8,383,122
Less accumulated depreciation and amortization	(2,513,552)	(2,058,685)
Property and equipment, net	6,855,976	6,324,437
Goodwill	4,264,845	4,150,247
Other assets, net of accumulated amortization of $313,028 and $258,547 at December 31, 2011 and December 31, 2010 respectively (including long-lived assets of hospitals held for sale of $0 and $182,688 at December 31, 2011 and 2010, respectively)	1,241,930	1,352,246
Total assets	15,208,840	14,698,123
Current liabilities:
Current maturities of long-term debt	63,706	63,139
Accounts payable	748,997	526,338
Deferred income taxes	0	8,882
Accrued liabilities:
Employee compensation	620,508	596,026
Interest	110,121	146,415
Other	367,807	301,240
Total current liabilities	1,911,139	1,642,040
Long-term debt	8,782,798	8,808,382
Deferred income taxes	704,725	608,177
Other long-term liabilities	949,990	1,001,675
Total liabilities	12,348,652	12,060,274
Redeemable noncontrolling interests in equity of consolidated subsidiaries	395,743	387,472
Commitments and contingencies (Note 15)
Community Health Systems, Inc. stockholders' equity
Preferred stock, $.01 par value per share, 100,000,000 shares authorized; none issued	0
Common stock, $.01 par value per share, 300,000,000 shares authorized; 91,547,079 shares issued and 90,571,530 shares outstanding at December 31, 2011, and 93,644,862 shares issued and 92,669,313 shares outstanding at December 31, 2010	915	936
Additional paid-in capital	1,086,008	1,126,751
Treasury stock, at cost, 975,549 shares at December 31, 2011 and December 31, 2010	(6,678)	(6,678)
Accumulated other comprehensive loss	(184,479)	(230,927)
Retained earnings	1,501,330	1,299,382
Total Community Health Systems, Inc. stockholders' equity	2,397,096	2,189,464
Noncontrolling interests in equity of consolidated subsidiaries	67,349	60,913
Total equity	2,464,445	2,250,377
Total liabilities and equity	$ 15,208,840	$ 14,698,123

XML

Employee Benefit Plans (Details 6) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011
Pension Plan [Member]
Expected amortization amounts, included in net periodic cost
Prior service (credit) cost	$ (141)
Actuarial loss	978
SERP [Member]
Expected amortization amounts, included in net periodic cost
Prior service (credit) cost	1,696
Actuarial loss	$ 2,028

XML

Business and Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2011

Business and Summary of Significant Accounting Policies [Abstract]

Business and Summary of Significant Accounting Policies

1. Business and Summary of Significant Accounting Policies

Business. Community Health Systems, Inc. is a holding company and operates no business in its own name. On a consolidated basis, Community Health Systems, Inc. and its subsidiaries (collectively the “Company”) own, lease and operate acute care hospitals in non-urban and selected urban markets. As of December 31, 2011, the Company owned or leased 131 hospitals, including four stand-alone rehabilitation or psychiatric hospitals, licensed for 19,695 beds in 29 states. Throughout these notes to the consolidated financial statements, Community Health Systems, Inc. (the “Parent”) and its consolidated subsidiaries are referred to on a collective basis as the “Company.” This drafting style is not meant to indicate that the publicly-traded Parent or any subsidiary of the Parent owns or operates any asset, business, or property. The hospitals, operations and businesses described in this filing are owned and operated, and management services provided, by distinct and indirect subsidiaries of Community Health Systems, Inc.

As of December 31, 2011, Indiana, Texas and Pennsylvania represent the only areas of geographic concentration. Operating revenues, net of contractual allowances and discounts (but before the provision for bad debts) generated by the Company’s hospitals in Indiana, as a percentage of consolidated operating revenues, were 10.3% in 2011, 10.6% in 2010 and 11.2% in 2009. Operating revenues, net of contractual allowances and discounts (but before the provision for bad debts) generated by the Company’s hospitals in Texas, as a percentage of consolidated operating revenues, were 13.1% in 2011, 13.0% in 2010 and 13.2% in 2009. Operating revenues, net of contractual allowances and discounts (but before the provision for bad debts) generated by the Company’s hospitals in Pennsylvania, as a percentage of consolidated operating revenues, were 11.5% in 2011, 10.3% in 2010 and 10.2% in 2009.

Use of Estimates. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates under different assumptions or conditions.

Principles of Consolidation. The consolidated financial statements include the accounts of the Parent, its subsidiaries, all of which are controlled by the Parent through majority voting control, and variable interest entities for which the Company is the primary beneficiary. All significant intercompany accounts, profits and transactions have been eliminated. Noncontrolling interests in less-than-wholly-owned consolidated subsidiaries of the Parent are presented as a component of total equity to distinguish between the interests of the Parent and the interests of the noncontrolling owners. Revenues, expenses and income from continuing operations from these subsidiaries are included in the consolidated amounts as presented on the consolidated statements of income, along with a net income measure that separately presents the amounts attributable to the controlling interests and the amounts attributable to the noncontrolling interests for each of the periods presented. Noncontrolling interests that are redeemable or may become redeemable at a fixed or determinable price at the option of the holder or upon the occurrence of an event outside of the control of the Company are presented in mezzanine equity on the consolidated balance sheets.

Cost of Revenue. Substantially all of the Company’s operating expenses are “cost of revenue” items. Operating costs that could be classified as general and administrative by the Company would include the Company’s corporate office costs at its Franklin, Tennessee office, which were $183.4 million, $155.4 million and $157.9 million for the years ended December 31, 2011, 2010 and 2009, respectively. Included in these amounts is stock-based compensation of $42.5 million, $38.8 million and $44.5 million for the years ended December 31, 2011, 2010 and 2009, respectively.

Cash Equivalents. The Company considers highly liquid investments with original maturities of three months or less to be cash equivalents.

Supplies. Supplies, principally medical supplies, are stated at the lower of cost (first-in, first-out basis) or market.

Marketable Securities. The Company’s marketable securities are classified as trading or available-for-sale. Available-for-sale securities are carried at fair value as determined by quoted market prices, with unrealized gains and losses reported as a separate component of stockholders’ equity. Trading securities are reported at fair value with unrealized gains and losses included in earnings. Interest and dividends on securities classified as available-for-sale or trading are included in net operating revenues and were not material in all periods presented. Accumulated other comprehensive income (loss) included an unrealized loss of $1.0 million and an unrealized gain of $3.7 million at December 31, 2011 and 2010, respectively, related to these available-for-sale securities.

Property and Equipment. Property and equipment are recorded at cost. Depreciation is recognized using the straight-line method over the estimated useful lives of the land and improvements (2 to 15 years; weighted-average useful life is 14 years), buildings and improvements (5 to 40 years; weighted-average useful life is 24 years) and equipment and fixtures (4 to 18 years; weighted-average useful life is 8 years). Costs capitalized as construction in progress were $397.2 million and $221.2 million at December 31, 2011 and 2010, respectively. Expenditures for renovations and other significant improvements are capitalized; however, maintenance and repairs which do not improve or extend the useful lives of the respective assets are charged to operations as incurred. Interest capitalized related to construction in progress was $21.4 million, $11.9 million and $16.7 million for the years ended December 31, 2011, 2010 and 2009, respectively. Purchases of property and equipment accrued in accounts payable and not yet paid were $94.2 million and $59.5 million at December 31, 2011 and 2010, respectively.

The Company also leases certain facilities and equipment under capital leases (see Note 9). Such assets are amortized on a straight-line basis over the lesser of the term of the lease or the remaining useful lives of the applicable assets.

Goodwill. Goodwill represents the excess of the fair value of the consideration conveyed in the acquisition over the fair value of net assets acquired. Goodwill arising from business combinations is not amortized. Goodwill is required to be evaluated for impairment at the same time every year and when an event occurs or circumstances change such that it is reasonably possible that an impairment may exist. The Company has selected September 30 as its annual testing date.

Other Assets. Other assets primarily consist of costs associated with the issuance of debt, which are included in interest expense over the life of the related debt using the effective interest method, and costs to recruit physicians to the Company’s markets, which are deferred and expensed over the term of the respective physician recruitment contract, which is generally three years, and included in amortization expense. Other assets also include capitalized internal-use software costs, which are expensed over the expected useful life, which is generally three years for routine software and eight years for major software projects, and included in amortization expense.

Third-Party Reimbursement. Net patient service revenue is reported at the estimated net realizable amount from patients, third-party payors and others for services rendered. Net operating revenues include amounts estimated by management to be reimbursable by Medicare and Medicaid under prospective payment systems, provisions of cost-reimbursement and other payment methods. Approximately 36.5%, 38.1% and 37.2% of operating revenues, net of contractual allowances and discounts (but before the provision for bad debts) for the years ended December 31, 2011, 2010 and 2009, respectively, are related to services rendered to patients covered by the Medicare and Medicaid programs. Revenues from Medicare outlier payments are included in the amounts received from Medicare and were approximately 0.42%, 0.43% and 0.43% of operating revenues, net of contractual allowances and discounts (but before the provision for bad debts) for the years ended December 31, 2011, 2010 and 2009, respectively. In addition, the Company is reimbursed by non-governmental payors using a variety of payment methodologies. Amounts received by the Company for treatment of patients covered by such programs are generally less than the standard billing rates. The differences between the estimated program reimbursement rates and the standard billing rates are accounted for as contractual adjustments, which are deducted from gross revenues to arrive at net operating revenues. These net operating revenues are an estimate of the net realizable amount due from these payors. The process of estimating contractual allowances requires the Company to estimate the amount expected to be received based on payor contract provisions. The key assumption in this process is the estimated contractual reimbursement percentage, which is based on payor classification and historical paid claims data. Due to the complexities involved in these estimates, actual payments the Company receives could be different from the amounts it estimates and records. Final settlements under some of these programs are subject to adjustment based on administrative review and audit by third parties. Adjustments to previous program reimbursement estimates are accounted for as contractual allowance adjustments and reported in the periods that such adjustments become known. Contractual allowance adjustments related to final settlements and previous program reimbursement estimates impacted net operating revenues and net income by an insignificant amount in each of the years ended December 31, 2011, 2010 and 2009.

Amounts due to third-party payors were $66.0 million and $80.5 million as of December 31, 2011 and 2010, respectively, and are included in accrued liabilities-other in the accompanying consolidated balance sheets. Amounts due from third-party payors were $86.5 million and $118.7 million as of December 31, 2011 and 2010, respectively, and are included in other current assets in the accompanying consolidated balance sheets. Substantially all Medicare and Medicaid cost reports are final settled through 2006.

Net Operating Revenues. Net operating revenues are recorded net of provisions for contractual allowance of approximately $42.4 billion, $35.8 billion and $30.8 billion in 2011, 2010 and 2009, respectively. Net operating revenues are recognized when services are provided and are reported at the estimated net realizable amount from patients, third-party payors and others for services rendered. Also included in the provision for contractual allowance shown above is the value of administrative and other discounts provided to self-pay patients eliminated from net operating revenues which was $852.4 million, $689.4 million and $531.9 million for the years ended December 31, 2011, 2010 and 2009, respectively. In the ordinary course of business, the Company renders services to patients who are financially unable to pay for hospital care. Also, included in the provision for contractual allowance shown above is the value (at the Company’s standard charges) of these services to patients who are unable to pay that is eliminated from net operating revenues when it is determined they qualify under the Company’s charity care policy. The value of these services was $651.1 million, $512.4 million and $451.0 million for the years ended December 31, 2011, 2010 and 2009, respectively. The estimated cost incurred by the Company to provide these services to patients who are unable to pay was approximately $125.7 million, $105.5 million and $104.0 million for the years ended December 31, 2011, 2010 and 2009, respectively. The estimated cost of these charity care services was determined using a ratio of cost to gross charges and applying that ratio to the gross charges associated with providing care to charity patients for the period. Gross charges associated with providing care to charity patients includes only the related charges for those patients who are financially unable to pay and qualify under the Company’s charity care policy and that do not otherwise qualify for reimbursement from a governmental program.

Currently, several states utilize supplemental reimbursement programs for the purpose of providing reimbursement to providers to offset a portion of the cost of providing care to Medicaid and indigent patients. These programs are designed with input from Centers for Medicare and Medicaid Services and are funded with a combination of state and federal resources, including, in certain instances, fees or taxes levied on the providers. Similar programs are also being considered by other states. After these supplemental programs are signed into law, the Company recognizes revenue and related expenses in the period in which amounts are estimable and collection is reasonably assured. Reimbursement under these programs is reflected in net operating revenues and fees, taxes or other program-related costs are reflected in other operating costs and expenses.

Allowance for Doubtful Accounts. Accounts receivable are reduced by an allowance for amounts that could become uncollectible in the future. Substantially all of the Company’s receivables are related to providing healthcare services to its hospitals’ patients.

The Company estimates the allowance for doubtful accounts by reserving a percentage of all self-pay accounts receivable without regard to aging category, based on collection history, adjusted for expected recoveries and, if present, anticipated changes in trends. For all other non-self-pay payor categories, the Company reserves 100% of all accounts aging over 365 days from the date of discharge. The percentage used to reserve for all self-pay accounts is based on the Company’s collection history. The Company collects substantially all of its third-party insured receivables, which include receivables from governmental agencies.

Collections are impacted by the economic ability of patients to pay and the effectiveness of the Company’s collection efforts. Significant changes in payor mix, business office operations, economic conditions or trends in federal and state governmental healthcare coverage could affect the Company’s collection of accounts receivable and the estimates of the collectability of future accounts receivable. The process of estimating the allowance for doubtful accounts requires the Company to estimate the collectability of self-pay accounts receivable, which is primarily based on its collection history, adjusted for expected recoveries and, if available, anticipated changes in collection trends. The Company also continually reviews its overall reserve adequacy by monitoring historical cash collections as a percentage of trailing net revenue less provision for bad debts, as well as by analyzing current period net revenue and admissions by payor classification, aged accounts receivable by payor, days revenue outstanding, and the impact of recent acquisitions and dispositions.

Operating revenues, net of contractual allowances and discounts (but before the provision for bad debts), recognized during the years ended December 31, 2011, 2010 and 2009, is as follows (in thousands):

	Year Ended December 31,
	2011		2010		2009
Medicare	$	3,654,247	$	3,464,117	$	3,212,424
Medicaid		1,318,756		1,345,315		1,146,033
Managed Care and other third-party payors		7,014,519		6,359,322		6,071,023
Self-pay		1,638,646		1,454,520		1,312,974
Total	$	13,626,168	$	12,623,274	$	11,742,454

Physician Income Guarantees. The Company enters into physician recruiting agreements under which it supplements physician income to a minimum amount over a period of time, typically one year, while the physicians establish themselves in the community. As part of the agreements, the physicians are committed to practice in the community for a period of time, typically three years, which extends beyond their income guarantee period. The Company records an asset and liability for the estimated fair value of minimum revenue guarantees on new agreements. Adjustments to the ultimate value of the guarantee paid to physicians are recognized in the period that the change in estimate is identified. The Company amortizes an asset over the life of the agreement. As of December 31, 2011 and 2010, the unamortized portion of these physician income guarantees was $33.0 million and $37.2 million, respectively.

Concentrations of Credit Risk. The Company grants unsecured credit to its patients, most of whom reside in the service area of the Company’s facilities and are insured under third-party payor agreements. Because of the economic diversity of the Company’s facilities and non-governmental third-party payors, Medicare represents the only significant concentration of credit risk from payors. Accounts receivable, net of contractual allowances, from Medicare were $250.8 million and $270.8 million as of December 31, 2011 and 2010, respectively, representing 6.7% and 8.1% of consolidated net accounts receivable, before allowance for doubtful accounts, as of December 31, 2011 and 2010, respectively.

Professional Liability Claims. The Company accrues for estimated losses resulting from professional liability. The accrual, which includes an estimate for incurred but not reported claims, is based on historical loss patterns and actuarially-determined projections and is discounted to its net present value. To the extent that subsequent claims information varies from management’s estimates, the liability is adjusted when such information becomes available.

Accounting for the Impairment or Disposal of Long-Lived Assets. Whenever events or changes in circumstances indicate that the carrying values of certain long-lived assets may be impaired, the Company projects the undiscounted cash flows expected to be generated by these assets. If the projections indicate that the reported amounts are not expected to be recovered, such amounts are reduced to their estimated fair value based on a quoted market price, if available, or an estimate based on valuation techniques available in the circumstances.

Income Taxes. The Company accounts for income taxes under the asset and liability method, in which deferred income tax assets and liabilities are recognized for the tax consequences of “temporary differences” by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying amounts and the tax bases of existing assets and liabilities. The effect on deferred taxes of a change in tax rates is recognized in the consolidated statement of income during the period in which the tax rate change becomes law.

Comprehensive Income (Loss). Comprehensive income (loss) is the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources.

Accumulated Other Comprehensive Income (Loss) consisted of the following (in thousands):

	Change in Fair Value of Interest Rate Swaps			Change in Fair Value of Available for Sale Securities			Change in Unrecognized Pension Cost Components			Accumulated Other Comprehensive Income (Loss)
Balance as of December 31, 2009	$	(202,260	)	$	(1,180	)	$	(17,945	)	$	(221,385	)
2010 Activity, net of tax		(15,676	)		3,716			2,418			(9,542	)
Balance as of December 31, 2010		(217,936	)		2,536			(15,527	)		(230,927	)
2011 Activity, net of tax		55,145			(960	)		(7,737	)		46,448
Balance as of December 31, 2011	$	(162,791	)	$	1,576		$	(23,264	)	$	(184,479	)

Segment Reporting. A public company is required to report annual and interim financial and descriptive information about its reportable operating segments. Operating segments, as defined, are components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. Aggregation of similar operating segments into a single reportable operating segment is permitted if the businesses have similar economic characteristics and meet the criteria established by U.S. GAAP.

The Company operates in three distinct operating segments, represented by the hospital operations (which includes the Company’s acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services), the home care agencies operations (which provide in-home outpatient care), and the hospital management services business (which provides executive management and consulting services to non-affiliated general acute care hospitals). U.S. GAAP requires (1) that financial information be disclosed for operating segments that meet a 10% quantitative threshold of the consolidated totals of net revenue, profit or loss, or total assets; and (2) that the individual reportable segments disclosed contribute at least 75% of total consolidated net revenue. Based on these measures, only the hospital operations segment meets the criteria as a separate reportable segment. Financial information for the home care agencies and hospital management services segments do not meet the quantitative thresholds and are therefore combined with corporate into the all other reportable segment.

Derivative Instruments and Hedging Activities. The Company records derivative instruments on the consolidated balance sheet as either an asset or liability measured at its fair value. Changes in a derivative’s fair value are recorded each period in earnings or other comprehensive income (“OCI”), depending on whether the derivative is designated and is effective as a hedged transaction, and on the type of hedge transaction. Changes in the fair value of derivative instruments recorded to OCI are reclassified to earnings in the period affected by the underlying hedged item. Any portion of the fair value of a derivative instrument determined to be ineffective under the standard is recognized in current earnings.

The Company has entered into several interest rate swap agreements. See Note 7 for further discussion about the swap transactions.

New Accounting Pronouncements. In August 2010, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2010-24, which provides clarification to companies in the healthcare industry on the accounting for professional liability insurance. This ASU states that receivables related to insurance recoveries should not be netted against the related claim liability and such claim liabilities should be determined without considering insurance recoveries. This ASU is effective for fiscal years beginning after December 15, 2010 and was adopted prospectively by the Company on January 1, 2011. The adoption of this ASU increased other current assets by $5.3 million, other assets, net by $36.9 million and long-term liabilities by $42.2 million in the consolidated balance sheet at December 31, 2011 and had no impact to the consolidated statement of income for the year ended December 31, 2011.

In June 2011, the FASB issued ASU 2011-05, which eliminates the option to present components of other comprehensive income as part of the statement of changes in stockholders’ equity. Instead, ASU 2011-05 requires that all nonowner changes in stockholders’ equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. In December 2011, the FASB issued ASU 2011-12, which amends ASU 2011-05 to defer the requirement to measure and present reclassification adjustments from accumulated other comprehensive income to net income by income statement line item in net income and also in other comprehensive income. ASU 2011-05, as amended by ASU 2011-12, is required to be applied retrospectively and is effective for fiscal years beginning after December 15, 2011, and has been reflected in the accompanying consolidated financial statements for all periods presented. The adoption of ASU 2011-05, as amended by ASU 2011-12, has not impacted the Company’s consolidated financial position, results of operations or cash flows.

In July 2011, the FASB issued ASU 2011-07, which requires healthcare organizations that perform services for patients for which the ultimate collection of all or a portion of the amounts billed or billable cannot be determined at the time services are rendered to present all bad debt expense associated with such patient service revenue as an offset to the patient service revenue line item in the statement of operations. The ASU also requires qualitative disclosures about the Company’s policy for recognizing revenue and bad debt expense for patient service transactions and quantitative information about the effects of changes in the assessment of collectability of patient service revenue. This ASU is effective for fiscal years beginning after December 15, 2011, and has been reflected in the accompanying consolidated financial statements for all periods presented.

In September 2011, the FASB issued ASU 2011-08, which simplifies how entities test goodwill for impairment. Previous guidance required an entity to perform a two-step goodwill impairment test at least annually by comparing the fair value of a reporting unit with its carrying amount, including goodwill, and recording an impairment loss if the fair value is less than the carrying amount. This ASU allows an entity to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If an entity determines after that assessment that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the two-step impairment test is not required. ASU 2011-08 is required to be applied to interim and annual goodwill impairment tests performed for fiscal years beginning after December 15, 2011, and will be adopted by the Company in 2012. The adoption of ASU 2011-08 is not expected to impact the Company’s consolidated financial position, results of operations or cash flows.

XML

Acquisitions and Divestitures (Details Textual) (USD $)	1 Months Ended	12 Months Ended																			1 Months Ended				1 Months Ended			1 Months Ended		1 Months Ended
	Jun. 30, 2009	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009	Jun. 01, 2009	Mar. 31, 2009	Dec. 31, 2011 Mercy health partners [Member]	May 01, 2011 Mercy health partners [Member]	Dec. 31, 2011 Forum Health [Member]	Sep. 30, 2010 Forum Health [Member]	Dec. 31, 2011 Bluefield Regional Medical Center [Member]	Sep. 30, 2010 Bluefield Regional Medical Center [Member]	Dec. 31, 2011 Marion Regional Healthcare System [Member]	Jul. 07, 2010 Marion Regional Healthcare System [Member]	Dec. 31, 2011 Physician practices, clinics and other ancillary businesses [Member]	Dec. 31, 2010 Physician practices, clinics and other ancillary businesses [Member]	Dec. 31, 2011 Tomball Regional Hospital [Member]	Sep. 30, 2011 Tomball Regional Hospital [Member]	Dec. 31, 2011 Wyoming Valley Health Care System [Member]	Apr. 30, 2009 Wyoming Valley Health Care System [Member]	Jan. 31, 2010 Siloam Springs Memorial Hospital [Member]	Feb. 28, 2009 Siloam Springs Memorial Hospital [Member]	Jan. 31, 2009 Siloam Springs Memorial Hospital [Member]	Mar. 31, 2009 Medical Center of South Arkansas [Member]	Mar. 31, 2009 Presbyterian Hospital of Denton [Member]	Feb. 28, 2011 Oregon Healthcare Resources LLC [Member]	Jan. 31, 2011 Oregon Healthcare Resources LLC [Member]	Sep. 30, 2011 Southcrest and Claremore Hospital [Member]	Aug. 31, 2011 Southcrest and Claremore Hospital [Member]	Oct. 31, 2011 New Directions Health Systems LLC [Member]	Oct. 22, 2011 New Directions Health Systems LLC [Member]
Acquisitions and Divestitures (Textual) [Abstract]
Financing to Rockwood Clinic				$ 54,200,000
Acquired Remaining percentage of noncontrolling interest in Massillon Community Health System, LLC					20.00%
Payments to Acquire Additional Interest in Subsidiaries	1,100,000
Total Consideration of Assets for Business combination								150,800,000		93,400,000		35,400,000		18,600,000				192,000,000		133,700,000
Purchase price allocation to property and equipment		280,639,000	169,209,000												13,100,000	35,600,000
Cash consideration paid including working capital															57,900,000	67,400,000
Cash paid for working capital								(2,100,000)		27,800,000		(1,800,000)		5,800,000				17,500,000		30,000,000			100,000
Cash paid for working capital															2,900,000
Assumed liabilities in business combination								12,300,000		40,300,000		8,900,000		3,900,000				15,800,000		25,400,000			1,000,000	14,100,000
Total Consideration								161,000,000		161,500,000		42,500,000		28,300,000				225,300,000		174,900,000				26,000,000
Purchase price allocation to Goodwill		73,923,000	10,537,000				43,100,000		8,100,000		2,400,000		0		40,300,000	35,400,000	30,800,000		0
Acquired bank account in business combination																				14,200,000
Acquisition of Interest in MCSA						50.00%
Business Acquisition Percentage of Voting Interests previously Acquired																								50.00%
Percentage of Interest in MCSA																								100.00%
Cash deposited by company in escrow account																						1,600,000
Additional cash deposited by the company in escrow account																					1,600,000
Purchase price to other intangible assets															1,600,000
Carrying amount of net assets including allocation of reporting unit goodwill																											19,700,000		193,000,000		14,200,000
Cash consideration		173,387,000		89,514,000																					103,000,000	14,600,000		154,200,000		900,000
Acquisitions and Divestitures (Additional Textual) [Abstract]
Acquisition costs related to prospective and closed acquisitions expensed		16,000,000	8,900,000	6,700,000
Operating revenues, net of contractual allowances and discounts (but before the provision for bad debts) from hospital acquisitions		169,700,000	139,000,000
Long-lived assets of hospitals held for sale		$ 0	$ 182,688,000

XML

Employee Benefit Plans (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Pension Plan [Member]
Change in benefit obligation:
Benefit obligation, beginning of year	$ 39,682	$ 42,245
Service cost	1,315	1,169	3,886
Interest cost	2,159	2,051	2,200
Curtailment		(7,407)
Actuarial loss (gain)	8,480	2,082
Benefits paid	(524)	(458)
Benefit obligation, end of year	51,112	39,682	42,245
Change in plan assets:
Fair value of assets, beginning of year	34,354	28,583
Actual return on plan assets	(536)	3,895
Employer contributions	1,758	2,334
Benefits paid	(524)	(458)
Fair value of assets, end of year	35,052	34,354	28,583
Unfunded status	(16,060)	(5,328)
SERP [Member]
Change in benefit obligation:
Benefit obligation, beginning of year	73,840	61,079
Service cost	5,197	4,661	4,437
Interest cost	3,434	3,728	2,469
Plan amendment		(24)
Actuarial loss (gain)	5,225	4,396
Benefits paid	(1,546)
Benefit obligation, end of year	86,150	73,840	61,079
Change in plan assets:
Benefits paid	(1,546)
Unfunded status	$ (86,150)	$ (73,840)

XML

Supplemental Condensed Consolidating Financial Information (Details 2) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008
Current assets:
Cash and cash equivalents	$ 129,865	$ 299,169	$ 344,541	$ 220,655
Patient accounts receivable, net of allowance for doubtful accounts	1,834,167	1,714,542
Supplies	346,611	329,114
Deferred income taxes	89,797	115,819
Prepaid expenses and taxes	214,002	219,218
Other current assets	231,647	193,331
Total current assets	2,846,089	2,871,193
Property and equipment, net	6,855,976	6,324,437
Goodwill	4,264,845	4,150,247	4,157,927
Other assets, net of accumulated amortization	1,241,930	1,352,246
Total assets	15,208,840	14,698,123
Current liabilities:
Current maturities of long-term debt	63,706	63,139
Accounts payable	748,997	526,338
Deferred income taxes	0	8,882
Interest	110,121	146,415
Accrued liabilities	988,315	897,266
Total current liabilities	1,911,139	1,642,040
Long-term debt	8,782,798	8,808,382
Deferred income taxes	704,725	608,177
Other long-term liabilities	949,990	1,001,675
Total liabilities	12,348,652	12,060,274
Redeemable noncontrolling interests in equity of consolidated subsidiaries	395,743	387,472
Community Health Systems, Inc. stockholders' equity:
Preferred stock	0
Common stock	915	936
Additional paid-in capital	1,086,008	1,126,751
Treasury stock, at cost, 975,549 shares at December 31, 2011 and December 31, 2010	(6,678)	(6,678)
Accumulated other comprehensive (loss) income	(184,479)	(230,927)	(221,385)
Retained earnings	1,501,330	1,299,382
Total Community Health Systems, Inc. stockholders' equity	2,397,096	2,189,464
Noncontrolling interests in equity of consolidated subsidiaries	67,349	60,913
Total equity	2,464,445	2,250,377	2,015,417	1,672,486
Total liabilities and equity	15,208,840	14,698,123
Parent Guarantor [Member]
Current assets:
Deferred income taxes	89,797	115,819
Prepaid expenses and taxes	101,389	118,464
Total current assets	191,186	234,283
Intercompany receivable	1,160,785	1,079,294
Net investment in subsidiaries	1,758,458	1,510,063
Total assets	3,110,429	2,823,640
Current liabilities:
Deferred income taxes		8,882
Accrued liabilities	7,580	7,595
Total current liabilities	7,580	16,477
Deferred income taxes	704,725	608,177
Other long-term liabilities	1,028	9,522
Total liabilities	713,333	634,176
Community Health Systems, Inc. stockholders' equity:
Preferred stock	0
Common stock	915	936
Additional paid-in capital	1,086,008	1,126,751
Treasury stock, at cost, 975,549 shares at December 31, 2011 and December 31, 2010	(6,678)	(6,678)
Accumulated other comprehensive (loss) income	(184,479)	(230,927)
Retained earnings	1,501,330	1,299,382
Total Community Health Systems, Inc. stockholders' equity	2,397,096	2,189,464
Total equity	2,397,096	2,189,464
Total liabilities and equity	3,110,429	2,823,640
Issuer [Member]
Current assets:
Prepaid expenses and taxes	117	116
Other current assets	10,235	41
Total current assets	10,352	157
Intercompany receivable	9,294,295	9,002,158
Other assets, net of accumulated amortization	99,521	131,352
Net investment in subsidiaries	6,413,757	5,267,860
Total assets	15,817,925	14,401,527
Current liabilities:
Current maturities of long-term debt	49,954	49,953
Accounts payable	345
Interest	109,984	146,297
Accrued liabilities	567	567
Total current liabilities	160,850	196,817
Long-term debt	8,707,805	8,734,473
Intercompany payable	4,936,587	3,619,651
Other long-term liabilities	254,228	340,526
Total liabilities	14,059,470	12,891,467
Community Health Systems, Inc. stockholders' equity:
Preferred stock	0
Additional paid-in capital	701,399	640,683
Accumulated other comprehensive (loss) income	(184,479)	(230,927)
Retained earnings	1,241,535	1,100,304
Total Community Health Systems, Inc. stockholders' equity	1,758,455	1,510,060
Total equity	1,758,455	1,510,060
Total liabilities and equity	15,817,925	14,401,527
Other Guarantors [Member]
Current assets:
Cash and cash equivalents	14,536	213,117	238,450	158,532
Patient accounts receivable, net of allowance for doubtful accounts	1,088,121	969,928
Supplies	215,203	193,902
Prepaid expenses and taxes	83,983	88,647
Other current assets	141,192	137,113
Total current assets	1,543,035	1,602,707
Intercompany receivable	1,741,928	1,424,734
Property and equipment, net	4,395,498	3,889,651
Goodwill	2,412,517	2,331,452
Other assets, net of accumulated amortization	523,645	438,131
Net investment in subsidiaries	2,450,625	1,944,795
Total assets	13,067,248	11,631,470
Current liabilities:
Current maturities of long-term debt	9,625	11,070
Accounts payable	511,145	361,088
Interest	131	116
Accrued liabilities	662,746	567,101
Total current liabilities	1,183,647	939,375
Long-term debt	49,184	44,831
Intercompany payable	9,290,461	8,424,670
Other long-term liabilities	433,119	371,667
Total liabilities	10,956,411	9,780,543
Community Health Systems, Inc. stockholders' equity:
Preferred stock	0
Common stock	1	1
Additional paid-in capital	769,841	685,921
Accumulated other comprehensive (loss) income	(21,687)	(12,990)
Retained earnings	1,362,682	1,177,995
Total Community Health Systems, Inc. stockholders' equity	2,110,837	1,850,927
Total equity	2,110,837	1,850,927
Total liabilities and equity	13,067,248	11,631,470
Non-Guarantors [Member]
Current assets:
Cash and cash equivalents	115,329	86,052	106,091	62,123
Patient accounts receivable, net of allowance for doubtful accounts	746,046	744,614
Supplies	131,408	135,212
Prepaid expenses and taxes	28,513	11,991
Other current assets	80,220	56,177
Total current assets	1,101,516	1,034,046
Intercompany receivable	1,672,003	1,370,494
Property and equipment, net	2,460,478	2,434,786
Goodwill	1,852,328	1,818,795
Other assets, net of accumulated amortization	618,764	782,763
Total assets	7,705,089	7,440,884
Current liabilities:
Current maturities of long-term debt	4,127	2,116
Accounts payable	237,507	165,250
Interest	6	2
Accrued liabilities	317,422	322,003
Total current liabilities	559,062	489,371
Long-term debt	25,809	29,078
Intercompany payable	6,229,469	6,086,227
Other long-term liabilities	261,615	279,960
Total liabilities	7,075,955	6,884,636
Redeemable noncontrolling interests in equity of consolidated subsidiaries	395,743	387,472
Community Health Systems, Inc. stockholders' equity:
Preferred stock	0
Common stock	2	2
Additional paid-in capital	59,941	39,693
Retained earnings	106,099	68,169
Total Community Health Systems, Inc. stockholders' equity	166,042	107,864
Noncontrolling interests in equity of consolidated subsidiaries	67,349	60,913
Total equity	233,391	168,777
Total liabilities and equity	7,705,089	7,440,885
Eliminations [Member]
Current assets:
Intercompany receivable	(13,869,011)	(12,876,680)
Net investment in subsidiaries	(10,622,840)	(8,722,718)
Total assets	(24,491,851)	(21,599,398)
Current liabilities:
Intercompany payable	(20,456,517)	(18,130,548)
Total liabilities	(20,456,517)	(18,130,548)
Community Health Systems, Inc. stockholders' equity:
Preferred stock	0
Common stock	(3)	(3)
Additional paid-in capital	(1,531,181)	(1,366,297)
Accumulated other comprehensive (loss) income	206,166	243,917
Retained earnings	(2,710,316)	(2,346,468)
Total Community Health Systems, Inc. stockholders' equity	(4,035,334)	(3,468,851)
Total equity	(4,035,334)	(3,468,851)
Total liabilities and equity	$ (24,491,851)	$ (21,599,399)

XML

Long-Term Debt (Details 3) (8% Senior Notes Due 2019 [Member])	12 Months Ended
	Dec. 31, 2011
8% Senior Notes Due 2019 [Member]
Redemption Price of 8 % Senior Notes in Long Term Debt
2015	104.00%
2016	102.00%
2017 and thereafter	100.00%

XML

Supplemental Condensed Consolidating Financial Information

12 Months Ended

Dec. 31, 2011

Supplemental Financial Information [Abstract]

Supplemental Condensed Consolidating Financial Information

18. Supplemental Condensed Consolidating Financial Information

In 2007, CHS issued the 8  ⁷/8% Senior Notes in the aggregate principal amount of approximately $3.0 billion. In 2011, CHS issued the 8% Senior Notes in the aggregate principal amount of $1.0 billion, the proceeds from which were used to purchase $1.0 billion of the 8  ⁷/8% Senior Notes. These 8  ⁷/8% Senior Notes and 8% Senior Notes are senior unsecured obligations of CHS and are guaranteed on a senior basis by the Company and by certain of its existing and subsequently acquired or organized 100% owned domestic subsidiaries.

Both the 8 ⁷ /8% Senior Notes and the 8% Senior Notes are guaranteed on a joint and several basis, with limited exceptions considered customary for such guarantees, including the release of the guarantee when a subsidiary’s assets used in operations are sold. The following condensed consolidating financial statements present Community Health Systems, Inc. (as parent guarantor), CHS (as the issuer), the subsidiary guarantors, the subsidiary non-guarantors and eliminations. These condensed consolidating financial statements have been prepared and presented in accordance with SEC Regulation S-X Rule 3-10 “Financial Statements of Guarantors and Issuers of Guaranteed Securities Registered or Being Registered.”

The accounting policies used in the preparation of this financial information are consistent with those elsewhere in the consolidated financial statements of the Company, except as noted below:

• Intercompany receivables and payables are presented gross in the supplemental consolidating balance sheets.

• Cash flows from intercompany transactions are presented in cash flows from financing activities, as changes in intercompany balances with affiliates, net.

• Income tax expense is allocated from the parent guarantor to the income producing operations (other guarantors and non-guarantors) and the issuer through stockholders’ equity. As this approach represents an allocation, the income tax expense allocation is considered non-cash for statement of cash flow purposes.

• Interest expense, net has been presented to reflect net interest expense and interest income from outstanding long-term debt and intercompany balances.

The Company’s intercompany activity consists primarily of daily cash transfers for purposes of cash management, the allocation of certain expenses and expenditures paid for by the parent on behalf of its subsidiaries, and the push down of investment in its subsidiaries. The Company’s subsidiaries generally do not purchase services from one another; thus, the intercompany transactions do not represent revenue generating transactions. All intercompany transactions eliminate in consolidation.

From time to time, the Company sells and/or repurchases noncontrolling interests in consolidated subsidiaries, which may change subsidiaries between guarantors and non-guarantors. Amounts for prior periods are restated to reflect the status of guarantors or non-guarantors as of December 31, 2011.

Condensed Consolidating Statement of Income

Year Ended December 31, 2011

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
	(In thousands)
Operating revenues (net of contractual allowances and discounts)	$	—		$	—		$	7,904,497		$	5,721,671		$	—		$	13,626,168
Provision for bad debts		—			—			1,003,252			716,704			—			1,719,956
Net operating revenues		—			—			6,901,245			5,004,967			—			11,906,212
Operating costs and expenses:
Salaries and benefits		—			—			3,065,753			2,512,172			—			5,577,925
Supplies		—			—			1,058,807			775,299			—			1,834,106
Other operating expenses		—			—			1,486,113			1,029,525			—			2,515,638
Electronic health records incentive reimbursement		—			—			(42,312	)		(21,085	)		—			(63,397	)
Rent		—			—			124,823			129,958			—			254,781
Depreciation and amortization		—			—			393,549			259,125			—			652,674
Total operating costs and expenses		—			—			6,086,733			4,684,994			—			10,771,727
Income from operations		—			—			814,512			319,973			—			1,134,485
Interest expense, net		—			87,095			495,258			62,057			—			644,410
Loss (gain) from early extinguishment of debt		—			66,019			—			—			—			66,019
Equity in earnings of unconsolidated affiliates		(201,948	)		(275,175	)		(101,101	)		—			528,733			(49,491	)
Income from continuing operations before income taxes		201,948			122,061			420,355			257,916			(528,733	)		473,547
Provision for (benefit from) income taxes		—			(79,887	)		151,748			65,792			—			137,653
Income from continuing operations		201,948			201,948			268,607			192,124			(528,733	)		335,894
Discontinued operations, net of taxes:
(Loss) income from operations of entities sold		—			—			—			(7,769	)		—			(7,769	)
Impairment of hospitals sold		—			—			—			(47,930	)		—			(47,930	)
Loss on sale, net		—			—			—			(2,572	)		—			(2,572	)
(Loss) income from discontinued operations, net of taxes		—			—			—			(58,271	)		—			(58,271	)
Net income		201,948			201,948			268,607			133,853			(528,733	)		277,623
Less: Net income attributable to noncontrolling interests		—			—			—			75,675			—			75,675
Net income attributable to Community Health Systems, Inc.	$	201,948		$	201,948		$	268,607		$	58,178		$	(528,733	)	$	201,948

Condensed Consolidating Statement of Income Year Ended December 31, 2010
	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
	(In thousands)
Operating revenues (net of contractual allowances and discounts)	$	—		$	—		$	7,271,078		$	5,352,196		$	—		$	12,623,274
Provision for bad debts		—			—			901,580			629,272			—			1,530,852
Net operating revenues		—			—			6,369,498			4,722,924			—			11,092,422
Operating costs and expenses:
Salaries and benefits		—			—			2,792,543			2,301,224			—			5,093,767
Supplies		—			—			989,241			748,847			—			1,738,088
Other operating expenses		—			—			1,295,527			1,000,536			—			2,296,063
Electronic health records incentive reimbursement		—			—			—			—			—			—
Rent		—			—			118,215			130,248			—			248,463
Depreciation and amortization		—			—			348,037			246,960			—			594,997
Total operating costs and expenses		—			—			5,543,563			4,427,815			—			9,971,378
Income from operations		—			—			825,935			295,109			—			1,121,044
Interest expense, net		—			113,464			477,418			56,711			—			647,593
Loss (gain) from early extinguishment of debt		—			—			—			—			—			—
Equity in earnings of unconsolidated affiliates		(279,983	)		(312,730	)		(142,174	)		—			689,444			(45,443	)
Income from continuing operations before income taxes		279,983			199,266			490,691			238,398			(689,444	)		518,894
Provision for (benefit from) income taxes		—			(80,717	)		180,574			63,824			—			163,681
Income from continuing operations		279,983			279,983			310,117			174,574			(689,444	)		355,213
Discontinued operations, net of taxes:
(Loss) income from operations of entities sold		—			—			—			(6,772	)		—			(6,772	)
Impairment of hospitals sold		—			—			—			—			—			—
Loss on sale, net		—			—			—			—			—			—
(Loss) income from discontinued operations, net of taxes		—			—			—			(6,772	)		—			(6,772	)
Net income		279,983			279,983			310,117			167,802			(689,444	)		348,441
Less: Net income attributable to noncontrolling interests		—			—			—			68,458			—			68,458
Net income attributable to Community Health Systems, Inc.	$	279,983		$	279,983		$	310,117		$	99,344		$	(689,444	)	$	279,983

Condensed Consolidating Statement of Income Year Ended December 31, 2009
	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
	(In thousands)
Operating revenues (net of contractual allowances and discounts)	$	—		$	—		$	6,763,647		$	4,978,807		$	—		$	11,742,454
Provision for bad debts		—			—			841,342			567,611			—			1,408,953
Net operating revenues		—			—			5,922,305			4,411,196			—			10,333,501
Operating costs and expenses:
Salaries and benefits		—			—			2,630,349			2,070,882			—			4,701,231
Supplies		—			—			933,730			716,049			—			1,649,779
Other operating expenses		—			—			1,169,896			959,185			—			2,129,081
Electronic health records incentive reimbursement		—			—			—			—			—			—
Rent		—			—			113,407			124,129			—			237,536
Depreciation and amortization		—			—			324,018			227,025			—			551,043
Total operating costs and expenses		—			—			5,171,400			4,097,270			—			9,268,670
Income from operations		—			—			750,905			313,926			—			1,064,831
Interest expense, net		—			110,507			479,458			53,643			—			643,608
Loss (gain) from early extinguishment of debt		—			(2,385	)		—			—			—			(2,385	)
Equity in earnings of unconsolidated affiliates		(243,150	)		(259,270	)		(157,491	)		—			623,380			(36,531	)
Impairment of long-lived and other assets		—			—			12,477			—			—			12,477
Income from continuing operations before income taxes		243,150			151,148			416,461			260,283			(623,380	)		447,662
Provision for (benefit from) income taxes		—			(92,002	)		159,921			73,932			—			141,851
Income from continuing operations		243,150			243,150			256,540			186,351			(623,380	)		305,811
Discontinued operations, net of taxes:
(Loss) income from operations of entities sold		—			—			(50	)		1,021			—			971
Impairment of hospitals sold		—			—			—			—			—			—
Loss on sale, net		—			—			—			(405	)		—			(405	)
(Loss) income from discontinued operations, net of taxes		—			—			(50	)		616			—			566
Net income		243,150			243,150			256,490			186,967			(623,380	)		306,377
Less: Net income attributable to noncontrolling interests		—			—			—			63,227			—			63,227
Net income attributable to Community Health Systems, Inc.	$	243,150		$	243,150		$	256,490		$	123,740		$	(623,380	)	$	243,150

Condensed Consolidating Statement of Comprehensive Income
Year Ended December 31, 2011
	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors		Eliminations			Consolidated
	(In thousands)
Net income	$	201,948		$	201,948		$	268,607		$	133,853	$	(528,733	)	$	277,623
Other comprehensive income, net of taxes
Net change in fair value of interest rate swaps		55,145			55,145			—			—		(55,145	)		55,145
Net change in fair value of available-for-sale securities		(960	)		(960	)		(960	)		—		1,920			(960	)
Amortization and recognition of unrecognized pension cost components		(7,737	)		(7,737	)		(7,737	)		—		15,474			(7,737	)
Other comprehensive income		46,448			46,448			(8,697	)		—		(37,751	)		46,448
Comprehensive income		248,396			248,396			259,910			133,853		(566,484	)		324,071
Less: Comprehensive income attributable to noncontrolling interests		—			—			—			75,675		—			75,675
Comprehensive income attributable to Community Health Systems, Inc.	$	248,396		$	248,396		$	259,910		$	58,178	$	(566,484	)	$	248,396

Condensed Consolidating Statement of Comprehensive Income
Year Ended December 31, 2010
	Parent Guarantor			Issuer			Other Guarantors		Non- Guarantors		Eliminations			Consolidated
	(In thousands)
Net income	$	279,983		$	279,983		$	310,117	$	167,802	$	(689,444	)	$	348,441
Other comprehensive income, net of taxes
Net change in fair value of interest rate swaps		(15,676	)		(15,676	)		—		—		15,676			(15,676	)
Net change in fair value of available-for-sale securities		3,716			3,716			3,716		—		(7,432	)		3,716
Amortization and recognition of unrecognized pension cost components		2,418			2,418			2,418		—		(4,836	)		2,418
Other comprehensive income		(9,542	)		(9,542	)		6,134		—		3,408			(9,542	)
Comprehensive income		270,441			270,441			316,251		167,802		(686,036	)		338,899
Less: Comprehensive income attributable to noncontrolling interests		—			—			—		68,458		—			68,458
Comprehensive income attributable to Community Health Systems, Inc.	$	270,441		$	270,441		$	316,251	$	99,344	$	(686,036	)	$	270,441

Condensed Consolidating Statement of Comprehensive Income
Year Ended December 31, 2009
	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors		Eliminations			Consolidated
	(In thousands)
Net income	$	243,150		$	243,150		$	256,490		$	186,967	$	(623,380	)	$	306,377
Other comprehensive income, net of taxes
Net change in fair value of interest rate swaps		76,225			76,225			—			—		(76,225	)		76,225
Net change in fair value of available-for-sale securities		412			412			412			—		(824	)		412
Amortization and recognition of unrecognized pension cost components		(2,447	)		(2,447	)		(2,447	)		—		4,894			(2,447	)
Other comprehensive income		74,190			74,190			(2,035	)		—		(72,155	)		74,190
Comprehensive income		317,340			317,340			254,455			186,967		(695,535	)		380,567
Less: Comprehensive income attributable to noncontrolling interests		—			—			—			63,227		—			63,227
Comprehensive income attributable to Community Health Systems, Inc.	$	317,340		$	317,340		$	254,455		$	123,740	$	(695,535	)	$	317,340

Condensed Consolidating Balance Sheet

December 31, 2011

	Parent						Other			Non-
	Guarantor			Issuer			Guarantors			Guarantors		Eliminations			Consolidated
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	—		$	—		$	14,536		$	115,329	$	—		$	129,865
Patient accounts receivable, net of allowance for doubtful accounts		—			—			1,088,121			746,046		—			1,834,167
Supplies		—			—			215,203			131,408		—			346,611
Deferred income taxes		89,797			—			—			—		—			89,797
Prepaid expenses and taxes		101,389			117			83,983			28,513		—			214,002
Other current assets		—			10,235			141,192			80,220		—			231,647
Total current assets		191,186			10,352			1,543,035			1,101,516		—			2,846,089
Intercompany receivable		1,160,785			9,294,295			1,741,928			1,672,003		(13,869,011	)		—
Property and equipment, net		—			—			4,395,498			2,460,478		—			6,855,976
Goodwill		—			—			2,412,517			1,852,328		—			4,264,845
Other assets, net of accumulated amortization		—			99,521			523,645			618,764		—			1,241,930
Net investment in subsidiaries		1,758,458			6,413,757			2,450,625			—		(10,622,840	)		—
Total assets	$	3,110,429		$	15,817,925		$	13,067,248		$	7,705,089	$	(24,491,851	)	$	15,208,840
LIABILITIES AND EQUITY
Current liabilities:
Current maturities of long-term debt	$	—		$	49,954		$	9,625		$	4,127	$	—		$	63,706
Accounts payable		—			345			511,145			237,507		—			748,997
Deferred income taxes		—			—			—			—		—			—
Accrued interest		—			109,984			131			6		—			110,121
Accrued liabilities		7,580			567			662,746			317,422		—			988,315
Total current liabilities		7,580			160,850			1,183,647			559,062		—			1,911,139
Long-term debt		—			8,707,805			49,184			25,809		—			8,782,798
Intercompany payable		—			4,936,587			9,290,461			6,229,469		(20,456,517	)		—
Deferred income taxes		704,725			—			—			—		—			704,725
Other long-term liabilities		1,028			254,228			433,119			261,615		—			949,990
Total liabilities		713,333			14,059,470			10,956,411			7,075,955		(20,456,517	)		12,348,652
Redeemable noncontrolling interests in equity of consolidated subsidiaries		—			—			—			395,743		—			395,743
Equity:
Community Health Systems, Inc. stockholders’ equity:
Preferred stock		—			—			—			—		—			—
Common stock		915			—			1			2		(3	)		915
Additional paid-in capital		1,086,008			701,399			769,841			59,941		(1,531,181	)		1,086,008
Treasury stock, at cost		(6,678	)		—			—			—		—			(6,678	)
Accumulated other comprehensive (loss) income		(184,479	)		(184,479	)		(21,687	)		—		206,166			(184,479	)
Retained earnings		1,501,330			1,241,535			1,362,682			106,099		(2,710,316	)		1,501,330
Total Community Health Systems, Inc. stockholders’ equity		2,397,096			1,758,455			2,110,837			166,042		(4,035,334	)		2,397,096
Noncontrolling interests in equity of consolidated subsidiaries		—			—			—			67,349		—			67,349
Total equity		2,397,096			1,758,455			2,110,837			233,391		(4,035,334	)		2,464,445
Total liabilities and equity	$	3,110,429		$	15,817,925		$	13,067,248		$	7,705,089	$	(24,491,851	)	$	15,208,840

Condensed Consolidating Balance Sheet

December 31, 2010

	Parent						Other			Non-
	Guarantor			Issuer			Guarantors			Guarantors		Eliminations			Consolidated
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	—		$	—		$	213,117		$	86,052	$	—		$	299,169
Patient accounts receivable, net of allowance for doubtful accounts		—			—			969,928			744,614		—			1,714,542
Supplies		—			—			193,902			135,212		—			329,114
Deferred income taxes		115,819			—			—			—		—			115,819
Prepaid expenses and taxes		118,464			116			88,647			11,991		—			219,218
Other current assets		—			41			137,113			56,177		—			193,331
Total current assets		234,283			157			1,602,707			1,034,046		—			2,871,193
Intercompany receivable		1,079,294			9,002,158			1,424,734			1,370,494		(12,876,680	)		—
Property and equipment, net		—			—			3,889,651			2,434,786		—			6,324,437
Goodwill		—			—			2,331,452			1,818,795		—			4,150,247
Other assets, net of accumulated amortization		—			131,352			438,131			782,763		—			1,352,246
Net investment in subsidiaries		1,510,063			5,267,860			1,944,795			—		(8,722,718	)		—
Total assets	$	2,823,640		$	14,401,527		$	11,631,470		$	7,440,884	$	(21,599,398	)	$	14,698,123
LIABILITIES AND EQUITY
Current liabilities:
Current maturities of long-term debt	$	—		$	49,953		$	11,070		$	2,116	$	—		$	63,139
Accounts payable		—			—			361,088			165,250		—			526,338
Deferred income taxes		8,882			—			—			—		—			8,882
Accrued interest		—			146,297			116			2		—			146,415
Accrued liabilities		7,595			567			567,101			322,003		—			897,266
Total current liabilities		16,477			196,817			939,375			489,371		—			1,642,040
Long-term debt		—			8,734,473			44,831			29,078		—			8,808,382
Intercompany payable		—			3,619,651			8,424,670			6,086,227		(18,130,548	)		—
Deferred income taxes		608,177			—			—			—		—			608,177
Other long-term liabilities		9,522			340,526			371,667			279,960		—			1,001,675
Total liabilities		634,176			12,891,467			9,780,543			6,884,636		(18,130,548	)		12,060,274
Redeemable noncontrolling interests in equity of consolidated subsidiaries		—			—			—			387,472		—			387,472
Equity:
Community Health Systems, Inc. stockholders’ equity:
Preferred stock		—			—			—			—		—			—
Common stock		936			—			1			2		(3	)		936
Additional paid-in capital		1,126,751			640,683			685,921			39,693		(1,366,297	)		1,126,751
Treasury stock, at cost		(6,678	)		—			—			—		—			(6,678	)
Accumulated other comprehensive (loss) income		(230,927	)		(230,927	)		(12,990	)		—		243,917			(230,927	)
Retained earnings		1,299,382			1,100,304			1,177,995			68,169		(2,346,468	)		1,299,382
Total Community Health Systems, Inc. stockholders’ equity		2,189,464			1,510,060			1,850,927			107,864		(3,468,851	)		2,189,464
Noncontrolling interests in equity of consolidated subsidiaries		—			—			—			60,913		—			60,913
Total equity		2,189,464			1,510,060			1,850,927			168,777		(3,468,851	)		2,250,377
Total liabilities and equity	$	2,823,640		$	14,401,527		$	11,631,470		$	7,440,885	$	(21,599,399	)	$	14,698,123

Condensed Consolidating Statement of Cash Flows

Year Ended December 31, 2011

	Parent						Other			Non-
	Guarantor			Issuer			Guarantors			Guarantors			Eliminations			Consolidated
	(In thousands)
Net cash (used in) provided by operating activities	$	(41,780	)	$	(111,011	)	$	840,582		$	574,117		$	—		$	1,261,908
Cash flows from investing activities:
Acquisitions of facilities and other related equipment		—			—			(370,243	)		(45,117	)		—			(415,360	)
Purchases of property and equipment		—			—			(440,754	)		(335,959	)		—			(776,713	)
Proceeds from disposition of hospitals and other ancillary operations		—			—			—			173,387			—			173,387
Proceeds from sale of property and equipment		—			—			2,283			8,877			—			11,160
Increase in other investments		—			(10,000	)		(129,852	)		(48,397	)		—			(188,249	)
Net cash used in investing activities		—			(10,000	)		(938,566	)		(247,209	)		—			(1,195,775	)
Cash flows from financing activities:
Proceeds from exercise of stock options		18,910			—			—			—			—			18,910
Repurchase of restricted stock shares for payroll tax withholding requirements		(13,311	)		—			—			—			—			(13,311	)
Deferred financing costs		—			(19,352	)		—			—			—			(19,352	)
Excess tax benefit (income tax payable increase) relating to stock-based compensation		5,290			—			—			—			—			5,290
Stock buy-back		(85,790	)		—			—			—			—			(85,790	)
Proceeds from noncontrolling investors in joint ventures		—			—			—			1,229			—			1,229
Redemption of noncontrolling investments in joint ventures		—			—			—			(13,022	)		—			(13,022	)
Distributions to noncontrolling investors in joint ventures		—			—			—			(56,094	)		—			(56,094	)
Changes in intercompany balances with affiliates, net		116,681			209,066			(95,945	)		(229,802	)		—			—
Borrowings under credit agreement		—			560,000			18,236			2,145			(2,145	)		578,236
Issuance of long-term debt		—			1,000,000			—			—			—			1,000,000
Repayments of long-term indebtedness		—			(1,628,703	)		(22,888	)		(2,087	)		2,145			(1,651,533	)
Net cash provided by (used in) financing activities		41,780			121,011			(100,597	)		(297,631	)		—			(235,437	)
Net change in cash and cash equivalents		—			—			(198,581	)		29,277			—			(169,304	)
Cash and cash equivalents at beginning of period		—			—			213,117			86,052			—			299,169
Cash and cash equivalents at end of period	$	—		$	—		$	14,536		$	115,329		$	—		$	129,865

Condensed Consolidating Statement of Cash Flows

Year Ended December 31, 2010

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations		Consolidated
	(In thousands)
Net cash (used in) provided by operating activities	$	(154,101	)	$	(87,018	)	$	782,993		$	646,856		$	—	$	1,188,730
Cash flows from investing activities:
Acquisitions of facilities and other related equipment		—			—			(204,773	)		(43,478	)		—		(248,251	)
Purchases of property and equipment		—			—			(342,735	)		(324,643	)		—		(667,378	)
Proceeds from disposition of hospitals and other ancillary operations		—			—			—			—			—		—
Proceeds from sale of property and equipment		—			—			8,140			261			—		8,401
Increase in other investments		—			—			(112,587	)		(24,495	)		—		(137,082	)
Net cash used in investing activities		—			—			(651,955	)		(392,355	)		—		(1,044,310	)
Cash flows from financing activities:
Proceeds from exercise of stock options		56,916			—			—			—			—		56,916
Repurchase of restricted stock shares for payroll tax withholding requirements		—			—			—			—			—		—
Deferred financing costs		—			(13,260	)		—			—			—		(13,260	)
Excess tax benefit (income tax payable increase) relating to stock-based compensation		10,219			—			—			—			—		10,219
Stock buy-back		(113,961	)		—			—			—			—		(113,961	)
Proceeds from noncontrolling investors in joint ventures		—			—			—			7,201			—		7,201
Redemption of noncontrolling investments in joint ventures		—			—			—			(7,318	)		—		(7,318	)
Distributions to noncontrolling investors in joint ventures		—			—			—			(68,113	)		—		(68,113	)
Changes in intercompany balances with affiliates, net		200,927			144,788			(142,864	)		(202,851	)		—		—
Borrowings under credit agreement					—			—			—			—		—
Issuance of long-term debt		—			—			—			—			—		—
Repayments of long-term indebtedness		—			(44,510	)		(13,507	)		(3,459	)		—		(61,476	)
Net cash provided by (used in) financing activities		154,101			87,018			(156,371	)		(274,540	)		—		(189,792	)
Net change in cash and cash equivalents		—			—			(25,333	)		(20,039	)		—		(45,372	)
Cash and cash equivalents at beginning of period		—			—			238,450			106,091			—		344,541
Cash and cash equivalents at end of period	$	—		$	—		$	213,117		$	86,052		$	—	$	299,169

Condensed Consolidating Statement of Cash Flows

Year Ended December 31, 2009

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
	(In thousands)
Net cash (used in) provided by operating activities	$	(62,883	)	$	(88,486	)	$	671,528		$	556,270		$	—		$	1,076,429
Cash flows from investing activities:
Acquisitions of facilities and other related equipment		—			—			(199,363	)		(64,410	)		—			(263,773	)
Purchases of property and equipment		—			—			(368,408	)		(208,480	)		—			(576,888	)
Proceeds from disposition of hospitals and other ancillary operations		—			—			—			89,514			—			89,514
Proceeds from sale of property and equipment		—			—			824			3,195			—			4,019
Increase in other investments		—			—			(115,799	)		(4,255	)		—			(120,054	)
Net cash used in investing activities		—			—			(682,746	)		(184,436	)		—			(867,182	)
Cash flows from financing activities:
Proceeds from exercise of stock options		12,759			—			—			—			—			12,759
Repurchase of restricted stock shares for payroll tax withholding requirements		—			—			—			—			—			—
Deferred financing costs		—			(82	)		—			—			—			(82	)
Excess tax benefit (income tax payable increase) relating to stock-based compensation		(3,472	)		—			—			—			—			(3,472	)
Stock buy-back		—			—			—			—			—			—
Proceeds from noncontrolling investors in joint ventures		—			—			—			29,838			—			29,838
Redemption of noncontrolling investments in joint ventures		—			—			—			(7,268	)		—			(7,268	)
Distributions to noncontrolling investors in joint ventures		—			—			—			(58,963	)		—			(58,963	)
Changes in intercompany balances with affiliates, net		53,596			135,518			100,944			(290,058	)		—			—
Borrowings under credit agreement		—			200,000			4,045			2,570			(6,615	)		200,000
Issuance of long-term debt		—			—			—			—			—			—
Repayments of long-term indebtedness		—			(246,950	)		(13,853	)		(3,985	)		6,615			(258,173	)
Net cash provided by (used in) financing activities		62,883			88,486			91,136			(327,866	)		—			(85,361	)
Net change in cash and cash equivalents		—			—			79,918			43,968			—			123,886
Cash and cash equivalents at beginning of period		—			—			158,532			62,123			—			220,655
Cash and cash equivalents at end of period	$	—		$	—		$	238,450		$	106,091		$	—		$	344,541

XML

Fair Value of Financial Instruments (Details 1) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011
Interest Rate Swaps 1 [Member]
Interest rate swaps
Notional Amount	$ 100,000
Fixed Interest Rate	3.847%
Termination Date	Jan. 04, 2012
Fair Value	30
Interest Rate Swaps 2 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	3.851%
Termination Date	Jan. 04, 2012
Fair Value	30
Interest Rate Swaps 3 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	3.856%
Termination Date	Jan. 04, 2012
Fair Value	30
Interest Rate Swaps 4 [Member]
Interest rate swaps
Notional Amount	200,000
Fixed Interest Rate	3.726%
Termination Date	Jan. 08, 2012
Fair Value	152
Interest Rate Swaps 5 [Member]
Interest rate swaps
Notional Amount	200,000
Fixed Interest Rate	3.5065%
Termination Date	Jan. 16, 2012
Fair Value	281
Interest Rate Swaps 6 [Member]
Interest rate swaps
Notional Amount	250,000
Fixed Interest Rate	5.0185%
Termination Date	May 30, 2012
Fair Value	4,509
Interest Rate Swaps 7 [Member]
Interest rate swaps
Notional Amount	150,000
Fixed Interest Rate	5.025%
Termination Date	May 30, 2012
Fair Value	2,709
Interest Rate Swaps 8 [Member]
Interest rate swaps
Notional Amount	200,000
Fixed Interest Rate	4.6845%
Termination Date	Sep. 11, 2012
Fair Value	5,574
Interest Rate Swaps 9 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	3.352%
Termination Date	Oct. 23, 2012
Fair Value	2,161
Interest Rate Swaps 10 [Member]
Interest rate swaps
Notional Amount	125,000
Fixed Interest Rate	4.3745%
Termination Date	Nov. 23, 2012
Fair Value	4,104
Interest Rate Swaps 11 [Member]
Interest rate swaps
Notional Amount	75,000
Fixed Interest Rate	4.38%
Termination Date	Nov. 23, 2012
Fair Value	2,466
Interest Rate Swaps 12 [Member]
Interest rate swaps
Notional Amount	150,000
Fixed Interest Rate	5.02%
Termination Date	Nov. 30, 2012
Fair Value	5,900
Interest Rate Swaps 13 [Member]
Interest rate swaps
Notional Amount	200,000
Fixed Interest Rate	2.242%
Termination Date	Feb. 28, 2013
Fair Value	3,550
Interest Rate Swaps 14 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	5.023%
Termination Date	May 30, 2013
Fair Value	5,952
Interest Rate Swaps 15 [Member]
Interest rate swaps
Notional Amount	300,000
Fixed Interest Rate	5.242%
Termination Date	Aug. 06, 2013
Fair Value	21,085
Interest Rate Swaps 16 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	5.038%
Termination Date	Aug. 30, 2013
Fair Value	6,967
Interest Rate Swaps 17 [Member]
Interest rate swaps
Notional Amount	50,000
Fixed Interest Rate	3.586%
Termination Date	Oct. 23, 2013
Fair Value	2,505
Interest Rate Swaps 18 [Member]
Interest rate swaps
Notional Amount	50,000
Fixed Interest Rate	3.524%
Termination Date	Oct. 23, 2013
Fair Value	2,451
Interest Rate Swaps 19 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	5.05%
Termination Date	Nov. 30, 2013
Fair Value	7,948
Interest Rate Swaps 20 [Member]
Interest rate swaps
Notional Amount	200,000
Fixed Interest Rate	2.07%
Termination Date	Dec. 19, 2013
Fair Value	5,080
Interest Rate Swaps 21 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	5.231%
Termination Date	Jul. 25, 2014
Fair Value	10,706
Interest Rate Swaps 22 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	5.231%
Termination Date	Jul. 25, 2014
Fair Value	10,707
Interest Rate Swaps 23 [Member]
Interest rate swaps
Notional Amount	200,000
Fixed Interest Rate	5.16%
Termination Date	Jul. 25, 2014
Fair Value	21,073
Interest Rate Swaps 24 [Member]
Interest rate swaps
Notional Amount	75,000
Fixed Interest Rate	5.0405%
Termination Date	Jul. 25, 2014
Fair Value	7,685
Interest Rate Swaps 25 [Member]
Interest rate swaps
Notional Amount	125,000
Fixed Interest Rate	5.0215%
Termination Date	Jul. 25, 2014
Fair Value	12,752
Interest Rate Swaps 26 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	2.621%
Termination Date	Jul. 25, 2014
Fair Value	4,436
Interest Rate Swaps 27 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	3.11%
Termination Date	Jul. 25, 2014
Fair Value	5,612
Interest Rate Swaps 28 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	3.258%
Termination Date	Jul. 25, 2014
Fair Value	5,968
Interest Rate Swaps 29 [Member]
Interest rate swaps
Notional Amount	200,000
Fixed Interest Rate	2.693%
Termination Date	Oct. 26, 2014
Fair Value	9,916
Interest Rate Swaps 30 [Member]
Interest rate swaps
Notional Amount	300,000
Fixed Interest Rate	3.447%
Termination Date	Aug. 08, 2016
Fair Value	27,728
Interest Rate Swaps 31 [Member]
Interest rate swaps
Notional Amount	200,000
Fixed Interest Rate	3.4285%
Termination Date	Aug. 19, 2016
Fair Value	18,401
Interest Rate Swaps 32 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	3.401%
Termination Date	Aug. 19, 2016
Fair Value	9,099
Interest Rate Swaps 33 [Member]
Interest rate swaps
Notional Amount	200,000
Fixed Interest Rate	3.50%
Termination Date	Aug. 30, 2016
Fair Value	19,048
Interest Rate Swaps 34 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	3.005%
Termination Date	Nov. 30, 2016
Fair Value	$ 7,613

XML

Employee Benefit Plans (Tables)

12 Months Ended

Dec. 31, 2011

Employee Benefit Plans [Abstract]

Benefit obligations and funded status for the Company's Pension and SERP Plans

A summary of the benefit obligations and funded status for the Company’s Pension and SERP Plans at December 31, 2011 and 2010 follows (in thousands):

	Pension Plan						SERP
	2011			2010			2011			2010
Change in benefit obligation:
Benefit obligation, beginning of year	$	39,682		$	42,245		$	73,840		$	61,079
Service cost		1,315			1,169			5,197			4,661
Interest cost		2,159			2,051			3,434			3,728
Curtailment		—			(7,407	)		—			—
Plan amendment		—			—			—			(24	)
Actuarial loss		8,480			2,082			5,225			4,396
Benefits paid		(524	)		(458	)		(1,546	)		—
Benefit obligation, end of year		51,112			39,682			86,150			73,840
Change in plan assets:
Fair value of assets, beginning of year		34,354			28,583			—			—
Actual return on plan assets		(536	)		3,895			—			—
Employer contributions		1,758			2,334			—			—
Benefits paid		(524	)		(458	)		—			—
Fair value of assets, end of year		35,052			34,354			—			—
Unfunded status	$	(16,060	)	$	(5,328	)	$	(86,150	)	$	(73,840	)

Summary of consolidated balance sheets

A summary of the amounts recognized in the accompanying consolidated balance sheets at December 31, 2011 and 2010 follows (in thousands):

	Pension Plan						SERP
	2011			2010			2011			2010
Noncurrent asset	$	—		$	—		$	—		$	—
Current liability		—			—			(1,191	)		(1,546	)
Noncurrent liability		(16,060	)		(5,328	)		(84,959	)		(72,294	)
Net amount recognized in the consolidated balance sheets	$	(16,060	)	$	(5,328	)	$	(86,150	)	$	(73,840	)

Summary of AOCL

A summary of the amounts recognized in AOCL at December 31, 2011 and 2010 follows (in thousands):

	Pension Plan						SERP
	2011			2010			2011		2010
Prior service (credit) cost	$	(1,076	)	$	(1,217	)	$	7,084	$	8,781
Net actuarial loss		13,260			1,474			23,779		20,087
Total amount recognized in AOCL	$	12,184		$	257		$	30,863	$	28,868

Plans' benefit obligation in excess of the fair value of plan assets

A summary of the plans’ benefit obligation in excess of the fair value of plan assets at December 31, 2011 and 2010 follows (in thousands):

	Pension Plan				SERP
	2011		2010		2011		2010
Projected benefit obligation	$	51,112	$	39,682	$	86,150	$	73,840
Accumulated benefit obligation		50,745		39,380		66,172		47,304
Fair value of plan assets		35,052		34,354		—		—

Weighted-average assumptions to determine benefit obligations

A summary of the weighted-average assumptions used by the Company to determine benefit obligations as of December 31 follows:

	Pension Plan						SERP
	2011			2010			2011			2010
Discount rate		4.33	%		5.50	%		4.00	%		4.75	%
Annual salary increases		4.50	%		4.50	%		4.00	%		4.00	%

Net periodic cost and other amounts recognized in OCI

A summary of net periodic cost and other amounts recognized in OCI for the years ended December 31, 2011, 2010 and 2009 follows (in thousands):

	Pension Plan									SERP
	2011			2010			2009			2011			2010			2009
Service cost	$	1,315		$	1,169		$	3,886		$	5,197		$	4,661		$	4,437
Interest cost		2,159			2,051			2,200			3,434			3,728			2,469
Expected return on plan assets		(2,771	)		(2,497	)		(1,683	)		—			—			—
Amortization of unrecognized prior service (credit) cost		(141	)		(38	)		689			1,696			1,697			1,704
Amortization of net loss		—			—			426			1,533			1,459			1
Curtailment credit		—			(1,910	)		—			—			—			—
Net periodic cost		562			(1,225	)		5,518			11,860			11,545			8,611
Prior service (credit) cost arising during period		—			(2,770	)		—			—			(24	)		—
Net (gain) loss arising during period		11,787			(2,044	)		(4,595	)		5,225			4,396			13,028
Amortization of:
Prior service cost (credit)		141			38			(689	)		(1,696	)		(1,697	)		(1,704	)
Net actuarial gain		—			—			(426	)		(1,533	)		(1,459	)		(1	)
Total amount recognized in OCI		11,928			(4,776	)		(5,710	)		1,996			1,216			11,323
Total recognized in net periodic cost and OCI	$	12,490		$	(6,001	)	$	(192	)	$	13,856		$	12,761		$	19,934

Expected amortization amounts, included in net periodic cost

A summary of the expected amortization amounts to be included in net periodic cost for 2012 are as follows (in thousands):

	Pension Plan			SERP
Prior service (credit) cost	$	(141	)	$	1,696
Actuarial loss		978			2,028

Weighted-average assumptions to determine net periodic cost

A summary of the weighted-average assumptions used by the Company to determine net periodic cost for the years ended December 31, 2011, 2010 and 2009 follows:

	Pension Plan									SERP
	2011			2010			2009			2011			2010			2009
Discount rate		5.50	%		5.99	%		5.96	%		4.75	%		6.00	%		6.00	%
Rate of compensation increase		4.50	%		4.50	%		4.00	%		4.00	%		5.00	%		5.00	%
Expected long term rate of return on assets		8.00	%		8.50	%		8.50	%		N/A			N/A			N/A

Weighted-average asset allocations by asset category

The Company’s weighted-average asset allocations by asset category at December 31, 2011 and 2010 follows:

	Pension Plan						SERP
	2011			2010			2011	2010
Equity securities		100	%		100	%	N/A	N/A
Debt securities		0	%		0	%	N/A	N/A
Total		100	%		100	%	N/A	N/A

Estimated future benefit payments reflecting future service

The estimated future benefit payments reflecting future service as of December 31, 2011 for the Pension Plan and SERP plan follows (in thousands):

Year Ending	Pension Plan		SERP
2012	$	1,236	$	1,191
2013		1,511		1,392
2014		1,701		10,782
2015		1,820		3,365
2016		2,237		44,737
2017-2021		15,115		40,072

XML

Stockholders Equity

12 Months Ended

Dec. 31, 2011

Stockholders' Equity [Abstract]

Stockholders' Equity

11. Stockholders’ Equity

Authorized capital shares of the Company include 400,000,000 shares of capital stock consisting of 300,000,000 shares of common stock and 100,000,000 shares of preferred stock. Each of the aforementioned classes of capital stock has a par value of $0.01 per share. Shares of preferred stock, none of which were outstanding as of December 31, 2011, may be issued in one or more series having such rights, preferences and other provisions as determined by the Board of Directors without approval by the holders of common stock.

On December 14, 2011, the Company adopted a new open market repurchase program for up to 4,000,000 shares of the Company’s common stock, not to exceed $100 million in repurchases. The new repurchase program will conclude at the earliest of three years, when the maximum number of shares has been repurchased, or when the maximum dollar amount has been reached. Through December 31, 2011, no shares have been purchased and retired under this program.

On September 15, 2010, the Company commenced an open market repurchase program for up to 4,000,000 shares of the Company’s common stock, not to exceed $100 million in repurchases. This program will conclude at the earliest of three years from the commencement date, when the maximum number of shares has been repurchased or when the maximum dollar amount has been expended. During the year ended December 31, 2010, the Company repurchased and retired 451,272 shares at a weighted-average price of $30.81 per share. During the year ended December 31, 2011, the Company repurchased and retired 3,469,866 shares at a weighted-average price of $24.68 per share. The cumulative number of shares that have been repurchased and retired under this program through December 31, 2011 is 3,921,138 shares at a weighted-average price of $25.39 per share.

On December 9, 2009, the Company commenced the predecessor open market repurchase program for up to 3,000,000 shares of the Company’s common stock, not to exceed $100 million in repurchases. This program concluded in September 2010 when purchases approximately totaled the permitted maximum dollar amount. During the year ended December 31, 2010, the Company repurchased and retired 2,964,528 shares at a weighted-average price of $33.69 per share, which is the cumulative number of shares that were repurchased under this program.

The Credit Facility limits the Company’s ability to pay dividends and/or repurchase stock to an amount not to exceed $50 million in the aggregate after November 5, 2010, the date of the initial amendment and restatement of the Credit Facility. In addition, the Credit Facility allows the Company to repurchase stock in an amount not to exceed the aggregate amount of proceeds from the exercise of stock options. The indentures governing the 8 ⁷/8% Senior Notes and the 8% Senior Notes (collectively, the “Senior Notes”) also limit the Company’s ability to pay dividends and/or repurchase stock. As of December 31, 2011, under the most restrictive test under these agreements, the Company has approximately $30.1 million remaining available with which to pay permitted dividends and/or make stock and Senior Notes repurchases.

The following schedule discloses the effects of changes in the Company’s ownership interest in its less-than-wholly-owned subsidiaries on Community Health Systems, Inc. stockholders’ equity (in thousands):

	Year Ended December 31,
	2011			2010			2009
Net income attributable to Community Health Systems, Inc.	$	201,948		$	279,983		$	243,150
Transfers (to) from the noncontrolling interests:
Net (decrease) increase in Community Health Systems, Inc. paid-in capital for purchase of subsidiary partnership interests		(4,556	)		(3,529	)		3,106
Net transfers (to) from the noncontrolling interests		(4,556	)		(3,529	)		3,106
Change to Community Health Systems, Inc. stockholders’ equity from net income attributable to Community Health Systems, Inc. and transfers (to) from noncontrolling interests	$	197,392		$	276,454		$	246,256

XML

Commitments and Contingencies (Details Textual) (USD $) In Millions, unless otherwise specified	5 Months Ended	12 Months Ended				17 Months Ended	24 Months Ended	36 Months Ended
	May 31, 2002	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2007	May 31, 2003	May 31, 2005	Dec. 31, 2007	Jan. 22, 2008	Oct. 04, 2007 Hospital
Commitments and Contingencies (Textual) [Abstract]
Amount expended through December 31, 2011		$ 247.8
Commitments and Contingencies (Additional Textual) [Abstract]
Number of New Mexico hospitals violated the norms under Federal False Claims Act										3
Civil Division notified that hospitals received ineligible federal participation payments									27.5
Minimum time period of long term purchase commitment		5 years
Maximum time period of long term purchase commitment		7 years
Commitment amount spend for capital improvements equipment selected leases and physician recruiting		652.5
Income guarantee period		12 months
Period to fulfill physician recruiting commitments		3 years
Potential future payment in excess of liability		27.4
Actuarially determined projections period		20 years
Weighted-average risk-free rate		1.20%	1.30%	1.40%
Estimated self insured professional and general liability claims		567.8	489.2
Estimated undiscounted claims		595.7	513.2
Current portion of self insured professional and general liability claims		98.1	82.9
Self-insured retention level for professional liability claims	0.5					2.0	4.0	5.0
Maximum self insured retention per claim		10			10
Sum of excess coverage insurance layers per occurrence and in aggregate reported on or after June 1, 2003		95
Sum of excess coverage insurance layers per occurrence and in aggregate reported on after January 1, 2008		145
Period to intervene and to act as plaintiff by government		60 days
Requested shorter period of time		90 days
Maximum [Member]
Commitments and Contingencies (Textual) [Abstract]
Average Lag Period between Claim Occurrence and Payment of Final Settlement		5 years
Claims settled as percentage of liability		1.00%
Amount of Triad claims insured through its wholly owned subsidiary after a specific date		5
Minimum [Member]
Commitments and Contingencies (Textual) [Abstract]
Average Lag Period between Claim Occurrence and Payment of Final Settlement		4 years
Amount of Triad claims insured through its wholly owned subsidiary after a specific date		1
Reuille [Member]
Commitments and Contingencies (Textual) [Abstract]
Period of stay in litigation		180 days
Additional Period of stay in litigation		180 days
California [Member]
Commitments and Contingencies (Textual) [Abstract]
Estimated construction cost		73.5
Amount expended through December 31, 2011		49.3
Valparaiso [Member]
Commitments and Contingencies (Textual) [Abstract]
Estimated construction cost		208.7
Amount expended through December 31, 2011		137.0
Siloam Springs [Member]
Commitments and Contingencies (Textual) [Abstract]
Estimated construction cost		35.0
Amount expended through December 31, 2011		24.0
Birmingham [Member]
Commitments and Contingencies (Textual) [Abstract]
Estimated construction cost		280.0
Amount expended through December 31, 2011		$ 3.5